Periodontal disease and oral health-related quality of life :smoking cessation adventures in primary dental care by Emslie, Karen
University of Dundee
DOCTOR OF PHILOSOPHY
Periodontal disease and oral health-related quality of life
smoking cessation adventures in primary dental care
Emslie, Karen
Award date:
2014
Awarding institution:
University of Dundee
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 17. Feb. 2017
DOCTOR OF PHILOSOPHY
Periodontal disease and oral health-
related quality of life: smoking cessation
adventures in primary dental care
Karen Emslie
2014
University of Dundee
Conditions for Use and Duplication
Copyright of this work belongs to the author unless otherwise identified in the body of the thesis. It is permitted
to use and duplicate this work only for personal and non-commercial research, study or criticism/review. You
must obtain prior written consent from the author for any other use. Any quotation from this thesis must be
acknowledged using the normal academic conventions. It is not permitted to supply the whole or part of this
thesis to any other person or to post the same on any website or other online location without the prior written
consent of the author. Contact the Discovery team (discovery@dundee.ac.uk) with any queries about the use
or acknowledgement of this work.
  
 
 
 
Periodontal disease  
and oral health-related quality of life:  
Smoking cessation adventures in primary dental care 
 
 
 
 
 
 
 
Thesis submitted in accordance with the requirements of 
the University Of Dundee for the degree of: 
DOCTOR IN PHILOSOPHY 
 
 
 
 
To the Faculty of Medicine, Dentistry and Nursing by 
Karen Emslie BDS (Hons), MCommH 
January 2014
 i 
Table of Contents 
 List of Tables vi 
 List of Figures ix 
 List of Appendices x 
 Acknowledgements xii 
 Declaration xiii 
 Abstract xiv 
Chapter 1 Introduction 1 
Chapter 2 The Periodontal Health and Smoking Cessation (PHaSCe) 
trial 
10 
2.0 Introduction 11 
2.1 Narrative literature review 12 
2.1.0 Introduction 12 
2.1.1 Definition and classification of periodontal diseases 12 
2.1.2 Chronic periodontitis 15 
2.1.2.1 Pathogenesis of chronic periodontitis 16 
2.1.2.2 Prevalence, global burden and impact of chronic             
periodontitis 
19 
2.1.2.3 Risk factors for chronic periodontitis 32 
2.1.3 Detailed review of smoking 50 
2.1.3.1 Smoking prevalence 50 
2.1.3.2 Oral health impacts of smoking other than periodontitis 52 
2.1.3.3 Systemic health effects of smoking 55 
2.1.3.4 Chronic periodontitis, smoking and dental implants 56 
2.1.4 Addiction 59 
2.1.5 Smoking cessation interventions 61 
2.1.5.1 Behavioural support 63 
 ii 
2.1.5.2 Pharmacological support 65 
2.1.6 Smoking cessation in the dental setting 68 
2.1.7 Conclusions 70 
2.2 Purpose of study 72 
2.2.0 Introduction 72 
2.2.1 Research question 72 
2.2.2 Aims and objectives 73 
2.3 Method 74 
2.3.0 Introduction 74 
2.3.1 Study population 74 
2.3.2 Exclusion criteria 74 
2.3.3 Recruitment strategy 76 
2.3.4 Sample and sampling methods 76 
2.3.5 Control and experimental interventions 79 
2.3.5.1 The dental health and smoking habits questionnaire 79 
2.3.5.2 The clinical examination 83 
2.3.5.3 The data collection process 88 
2.3.6 Ethical considerations 92 
2.3.7 Data analysis 92 
2.3.8 Statistical analysis 93 
2.3.9 Quality assurance 94 
2.4  Results 96 
2.4.0 Introduction 96 
2.4.1 Sample 96 
2.4.2 Demographic characteristics 99 
2.4.3 Medical status 99 
2.4.4 Smoking-related knowledge, attitudes and behaviours 99 
 iii 
2.4.5 Oral health-related behaviours 104 
2.4.6 Clinical examination 104 
2.5 Discussion and reflections on PHaSCe trial 106 
2.6 Conclusions and recommendations 108 
Chapter 3 Modelling a smoking cessation intervention for primary 
dental care in remote-rural Scotland 
111 
3.0 Introduction 112 
3.1 Aims and objectives 113 
3.1.1 Objective 1 113 
3.1.2 Objective 2 113 
3.1.3 Objective 3 113 
3.1.4 Objective 4 113 
3.2 Systematic literature review 114 
3.2.0 Introduction 114 
3.2.1 Research question 116 
3.2.2 Study selection criteria 117 
3.2.3 Study design 117 
3.2.4 Study participants 118 
3.2.5 Study interventions 118 
3.2.6 Outcome measures 119 
3.2.7 Search strategy 120 
3.2.7.1 Search terms 120 
3.2.7.2 Data sources 121 
3.2.8 Search results 121 
3.2.9 Study selection 123 
3.2.10 Data extraction 124 
3.2.11 Data synthesis 124 
 iv 
3.2.12 Characteristics of included papers 125 
3.2.13 Results 125 
3.2.14 Study quality assessment 134 
3.2.15 Limitations of included studies 146 
3.2.16 The meta-analysis 147 
3.2.17 Discussion 149 
3.2.18 Conclusions 155 
3.3 Modelling a smoking cessation intervention 157 
3.3.0 Introduction 157 
3.3.1 Method for the smoking and periodontal health study 158 
3.3.2 Results 165 
3.3.2.1 Sample 165 
3.3.2.2 Demographic data 165 
3.3.2.3 Reported medical status 168 
3.3.2.4 Reported smoking status 170 
3.3.2.5 Knowledge of impacts of smoking on health 171 
3.3.2.6 Smoking-related attitudes 175 
3.3.2.7 Smoking-related behaviours 182 
3.3.2.8 Smoking cessation activities in a dental setting 185 
3.3.2.9 Oral health: quality of life and behaviours 188 
3.3.2.10 Periodontal status 198 
3.3.2.11 Summary of findings of prevalence study 211 
3.4 Structural Equation Modelling 215 
3.5 Discussion 220 
3.5.1 Demography 220 
3.5.2 Smoking status 222 
3.5.3 Oral health-related quality of life 229 
 v 
3.5.4 Oral health behaviours 231 
3.5.5 Periodontal status 232 
3.5.6 Modelling a smoking cessation intervention 235 
3.5.7 Limitations 236 
3.6 Conclusions 236 
Chapter 4 Overall discussion and conclusions 237 
4.0 Introduction 238 
4.1 Recruitment 238 
4.2 Quit rates and power calculations 239 
4.3 Recommendations 239 
4.4 Conclusions 240 
Chapter 5 Recommendations 242 
 References 243 
 Appendices 284 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi 
List of tables 
 
Table 2.1  Scoring codes for Basic Periodontal Examination (BPE) 32 
Table 2.2  Health benefits of quitting smoking 56 
Table 2.3  Smoking attitudes 80 
Table 2.4  The Fagerstrom Nicotine Dependence test 82 
Table 2.5  Knowledge of smoking-related health conditions 100 
Table 2.6  Smoking-related attitudes 101 
Table 2.7   Cotinine and carbon monoxide measurements at initial visit 
and 6 month follow-up 
103 
Table 2.8  OHIP-14 scores and number of impacts experienced 103 
Table 3.1   Key words related to tobacco cessation and oral disease 120 
Table 3.2   Search terms 120 
Table 3.3  Detailed quality analysis of randomised controlled trials 135 
Table 3.4  Demographic profile by age, location and gender 166 
Table 3.5  Occupational group by frequency 167 
Table 3.6  Occupational group by age group, location and gender 167 
Table 3.7  Reported medical condition by age group, gender, 
occupational group and location 
169 
Table 3.8  Frequency of reported smoking status 170 
Table 3.9  Reported smoking status by demographic profile 171 
Table 3.10  Knowledge of smoking-related health conditions 172 
Table 3.11  Smoking-related health knowledge by age group, gender, 
occupational group and location 
174 
Table 3.12  Smoking-related health knowledge by reported smoking status 175 
Table 3.13  Smoking-related attitudes 176 
Table 3.14  Smoking attitudes scales and items 178 
Table 3.15  Confidence to quit by pack years and nicotine dependence 179 
 vii 
Table 3.16  Willingness to quit scale and confidence to quit scale by quit 
attempts 
179 
Table 3.17  Willingness to quit scale and confidence to quit scale by 
readiness to quit 
180 
Table 3.18  Willingness to quit scale and confidence to quit scale by 
complexity of periodontal treatment need 
181 
Table 3.19  Willingness to quit scale and confidence to quit scale by 
agreement with dental involvement in smoking cessation 
activities 
182 
Table 3.20  Mean frequency attitudes to dental involvement in smoking 
cessation activities 
186 
Table 3.21  Attitudes to dental involvement in smoking cessation activities 
by occupational group 
187 
Table 3.22  Attitudes to dental involvement in smoking cessation activities 
by smoking status 
187 
Table 3.23  Past experience of dental involvement in smoking cessation 
activities 
188 
Table 3.24  Oral health impact profile 189 
Table 3.25  Oral health-related quality of life by smoking status 194 
Table 3.26  Mean BPE per sextant 198 
Table 3.27  Frequency of complexity of periodontal need category 199 
Table 3.28  Complexity of periodontal treatment need category by 
demographic profile and smoking status 
201 
Table 3.29  Complexity of periodontal treatment need category by sextant 
by smoking status 
202 
Table 3.30  Complexity of periodontal treatment need category by reported 
medical condition 
204 
 viii 
Table 3.31  Complexity of periodontal treatment need category by mean 
Oral Health Impact Profile scores 
207 
Table 3.32  Complexity of periodontal treatment need category by pack 
years 
208 
Table 3.33  Complexity of periodontal treatment need category by nicotine 
dependence 
208 
Table 3.34  Complexity of periodontal treatment need category by 
attitudes to smoking cessation activities in a dental setting 
209 
Table 2.35  Correlation matrix of variables included in the SEM analysis 218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
List of figures 
 
Figure 1.1  Location of Lochgilphead, Dunoon and Argyll & Bute CHP 4 
Figure 2.1  Model for the pathogenesis of human periodontitis 16 
Figure 2.2   Locker’s conceptual model for measuring oral health 22 
Figure 2.3  Factors associated with smoking 51 
Figure 2.4  Summary of research process for randomised controlled trial 78 
Figure 2.5  Study sample analysis using CONSORT 2010 Flow Diagram 98 
Figure 2.6  Key elements of the MRC Framework for Complex 
Interventions 
110 
Figure 3.1  Review process 122 
Figure 3.2  Forest plot of trials included in the systematic review 148 
Figure 3.3  Agreement with smoking cessation activities in a dental setting 186 
Figure 3.4  Percentage of participants reporting each oral health-related 
impact 
190 
Figure 3.5  Percentage of participants reporting each oral health-related 
impact by frequency excluding ‘never’ 
190 
Figure 3.6  Percentage of participants reporting oral health-related impact 
by smoking status 
193 
Figure 3.7  Frequency of use of interdental cleaning aids 197 
Figure 3.8  Periodontal status by sextant by smoking status 203 
Figure 3.9  Percentage of participants reporting each oral health-related 
impact by complexity of periodontal need 
206 
Figure 3.10  Structural equation model of smoking status, periodontal 
health and oral health-related quality of life 
219 
 
 
 
 
 
 
 x 
List of appendices 
 
Appendix 1   Behaviour change theories 284 
Appendix 2  The dental health and smoking habits questionnaire 287 
Appendix 3  Pilot study of characteristics of semi-quantitative salivary 
cotinine tests 
295 
Appendix 4  Clinical Examination form 298 
Appendix 5  Participant information sheet 305 
Appendix 6   Consent form 310 
Appendix 7   Protocol for the supply of nicotine replacement therapy 
products 
311 
Appendix 8  Scottish Government Minimum Dataset 318 
Appendix 9  Ethical approval 320 
Appendix 10  NHS Highland Research and Development Committee 
Decision 
322 
Appendix 11  Exclusion criteria checklist 323 
Appendix 12  Initial analysis of papers for inclusion – all databases 324 
Appendix 13  Data extraction checklist 328 
Appendix 14  STROBE checklist 329 
Appendix 15  CONSORT checklist  331 
Appendix 16  Summary of STROBE checklist data 333 
Appendix 17  Summary of CONSORT checklist data 336 
Appendix 18  Table A1:   Reported smoking status by reported medical     
condition 
338 
Appendix 19  Table A2:   Number of other smokers in house by age 
group, gender, occupational group, location and smoking 
status 
338 
 
 
 xi 
Appendix 20  Table A3: Quit attempts by age group 339 
  Table A4: Quit attempts by gender 339 
  Table A5: Quit attempts by occupational group 339 
  Table A6: Quit attempts by location 339 
Appendix 21  Table A7: Intention to quit by age group 340 
Appendix 22  Table A8: Attitudes to smoking cessation in a dental setting 
by age group, gender, occupational group, location and 
smoking status. 
341 
Appendix 23  Table A9: Oral health-related quality of life by location 343 
Appendix 24  Table A10: Complexity of periodontal treatment need by 
past experience of smoking cessation activity in a dental 
setting  
343 
Appendix 25  Table A11: Complexity of periodontal treatment need by 
reason for last dental attendance 
344 
Appendix 26  Table 12: Complexity of periodontal treatment need by use 
of interdental aids 
344 
    
 
 
 
 
 
 
 
 
 
 
 
 
 xii 
Acknowledgements 
 
It would not have been possible to complete this thesis without the support of many 
people, principally my supervisors, Professor Ruth Freeman and Dr. Andrew Hall. 
They freely shared their professional experience and expertise throughout the 
project, as well as providing encouragement when my enthusiasm faltered. 
 
The funding I received from NHS Education Scotland in the form of a Rural Training 
Fellowship was invaluable and greatly appreciated. My path to completion of this 
thesis was eased by Isobel Madden, Remote & Rural Fellowship Training Adviser, 
who shared her specialist knowledge in my area of research.  
 
Argyll & Bute CHP Dental Directorate allowed me the time and resources to 
undertake this project and much thanks is due to everyone who supported me. 
Special thanks go to Pat Daniels, Dental Hygienist/Therapist for applying herself to 
this project with dedication and enthusiasm. The assistance of the dental teams in 
Dunoon and Lochgilphead is much appreciated. Without the encouragement of John 
Herrick, Clinical Director, I would never have embarked on this project, and he has 
my gratitude for starting me on this adventure. 
 
Jill Denton, Smoking Cessation Coordinator for Argyll & Bute CHP, gave invaluable 
advice and support throughout the project for which I am very grateful. Many thanks 
are due to Gerry Humphris for the statistical support he provided.  
 
The generosity of all the dental patients in Dunoon and Lochgilphead who agreed to 
participate in this project is greatly appreciated. 
 
And finally, to all my family and friends, thanks for sticking by me during this project. 
 xiii 
Declaration 
 
 
I declare that I am the author of this thesis and have consulted all references 
cited. I have carried out the work of which this thesis is a record. This work has 
not been previously accepted for a higher degree. 
 
 
 
28th May 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv 
Abstract 
 
Much of the workload of primary dental care teams in remote-rural Scotland 
consists of treating periodontal disease, an inflammatory condition for which 
smoking is a proven risk factor.  
 
This thesis sought to ascertain the effectiveness of a smoking cessation 
intervention applied in a primary care dental setting and employed a narrative 
literature review to explore periodontal disease, smoking and smoking cessation 
interventions. This literature review informed the design of a randomised 
controlled trial which failed due to lack of recruitment.  
 
The Medical Research Council Framework for the Development and Evaluation 
of Complex Interventions was employed to provide structure to the modelling of a 
feasibility trial likely to succeed in evaluating the benefit of smoking cessation 
provision in rural dental settings.  
 
A systematic literature review was undertaken to evaluate evidence regarding 
prevalence of periodontal disease, tobacco use and the effectiveness of tobacco 
cessation interventions applied in remote-rural areas. This identified a dearth of 
robust evidence particularly in relation to smoked tobacco. In order to model a 
feasibility study better adapted to the current study population, a prevalence 
study exploring the smoking attitudes and behaviours, the oral health-related 
quality of life and periodontal status of 398 dental patients was undertaken at the 
two study locations. 
 
 xv 
Twenty three percent of the participants were found to be smokers and 
periodontal health was significantly poorer in those who smoked. Both smokers 
and non-smokers strongly agreed that dentists should be involved in provision of 
smoking cessation activities. 
 
The willingness of smokers to quit was not related to the degree of periodontal 
disease they experienced, suggesting that periodontal health is not valued 
sufficiently to factor into a decision to stop smoking. However periodontal health 
and smoking status both impacted greatly on oral health-related quality of life. 
 
It is recommended that a feasibility trial be undertaken in remote-rural primary 
dental care of a smoking cessation intervention which forms an integral part of 
periodontal care and focuses on improving quality of life parameters rather than 
periodontal measures. 
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Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
The work for this thesis was conducted within the Argyll & Bute Community 
Health Partnership (CHP), which has a population of 91,000, and is in an area 
categorised as remote-rural according to the Scottish Government’s 6-Fold 
Urban Rural Classification definition of being more than 30 minutes drive time 
from the nearest settlement with a population of 10,000 or over (Scottish 
Government 2009 -2010). Its economy is service-based with a high proportion of 
its population employed in health, education, agriculture, fishing and tourism. 
 
This thesis was undertaken in the dental departments of the Mid Argyll 
Community Hospital and Integrated Care Centre in Lochgilphead, and Cowal 
Community Hospital in Dunoon.  Lochgilphead and Dunoon are small towns with 
populations of 2,300 and 8,200 respectively. Figure 1.1 on page 4 shows the 
location of Argyll & Bute CHP within Scotland, as well as the locations of 
Lochgilphead and Dunoon within the CHP. The primary dental care practices in 
each site comprise three dental surgeries and operate under the auspices of the 
Salaried Primary Care Dental Services of Argyll & Bute CHP.  The presence of 
Salaried rather than Independent general dental practices reflects the difficulty of 
recruiting healthcare professionals, including dental professionals, to remote and 
rural areas (Skillman et al. 2010; Richards et al. 2005).  
 
The majority of the dental care required by the population of patients attending 
these dental practices related to chronic periodontitis, which seemed to be 
particularly prevalent amongst smokers. Therefore, when an opportunity arose to 
undertake a research project under the auspices of the University of Dundee, 
with funding provided by a Remote and Rural Fellowship from NHS Education 
Scotland, the potential role of the dental team in improving periodontal health as 
 3 
a result of encouraging smoking cessation seemed the obvious subject to 
explore. 
 
Providing healthcare in remote and rural areas presents specific problems of 
accessibility. Geographical remoteness increases travelling times to reach 
healthcare services, and public transport may not be available. Higher levels of 
poverty are often found in rural areas which may also make travelling more 
difficult and support systems less well-developed (Cramp 2006). It may be 
necessary to tailor healthcare interventions to suit the challenges of meeting the 
healthcare needs of a rural population (Skillman et al. 2010). 
 
Chronic periodontitis is a multifactorial disease which arises as a result of the 
host inflammatory response to the presence of a biofilm containing plaque 
bacteria. The inflammatory reaction can result in progressive, sporadic 
destruction of the periodontal ligament and bony support of the teeth (Socransky 
et al. 1998; Page and Kornman 1997). Increasing mobility and loss of the tooth 
can occur if the plaque biofilm is not disturbed by toothbrushing and other oral 
hygiene measures (Schaltze et al. 2004).  
 
Chronic periodontitis in its mild form is almost endemic across the world (Baelum 
and Lopez 2013; Kinane et al. 2005). Moderate periodontal disease was found in 
45% of adults in the UK in 2009 (ADHS 2009) and a global prevalence of severe 
chronic periodontitis of between 5% and15% has been found (Slots 2013).  
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Figure 1.1: Location of Lochgilphead, Dunoon and Argyll & Bute CHP 
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The global burden of disease represented by chronic periodontitis is verified by 
its position as the sixth most prevalent disease (Marcenes et al. 2013). However, 
periodontal disease also presents the  individual with a disease burden, since it 
has been shown to impact negatively upon an individual’s oral health-related 
quality of life (Nagarajan and Chandra 2012; White et al. 2011; Berbnabe and 
Marcenes 2010; Jowett et al. 2009; Sanders et al. 2009; Slade et al. 2005). 
 
With regard to aetiology, smoking has been identified as one of the most 
significant causative factors in chronic periodontitis (Javed et al. 2012; Patel et al. 
2012; Hanioka et al. 2011).  The prevalence of smoking in the UK has decreased 
from a high of over 60% of men and over 40% of women smoking in the 1960s, 
to around 28% of men and 26% of women in the year 2000 (WHO 2011). The  
prevalence of tobacco smoking in Argyll & Bute CHP is 22%, slightly below the 
Scottish average of 23% in 2011 (Scottish Household Survey 2011). However, 
the rates of smoking tobacco in Scotland have stopped declining, suggesting that 
those individuals who still smoke are more deeply entrenched in their smoking 
habit and find it difficult to stop (ASH Scotland 2013). Research suggests that the 
majority of these ‘hard-core’ smokers would like to quit, however, of the 33% who 
attempt to quit each year, only 2% succeed (Beaglehole and Watt 2004; NICE 
2006; Health Scotland and ASH Scotland 2010) due largely to the highly 
addictive nature of nicotine.  
 
These disappointing results with regard to quit rates are at odds with the smoking 
cessation services which have been available throughout Scotland since 2004 
when “A Breath of Fresh Air for Scotland” (Scottish Executive 2004) was first 
launched.  Smoking cessation services across Scotland provide interventions 
 6 
combining pharmacological and behavioural support, which have improved quit 
rates at six months to 13–19% as opposed to 2-8% for pharmacological support 
alone and 7% for behavioural support alone (Stead and Lancaster 2012; NHS 
Health Scotland and ASH Scotland 2010; NICE 2007; Silagy et al. 2004; West et 
al. 2000). 
 
The Smoking Cessation Guidelines for Scotland (2004) and the NICE Guidelines 
(2006) state that all healthcare professionals, including dental professionals, 
must determine their patient’s smoking status, advise them to quit and assess 
their readiness to quit.  If patients are interested in quitting they should either be 
assisted to quit or be referred to specialist smoking cessation services (NICE 
2006; NHS Health Scotland 2004). Despite this guidance, smoking cessation 
activity in a dental setting appears limited (Gonseth et al. 2010; Binnie 2009; 
Brothwell and Armstrong 2004).  Given the acknowledged access issues in 
provision of healthcare interventions in remote and rural areas, the integration of 
smoking cessation interventions into routine dental care could represent an even 
more effective proposition in remote and rural areas than in urban areas. 
 
The above observations gave rise to the original aim of the thesis, which was to 
determine whether an additional benefit in terms of quit status and periodontal 
health could be achieved by an intensive smoking cessation intervention 
compared with a brief smoking cessation intervention in primary dental care for 
patients residing in a remote and rural area in Scotland.  The study designed was 
a randomised controlled trial, parallel-group study: Periodontal Health and 
Smoking Cessation (PHaSCe) trial.  
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Despite 16 months recruitment to the PHaSCe trial recruitment rates were 
extremely disappointing, with only 14 patients agreeing to participate of whom 3 
fulfilled the inclusion criteria.  It seemed impossible to continue with PHaSCe, 
and it was necessary to consider the reasons for failure and make 
recommendations for the way forward.  Important lessons were learnt which 
included a lack of systematic review of the available evidence as well as the 
need to model the characteristics of a smoking cessation intervention for primary 
dental care in remote-rural areas.  This permitted the careful examination of the 
MRC Framework for Complex Interventions (2010) (Figure 2.5). The MRC 
Framework for Complex Interventions showed clearly the mistakes that had 
occurred with regard to the development of the intervention and consequently the 
PHaSCe trial.  With this in mind, it was decided to populate the first aspect of the 
MRC Framework for Complex Interventions and undertake systematic review 
and meta-analysis of the evidence underpinning the effectiveness of tobacco 
cessation interventions provided by dental health professionals in remote and 
rural primary dental care followed by the collection of patient data regarding 
smoking status and periodontal health from those attending two general dental 
practices in remote and rural areas.  The information gathered via the systematic 
literature review and the cross-sectional survey would be used to model a 
feasibility trial to inform a randomised controlled trial for smoking cessation 
provided by dental health professionals in remote and rural primary dental care.  
 
This thesis is therefore in several parts and constitutes the journey taken by KE 
in her adventures in smoking cessation in primary dental care.   
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The first part consists of a narrative literature review (Chapter 2) which 
examines chronic periodontitis and its prevalence, pathogenesis, risk factors 
and impact on quality of life.  It explores the prevalence and health impacts of 
smoking, and the role of dental professionals in supporting smokers to quit.  
The PHaSCe trial which aimed to examine the effectiveness of an intensive 
smoking cessation intervention applied in the dental surgery compared with 
an intensive smoking cessation intervention applied in NHS specialist stop 
smoking services in a remote and rural area to promote periodontal health, 
together with the findings and recommendations are presented.  
 
The second part is based on the MRC Framework for Complex Interventions 
to allow the modelling of a feasibility trial to inform a randomised controlled 
trial for smoking cessation provided by dental health professionals in remote 
and rural primary dental care.  
 
In Chapter 3 the systematic review queried: “How effective are tobacco 
cessation interventions applied by dental health professionals in remote and 
rural primary dental care?” This systematic review involved a rigorous and 
methodical search of the peer-reviewed and unpublished literature exploring 
any tobacco-related intervention with a dental or oral health related 
component undertaken in a rural area.  
 
The survey of primary dental care patients is also presented in Chapter 3.  
This survey examined the prevalence of smoking and periodontal disease.  It 
also assessed the participants’ smoking-related knowledge, attitudes and 
behaviours as well as their oral health-related quality of life.  Using structural 
 9 
equation modelling a model for a complex smoking cessation intervention in 
remote-rural primary dental care was formulated.  This formulation suggested 
that smoking status and periodontal status had direct and significant 
relationships with oral health-related quality of life.  Therefore it was proposed 
that an intervention focusing on oral health-related quality of life with 
elements relating to smoking cessation (behavioural and pharmacological) 
together with maintenance programmes for periodontal health could provide 
the basis for a feasibility study for a smoking cessation trial in remote-rural 
primary dental care in Scotland.  
 
Chapter 4 presents the overall discussion and Chapter 5 presents the 
recommendations for a feasibility study for a smoking cessation trial in 
remote-rural primary dental care in Scotland.  
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Chapter 2:  
The Periodontal Health and Smoking Cessation 
(PHaSCe) trial for primary dental care in remote-rural 
Scotland 
 
2.1 Narrative literature review 
2.2 Purpose of study 
2.3 Method 
2.4 Results 
2.5 Discussion and reflections 
2.6 Recommendations 
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2.0 Introduction 
 
Periodontal disease is an inflammatory condition affecting the supporting tissues 
surrounding the teeth and presents in various forms, the most prevalent of which 
is chronic periodontitis. Despite its prevalence, most individuals are unaware of 
the presence of chronic periodontitis until it is well advanced, although in 
susceptible individuals it can rapidly progress to cause functional problems such 
as mobility of the teeth and tooth loss.  
 
The aetiology of chronic periodontitis is complex with a variety of innate factors 
such as age, gender and genetic susceptibility. External factors such as socio-
economic status, stress and alcohol consumption all playing their part. Smoking 
is one of the most important risk factors implicated in the development of chronic 
periodontitis and thus this study goes on to investigate chronic periodontitis in 
depth and its relationship to smoking in particular.  
 
The study was undertaken in a remote and rural area, and aimed to determine 
the effectiveness of smoking cessation interventions provided in the dental 
setting in promoting periodontal health in the population attending primary dental 
care services in this area. 
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2.1 Chronic periodontitis and smoking: a narrative literature review 
 
2.1.0 Introduction 
This narrative literature review considers the condition known as “periodontal 
disease” with respect to its prevalence, pathogenesis, treatment and its links with 
systemic disease. The risk factors for periodontal disease are explored, as is the 
impact periodontal disease has on the quality of life of an individual. It particularly 
focuses on chronic periodontitis (see Section 2.1.2). 
 
The narrative review goes on to examine the health impacts and prevalence of 
tobacco use. The introduction of tobacco control legislation, the development of 
specialist smoking cessation services and the behaviour change and addiction 
theories underpinning them are discussed.  
 
The impact of tobacco smoking on periodontal health is explored, and a review of 
literature describing smoking-related research undertaken in a dental setting is 
presented.  
 
2.1.1 The definition and classification of periodontal diseases 
Periodontal disease is a term used to cover several inflammatory conditions 
associated with specific anatomical structures surrounding the teeth. These 
structures comprise the free and attached gingival tissues, the periodontal 
ligament and gingival connective tissue fibres and the alveolar bone (Schroeder 
1997). Disease activity and progression occurs in the presence of a biofilm of 
microorganisms which can be found both above and below the gingival margin. 
This biofilm may calcify to form dental calculus (Jepsen et al. 2011). 
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An International Workshop for a Classification of Periodontal Diseases and 
Conditions which took place in 1999 developed the classification of periodontal 
conditions seen below and which is still currently in use (Armitage 1999): 
 
I  Gingival diseases 
There are many conditions which affect the gingival tissues, the most common of 
which is gingivitis. Gingivitis is characterised by oedema and redness of the 
gingival margins associated with the presence of a plaque biofilm. 
 
Gingival hyperplasia is characterised by thickening of the gingival tissues and its 
aetiology includes physical causes such as irritation by plaque or calculus or 
repeated trauma, and, pharmacological causes such as calcium channel 
blockers, anti-rejection medication for organ transplant patients and phenytoin, a 
medication used to treat epilepsy. 
 
Hormonal imbalances such as occur during puberty and pregnancy can also 
affect the gingivae, as can viral infections such as herpes simplex and fungal 
infections e.g. generalised gingival candidosis.  Mucocutaneous conditions such 
as lichen planus can also affect the gingival tissues, as can allergic reactions and 
trauma. 
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II Chronic periodontitis 
Chronic periodontitis is defined as an inflammatory condition characterised by 
erythema and oedema of the gingival margins, along with destruction of the 
junctional epithelium and alveolar bone to form periodontal pockets.  More detail 
regarding chronic periodontitis can be found in Section 2.1.3. 
 
III Aggressive periodontitis 
Aggressive periodontitis may be localised or generalised and is characterised by 
rapid bone loss around teeth giving vertical bony defects. Loss of supporting 
bone may lead to severe mobility or loss of teeth in people under 35 years of 
age, and this may happen with little plaque or calculus present. 
 
IV Periodontitis as a manifestation of systemic disease 
Periodontitis may result from some haematological conditions such as 
neutropenia or leukaemia, and may affect individuals with genetic disorders such 
as Downs syndrome or Papillon-Lefevre syndrome.  
 
V Necrotizing periodontal diseases 
Necrotizing ulcerative gingivitis and periodontitis is a painful condition 
characterised by loss of the interdental papillae with ulceration and necrosis. 
Submandibular lymphadenopathy can also be present, and a characteristic 
halitosis is noted. This condition is related to moderate and heavy smoking, and 
poor oral hygiene. 
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VI Abscesses of the periodontium 
Periodontal abscesses form in periodontal pockets and the infection can be acute 
or chronic. They may be pain-free if they are draining from the pocket, and they 
can occur in vital teeth. They are characterised by swelling in the gingival sulcus 
and/or pus draining from the periodontal pocket. 
 
VII Periodontitis associated with endodontic lesions 
Periodontal abscesses can be found in association with endodontic abscesses 
and may present with swelling either apically or at any point in the periodontal 
pocket. It can be difficult to determine where the infection originated. 
 
VIII Developmental or acquired deformities and conditions 
Periodontal health can be affected by localised anatomical deformities such as 
an enlarged fraenum or lack of keratinised gingival tissue.  
 
2.1.2 Chronic periodontitis 
Chronic periodontitis is usually a slowly-progressing condition and whilst it is 
plaque-related, individuals demonstrate markedly different disease responses to 
similar levels of dental plaque (British Society of Periodontology 2011). Chronic 
periodontitis exhibits a genetic component with family members often showing 
similar susceptibility (American Academy of Periodontology 2000).  
 
This section will examine the pathogenesis, prevalence, global burden and oral 
health impacts of chronic periodontitis as well as the risk factors for chronic 
periodontitis. 
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2.1.2.1 Pathogenesis of chronic periodontitis 
At the pathogenesis level, chronic periodontitis is viewed as a chronic 
inflammatory condition resulting from a complex interaction between plaque 
biofilm and host response. The clinical features of chronic periodontitis include 
inflammatory changes in the gingival and periodontal tissues resulting in capillary 
proliferation, increased capillary and tissue fragility, destruction of connective 
tissue attachment and the subsequent loss of alveolar bone. Clinical 
observations as a result of these changes comprise increased redness of tissues 
with a tendency to bleed as a result of minor trauma, formation of periodontal 
pockets and bone loss with or without associated gingival recession and 
exposure of the root surface. Ultimately, the tooth may exhibit increased mobility, 
which can lead to its drifting and possible exfoliation with or without associated 
acute exacerbation or abscess formation (Schaltze et al. 2004). 
 
Figure 2.1: Model for the pathogenesis of human periodontitis (Page and 
Kornman 1997) 
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Page and Kornman (1997) developed the model of pathogenesis of human 
periodontitis shown in Figure 2.1 which shows the multifactorial nature of 
periodontal disease and that conflicting processes are at play which, whilst in 
biological balance, maintain periodontal health, but disruption to any of the 
component factors can lead to disease. The microbial challenge occurs in the 
presence of a plaque biofilm which can become established if not disturbed by 
oral hygiene measures. Salivary mucins and proteins adhere to the tooth surface 
forming an acquired pellicle, which increases the adherence of bacteria. As the 
biofilm becomes thicker oxygen levels decrease at the base allowing the 
proliferation of anaerobic species of bacteria (Socransky et al. 1998). In chronic 
periodontitis higher proportions of gram-negative species are found, but 
pathogens are also found at healthy sites (Socransky and Haffajee 1992). This is 
discussed further in the section examining risk factors for chronic periodontitis. 
 
The host response to the microbial challenge combines innate and adaptive 
immune responses (Genco 1992). Innate immunity involves the protective 
presence of saliva and an intact gingival epithelium. Bacteria produce 
lipopolysaccharides and other antigens resulting in the gingival tissues releasing 
antibodies and neutrophils which can cause non-specific tissue damage. 
Adaptive immunity occurs in response to specific bacterial antigens resulting in 
cytokines being released.  These activate T and B cells and their activity can lead 
to periodontal tissue destruction. Gingival crevicular fluid produces increasing 
levels of antibodies such as IgG, IgA and IgM in response to specific plaque 
antigens (Landi et al. 1997). The host response both protects and damages 
periodontal tissues and the balance between these responses determines 
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whether health is maintained or destruction of the periodontal tissues results 
Ebersole et al. 2001). 
 
There are two main theories for the initiation and progression of chronic 
periodontitis. In the longitudinal model (Loe et al. 1965) it is hypothesised that the 
presence of plaque leads to gingivitis with associated gingival hypertrophy 
enhancing plaque collection below the gingival margin. This subgingival plaque 
may calcify to form dental calculus thus further enhancing plaque collection. The 
host inflammatory response to plaque collection results in localised chemical 
breakdown of the connective tissue attachment of the periodontium and pocket 
formation. The connective tissue attachment between the tooth and alveolar 
bone provides the stimulus required for localised bone turnover. Loss of this 
attachment therefore ultimately results in alveolar bone loss. This continues if 
untreated until the tooth becomes progressively mobile and is shed (Lindhe et al. 
1975).  This model proposes a slow, gradual, linear progression from mild to 
severe disease.  
 
However, studies have shown that it is not the case that all gingivitis progresses 
to destructive periodontal disease (Baelum et al. 1988). A review of the literature 
by Kinane and Attstrom (2005) found that gingivitis and periodontitis are in fact 
stages of the same disease and host susceptibility may explain the differences in 
progression at different tooth sites and in different individuals. 
 
Earlier, in 1984, Socransky et al. examined the data from longitudinal studies and 
proposed that chronic periodontitis progressed in “bursts” with periods of 
exacerbation and remission. These episodes could be related to the pathogens 
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present at the site or to changes in the host susceptibility. This explanation of 
bursts of periodontal disease is supported by Flemmig (1993). 
 
Flemmig (1999) suggested that chronic periodontitis tended towards a mainly 
longitudinal model with the possibility of an occasional episode of relatively rapid 
deterioration. Current thinking proposes that chronic periodontitis is cyclical in 
nature with some sites in the mouth progressing in a linear fashion whilst others 
are improving or deteriorating (Gilthorpe et al. 2003). 
 
2.1.2.2   Prevalence, global burden and impact of chronic periodontitis 
Chronic periodontitis is the most common form of periodontal disease and is 
almost universal in adults in its mild form i.e. where gingival inflammation and 
periodontal attachment loss of 1 – 2 mm are present at one or more sites 
(Baelum and Lopez 2013; Kinane and Attstrom 2005). Early studies measuring 
the prevalence of chronic periodontitis found that its prevalence increased with 
age and, that by the age of 40 years, destructive periodontal disease affected the 
majority of people (van der Velden 1984; Scherp 1964). These findings were 
based on whether an individual was disease free or not, but did not indicate the 
extent or severity of the disease. As the clinical symptoms of chronic periodontitis 
vary from site to site in the mouth as well as between individuals and 
populations, studies in the 1980s began to report the extent and severity of 
periodontitis (Baelum et al. 1986). 
 
Recent studies of large populations from diverse geographical areas have found 
that, in industrialised countries, 10 – 15% of the adult population have severe 
periodontitis and that the prevalence increases with age until subjects reach 50-
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60 years of age (Petersen and Ogawa 2005). It is thought that the decrease after 
this age is due to tooth loss among older age groups.  
 
The global prevalence of advanced periodontitis is 5 – 15%, with limited variation 
across countries with highly differing income levels and ethnic groups (Slots 
2013). Studies in the UK have shown that in 35 – 44 year old subjects, 54% have 
at least one shallow periodontal pocket and 13% have deep pocketing (Sheiham 
and Netuveli 2002). The 2009 Adult Dental Health Survey demonstrated that 
45% of adults in the UK presented with periodontal pocketing of 4 mm or more 
(NHS Information Centre for Health and Social Care 2009). This demonstrates 
an improving picture of periodontal health as figures from 1988 and 1998 were 
75% and 59% respectively (Dye 2012). 
 
Whilst it is difficult to determine the exact reason for tooth extraction 
retrospectively, the number of teeth lost must be considered when assessing 
prevalence of chronic periodontitis as teeth which have been extracted are likely 
to have been the most severely affected (Gilbert et al 2005).   
 
Global Burden of Periodontal Disease 
The Global Burden of Disease (GBD) 1990 Study (Murray and Lopez 1997; 
World Bank 1993) measured the global burden of disease across the world using 
Disability-Adjusted Life-Years (DALYs) and Years Lived with a Disability (YLDs). 
It included three oral health diseases; untreated caries, severe periodontitis and 
tooth loss. The GBD study was repeated in 2010 allowing comparison across 
different regions of the world and over time (Murray et al. 2012).  
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Marcenes et al. (2013) analysed the data collected in both GBD 1990 and GBD 
2010 with respect to oral diseases. Of the 291 diseases included in the 2010 
GBD study, the most prevalent of all was untreated caries in permanent teeth, 
whilst severe periodontitis was sixth most prevalent, and tooth loss thirty-sixth. 
This equates to a huge global burden due to oral diseases, with almost 2% of all 
YLDs attributable to them. An increase was found in DALYs associated with 
severe periodontitis between 1990 and 2010 but this was mostly due to 
population growth and aging rather than increased severity at an individual level. 
The rise did not occur evenly throughout the world, and in fact severe chronic 
periodontitis compared with moderate or mild chronic periodontitis was more 
prevalent than untreated caries in Australasia, Sub-Saharan Africa, many parts of 
Asia and Latin America. The burden of disease caused by severe chronic 
periodontitis was found to be comparable to cardiovascular disease, mental 
illness and blood dyscrasias (Marcenes et al. 2013).  
 
Oral Health-related Quality of Life 
While the biomedical model of health tends to concentrate on physical 
measurements such as clinical attachment loss an alternative way of considering 
the effects of chronic periodontitis is in the impact it has on the oral health and 
wellbeing of the person affected (Allen 2003). In 1980 the World Health 
Organisation produced a classification of impairment, disability and handicap 
which described the interlinking nature of biological, behavioural and 
psychosocial impacts of disease (World Health Organization 1980).  
 
Locker (1988) developed his conceptual model for measuring oral health, based 
on the World Health Organisation classification (see Figure 2.2). This model 
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described the mechanisms by which impairment such as the loss of a tooth might 
produce functional limitation or discomfort and pain leading to physical, social or 
psychological disability and thus handicap.  
 
Figure 2.2: Locker’s conceptual model for measuring oral health 
 
 
 
 
 
 
 
 
 
 
 
 
A variety of tools have been developed and validated to measure the impact of 
oral health on the quality of daily living of an individual. The General Oral Health 
Assessment Index (GOHAI) was developed in 1990 by Aitchison and Dolan. 
Originally, this index was designed to measure patient-reported oral functional 
problems in older people and was known as the Geriatric Oral Health 
Assessment Index. It has since been validated for use in younger age groups 
too, hence the name change.  The GOHAI comprises 12 questions answered 
using a six-point Likert scale covering physical function, psychosocial function 
and pain or discomfort (Atchison and Dolan 1990).  
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The UK Oral Health-Related Quality of Life Measure (OHQOL-UK) aims to 
measure both the impact and the effect of poor oral health on quality of life 
(McGrath and Bedi 2001). The index correlates well with both self-reported and 
actual oral health status and is thus a reliable and valid measure of oral health-
related quality of life. 
 
Leao and Sheiham (1995) developed the Oral Impact on Daily Living Index, 
which examined the severity of the oral impacts identified by the Oral Health 
Impact Profile described in the following paragraph. Further development of this 
model has resulted in the Oral Impacts on Daily Performance (OIDP) which 
focuses on the disability and handicap concepts of Locker’s conceptual model 
(Adulyanon and Sheiham 1997). The OIDP index assesses the severity of 
impacts with respect to nine daily tasks: eating, speaking, cleaning teeth or 
dentures, going out, relaxing, including sleeping, smiling, laughing and showing 
teeth without embarrassment, carrying out major role or work, emotional 
instability, for example becoming more easily upset than usual and enjoying 
contact with other people such as friends, relatives and neighbours.  
 
Slade and Spencer (1994) developed the Oral Health Impact Profile (OHIP) 
which consisted of a series of forty nine questions covering seven dimensions of 
impact of oral health; functional limitation, physical pain, psychological 
discomfort, physical disability, psychological disability, social disability and pain.  
Its advantages over other scales are that the statements were developed by 
dental patients rather than researchers and it can be used to measure both 
frequency and severity of impacts. It employs a Likert response format where 
0=never, 1=hardly ever, 2=occasionally, 3=fairly often and 4=very often.  
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A shortened version of the OHIP questionnaire was developed using regression 
analysis in 1997 and this reduced the number of statements to 14. The OHIP-14, 
as the smaller version is known, contained questions from each of the theoretical 
domains in the original (Slade 1997). It has been shown to be valid and reliable 
across many different populations and in several languages.   
 
Similar results have been found in impacts of oral disorders on populations 
across the developed world with 16% of participants in surveys in both the United 
States and Australia experiencing at least one impact fairly often or very often. 
Impacts on daily living related to oral disorders were more prevalent amongst 
disadvantaged groups (Sanders et al. 2009). A survey conducted in Australia and 
the United Kingdom found that 18.2% of Australians experienced impacts fairly 
often or very often as compared with 15.9% of UK participants. Variation was 
found between the four countries of the United Kingdom, with 19.8% of 
participants in Scotland demonstrating impacts fairly often or very often as 
opposed to 13.6% in Wales. The degree to which oral diseases impact on quality 
of life are most associated with tooth loss and socio-economic status in this study 
(Slade et al. 2005). 
 
The Adult Dental Health Survey undertaken in 2009 in England, Wales and 
Northern Ireland used both the OHIP-14 and OIDP indices to measure the impact 
of oral health and the severity of those impacts on daily living in the population 
surveyed (Nuttall et al. 2011). The OHIP-14 demonstrated that 29% of those with 
no untreated caries had experienced pain in the last 12 months, a proportion of 
which would result from periodontal disease. Forty six percent of individuals 
presenting with periodontal pocketing of 6mm or more had at least one oral 
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impact as compared with 35% of those without pocketing. Dentate adults with 
poor periodontal health were shown to have more oral impacts, and more severe 
impacts on daily performance, than those with better periodontal health. Bernabe 
and Marcenes (2010) analysed the data from the Adult Dental Health Survey and 
proved that periodontal disease is associated with poor quality of life after taking 
demographic, socioeconomic and other clinical variables into account. 
 
Few studies have looked at quality of life issues specifically associated with 
periodontal disease and most that have evaluated specific patient groups e.g. 
pregnant women (Wandera et al. 2009), patients undergoing haemodialysis 
(Guzeldemir et al. 2009) or postoperative periodontal patients (Ozcelik et al. 
2007). Zhou et al. (2010) found that poor periodontal health was significantly 
related to low oral health-related quality of life in a population of hospital 
inpatients with chronic obstructive pulmonary disease.  
 
A study which examined the oral health related quality of life of passengers and 
crew on a cruise ship (Sobotta 2006) found significant levels of periodontal 
disease, but low impact, in both passengers and crew. This may have been 
explained in part by the immediate availability of dental care when required, and 
may have been related to the stress-free holiday environment the passengers 
were enjoying but this was unlikely to explain the low impact of periodontal 
disease on the crew.  
 
Jowett et al. (2009) investigated the oral health related quality of life in patients 
with chronic periodontal disease and found that it was worse than in people with 
good periodontal health. They also found that routine non-surgical periodontal 
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treatment was successful in minimising poor oral health related quality of life. It is 
clear that the impact of disease on an individual’s quality of life is dependent not 
only on the extent of the condition, but also on their perception of how much 
disability it causes (Allen 2003). 
 
Nagarajan and Chandra (2012) divided a population of patients with chronic 
periodontitis into three groups according to their periodontal risk and assessed 
their oral health-related quality of life before and after non-surgical periodontal 
treatment. They found that oral health-related quality of life improved in those 
with moderate or high periodontal disease risk following periodontal therapy, and 
that there was a highly significant negative impact on quality of life associated 
with high risk for chronic periodontitis as opposed to low or moderate risk 
(Nagarajan and Chandra 2012). 
 
In summary, mild and moderate chronic periodontitis affects between 70% and 
85% of the population and ranges in its intensity. Work from Marcenes and 
colleagues (2013) has shown that chronic periodontitis in its most severe form is 
the sixth most prevalent condition regarding global burden of disease. Moreover, 
the impact of chronic periodontitis has been explained with regard to oral health-
related quality of life suggesting and supporting the view of Bernabe and 
Marcenes (2010) that this periodontal condition impacts on people’s quality of 
life. 
 
 Measurement of chronic periodontitis 
The ability to compare results between studies of the prevalence of chronic 
periodontitis is limited as there is no definitive measure of the severity of 
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periodontal disease, or of the preferred method for measuring periodontitis 
(Papapanou and Lindhe 2008). The majority of studies measuring periodontal 
disease will use some combination of a plaque index, bleeding index, tooth 
mobility index, pocket depth measurement or clinical attachment loss 
measurement.  
 
 Plaque indices 
An overview of plaque indices cited in academic papers illustrates the breadth of 
measures available. They range from simply running a probe around the gingival 
margin to determine the presence or absence of plaque (O’Leary et al. 1972),   to 
technologically sophisticated methods such as fluorescence camera imaging 
(Raggio et al. 2009). Some plaque indices require staining of the plaque prior to 
scoring e.g. the Visible Plaque Index (Turesky 1970), the Modified Navy Index 
(Elliott et al. 1972), and the Ekstrand Index (Ekstrand et al. 1998). Other plaque 
indices such as the Oral Hygiene Index (Greene and Vermillion 1964) and the 
Plaque Index (Silness and Loe 1964) rely on running a probe around the gingival 
margin to determine the quantity of plaque present. Some of the indices measure 
the thickness of plaque and others the distribution, and others give greater 
weight to some sites on the tooth e.g. in the gingival third of the tooth. It can be 
seen that this plethora of indices makes comparison of studies very difficult 
(Raggio et al. 2010).  
 
Eaton et al. (1997), using the dichotomous Plaque Index, demonstrated that 
reliable results can be achieved in primary care by inexperienced examiners. 
They also showed that, with regular checks, it is possible to maintain intra- and 
inter-examiner reliability over a period of twelve months which is comparable to 
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the duration of data collection in this current study. Galgut (1999) has 
demonstrated that a dichotomous scale i.e. 0 = absence of plaque and 1= 
presence of plaque consistently shows lower levels of plaque than an ordinal 
scale but the differences are small.  
 
 Pocket depth and clinical attachment loss 
A similar picture is found when comparing papers discussing the severity of 
periodontal disease, as differing methods of measurement are employed and 
different thresholds used to indicate whether disease is present, and if so, if it is 
mild, moderate or severe (Kingman and Albandar 2002; Papapanou 1996).  
 
Periodontal pocket depth is defined as the distance from the gingival margin to 
the bottom of the pocket using a periodontal probe held perpendicular to the long 
axis of the tooth and using a moderate force of 15 – 20 grams. Clinical 
attachment loss is measured using the periodontal probe in the same way but 
measures the distance from the cemento-enamel junction to the base of the 
pocket (Andrade et al. 2012; Papapanou and Lindhe 2008).  Six measures are 
recorded for each tooth excluding third molars; mesial, central and distal on both 
buccal and lingual/palatal aspects, giving a possible total of 168 measurements 
for each individual. In order to simplify and reduce the time involved in data 
collection and analysis, some studies have used index teeth to represent the 
whole mouth rather than recording six measures of clinical attachment loss and 
pocket depth on each tooth (Dye and Thornton-Evans 2007). The number and 
site of index teeth varies between studies further reducing comparability (Susin et 
al 2005; Kingman and Albandar 2002). If a partial mouth design is employed then 
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a percentage of examinations should examine the full mouth to provide a 
correction factor to compensate for any inaccuracies (Susin et al 2005). 
 
The clinical attachment loss, pocket depth and gingival recession are all 
measured using a periodontal probe. However, there is no agreement on the 
type of probe used in periodontal research. Differences in the probe tip shape 
and diameter can cause significant differences in pocket depth recordings, as 
can the accuracy of markings on the probe, all of which makes comparison of 
results from different studies problematic (Savage et al. 2009).  
 
 Consistency and reliability of measurement 
The consistency of measurements achieved using periodontal probes can also 
be compromised by varying the angulation at which the probe is inserted in the 
pocket and the force used. In order to minimise errors of measurement the angle 
of insertion of the probe in this study was parallel to the long axis of the tooth at 
all times, although clinical factors such as difficult to reach teeth and poor 
angulation of teeth had to be overcome on occasions.  
 
When using a conventional manual probe to measure probing depth it is possible 
to use varying amounts of force when probing thereby compromising the 
accuracy of the measurements. It has been determined that the ideal force 
required to reach the base of a periodontal pocket without causing any tissue 
damage is 20g (Leroy et al. 2010). Attempts have been to calibrate the force 
used when probing periodontal pockets using manual and electronic probes. 
Probes may be classified as follows (Grossi et al. 1996): 
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First generation: Non-pressure controlled (manual) with visual data recording 
Second generation: Pressure controlled with visual recording 
Third generation: Pressure controlled with direct computer data capture 
 
A systematic review examining the reproducibility of measurements using first, 
second and third generation periodontal probes failed to demonstrate significant 
differences (da Silva-Boghossian et al. 2008). 
 
The largest source of data on the prevalence of periodontal disease in the United 
States is the National Health and Nutrition Examination Survey (NHANES), and 
this utilises a partial mouth periodontal examination. Eke et al. compared the 
prevalence of periodontal disease in 454 adults using both the partial mouth 
periodontal examination and a full mouth examination with six sites per tooth 
being examined. They found that their partial mouth periodontal examination 
routinely recorded only half the periodontal disease measured by the gold 
standard examination (Eke et al. 2010). This suggests that data gathered in other 
large scale epidemiological studies have underestimated periodontal disease 
prevalence.  
 
Eke et al. (2010) identified seven different methodologies that had been used to 
define presence and severity of periodontal disease in national prevalence 
studies of periodontitis in the United States alone. Variations existed in the sites 
considered e.g. Page and Eke (2007), used the number of interproximal sites 
affected to determine severity, while e.g. Arbes et al. (2001), required a specific 
number of sites to be affected by a pre-determined level of clinical attachment 
loss, while still others e.g. Dye et al. 2007, used a dichotomised measure of a 
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specified level of clinical attachment loss or pocket depth being present or 
absent. 
 
The World Health Organisation developed the Community Periodontal Index 
(CPI) as a simple tool for assessing and comparing periodontal health status in 
countries across the world. It involves dividing the mouth into sextants and 
recording gingival bleeding, calculus and pocket depths at 6 sites on all teeth 
excluding third molars. The highest score found is assigned to each sextant as 
follows: CPI0 = periodontal health, CPI1 = gingival bleeding, CPI2 = gingival 
bleeding and calculus, CPI3 = periodontal pocketing of 4-5mm, and CPI4 = 
periodontal pocketing of 6 mm or over (World Health Organisation 1987).  Data 
gathered from across the globe shows that periodontal disease affects a 
significant proportion of all populations wherever they live, with the proportion of 
the population experiencing mild (CPI2) and moderate (CPI3) periodontal 
disease ranging from 70% in the region of the Americas and the European 
Region, to 85% in the Western Pacific Region (Petersen and Ogawa 2005).  
 
The British Society of Periodontology (2011) has further developed the 
Community Periodontal Index to provide a tool for assessing the periodontal 
treatment need of individuals attending dental practice known as the Basic 
Periodontal Examination. The scoring system used is shown in Table 2.1.  
 
Table 2.1 Scoring codes for Basic Periodontal Examination (BPE) 
0 No pockets >3.5mm, no calculus/overhangs, no bleeding after probing 
1 No pockets >3.5mm, no calculus/overhangs, but bleeding after probing 
2 No pockets >3.5mm, but supra- or subgingival calculus/overhangs 
3 Probing depth 3.5-5.5mm 
4 Probing depth > 5.5mm 
* Furcation involvement 
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Radiographs have been found to provide a valid measure of the severity of 
periodontal disease by allowing the level of bony destruction and loss of lamina 
dura to be determined (Pitiphat et al. 2004). As with other methodologies for 
assessing the extent and severity of periodontal disease, there are no specific 
standards defined. 
 
There is an urgent need for standardisation of indices engaged to determine the 
prevalence of periodontal diseases, and the parameters used to establish its 
extent and severity.  
 
2.1.2.3  Risk factors for chronic periodontitis 
 
Chronic periodontitis has a multifactorial aetiology and a variety of proven and 
proposed innate and external risk factors (Genco and Borgnakke 2013; Petersen 
and Ogawa 2013; Baelum and Lopez 2013; Hart et al. 2012; Watt and Petersen 
2012; Irwin et al. 2007). These risk factors may be divided into categories relating 
to innate susceptibility e.g. genetics, and external behavioural factors e.g. 
smoking. The innate factors affecting periodontal disease are said to be age, 
gender, race/ethnicity and genetic susceptibility (Borrell and Talih 2012; Taba et 
al. 2012; Shiau and Reynolds 2010; Petersen and Ogawa 2005; Klinge and 
Norlund 2005; Jepsen et al 2003; Sheiham and Netuveli 2002).  
 
For the purposes of this section of the review, the aetiological factors will be 
presented as follows: demographic factors, genetic factors, pathogens, socio-
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economic status, medical conditions and psychosocial factors including 
psychological stress, alcohol and smoking. 
 
Demographic factors 
 Age 
Studies (Sheiham and Netuveli 2002; Petersen and Ogawa 2005;) have shown 
that an increased loss of gingival attachment with age, but this may be due to an 
increased exposure to other innate and external risk factors alongside the aging 
process. Whether or not age is an independent risk factor, chronic periodontitis is 
certainly considered to be age-related (Eke et al. 2012; Haas et al. 2012; White 
et al. 2012; Holtfreter et al. 2010; Grossi et al. 1995). 
 
 Gender 
Studies have shown better periodontal health in women compared with men but 
this may be due to their increased use of health services (Christenen et al. 2003) 
or to better oral hygiene practices (Yu et al. 2001). The Adult Dental Health 
Survey supported these findings, as 68% of women reported attending for 
regular check-ups compared with 54% of men, and it also found that 82% of 
women reported brushing their teeth at least twice daily as opposed to 67% of 
men (Chadwick et al. 2011). A systematic review found an unexplained increase 
of 9% prevalence of destructive periodontal disease in men compared with 
women, but no difference in the rate of progression of this disease between 
genders (Shiau and Reynolds 2010). Therefore the role of gender remains 
unexplained (Genco and Borgnakke 2013; Eke et al. 2012; Haas et al. 2012; 
Holtfreter et al. 2012; Kocher et al. 2005; Grossi et al. 1995). 
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Innate factors 
 Ethnicity/race 
The prevalence of periodontal disease varies from country to country and within 
racial/ethnic groups in the same country (Albandar et al. 1999). There is an 
inverse relationship between the proportion of the population who report 
experiencing problems with their teeth and the income level of the country in 
which they live (Petersen 2007).  
 
Studies conducted in the United States have shown higher levels of periodontal 
disease in African-Americans and other black groups compared with Caucasians 
(Borrell et al. 2002; Beck et al 1990). Ethnicity has also proved to be a significant 
factor for prevalence of periodontal disease in other countries (Kruger et al. 2010; 
Varenne et al. 2004). 
 
 Genetic factors 
The propensity of periodontal disease to be found in family groups has long lead 
to speculation that a genetic component is involved in susceptibility to the 
condition. Advances in techniques for exploration of genetic factors has resulted 
in various approaches being taken to investigate which genes may be involved in 
increasing susceptibility to developing periodontal disease (Genco and 
Borgnakke 2013; Taba et al. 2012). 
 
Studies investigating familial or twin traits for periodontal disease have suggested 
that there is a genetic factor involved in aggressive periodontitis, with some 
showing up to 50% of siblings and offspring of those with aggressive periodontitis 
also affected (Rapp 2011; Meng et al. 2011; Marazita et al. 1994).  
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The confounding effects of environmental factors complicated the assessment of 
the importance of genetic factors in familial aggregation studies of chronic 
periodontitis (Shearer et al. 2011; Petit et al. 1994). However they did 
demonstrate that parents with poor periodontal health will have children with poor 
periodontal health. In order to compensate for environmental factors, studies of 
monozygotic twins have allowed the magnitude of genetic factors to be 
attributed. The results of these studies suggest that genetics play a smaller part 
in chronic periodontitis than in aggressive periodontitis (de Heens 2010; 
Michalowicz 1991). 
 
In a review of studies investigating the role of gene polymorphisms in chronic 
periodontitis several were linked to chronic periodontitis – interleukin-1, 
interleukin-6, interleukin-10, vitamin D receptor and CD-14 genes – but only in 
specific ethnic groups, not across the general population (Laine et al. 2012).  
 
Another approach to assessing the impact of genetic factors on chronic 
periodontitis has been to analyse the whole genome. To date, results have again 
indicated a larger role for genetics associated with aggressive rather than chronic 
periodontitis (Divaris et al. 2012; Schaefer et al. 2010; Kornman 2008).  
 
It is hypothesised that increased propensity to periodontitis and other conditions 
such as cancer and diabetes have a shared genetic basis, but, though the 
evidence suggests this may be the case, definitive proof is not available and the 
mechanisms involved have not been explained (El-Omar et al. 2000). 
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At present, there is not sufficient evidence to prove a causal link between certain 
gene polymorphisms and severe periodontal disease (Jepsen et al. 2003). 
Conflicting results are found in some studies whilst others are not sufficiently 
robust to draw firm conclusions from (Loos et al. 2005; Weiss 2004).  
 
 Pathogens 
Chronic periodontitis requires the presence of a biofilm of dental plaque and in 
the past it was thought that dental plaque inevitably lead first to gingivitis, and 
thence to periodontitis (Armitage 2013; Marsh 2005). However, longitudinal 
studies have shown that the presence of dental plaque and gingivitis does not 
progress to periodontitis in all individuals (Loe et al. 1992; Ismail et al. 1990, 
Anerud et al. 1979).  
 
Research has identified several plaque pathogens as risk factors for chronic 
periodontitis (Armitage 2010; Genco et al. 1996; Haffajee and Socransky 1994), 
and the validity of pathogens such as Aggregatibacter actinomycetemcomitans, 
Porphyromonas gingivalis and Tanerella forsythia as true risk factors has been 
demonstrated by successfully treating periodontal disease through removal of 
subgingival plaque (Heitz-Mayfield et al. 2002). It has also been demonstrated 
that the progress of the disease process for chronic periodontitis can be 
estimated by studying the levels of pathogens Porphyromonas gingivalis and 
Treponema denticola in subgingival plaque (Byrne et al. 2009).  
 
However, all potential plaque pathogens can be found in the absence of 
periodontal disease, and the factors affecting the healthy balance which result in 
periodontal disease are insufficiently understood (Socransky and Haffajee 2005; 
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Lammell et al. 2000).  Insufficient evidence exists to suggest that testing for the 
presence of specific microbes would enhance diagnosis or treatment of 
periodontal disease (Teles et al. 2012; da Silva-Boghossian et al. 2011; Shaddox 
and Walker 2009; Hayashi et al. 2006; Listgarten and Loomer 2003). 
 
Bacteria are not the only microbes found in the plaque biofilm, and the potential 
role of viruses such as Epstein-Barr, herpes virus and human cytomegalovirus 
has provoked interest (Saygun et al. 2011; Chalabi et al. 2010; Dawson et al. 
2009; Botero et al. 2007). Whilst these viruses are found in healthy sites, their 
numbers are much increased in sites affected by periodontal disease. It has been 
suggested that these viruses may weaken host defences thereby allowing 
proliferation of plaque pathogens leading to periodontal disease (Chalabi et al 
2010; Slots 2010). 
 
External factors 
 Socio-economic status  
The role of socio-economic status in periodontitis is difficult to determine due to 
the complexity of disentangling other associated risk factors such as poor 
nutrition and smoking (Klinge and Norlund 2005). Bonfim et al. (2013) divided 
participants in a cross-sectional trial into three groups dependent upon their 
periodontal health status and found that periodontal health was significantly 
linked with years of formal education and low income. Similar results linking 
indicators of poor socio-economic status with periodontal ill health have been 
found in other epidemiological studies (Borrell et al. 2006; Albandar and Tinoco 
2002; Drury et al. 1999; Papapanou 1999).   
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Data collected in the 2009 Adult Dental Health Survey in the United Kingdom 
found that low educational attainment was highly significantly linked to smoking, 
suboptimal levels of toothbrushing frequency and dental attendance only when in 
pain (Chadwick et al. 2011). International population-based surveys in Australia 
(Slade et al. 2007), Denmark (Krustrup and Petersen 2006), Germany (Geyer et 
al. 2010), Hungary (Hermann et al. 2009), United States (Eke et al. 2012; Dye et 
al. 2007) and Zimbabwe (Frencken et al. 1999) have also found a significant 
association between periodontal disease and low levels of education. A 
systematic review of literature relating to the link between periodontal disease 
and socio-economic status in Brazil also established a strong relationship 
(Bastos et al. 2011). 
 
In a systematic review exploring the link between educational attainment and 
chronic periodontitis, a total of 15 papers were included and the meta-analysis 
showed an increased odds ratio of 1.86 for chronic periodontitis among those 
with low educational attainment (Boillot et al. 2011).  
 
Borrell and Crawford (2012) in their review of literature dealing with socio-
economic position and periodontal disease maintain that despite multivariate 
analysis of data, there may still be residual effects of some variants acting as 
confounding factors. However, they also found that whichever measure of socio-
economic position was employed – educational attainment, occupation or income 
– they confirm a strong link between socio-economic status and periodontal 
disease (Borrell and Crawford 2012). 
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 Medical conditions 
Diabetes 
Evidence exists to indicate a strong link between diabetes (Type 1 and Type 2) 
and periodontal disease (Lalla and Papapanou 2011; Chavarry et al. 2009; 
Taylor and Borgnakke 2008; Schlossman et al. 1990). Data also suggest a 
reciprocal relationship as poor periodontal health also leads to blood glucose 
levels in diabetics being less well controlled (Lalla and Papapanou 2011; Taylor 
and Borgnakke 2008; Genco et al. 2005; Grossi et al. 1994). Periodontal disease 
prevalence has also been found to increase in women with gestational diabetes 
(Xiong et al. 2009; Novak et al. 2006). 
 
Longitudinal data from the First National Health and Nutrition Examination Study 
shows that periodontal disease is a risk factor for future development of diabetes 
(Demmer et al. 2008). Systematic reviews and meta-analyses have 
demonstrated that treatment of periodontal disease improves glycaemic control 
in Type 2 diabetics (Engebretson and Kocher 2013; Simpson et al. 2010; Darre 
et al. 2008, Janket et al. 2005). 
 
The mechanism by which the bidirectional relationship between periodontal 
disease and diabetes functions is said to be related to inflammatory pathways 
(Seppala et al. 1993). Diabetes results in elevated levels of proinflammatory 
markers which in turn cause more severe periodontal disease leading to even 
higher levels of proinflammatory markers (Yoon et al. 2012; Dandona et al. 
2004). 
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Collaboration between medical and dental practitioners is required to ensure 
diabetic patients are aware of the relationship between diabetes and periodontal 
disease (Karikoski et al. 2002) and are encouraged to maintain good oral 
hygiene thus improving both oral and general health (Lalla and Papapanou 
2011). 
 
Cardiovascular disease 
A link between periodontitis and cardiovascular disease has been proposed for 
many years and the research base is growing. Cardiovascular outcomes have 
been shown to be poorer in patients with periodontitis or tooth loss in two 
systematic reviews (Bahekar et al. 2007; Humphrey et al. 2008). They concluded 
that when results were adjusted for all other known risk factors for ischaemic 
heart disease, periodontitis remained as a substantive risk factor.  
 
Hujoel et al. (2003) concluded that periodontal treatment is not a causal factor for 
cardiovascular disease and that periodontal treatment is therefore unlikely to 
benefit cardiovascular outcomes. However, Ouyang et al. (2011) reviewed the 
topic and found stronger evidence supporting improved cardiovascular health 
following periodontal treatment, with the caveat that the design of the studies 
included was not robust enough to provide conclusive proof.   
 
Several mechanisms have been proposed for the correlation found between 
cardiovascular disease and periodontal disease including infection by shared 
pathogens or systemic inflammatory processes leading to atherosclerosis 
(Cullinan and Seymour 2013). Studies have shown that inflammatory markers 
are elevated in patients with periodontal disease, but conflicting results are 
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reported as to whether non-surgical periodontal treatment can reduce them 
(Lopez-Jornet et al. 2012; Monteiro et al. 2012). 
 
In 2012, the American Heart Association formed an expert group to determine 
whether a causative association had been proven between cardiovascular 
disease and periodontal disease. They concluded that, to date, the robust 
evidence to this effect does not exist, and that the influence of common risk 
factors such as smoking and diabetes may explain the frequency of periodontal 
disease and cardiovascular disease being found as co-morbidities (Lockhart et 
al. 2012).  
 
The Joint European Federation of Periodontology/American Academy of 
Periodontology Workshop on Periodontitis and Systemic Diseases concluded 
that strong evidence indicates that chronic periodontitis is a risk factor for future 
cardiovascular disease but further intervention studies are required (Tonetti and 
Van Dyke 2013). 
 
 
Preterm and low birthweight babies 
Despite findings that there is an association between periodontitis and preterm or 
low birthweight babies (Offenbacher et al. 1996), further research has failed to 
confirm that improved periodontal health has reduced poor pregnancy outcomes. 
In fact, conflicting results are reported with some studies concluding that 
periodontal treatment has no beneficial effect on pregnancy outcomes 
(Offenbacher et al. 2009; Michalowicz and Durand 2007) and others that it does 
(Armitage 2013). The Joint European Federation of Periodontology/American 
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Academy of Periodontology Workshop on Periodontitis and Systemic Diseases 
concluded that insufficient evidence exists to suggest that periodontal treatment 
will improve pregnancy outcomes for women with periodontitis (Michalowicz et al. 
2013). 
 
The exact mechanism for the putative association is unclear but it has been 
suggested that both periodontitis and preterm or low birthweight are linked to the 
release of endotoxins from Gram-negative bacterial infection. The systemic 
dissemination of inflammatory products common to both diseases has also been 
mooted. A third theory is that the foeto-maternal immune response in pregnancy 
affects the microbial balance in the oral plaque biofilm (Huck et al. 2011). 
 
Obesity and metabolic syndrome 
It has been found in cross-sectional studies that an association exists between 
obesity and periodontal disease (Han et al. 2010; Genco et al. 2005; Wood et al. 
2003; Saito et al. 2001). A systematic review conducted in 2010 found a 35% 
increase in periodontitis in obese patients, and suggested a dose response with 
levels of increasing periodontal disease with increasing obesity (Chaffee and 
Weston 2010). Another review and meta-analysis completed by Suvan et al. 
(2011) found an odds ratio of 2.13 (CI 1.40, 3.26) for having periodontal disease 
if obese. 
 
Susceptibility to diseases such as periodontal disease in obese individuals is 
thought to be modified due to the systemic inflammation obesity produces (Yoon 
et al. 2012; Falagas and Kompoti 2006; Genco et al. 2005).  
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Metabolic syndrome is diagnosed when an individual has three or more of the 
following disorders: increased blood pressure, raised plasma glucose, excess 
abdominal fat and raised high-density lipoprotein cholesterol levels. Analysis of 
the NHANES III data has shown that those with periodontal disease are more 
likely to have metabolic syndrome (D’Aiuto et al. 2008).  Conversely, other 
studies demonstrate that metabolic syndrome is predictive of periodontal disease 
(Kushiyama et al. 2009; Morita et al. 2009). 
 
Metabolic syndrome is related not only to periodontal disease, but also to 
diabetes and cardiovascular disease suggesting that all these conditions are 
interrelated (Alberti et al. 2009).  
 
Osteoporosis 
Osteoporosis is characterised by reduced bone mineral density and is found 
particularly in postmenopausal women where reduced levels of oestrogen leads 
to bone resorption (Gomes-Filho et al. 2013). Studies investigating a link 
between osteoporosis and periodontal disease have reported conflicting results 
but are suggestive of an association (Martinez-Maestre et al. 2010; Megson et al. 
2010; Persson et al. 2002).  
 
It has been hypothesised that treatments for osteoporosis may improve 
periodontal outcomes and some limited evidence exists to this effect e.g. 
Ronderos et al. (2000) using NHANES III data found that lack of dietary calcium 
was associated with severe periodontal disease. Calcium and Vitamin D 
supplements may improve tooth retention (Miley et al. 2009) and 
bisphosphonates reduce alveolar bone loss (Jeffcoat et al. 2007). However, 
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bisphosphonates are associated with osteonecrosis of the jaw and so their 
beneficial impact on alveolar bone does not warrant their use as a treatment for 
periodontal disease (Hellstein et al. 2011). 
 
Human Immunodeficiency Virus 
Initial reports of very severe periodontal disease in those with human 
immunodeficiency virus (HIV) infection are no longer found in more recent 
studies in developed countries (Robinson et al. 2000; Barr et al. 1992). This may 
be due to the development of anti-retroviral therapy which now enhances the 
immune response in these subjects (Chapple and Hamburger 2000). In the 
developing world HIV still has a major impact on oral ill-health (Ryder et al. 
2012). 
 
Psychosocial factors 
Psychological stress 
A causal link has been strongly suggested between emotional distress and acute 
ulcerative necrotising gingivitis, but evidence is less conclusive with regard to 
chronic periodontitis (Akcali et al. 2013; da Silva et al. 1995). For instance, 
increased psychological stress was related to increased pocket depth (Freeman 
and Goss 1993), which was in turn related to increased smoking and other 
stress-related behaviours. Nevertheless, animal experiments have demonstrated 
increased periodontal ligament breakdown in stressed subjects (Breivik et al. 
2006), and as stress diminishes the efficacy of immune responses this could 
explain a possible causal relationship (Reners and Brecx 2007). A systematic 
review conducted in 2007 found increased levels of stress associated with 
increased severity of periodontal disease (Peruzzo et al. 2007).  Genco et al. 
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(1999) found that the detrimental effects of stress on periodontal health were 
alleviated in those with effective coping mechanisms. Preeja et al. (2013) 
suggested that increasing an individual’s coping mechanisms can decrease the 
impact of stress on periodontal health. Borrell and Crawford (2011) used a 
measure of an individual’s capacity to cope with change – the allostatic load – to 
explore the link between periodontal status and stress, and found a highly 
significant association in a population of Mexican Americans. 
 
In conclusion, more research is required to fully understand the mechanism by 
which stress impacts negatively on periodontal health, and the possible role of 
stress management to improve periodontal health.  
 
Alcohol 
Analysis of data from the NHANES III study suggests not only that alcohol is a 
risk factor for periodontal disease, but that severity of periodontal disease is 
directly dose-related (Tezal et al. 2004). The authors of a systematic review 
conducted in 2009 concluded that the few relevant studies available point to a 
correlation between periodontal disease and alcohol consumption but that the 
widely varying methodologies precluded a meta-analysis and more studies are 
required (Amaral et al. 2008). 
 
Lages et al. (2012) found a linear negative correlation with periodontal health 
between groups of patients who did not drink alcohol or were occasional users, 
patients who were moderate alcohol users, patients who were intense alcohol 
users and patients dependent on alcohol.  In smokers, the same correlation was 
found but the odds of developing periodontal disease were doubled (Lages et al. 
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2012). Despite growing evidence of the importance of the link between high 
alcohol consumption and poor periodontal health, and its long-established link to 
oral cancer, few primary care dentists in a postal survey in Scotland were found 
to offer alcohol-related interventions (Shepherd et al. 2011). 
 
Smoking 
Early research investigating risk factors for periodontal disease tended to dismiss 
smoking, as the higher levels of plaque found in smokers was considered to be 
the cause of their poorer periodontal health (Genco and Borgnakke 2013). 
However, when data is adjusted to take account of confounding factors, including 
oral hygiene, cigarette smoking remains a major factor (Grossi et al. 1994). The 
impact on periodontal health of smoking cigars and pipes is comparable to that of 
cigarette smoking (Albandar et al. 2000). There is limited evidence available that 
exposure to second hand smoke can lead to periodontal disease (Walter et al. 
2012). 
 
It is postulated that there are several mechanisms which play a part in the effect 
of smoking on periodontal health. The finding that gingival bleeding is less 
frequent in smokers compared with non-smokers with similar plaque levels is due 
to the peripheral vasoconstriction caused by smoking (Morozumi et al. 2004; 
Mavropoulos et al. 2003; Bergstrom and Bostrom 2001). This vasoconstriction 
thereby masks one of the main symptoms that would prompt an individual to 
seek dental treatment or advice (Tonetti and Claffey 2005).  
 
Plaque levels and oral hygiene do not explain the difference in chronic 
periodontitis between smokers and non-smokers. Smoking allows the 
 47 
proliferation of greater proportions of known periodontal pathogens such as 
Porphyromonas gingivalis, Treponema denticola and Tanerella forsythia thus 
leading to poorer periodontal health (Haffajee and Socransky 2009; Kazor et al. 
1999; Zambon et al. 1996). As well as the increased proportion of periodontal 
pathogens in smokers, nicotine is believed to increase both the numbers and 
responsiveness of neutrophils and T-cells in the periodontium (Palmer et al. 
2005; Loos et al. 2004; Johnson and Slach 2001; James et al. 1999; Page et al. 
1983). Genetic factors also have a role in periodontal health as interleukin-1 
genotype-positive individuals show increased periodontal pocketing over those 
without, but only in smokers (Meisel et al. 2003). 
 
Toker et al. (2012) found in a sample of patients with chronic periodontitis that 
higher levels of interleukin-1 were present in the gingival crevicular fluid in 
smokers than non-smokers.  Non-surgical periodontal treatment significantly 
reduced levels of interleukin-1 in both smokers and non-smokers (Toker et al. 
2012). 
 
A systematic literature review examining the relationship between smoking and 
tooth loss in many populations found that a causal relationship is highly probable, 
with all studies identified showing significantly increased tooth loss amongst 
smokers (Hanioka et al. 2011).  
 
Smokers have a greater rate of alveolar bone loss and tooth loss than non-
smokers, and increased frequency of smoking increases this effect (Grossi et al. 
1994; Warnakulasuriya 2008; Han et al. 2012).  
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Bloom et al reported in 2012 that not only do smokers have poorer oral health 
than non-smokers; they are also more likely to postpone seeking routine 
treatment and to be more concerned about their oral health problems (Bloom et 
al. 2012). Han et al. studied a population of people with periodontitis to measure 
the impact of smoking and diabetes on periodontal disease. They found an odds 
ratio of 1.40 (CI: 1.02 – 1.90) for smokers but no additional significant 
relationship was found for smokers who also had diabetes (Han et al. 2012). 
 
Torrungruang et al. (2012) found that the greatest increase in pocket depths in 
smokers compared with non-smokers was to be found in the posterior maxillary 
sextants suggesting a local effect of smoking as well as the systemic effects. 
Studies have shown that over half of severe periodontal cases among US adults 
can be attributed to smoking (Tomar and Asma 2000). 
 
Not only have smokers been found to experience more severe disease than non-
smokers, but they also have a diminished response to periodontal treatment 
(Adler et al. 2008; Grossi et al. 1997; Preber and Bergstrom, 1990). Reductions 
in pocket depth have been demonstrated to be significantly greater in non-
smokers than smokers following periodontal therapy (Jin et al. 2000).  
 
In a systematic review and meta-analysis of ten studies, Patel et al. (2012) found 
that bone regeneration following periodontal treatment was reduced in smokers 
compared with non-smokers. Researchers who conducted a systematic review of 
24 papers investigating the relationship between smoking and results of 
periodontal surgery concluded that smoking has a negative effect on healing 
after periodontal surgery (Javed et al. 2012).  It has also been found that 
 49 
smokers are significantly more likely to require more treatment after the initial 
treatment phase has been completed (Papantonopoulos 1999). Smokers 
demonstrate poorer results in response to guided tissue regeneration as 
compared to non-smokers (Patel et al. 2012; Tonetti 1998). 
 
Studies examining the response of patients to periodontal treatment which 
included antibiotic therapy have shown that smokers respond less well than non-
smokers (Tomasi and Wennstrom 2004; Kinane and Radvar 1997). 
 
Smokers who quit have a periodontal health status intermediate between never-
smokers and current smokers and after ten years they stabilise to the level of 
non-smokers (Chen et al. 2001).  Heasman et al found that smoking cessation 
improved healing after periodontal treatment (Heasman et al. 2006). Cessation of 
smoking and non-surgical periodontal treatment lead to proliferation of pathogens 
associated with periodontal health and reduction in numbers of known plaque 
pathogens (Delima et al. 2010).  Smoking cessation can reduce the rate of 
alveolar bone loss in chronic periodontitis patients (Chambrone et al. 2013; Bolin 
et al. 1993) and a reduction in pocket depths (Preshaw et al. 2005). 
 
2.1.3 Detailed review of smoking 
Whatever the precise mechanisms affecting the periodontal health status of 
smokers, sufficient evidence exists regarding the negative impact of smoking on 
periodontal health, and the benefits to be gained if an individual quits smoking. In 
light of the importance of smoking to periodontal health, further exploration of 
smoking: its prevalence, systemic health impact and benefits of quitting, 
smoking-related legislation, smoking cessation interventions and the potential 
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role of dental personnel in changing smoking behaviours are discussed below, 
since in-depth knowledge of smoking together with a smoking cessation 
intervention should be the cornerstone of periodontal treatment. 
 
2.1.3.1 Smoking prevalence 
As the detrimental health effects of smoking have become widely known, and 
legislation and support have been available to support people in quitting, 
smoking prevalence in the United Kingdom has decreased. In 1960 61% of men 
and 42% of women in the UK smoked, but by the year 2000 this had reduced to 
28% and 26% respectively (World Health Organisation 2011). The rate of decline 
has slowed however, and it seems likely that the remaining smokers are those 
who are completely uninterested in quitting or who find it extremely hard. Figure 
2.3 shows the multitude of factors which influence decisions to take up or 
continue to smoke tobacco. 
 
Figure 2.3: Factors associated with smoking (Towards A Future Without 
Tobacco: The report of the Smoking Prevention Working Group, Scottish 
Government 2006) 
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There is a stark contrast in the prevalence of smoking in deprived and affluent 
areas of Scotland, ranging from 43% of adults smoking in the most deprived 
areas and only 9% smoking in the most affluent areas (ASH Scotland 2010). 
 
The Adult Dental Health Survey conducted in 2009 found that 22% of over 
sixteen year olds in England, Northern Ireland and Wales were current smokers, 
and that smokers were more likely to be edentulous than non-smokers – 24% 
versus 22% (Chadwick et al, 2011). Younger age groups were more likely to 
smoke, as were men (24%) rather than women (21%). Thirty percent of adults in 
households with manual occupations smoked as opposed to 16% from 
managerial and professional occupation households (Chadwick et al, 2011).   
 
The Scottish Executive and Government have had various targets for smoking 
rates and in 2005 a reduction in adult smoking to 22% by 2010 was set (ASH 
Scotland 2010). Latest figures available show that adult smoking prevalence 
across Scotland is 23.3%, with 25% of men and 22% of women smoking. Those 
in the 25 – 34 year age group have the highest smoking prevalence at 31% and 
26% of men and women respectively, reducing to 19% of men and 17% of 
women in the 60 – 74 years age group. Extreme differences in smoking 
prevalence are found by socioeconomic status in Scotland with 40% of those in 
the most deprived areas smoking as compared with 11% in the least deprived 
areas. The adult smoking prevalence in Argyll & Bute Community Health 
Partnership area is 22% (Scottish Household Survey 2011). 
 
One of NHS Health Scotland’s key targets known as the HEAT (Health Efficiency 
Access and Treatment) targets stated that, through smoking cessation services, 
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8% of smokers should be supported to successfully quit over the period 2008-
2011 (NHS Health Scotland 2007) and Argyll & Bute CHP met this target 
(Galbraith and Hecht, 2012). An updated HEAT target aims that NHS Scotland 
delivers at least 80,000 successful quit attempts at one month post quit, including 
48,000 in the most deprived SIMD areas in each Board over the three years 
ending March 2014. NHS Highland is exceeding the target for the population as a 
whole and is marginally ahead of target in the most deprived areas (ASH 
Scotland Tobacco Factsheet 2013). 
 
2.1.3.2 Oral health impacts of smoking other than chronic periodontitis 
In addition to its impact on the periodontal tissues, smoking is associated with 
discolouration of the teeth and tooth-coloured restorations, halitosis, soft tissue 
lesions, pre-cancerous lesions and oral cancer (Beaglehole and Watt 2004).  
 
Benign smoking-related soft tissue lesions include smoking related melanosis 
which is characterised by brown pigmented spots on the oral mucosa which can 
be localised or widespread. Black or brown hairy tongue is a benign lesion on the 
dorsum of the tongue caused by staining of the filiform papillae by nicotine, 
coffee or red wine (Bagan et al. 2010). Median rhomboid glossitis presents as a 
characteristic red lesion in the midline of the dorsal surface of the tongue anterior 
to the circumvallate papillae which is created by atrophy of the papillae 
(Warnakulasuriya et al. 2010). Nicotinic stomatitis is mainly associated with 
smoking pipes or cigars and presents as keratosis of the palate (Hunter and 
Yeoman 2013; Bagan et al. 2010; Warnakulasuriya et al. 2010). 
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Leukoplakia, erythroplakia and chronic hyperplastic candidosis are among the 
smoking-related pre-cancerous lesions found in the oral cavity (Brocklehust et al. 
2010). Leukoplakia is characterised by white or speckled lesions which cannot be 
explained by another cause (Hunter and Yeoman 2013). It is potentially 
malignant and a biopsy will show the degree of dysplasia present. In a ten year 
period 5 – 20% of leukoplakias become malignant. Erythroplakia presents as a 
red patch on the oral mucosa and requires a biopsy to determine its malignant 
potential. Erythroplakias are more likely to become malignant than leukoplakias. 
Chronic hyperplastic candidosis is a potentially malignant candidal infection 
which is likely to recur if the patient continues to smoke. It is characterised by 
white plaques of varying thickness and shows dysplasia in 15 – 50% of lesions 
(Bagan et al. 2010).  
 
The incidence of oral cancer is increasing in Scotland and is greater than in the 
rest of the UK (Conway et al. 2010). It is found twice as frequently in males rather 
than females, and is commonest in older age groups. However, the number of 
younger people being diagnosed with oral cancer is increasing (Mackenzie et al. 
2000). Whatever the age group or gender of those with oral cancer, cigarette 
smoking and alcohol intake are strong risk factors. Oral cancer and its risk 
factors are strongly linked to socio-economic status and Conway et al. found 
widening social inequalities amongst those diagnosed with oral cancer in 
Scotland between 1976 and 2002 (Conway et al. 2007). 
 
Despite the relative ease of examination of the oral mucosa, half of those with 
oral cancer already have metastases on diagnosis, which greatly reduces 
survival rates (McCann et al. 2000). Public health campaigns advising the 
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population of Scotland of the importance of oral examinations and educational 
initiatives with dental professionals demonstrating the role they have in the 
prevention and early diagnosis of oral cancer, have failed to improve the five-
year survival rate of 50% (Brocklehurst et al. 2010; Carter and Ogden 2007; 
McCann et al. 2000).  
 
Oral cancer should be included in the differential diagnosis of any patient 
presenting with one or more of the following which cannot be explained by 
another cause (Hunter and Yeoman 2013; Bagan et al. 2010): 
 
o Non-healing ulcer present for several weeks 
o Red or white or speckled lesion 
o Bony or soft tissue swelling 
o Mobile teeth not related to periodontal disease 
o Altered sensation e.g. paraesthesia 
o Altered function e.g. difficulty in moving tongue 
o Mass in neck or lymphadenopathy 
 
2.1.3.3 Systemic health effects of smoking 
The adverse health effects of cigarette smoking have been recognised for 
decades since the work of Richard Doll proved a link between cigarette smoking 
and lung cancer in 1950 (Doll and Hill 1950) and with increased mortality from all 
causes in a population of doctors in 1954 (Doll and Hill 1954). Since then, 
tobacco has been shown to be a causal factor in many other diseases, notably 
chronic obstructive pulmonary disease, peripheral vascular disease and coronary 
heart disease (Doll et al. 2004; Peto et al. 1996).  
 55 
 
The estimated annual number of smoking-related deaths in Scotland is 13,000 
(ASH Scotland 2010) and 1,500 – 2,000 of these are thought to be due to second 
hand smoke (NHS Health Scotland 2005). Adults exposed to second hand 
smoke have a 20-30% increased risk of lung cancer and coronary heart disease. 
Rates of asthma, bronchitis, pneumonia and croup are all increased in children 
exposed to second hand smoke, as is sudden infant death syndrome (British 
Medical Association 2004).  
 
The National Institute for Health and Clinical Excellence (NICE) guidance 
produced in 2006 stated that not only is smoking the greatest cause of 
preventable morbidity, but that it is also the major factor in explaining health 
inequalities between high and low socioeconomic groups (NICE 2006).  
Action on Smoking and Health (Scotland) - ASH Scotland - is a campaigning 
organisation seeking effective tobacco control legislation in Scotland.  They have 
a role in raising awareness about the harm caused by tobacco, protecting 
children from tobacco and influencing legislation about tobacco. They also 
contribute to public health policies targeted at smokers wishing to quit. They 
produced statistics estimating the cost of smoking to the NHS in Scotland to have 
been £323 million in 2009, taking into account treating tobacco-related disease, 
outpatient and inpatient costs and prescription costs (ASH Scotland 2013). They 
also estimate that in the period from 2006 – 2010, £1.1 billion was spent annually 
in Scotland for all smoking-related costs including health and productivity losses 
(ASH Scotland 2013). 
 56 
In addition to the direct effects of cigarette smoking studies have shown that 
adolescents who smoke cigarettes are more likely to use smokeless tobacco, 
alcohol and illegal drugs (Torabi et al. 1993). Tobacco is therefore described as a 
“gateway drug” which encourages uptake of other health-damaging behaviours. 
The differential between rates of alcohol and illegal drug use in smokers and 
non-smokers is greater in children with behavioural difficulties such as those with 
attention deficit hyperactivity disorder (Biederman et al. 2006). 
Table 2.2: Health benefits of quitting smoking (American Cancer Society 2010) 
Time after quitting Health benefit 
20 minutes Heart rate and blood pressure drops 
12 hours Carbon monoxide level in bloodstream drops to normal 
2weeks – 3 months Circulation improves and lung function increases 
1 – 9 months Coughing and shortness of breath decreases 
1 year Increased risk of coronary heart disease halves 
5 years Stroke risk reduces to that of a non-smoker 
10 years Lung cancer death rate half of a continuing smoker 
 
2.1.3.4  Chronic periodontitis, smoking and dental implants 
The use of osseointegrated dental implants to replace natural teeth is increasing 
and it would be expected that chronic periodontitis could affect their long-term 
success (Singh 2011). Pye et al. (2009) found in a review of studies examining 
peri-implant infections that similar pathogens were found as in chronic 
periodontitis e.g. Porphyromonas gingivalis and Treponema denticola. In a five 
year prospective trial, Weenstrom et al. (2004) found that in patients susceptible 
to periodontitis only small levels of bone loss occurred over the follow-up period. 
Anner et al. (2010) found in a retrospective assessment of patients over a ten-
year period that those with chronic periodontitis had increased risk of losing their 
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dental implants – 14% rather than 8% in those without periodontitis – but this did 
not reach statistical significance. 
 
Aloufi et al. (2009) found that there was significantly greater bone loss around 
implants in patients with severe periodontitis. In a prospective study among 
patients susceptible to periodontitis Machtei et al. (2007) found that bone loss 
was more marked in molar regions than at the front of the mouth. Levin et al. 
(2011) conducted a cohort study to evaluate the impact of periodontal status on 
implant survival and found that poor periodontal status did adversely affect 
survival rates. They also found a fluctuating risk of implant loss over a long-term 
follow-up period suggesting that the pattern of peri-implantitis is similar to that of 
chronic periodontitis around natural teeth with bursts of activity causing 
significant destruction of surrounding tissues (Levin et al. 2011). 
 
Smoking has been found to be a risk factor for early loss of dental implants in 
many studies, with a failure rate of around double that of non-smokers being 
found consistently (Anner et al. 2010; Baig and Rajan 2007; Mundt et al. 2006; 
Galindo-Moreno et al. 2005; Nitzan et al. 2005; Levin et al. 2004). As well as 
being associated with increased bone loss, bone grafts are less successful in 
smokers and peri-implantitis is more common (Heitz-Mayfield 2008; Galindo-
Moreno et al. 2005; Nitzan et al. 2005; Baelum and Ellegard 2004; Lindquist et 
al. 1997; Haas et al. 1996). It is understood that the mechanisms by which 
smoking affects periodontal health by its impact on wound healing and immune 
responses, also affects peri-implant tissues although the extent and rate of 
progression may be greater (Lang et al. 2011). 
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The increased failure rate of dental implants in smokers appears to be dose-
related, with heavy smokers being more greatly affected than light or moderate 
smokers (Bain 2003; Lindquist et al. 1996; Bain and Moy 1993). Dental implant 
failure rates are higher in the maxilla than in the mandible, which may be due to 
the lower bone density of the maxilla (Nitzan et al. 2005; Lambert et al. 2000; 
Haas et al. 1996; Bain and Moy 1993). 
 
A higher level of marginal bone loss around implants was found in smokers than 
non-smokers by Nitzan et al. in 2005, and Anner et al. 2010 found reduced 
osseointegration. Stoker et al. discovered, in a randomised controlled trial 
comparing three different implant-retained prostheses, that marginal bone loss 
was twice that in smokers as in non-smokers whichever type of prosthesis they 
received (Stoker et al. 2012). However, the overall rate of implant loss remains 
relatively low in smokers and so smoking should not be seen as a prohibiting 
factor when considering implant placement (Johnson and Hill 2004). Smokers 
should of course be informed of the increased risk of implant loss and 
encouraged to quit (Peleg et al. 2006). 
 
2.1.4  Addiction 
It is widely reported that around seventy percent of smokers would like to quit 
(Health Scotland and ASH Scotland 2010; NICE 2006; Beaglehole and Watt 
2004) However, tobacco is a highly addictive drug and whilst a third of smokers 
make a quit attempt each year, only two percent succeed.  
 
Nicotine is the constituent of tobacco which leads to its addictive nature. Inhaled 
tobacco smoke enters the bloodstream and reaches the brain within seconds 
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(Hatsukami et al. 2008). The nicotinic receptors in the brain are then activated, 
which allows the release of several neurotransmitters such as dopamine, 
serotonin and acetylcholine which produce feelings of wellbeing (Glover et al. 
2003). Peak dopamine levels are reached five minutes after smoking a cigarette, 
and the effects of the nicotine reduce significantly after thirty minutes (Royal 
College of Physicians 2007). Smoking another cigarette will reactivate the 
dopamine reward system and reproduce feelings of wellbeing.  
 
Chronic use of addictive substances such as nicotine is thought to modify the 
dopamine reward system so that increased doses are required to produce the 
same effects. This neuroadaptation also explains withdrawal symptoms if the 
substance is withdrawn, and makes relapse more likely (Benowitz 2008). 
Withdrawal symptoms are also a response to motivational symptoms 
experienced when an addictive substance is withdrawn e.g. dysphoria, 
depression, irritability and anxiety, although do not appear to be related to 
underlying depressive illness (Edwards and Kendler 2011). 
 
Studies in twins raised in separate environments have shown a genetic 
component in vulnerability to addiction to all substances including tobacco (Vink 
et al. 2005). It has not been possible as yet to determine the exact genes 
associated with nicotine addiction but it would seem that there are many genes 
involved (The Tobacco and Genetics Consortium 2010). 
 
The neurological effects of nicotine explain part of the addictive nature of 
smoking cigarettes; however, there is more than physiology at play. Behavioural 
theories of addiction include the drug self-administration model in which a 
 60 
combination of neurological effects and social effects such as admiration of one’s 
peers encourages continued drug use (Altman et al. 1996; Benowitz 2008). 
Another theory postulates that cues are important in sustaining drug misuse e.g. 
smelling alcohol or finishing a meal when one would normally light up a cigarette. 
This cue exposure theory explains why cravings may persist long after physical 
dependence has been overcome (Drummond et al. 2001).  
 
Cognitive theories of addiction suggest that addiction is a failure of self-
regulation, with a defective reliance on substance misuse to maintain 
psychological equilibrium, and has been demonstrated in smokers (Waters et al. 
2003). It has been suggested that some personality types have a higher risk of 
developing addiction than others and some evidence exists that those 
personalities scoring high for irritability and impulsivity are more vulnerable 
(Conway et al. 2003).  
 
There are several rational choice theory models of addiction which propose that 
short term benefits are heavily weighted over longer-term ones, so that the 
immediate gratification obtained by having a cigarette now may rationally 
outweigh the long-term benefits of stopping (Vuchinich and Heather 2003). 
 
Sociocultural factors such as socioeconomic background, exposure to drug-
taking and peer pressure also influence the likelihood of legal and illegal 
substance misuse (Pruitt et al. 1991). Increased social capital has been shown to 
improve smoking quit rates in a British population (Giordano and Lindstrom 
2011). 
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In addition to the myriad theories of addiction, many models of behavioural 
change have been described which aim to encourage people to avoid unhealthy 
behaviours in favour of more beneficial ones. When developing behaviour 
change interventions, such as smoking cessation interventions, a theoretically-
based model can be used to help individuals to adopt a healthy change and also 
to sustain it (Family Health International 2007). A review of commonly cited 
behaviour change models can be found in Appendix 1.  
 
2.1.5 Smoking cessation interventions 
 
Research into the most effective methods of delivering smoking cessation advice 
is ongoing, but there is robust evidence existing to show that they are worthwhile. 
A Cochrane Review conducted in 2000 showed that all available interventions 
are more effective than doing nothing (Lancaster et al. 2000).  
 
Two types of smoking cessation intervention are recommended for use by the 
Scottish Government i.e. brief interventions and intensive interventions, and 
these are commonly used worldwide (Health Scotland and ASH Scotland 2010; 
Gordon 2010; Gonseth et al. 2010; Hanioka et al. 2010; Twardella 2007; Wang 
1994).  
 
Brief Intervention 
Brief interventions consist of asking the patient about their smoking habits, 
advising them of the benefits of quitting and assessing their readiness to quit 
(Gordon 2010; Twardella 2007). This is also known as the 3 As model of 
smoking cessation. No more than 10 minutes should be spent on this activity. If 
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the patient is interested in quitting at this point they should be referred to 
specialist services (Health Scotland and ASH Scotland 2010). 
 
Intensive intervention 
Intensive smoking cessation interventions are most often delivered by specialist 
smoking cessation services although other healthcare professionals who are 
suitably trained may also provide them. As well as following the steps of a brief 
intervention, the healthcare provider goes on to assist the smoker in quitting, 
and arranges follow-up appointments. This is referred to as the 5 As model of 
smoking cessation (Health Scotland and ASH Scotland 2010). 
 
Evidence points to smoking cessation interventions which combine 
pharmacological and behavioural support being most effective, with a Cochrane 
systematic review and meta-analysis finding a risk ratio of 1.82 in favour of 
combined therapy over control groups (Stead and Lancaster 2012; NICE 2006).  
 
2.1.5.1 Behavioural support 
NHS Health Scotland in conjunction with ASH Scotland have devised guidelines 
for  smoking cessation interventions, the behavioural support component of 
which is based on the theories of addiction (see page 58) and behaviour change 
(see page 60 and Appendix 2). The details of the smoking cessation intervention 
described here are based on the model devised by NHS Health Scotland.  
 
The behavioural support component of the smoking cessation intervention 
consists of preparing the smoker for their quit attempt (see Stages of Change 
model, Appendix 1) by encouraging them to set a quit date, and to avoid 
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changing their smoking habits prior to this. Ideally the last cigarette should be 
smoked just before the quit date visit to the stop smoking services. Smokers 
should be advised to tell friends and family of the date they are going to quit in 
order to maximise the support they receive (Park et al. 2012; Patten 2012). They 
should remove all smoking paraphernalia prior to the quit session to avoid 
temptation. The counsellor encourages the client to explore their smoking habits 
and the difficulties they face in quitting. If they have made previous quit attempts, 
the reasons for relapse should be explored (NHS Health Scotland and ASH 
Scotland 2010). As there is a relationship between the level of dependence on 
nicotine and the difficulty in giving up smoking, the national smoking cessation 
intervention recommends assessing the level of nicotine dependence prior to the 
quit attempt getting underway. There are several tools available for determining 
nicotine dependence but the Fagerstrom test of nicotine dependence is the most 
frequently used tool in Scotland and this test has been validated in assessing 
dependence and predicting relapse (Zhou et al. 2009, Piper et al. 2006) (see 
Table 2.4. page 82).  
 
The majority of smokers will have lapses during their quit attempts i.e. will smoke 
a few puffs or a few cigarettes at a weak moment but many will then continue 
without tobacco longer term. It is estimated from studies that 60-90% of 
individuals who stop smoking will relapse i.e. sustained use of smoking, within 
the first year (Krall et al. 2002). A systematic literature review of relapse 
prevention strategies did not identify any one strategy which was more 
successful than the others and concluded that more research is required to 
identify the best methods to prevent relapse (Hajek et al. 2009). Nevertheless, it 
is important that counsellors help clients to recognise the dangers of relapse and 
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identify their own strategies for dealing with triggers to smoke (McEwen et al. 
2006). 
 
Information regarding the likely consequences of stopping smoking can help 
clients to prepare therefore counsellors should advise clients that they will 
experience nicotine withdrawal symptoms which can be counteracted by using 
nicotine replacement therapy (NRT). Cravings can continue for several years in 
some people but NRT, and distraction strategies such as physical exercise can 
help. This approach shows the combined thrust of behavioural and 
pharmacological support in intensive smoking cessation interventions. 
 
A common concern among potential quitters is that they will gain weight. Nicotine 
is an appetite suppressant and so stopping smoking can increase food intake 
due to increased appetite. Many people use food as a cigarette substitute in the 
early stages of a quit attempt. It is normal for a smoker to gain six kilograms in 
the twelve months after quitting but it is not inevitable. Increasing exercise, 
keeping healthy snacks at hand and using chewing gum can help minimise 
weight gain. A Cochrane review of intervention aimed at reducing weight gain 
post quitting smoking found little evidence of long term success for any 
pharmacological or behavioural intervention, but exercise proved most 
successful (Farley et al. 2011). These additional concerns are debated and 
discussed with smoking cessation counsellors as they assist clients to quit. 
 
There are many potential effects of stopping smoking, some of them negative in 
the short-term e.g. disturbed sleep, irritability, bleeding gums; therefore 
counsellors must ensure clients are well-informed of the overwhelmingly positive 
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short and long-term health, social and financial benefits of quitting smoking 
(Hajek et al. 2009).  
 
Clients are therefore supported to develop their own strategies for coping with 
cravings, and to review their motivations for quitting (Lai et al. 2010; Miller 2002). 
Reassurance and advice should be offered at the quit visit and each follow-up 
visit, regardless of whether the quit attempt is succeeding (Soria et al. 2006; 
Stein et al. 2006). Evidence shows that a minimum of 4 hour-long weekly 
sessions are required to maximise the benefit of behavioural support, with 6-8 
sessions being recommended as ideal (NHS Health Scotland and ASH Scotland 
2010). 
 
2.1.5.2 Pharmacological support 
Nicotine is a highly addictive substance which makes quitting smoking very 
difficult for most people. As addiction to smoking is due to nicotine, the use of 
nicotine replacement therapy (NRT) alleviates withdrawal symptoms. No adverse 
effects have been found from the use of NRT, because despite its highly 
addictive nature, it is one of the less harmful of the over 4000 chemicals found in 
tobacco smoke, and the amount of nicotine delivered by any NRT product is less 
than that obtained by smoking (US Department of Health and Human Services 
2004). A Cochrane Review conducted in 2008 showed no significant difference in 
the quit rates achieved using any of the NRT products available and so the 
personal choice of the person wishing to quit will determine which to provide 
(Stead et al. 2008). This review demonstrated a 50-70% increase in quit rates 
using a single NRT product over control groups. 
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Further research shows that a combination of nicotine replacement therapies can 
safely be used, and are more effective than only one therapy e.g. patch and 
nicotine chewing gum (Silagy et al. 2004). This combination provides a steady 
background level of nicotine from the patch, as well as a means of providing an 
instant nicotine boost to overcome cravings. An additional 35% of smokers 
succeed in quitting using a combination of NRT products compared with those 
using only one (Stead et al. 2008).  
 
Two drugs which do not contain nicotine are used in smoking cessation. 
Bupropion is an atypical antidepressant and has been shown to be at least as 
effective as NRT in assisting people in stopping smoking. It has not been 
associated with adverse side-effects. The mechanism by which bupropion assists 
in smoking cessation is unclear, but it is thought to involve the dopamine reward 
system (NICE 2007).  
 
Varenicline has been developed specifically to assist people to quit smoking and 
has been demonstrated to increase quit rates by around 50% more than single 
NRT products or bupropion, and 10-20% more than combination NRT. It acts on 
the nicotinic receptors of the brain in a similar manner to nicotine. However, it 
has been implicated in causing serious, potentially psychotic, side-effects in 
about twenty percent of recipients but is worth considering for short-term use. 
Either of these drugs can be used in place of, but not in addition to NRT (NICE 
2007). 
 
Studies have shown that providing NRT increases six month cessation rates from 
2-3% to 5-8% (Stead et al. 2012; West et al. 2000). Intensive counselling support 
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alone gives around 7% 6-month quit rates but this increases to 13 – 19% if 
intensive support is provided by specialist services and supplemented by NRT or 
bupropion (Silagy et al. 2004).  
 
Due to the evidence of the increased effectiveness of smoking cessation 
interventions when the person wishing to quit is fully engaged, NRT should only 
be prescribed when they have set a quit date and agreed to counselling support 
(NHS Health Scotland and ASH Scotland 2010). 
 
Guidance has been produced by NICE (2006), and by both UK and Scottish 
Governments, indicating that a brief smoking cessation intervention should be 
provided opportunistically to all smokers by all healthcare providers, including 
dental professionals, at appropriate times. Intensive support should then be 
arranged in-house if the expertise is available, or be referring the client on to 
NHS specialist stop smoking services. 
 
2.1.6 Smoking Cessation in the Dental Setting 
The Smoking Cessation Guidelines for Scotland (2004) and NICE Guidelines 
(2006) indicate that all healthcare professionals, including dental professionals, 
should determine their patients’ smoking habits, advise them to quit and provide 
smoking cessation advice or refer any patient indicating a desire to quit to 
specialist services. It is particularly pertinent for dental personnel to provide this 
support in light of the oral health impacts of smoking. 
 
Research into the effects of cigarette smoking on oral health began in the 1980s 
and the link between cigarette smoking and oral disease is proven, particularly 
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the association with oral cancer and periodontal disease (Mecklenberg 1998), but 
also wound healing, success of dental implants and aesthetic considerations 
(Watt et al. 2003). An improvement in periodontal health over and above that 
seen in smokers receiving periodontal treatment alone has been demonstrated in 
those quitting smoking (Preshaw et al. 2005). A study examining tooth loss 
among young adults in Japan indicated that smokers experience more loss of 
teeth than non-smokers (Ojima et al. 2007). 
 
Despite the importance to public health of smoking cessation and the variety of 
studies indicating that the dental team has a role to play in helping their patients 
to quit, a Cochrane Review in 2006 did not find studies of sufficient rigour to 
prove this (Carr and Ebbert 2006). An update of this review provided further, but 
still limited,  evidence pointing to the effectiveness of smoking cessation 
interventions undertaken in a dental setting (Carr and Ebbert 2012; Needleman 
et al. 2010). 
 
Several more recent studies have shown that smoking cessation interventions 
can be successfully delivered by dental hygienists (Gordon et al. 2009; Binnie et 
al. 2007). As dental hygienists are the dental team members most often providing 
behaviour change advice, it is reasonable to think that they are ideally suited to 
provide smoking cessation support.  Both brief and intensive smoking cessation 
interventions provided by the dental team have been shown to be effective in 
recent studies across primary and secondary care, and in public and private 
dental facilities (Gordon et al. 2010; Gonseth et al. 2010; Hanioka et al. 2010).  
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Evidence pointing to the effectiveness of smoking cessation services provided by 
dental professionals is growing, yet few dental teams assist patients in giving up 
smoking (Gonseth et al. 2010; Binnie 2009; Brothwell and Armstrong 2004). The 
main barriers cited include lack of training, lack of time, uncertainty of their 
effectiveness and fear that patients will not accept dental professionals tackling 
this issue. Even recent studies examining the attitudes of dentists and dental 
students to smoking cessation show that these barriers still exist (Clareboets et 
al. 2010; Rosseel et al. 2009), although most dentists do ask their patients about 
their smoking habits and advise them on the oral health effects of smoking 
(Johnson et al. 2006). However, evidence shows that the status of a dental 
practice can be enhanced if it is seen to be promoting general, as well as oral, 
health (Watt et al. 2000). Several studies have shown that patients expect their 
dental team to discuss smoking habits with them (Rosseel et al. 2009, Terrades 
et al. 2009). Campbell et al. (1999) showed that in a US population over half 
thought that smoking cessation support should be provided in the dental setting. 
 
The British Dental Association (BDA) guide to helping smokers stop (Beaglehole 
and Watt 2004) advocates the use of a 4 As approach. This involves asking all 
patients about their smoking status, advising them on the value of quitting, 
assessing their readiness to quit and arranging a referral to local smoking 
cessation services for motivated smokers. This mirrors the 3As approach 
described on page 61 but integrates the referral of smokers to specialist stop 
smoking services into the model, hence the additional “A”. The BDA also 
advocate that, where appropriately trained dental professionals are available, 
they may proceed to assist smokers to quit in the dental setting i.e. to adopt the 
5As model described on page 61. The assistance given to those who receive 
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smoking cessation support in the dental surgery includes provision of nicotine 
replacement therapy (NRT), behavioural advice and encouragement. Evidence 
suggests that using this more intensive 5 As approach in the dental surgery is 
more effective than referral (Gordon et al. 2007; Nohlert et al. 2009). 
 
It is thought that dentists may become discouraged due to the small proportion of 
patients with whom they broach the subject of quitting actually stop smoking, but 
the cumulative effect if all dentists were to do so would produce a very large 
public health benefit (Chestnutt 2010).  
 
2.1.7  Conclusions 
This literature review has shown that chronic periodontitis has a multifactorial 
aetiology and that some of the risk factors involved e.g. gender, genetics and 
medical conditions are innate and therefore not conducive to modification.  
However, a knowledge of these innate factors may allow better targeting of 
resources at those most likely to benefit from periodontal therapy.  
 
Evidence showing an association between medical conditions such as diabetes 
and cardiovascular disease with periodontal disease has not yet proven a 
causative link, but in spite of this, patients should be informed of the evidence 
that exists. This may allow them to make more informed decisions regarding the 
periodontal care they seek from dental professionals and the oral hygiene 
measures they undertake at home to maximise their periodontal health. It has 
been shown that the aforementioned medical conditions and periodontal disease 
share common risk factors. It therefore makes sense to approach public health 
and preventive strategies in an integrated manner with other healthcare 
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professionals in order to improve both oral and general health (Sheiham and 
Watt 2000). 
 
Chronic periodontitis has been found in this literature review to impact negatively 
on oral health-related quality of life, as has tobacco use. Prevention and 
treatment of periodontal disease, and smoking cessation support from dental 
professionals should therefore result in improved quality of life for dental patients. 
 
This literature review provides evidence that smoking is a major risk factor for 
chronic periodontitis, and therefore all periodontal treatment regimes should 
include some form of smoking cessation intervention. Scottish and UK 
Government legislation (NHS Health Scotland & ASH Scotland 2010; 
Department of Health 2011; NICE 2006), as well as guidance produced by dental 
professional bodies, also indicate that dental professionals, in common with all 
other healthcare professionals, should make the most of all opportunities to 
provide smoking cessation interventions.  
 
2.2     Purpose of Study 
 
2.2.0 Introduction 
The narrative literature review has demonstrated the high prevalence of chronic 
periodontitis found globally (Baelum and Lopez 2013; Kinane and Attstrom 2005) 
and a diversity of genetic, environmental and behavioural factors which 
determine periodontal health (Petersen and Ogawa 2005). Evidence of poor 
periodontal health causing a negative impact on oral health-related quality of life 
was also found in the narrative literature review (Bernabe and Marcenes 2010; 
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Nuttall et al. 2011). Furthermore, the narrative review indicated that all healthcare 
professionals, including dental professionals have a responsibility to offer 
tobacco cessation support at every opportunity (Clareboets et al. 2010; Rosseel 
et al. 2009). 
 
The narrative literature review encountered limited previous research in the field 
of smoking cessation in dental care settings, especially in primary care, although 
the available evidence suggests that it can be successful in supporting smokers 
to quit (Carr and Ebbert 2012).  Evidence of the effectiveness of provision of 
smoking cessation interventions in remote and rural primary dental care was 
lacking. The results of the narrative literature review led to the formulation of the 
research question found in section 2.2.1. 
 
2.2.1  Research question 
Is there an additional benefit for the promotion of periodontal health in a remote 
and rural population, achieved by comparing (A) an intensive smoking cessation 
intervention provided by a dental therapist in the dental surgery, with (B) an 
intensive smoking cessation intervention provided by an NHS smoking cessation 
specialist outwith a dental setting? 
 
2.2.2 Aim and objectives 
Aim 
To determine the amount of additional benefit for the promotion of periodontal 
health in a remote and rural population, achieved by comparing (A) an intensive 
smoking cessation intervention provided by a dental therapist in the dental 
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surgery, with (B) an intensive smoking cessation intervention provided by an 
NHS smoking cessation specialist outwith a dental setting. 
 
Research objectives 
1. To determine the number of regular dental attenders who are smokers 
who wish to quit smoking. 
2. To apply protocol (A) or protocol (B) to randomly allocated groups of 
smokers who wish to quit. 
3. To assess the effectiveness of protocols (A) and (B) as defined by self-
report and biochemical markers.  
4. To compare the benefit of protocols (A) and (B) on the periodontal health 
of successful quitters. 
5. To determine the improvement in the impact of oral health on daily living 
when periodontal health improves. 
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2.3 Method 
2.3.0 Introduction 
In any study investigating the effectiveness of an intervention the gold standard 
design is a randomised controlled trial. As subjects are randomly assigned to the 
control and intervention groups, provided that the numbers are sufficient, known 
and unknown confounding factors should be randomly distributed thus ensuring 
that any effect found can be attributed the intervention (Higgins et al. 2011). 
 
As this study aims to compare the effectiveness of two different smoking 
cessation interventions a blinded randomised controlled trial design is utilised to 
maximise the validity of the results (Schultz et al. 2010). 
 
2.3.1 Study population 
The population included in this study were adults who regularly attended a rural 
salaried general dental practice for dental care. Adults were defined as those 
eighteen years and over and no upper age limit was applied. Regular attenders 
were defined as registered patients who had attended the dental practice at least 
once per year in the previous two years. All those invited to participate were 
cigarette smokers wishing to quit and who were not currently attending smoking 
cessation services. Those who smoked on a daily basis were deemed to be 
smokers irrespective of the quantity of cigarettes consumed.   
 
2.3.2 Exclusion criteria 
In all research it is imperative to obtain informed consent from participants and 
therefore any adult meeting other inclusion criteria but who did not have the 
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capacity to provide informed consent was excluded from the study (Adults with 
Incapacity (Scotland) Act 2000 s5). 
 
Pregnant smokers were excluded from this study as very successful and well-
established specialised stop smoking support provided by midwives was 
available locally. Provision of tobacco cessation counselling and support for this 
specific group has proven to be most effective when provided alongside ante-
natal care (NHS Health Scotland and ASH Scotland 2010). 
 
Any potential participant with a medical condition known to adversely affect 
periodontal health was excluded as the response of their periodontal tissues to 
quitting smoking could be masked by their condition. The medical conditions 
which led to exclusion from the study included diabetes and fulminating immune 
deficiency diseases (Lalla and Papapanou 2011). Similarly, anyone receiving 
medication known to affect gingival health e.g. cyclosporin, an immune 
suppressant used in transplant recipients, was excluded from the study (Hyland 
et al. 2003). Those receiving palliative care for terminal illness were also 
excluded.  
 
Individuals who were receiving stop smoking support elsewhere were excluded 
from the study as this would confound results making it impossible to attribute 
any changes to the interventions applied as part of this study. 
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2.3.3 Recruitment strategy 
All participants recruited to this study were registered dental patients who 
attended regularly for dental care, and their smoking status was known to the 
dental team. Leaflets giving information about the research project were 
displayed at the dental reception desk and attention drawn to them by the dental 
receptionists. All patients confirmed as smokers by their dentist or dental 
hygienist/therapist were verbally informed of the project and offered an 
information leaflet. The contact details of the researcher were listed on the leaflet 
– both a landline and dedicated mobile telephone number were available. 
 
The local general medical practitioners were informed of the project and were 
fully in support, as were the heads of department of all other healthcare and 
social services available in the local community hospital. The Planning and 
Public Involvement Officer of Argyll and Bute CHP ensured that patient groups 
were aware of the project.  
 
In order to take full advantage of national advertising of smoking cessation 
activities for No Smoking Day, information stands were deployed in local 
healthcare settings, colleges, youth clubs, supermarkets etc. and staffed by the 
researcher in conjunction with specialist stop smoking counsellors. Recruitment 
of smokers was conducted from June 2011 – December 2012.  
 
2.3.4 Sample and sampling methods 
Sample size 
A sample size of 65 in the control group and 65 in the intervention group was 
required to give an 80% power to detect a difference in means of 8% in 
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periodontal pocket depth between the control group (40%) and the intervention 
group (42%) with a 5% two-sided significance level. Power analysis was based 
upon previously reported data (Adler et al. 2008). 
 
Randomisation 
An electronic randomisation package (www.random.org) was used to produce 
two lists containing all numbers between 1 and 200. Each number was randomly 
assigned to List 1 – control group – or List 2 – intervention group. The participant 
was then assigned to one of these two groups according to their individual 
participant identifier. The production of the randomisation lists and assignment of 
each participant was undertaken by an independent administrator, an employee 
of the Dental Directorate of Argyll & Bute CHP based distant form the research 
site and with no other involvement in the study.   
 
KE, who undertook the initial and follow-up clinical examinations, was unaware of 
whether the participants had been assigned to the control or intervention groups 
until after participants had completed the trial. 
 
The trial diagram illustrating the research process is shown in Figure 2.4. 
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Figure 2.4: Summary of Research Process for Randomised Controlled Trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruit 130 participants – adults who are smokers 
and regularly attend at dental surgery. 
Obtain consent 
Participants complete questionnaire about medical and smoking history. 
Undergo detailed oral examination to measure periodontal health. 
Provide saliva and expired breath sample to confirm amount smoked. 
CONTROL GROUP – 65 participants 
Referred by the dental therapist to NHS 
smoking cessation specialist counsellor 
 
 
INTERVENTION GROUP – 65 participants 
Receive intensive smoking cessation 
intervention from the dental therapist over 6 
– 8 weekly visits. 
Participants randomly allocated to control 
group or experimental group 
BOTH GROUPS – 130 participants (Six months later) 
Participants complete questionnaire about medical and smoking history. 
Undergo detailed oral examination to measure periodontal health. 
Provide saliva and expired breath sample to confirm amount smoked. 
Receive advice and treatment needed 
to improve periodontal health 
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2.3.5   Control and Experimental Interventions 
The smoking cessation interventions administered in this randomised controlled 
trial were those recommended by the Scottish Government document “A Guide 
to Smoking Cessation in Scotland” (NHS Health Scotland and ASH Scotland 
2010). The dental therapist, a long-standing employee of Argyll & Bute CHP 
Salaried Primary Care Dental Services who had demonstrated an interest in 
helping patients quit smoking, provided the intensive smoking cessation 
intervention in the dental surgery – Protocol  (A). She attended the nationally-
recognised training in stop smoking support at Glasgow Caledonian University. 
She obtained a Certificate of Accreditation in Specialist Stop Smoking Support 
for Individuals and Groups. The dental therapist therefore provided periodontal 
advice and stop smoking support to participants in the experimental group.  
 
2.3.5.1 The dental health and smoking habits questionnaire 
The questionnaire inquired about the participant’s smoking status, periodontal 
health and oral health-related quality of life and can be found in Appendix 2. 
 
Demographic profile 
Demographic data questions relating to gender, age, ethnic origin and 
occupation were recorded.  
 
Medical history 
The questionnaire asked respondents to record details of their medical history 
including current and past medical conditions and current medication.  
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Smoking-related knowledge 
Knowledge of the health impacts of smoking was explored in the questionnaire. 
The participants were asked to record whether a list of medical disorders could 
be caused or exacerbated by smoking using a simple yes/no or don’t know 
format.  
 
Smoking-related attitudes 
The attitude towards smoking was assessed using a five-point Likert-scale 
ranging from “not at all concerned” = 1 to “very concerned” = 5.  The twelve 
statements in Table 2.3 used the smoking cessation questionnaire as developed 
by Manfredi et al. (2006).  
 
Table 2.3: Smoking attitudes 
Statement Category 
I am concerned about effects of 
smoking on my health 
Health concerns 
I am concerned about effects of 
smoking on health of others 
Health concerns 
People close want me to quit smoking 
 
Social pressure to quit 
I am confident with personal problems 
 
Perceived stress 
Things gone my way recently 
 
Perceived stress 
I want to cut down my smoking 
 
Motivation 
I want to quit smoking 
 
Motivation 
I intend to quit smoking 
 
Motivation 
I am confident I could refrain from 
smoking when angry 
Situational self-efficacy 
I am confident I could refrain from 
smoking when under pressure 
Situational self-efficacy 
I am confident I could cut down on my 
smoking 
Confidence 
I am confident I could quit smoking 
altogether 
Confidence 
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Oral health-related quality of life 
The oral health related quality of life of respondents was measured using the 
OHIP-14 tool (see Table 3.24, page 189), first developed in 1997 by Slade and 
Spencer, and subsequently found to be valid and reliable when applied to a 
variety of populations, and in several different languages (Bernabe and 
Marcenes 2010; Sanders et al. 2009; Slade et al. 2005). It contains fourteen 
statements, two for each of the following seven dimensions of impact of oral 
health: functional limitation, physical pain, psychological discomfort, physical 
disability, psychological disability, social disability and pain. It utilises a Likert-
scale format with five possible responses ranging from “strongly disagree” to 
“strongly agree”. 
 
Oral health-related behaviours 
Questions regarding dental habits, including recent dental attendance patterns, 
frequency of toothbrushing and use of interdental cleaning aids were asked. 
These questions were based on those recorded in the 2009 Adult Dental Health 
Survey (Chadwick et al. 2011). The collection of this data allowed an assessment 
of the importance given to oral health by the respondents, and as the presence of 
a biofilm of dental plaque is related to periodontal health, data concerning oral 
hygiene practices was collected and correlated with periodontal treatment need 
(Marsh 2005). 
 
Smoking-related behaviours 
It has been demonstrated that the greater the level of dependence on tobacco an 
individual has, the more difficult they find it to achieve a successful quit attempt 
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(Zhou et al. 2009).  The questionnaire therefore sought to determine the nicotine 
dependence of the smokers participating in the randomised controlled trial. 
There are several tools available for determining nicotine dependence but the 
Fagerstrom Nicotine Dependence test is recommended by the Scottish 
Government (NHS Health Scotland and ASH Scotland 2010) and has been 
validated in assessing dependence and predicting relapse (Park et al. 2012; 
Zhou et al. 2009; Piper et al. 2006). This test was therefore selected for use in 
this trial and details can be found in Table 2.4. 
 
Table 2.4: The Fagerstrom Nicotine Dependence test 
Question Criteria Score 
How soon after you wake up do you smoke your first 
cigarette? 
Within 5 minutes 3 
6 – 30 minutes 2 
31 – 60 minutes 1 
After 60 minutes 0 
If you wake during the night, do you smoke a cigarette? Yes 1 
No 0 
Which cigarette would you find it hardest to give up? First one in morning 1 
Any other 0 
How many cigarettes or roll-ups do you smoke per 
day? 
10 or less 0 
11 – 20 1 
21 – 30 2 
31 or more 3 
Do you smoke most frequently in the morning? Yes 1 
No 0 
Do you smoke if you are ill enough to spend most of 
the day in bed? 
Yes 1 
No 0 
 
Smokers were asked about which tobacco products they used e.g. cigarettes, 
roll-ups, pipes etc. using a yes/no format. They were asked to state the number 
of smokers with whom they shared their house. Intensity of tobacco use was 
assessed by inquiring at what age the participants started smoking and the 
number of cigarettes they consumed per day. Lifetime exposure to tobacco is 
reported as the “pack year” which is calculated by multiplying the number of 
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years smoked (current age minus age on starting to smoke) by the reported 
quantity smoked per day (Binnie et al. 2007; Hanioka et al. 2007).   
 
Respondents were asked if they had made any recent attempts to cut down or 
quit smoking, and to describe their future plans for stopping (Hanioka et al. 
2007). These questions were based on those devised by Prochaska and 
DiClemente (1982) in their Stages of Change model, and widely used to assess 
motivation to quit in a population of smokers. 
 
2.3.5.2 The clinical examination 
Despite the high prevalence of periodontal diseases and the plethora of research 
papers investigating them, there is no standard methodology employed in the 
measurement of periodontal health and disease, or agreement as to the 
threshold at which health becomes disease (Tonetti and Claffey 2005). This 
complicates the comparison of results from different studies as well as the 
process of determining which measures to utilise when embarking on a project 
involving measurement of periodontal health. 
 
After reviewing the literature it was clear that measurement of more than one 
variable was required to determine periodontal health. A recent systematic 
review of methods used to identify periodontal disease concludes that all 
researchers should use a measure of clinical attachment loss to allow 
comparison of results across studies (Savage et al. 2009). The European 
Association of Dental Public Health commissioned a paper to examine 
methodological issues in periodontal epidemiology and this recommends 
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combining bleeding on probing, pocket depth and clinical attachment loss 
measurements as the principal variables (Leroy et al. 2010). 
 
This study uses the following indicators: bleeding on probing, plaque index, 
pocket depth and clinical attachment loss. 
 
Bleeding on probing 
Bleeding on probing has been shown to be a strong indicator of the presence of 
periodontal disease, providing a reliable and verifiable outcome measure. It is 
recorded in this study using a dichotomous scale i.e. present or absent as this 
has proven to be a reliable methodology (McClanahan et al. 2001).  
 
Plaque indices 
The majority of plaque indices report the area of the tooth covered by plaque. 
The earliest indices developed tended to divide the tooth into thirds i.e. cervical, 
middle and incisal thirds and score from 0-3 dependent on the coverage of 
plaque (Modified plaque index of Schick and Ash, 1961; Oral Hygiene Index of 
Greene and Vermillion, 1964). The Visible Plaque Index of Quigley and Hein as 
modified by Turesky in 1970 uses the same methodology as above but discloses 
the plaque to make it easier to measure.  
 
Other area-based plaque indices divide the tooth into a larger number of areas 
e.g. the Modified Navy Index divides the tooth into nine areas and weights results 
in favour of gingival plaque (Elliott et al. 1972). The axial plaque extension index 
and the proximal plaque extension index measure the height of disclosed plaque 
using a calibrated probe (Matthijs 2001). 
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The Plaque Index devised by Silness and Loe in 1964 sought to determine the 
amount of plaque present on each third of the tooth by recording the thickness of 
plaque accumulation. 
 
The Ekstrand Index attempts to determine oral hygiene by introducing a measure 
of the length of time the plaque has been present on the tooth using two-tone 
disclosing solutions which differentiate between mature and immature plaque 
(Ekstrand 1998). O’Leary (1972) developed a simple dichotomous plaque index 
in which 0 indicated no plaque present and 1 indicated that plaque was present. 
 
All of the above indices require some degree of subjectivity e.g. deciding what 
constitutes a third of the tooth, and, where disclosing solution is used, which 
proportion of the stained area represents plaque and which pellicle. Some of the 
indices measure the thickness of plaque and others the distribution, with or 
without weighting for specific sites. 
 
Eaton et al. (1997), using the dichotomous Plaque Index, demonstrated that 
reliable results can be achieved in primary care by inexperienced examiners. 
They also showed that with regular checks it is possible to maintain intra- and 
inter-examiner reliability over a period of twelve months which is comparable to 
the duration of data collection in this current study. Galgut (1999) has 
demonstrated that a dichotomous scale i.e. 0 = absence of plaque and 1= 
presence of plaque consistently shows lower levels of plaque than an ordinal 
scale but the differences are small. The dichotomous plaque record used by 
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Galgut (1999) gives adequate information to show levels of plaque as required in 
this clinical trial and simplifies data analysis and thus is the chosen methodology.  
 
Pocket depth and clinical attachment loss 
Pocket depth was recorded from the bottom of the pocket to the gingival margin 
with a standardised manual probe (Periodontal Probe EN15, Dentsply Ash, batch 
number 62012021). All probes used in this study were from the same batch so as 
to minimise inaccuracies in the markings on the tine of the probes. 
 
Clinical attachment loss represents the overall loss of periodontal attachment, 
both current and historical, and was measured from the bottom of the pocket to 
the cemento-enamel junction thus incorporating any gingival recession in the 
measurement.  
 
Although some researchers have espoused the use of periodontal 
measurements on selected teeth only so as to reduce the time required to 
assess periodontal status and the quantity of data generated, this has been 
shown to underestimate the extent of periodontal disease present (Borrell et al. 
2005; Craig et al. 2001). It was therefore decided to employ a full mouth 
examination to determine clinical attachment loss in this research project to 
maximise the quality of the data collected. Clinical attachment loss and pocket 
depth were recorded at six points on each tooth i.e. mesio-buccal, mid-buccal, 
disto-buccal, mesio-lingual, mid-lingual and disto-lingual.  
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Verification of smoking status 
Two different measures of the effectiveness of smoking cessation interventions 
are cited in research studies; point abstinence and continuous abstinence. Point 
abstinence defines success as no smoking in a pre-determined time interval e.g. 
in the previous one week or one month. A more stringent measure is that of 
continuous abstinence which measures success as no smoking over the entire 
study period. Both measures are reported here at the six month follow-up visit in 
order to facilitate comparisons with other trials and with the data collected by the 
Scottish Government from specialist stop smoking services. Self-report of 
smoking status was collected at twelve months. 
 
As self-report of smoking habits tends to lead to under-reporting, two methods of 
biochemical verification were utilised in the randomised controlled trial. 
Measuring of carbon monoxide in expired breath is inexpensive and easily 
understood and helps to motivate smokers to continue their quit attempt (Bittoun 
2008). However, carbon monoxide monitors can only reliably measure smoking 
activity for the previous 3 – 6 hours. 
 
Cotinine is a nicotine metabolite which accurately measures actual smoking 
behaviour.  It can be measured in urine, plasma or saliva, and can detect 
exposure to smoking in the previous 2-3 days (Barnfather et al. 2005). 
 
A chairside cotinine analyzer is currently available to measure cotinine levels in 
urine and it was hoped that an equivalent machine for the measurement of 
salivary cotinine would be piloted in this study. Unfortunately, the development of 
the prototype took longer than anticipated and data collection had to commence 
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before it was ready.  Instead of using the chairside quantitative analyzer, saliva 
samples could be sent to a laboratory for cotinine analysis. However, the lack of 
immediate patient feedback from the laboratory analysis of saliva samples was 
considered to be a significant shortcoming and so alternative methods of cotinine 
measurement were sought.  
 
As this is a dental based research project it was not felt appropriate to analyse 
cotinine in urine or blood in preference to saliva. It transpired that two brands of 
semi-quantitative chairside salivary cotinine measuring kits are available in the 
UK:  SmokeScreen Saliva produced by GFC Diagnostics, and NicAlert Saliva 
produced by Nymox Pharmaceutical Corporation. It was decided to undertake a 
pilot project to assess the accuracy and acceptability of these tests to determine 
their fitness for use in this research project. A full description of this pilot study 
can be found in Appendix 3. The results found that both tests had sufficient 
accuracy to distinguish non-smokers, light smokers, moderate smokers and 
heavy smokers. Both tests proved acceptable to participants but KE found the 
NicAlert test easier to administer and so it was chosen for this trial. 
 
All clinical data was recorded on the Clinical Examination form (Appendix 4). 
 
2.3.5.3  The data collection process 
At the initial visit with KE potential participants were informed of the aims of the 
study and provided with a Patient Information Sheet (Appendix 5). They were 
then allowed a week for reflection on whether or not to take part. At the following 
meeting they provided informed consent on the appropriate form (Appendix 6) 
and completed the self-administered questionnaire (Appendix 2), underwent a 
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clinical examination and had their smoking status verified by carbon monoxide 
and salivary cotinine measurements (Appendix 4). All participants were then 
provided with an appointment to see the dental therapist. 
 
At the first visit with the dental therapist the participant was provided with 
preventive advice i.e. oral hygiene instruction including toothbrushing and use of 
interdental aids. Routine non-surgical periodontal treatment was provided as 
required. At this point, randomisation was performed by an independent 
administrator. The dental therapist arranged an appointment for those 
participants assigned to the control group to see the specialist smoking cessation 
counsellor attached to this trial – Protocol (B). 
 
Those participants assigned to the intervention group were retained by the dental 
therapist and received Protocol (A), the 5As intensive smoking cessation 
intervention (NHS Health Scotland and ASH Scotland 2010).   
 
Participants in both groups continued to receive periodontal treatment and 
supportive care from the dental therapist as indicated by their individual 
treatment needs. 
 
Six months after the pre-randomisation visit with the principal researcher, 
participants from both control and intervention groups returned for repeat 
collection of the same data recorded initially i.e. completion of the questionnaire, 
clinical examination and carbon monoxide and cotinine measurements. 
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The intensive smoking cessation intervention – Protocol (A) – combined 
provision of nicotine replacement therapy (NRT) and behavioural support tailored 
to individual needs (NHS Health Scotland and ASH Scotland 2010).  
 
The behavioural component of the intervention allowed the participant to identify 
their own motivation to quit and difficulties they would face in their quit attempt. 
The techniques used were those of motivational interviewing which is a directive, 
client-centred counselling style used to encourage behaviour change (Soria et al. 
2006). Participants were encouraged to set a quit date and to prepare for that 
date in advance. Preparation included keeping a written record of why they 
wished to give up. This could then be consulted in moments of temptation. 
Having identified their “favourite” cigarettes, they were encouraged to find a 
change in routine that fitted their individual circumstances to help overcome 
these difficult times. In keeping with the ethos of motivational interviewing (van 
Schayck et al. 2008), clients were encouraged to identify the sources and 
solutions to their own difficulties during the quit process with direction from the 
dental therapist. 
 
The pharmacological component of the intervention involved providing the 
participant with nicotine replacement therapy (NRT). As no evidence exists to 
favour one presentation of NRT over another (West et al. 2000), personal choice 
was exercised by the participant in determining which of the following 
presentations were used: patch, gum, nasal spray, oral spray, sublingual tablet, 
lozenge or inhalator. An increase in quit rates has been demonstrated when a 
combination of NRT is used (Silagy et al. 2004) and so participants were offered 
combination therapy where appropriate. As NRT is not available in the Dental 
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Practitioner’s Formulary, a Patient Group Direction was developed by KE in 
conjunction with the Lead Pharmacist and Lead Smoking Cessation Adviser of 
Argyll & Bute CHP. The Patient Group Direction was employed by the dental 
therapist and can be found in Appendix 7.  
 
Two pharmacological interventions, bupropion and varenicline, which have been 
shown to increase quit rates and are not based on NRT were not offered in this 
study. This decision was taken as the local specialist stop smoking services do 
not offer these drugs routinely and discouraged their inclusion in this trial. Any 
participant wishing to use either of these drugs was referred to their general 
medical practitioner and removed from the study. 
 
Weekly visits were arranged with the dental therapist for 6-8 weeks, as this has 
been shown to be the most effective and efficient time period and interval for 
promoting smoking cessation. The choice of nicotine replacement therapy was 
discussed and the presentation or combination of presentations preferred by the 
client was provided. At subsequent visits, changes to dosage or presentation 
were arranged as deemed appropriate by the dental therapist after discussion 
with the participant. Nicotine replacement therapy was withdrawn when the client 
was ready – between six and twelve weeks after starting therapy.  
 
The weekly visits allowed the dental therapist to motivate the participant, 
congratulating them on their success so far, or encouraging them to continue if 
they had lapsed. Strategies to counteract cravings and prevent relapse were 
reinforced at each visit. The measurement of the level of carbon monoxide in 
expired breath at each visit served a twofold purpose. As well as verifying a 
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cessation or reduction in smoking, the decreasing levels provided motivation for 
participants to continue with their quit attempt. Carbon monoxide is expelled from 
the body twenty four hours after quitting and so participants received tangible 
evidence of health improvements at an early stage (Bittoun 2008).  
 
Details of the smoking cessation intervention were recorded using the Scottish 
Government Minimum Dataset record, allowing the results of this study to 
contribute to the overall picture of smoking cessation activity in Argyll & Bute 
CHP (see Appendix 8). 
 
2.3.6 Ethical considerations 
Ethical approval was obtained from the East of Scotland Research Ethics Service 
– REC reference number 10/S0501/37 (See Appendix 9). NHS Highland 
Research & Development Department also approved the project – R&D 
reference number 684 (See Appendix 10). 
 
Potential participants were invited to meet with KE and the purpose and process 
of the research project was explained. They were given an opportunity to ask any 
questions they wished and it was made clear that a decision not to participate, or 
to withdraw from the project at any time, would not have any negative 
repercussions. Each potential participant was given a copy of the Participant 
Information Sheet (see Appendix 5) to take away with them and encouraged to 
discuss it with family and friends if they wished. Following a week for reflection, 
prospective participants attended a further appointment with KE and provided 
written consent (see Appendix 6) if they wished to participate.  
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2.3.7 Data Analysis 
In order to facilitate data analysis, demographic data such as age and occupation 
were categorised. Participants were divided into younger and older age groups 
using a median split, whilst occupations were divided into four groups – Group 1: 
requiring school level qualifications only, Group 2: requiring workplace training, 
Group 3: requiring sub-degree level qualifications and Group 4: requiring degree 
level qualifications – according to the Standard Occupational Classification 
(Office of National Statistics 2010). 
 
The variables which utilised Likert scales were analysed using mean scores 
and/or categorised data according to convention to allow comparison with results 
found elsewhere e.g. OHIP-14 results found in the Adult Dental Health Survey. 
 
Nicotine dependence was calculated by assigning numerical values to participant 
responses according to the recommendations of Fagerstrom who devised the 
questionnaire (Table 2.4, page 82).  
 
Bleeding on probing and plaque were both recorded at six sites per tooth using a 
dichotomous scale and so the scores of 0 or 1 were totalled and the percentage 
full mouth score calculated. Clinical attachment loss was presented as a mean of 
the total values per site, and also stratified to present percentages of participants 
with loss of attachment of over 4mm, over 6mm and over 9mm. This stratification 
allowed comparisons of the data with those found in the Adult Dental Health 
Survey in 2009 as their data was presented this way (White et al. 2011). 
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Missing data were handled by replacing them with the mean value of the variable 
in question. 
 
2.3.8 Statistical analysis 
All data analysis in the randomised controlled trial used the SPSS electronic 
statistical programme Version 16.0. Following pooling of the data from the self-
administered questionnaire they were coded and entered into the SPSS 
database. Frequency distributions were employed to provide a basic analysis of 
the data. Chi-squared tests were used to analyse categorical data, whilst t-tests 
and Analysis of Variance (ANOVA) were used to analyse continuous data, with 
statistical differences between groups being determined by post hoc Scheffe 
tests.  
 
Outcome measures of smoking cessation were analysed at six and twelve 
months and the odds ratio was calculated by dividing the number of quitters in 
the treatment group by the number of non-quitters in the treatment group, and 
dividing that figure by the number of quitters in the control group by the number 
of non-quitters in the control group. The smoking cessation intervention offered to 
the intervention group – Protocol (A) – was considered to be more effective than 
referral to specialist smoking cessation services – Protocol (B) – if the odds ratio 
was greater than 1. All participants lost to follow-up underwent an intention-to-
treat analysis and were treated as non-quitters. 
 
Pocket depths and clinical attachment loss were analysed using repeated values 
of analysis of variance (ANOVA) to determine any changes between baseline 
and follow-up at six months. Differences in periodontal outcomes between the 
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control and the intervention group were analysed using negative binomial 
regression (Preshaw et al. 2005). 
 
2.3.9 Quality Assurance 
The data collected in this trial were based on validated measures where possible 
e.g. Fagerstrom assessment of smoking dependency and OHIP-14. The 
measures of periodontal health were selected following an extensive review of 
the literature in this area. The aim was to record the most comprehensive and 
appropriate level of information possible.   
 
The smoking cessation intervention was evidence-based and followed best 
practice guidelines produced nationally. The dental staff involved in the project 
i.e. KE and the dental therapist, undertook a nationally-recognised qualification in 
provision of stop smoking support – “Specialist Stop-smoking Support for 
Individuals and Groups” delivered by Partnership Action on Tobacco and Health 
(PATH), a joint initiative between ASH Scotland, NHS Scotland and the Scottish 
Government to reduce the prevalence of tobacco use in Scotland, under the 
auspices of Glasgow Caledonian University. Both the researcher and the dental 
therapist received mentoring from the Lead Smoking Cessation Counsellor for 
Argyll & Bute CHP. 
 
Selection bias was minimised by ensuring that randomisation was undertaken by 
an independent person. The researcher endeavoured to remain unaware of 
whether participants had been assigned to the control or intervention groups until 
after recording the post-intervention data and analysing it, thus removing 
detection bias. Attrition rates in both control and intervention groups were 
 96 
reported. All data were analysed on an “intention to treat” basis ensuring that any 
participants lost to follow-up were assumed to still be smokers. The most robust 
measure of smoking abstinence was reported i.e. continuous abstinence, 
alongside point prevalence of smoking in the previous seven days at six months 
and one year which allowed comparison with results in specialist stop smoking 
services in Scotland. 
 
Verification of smoking status took place at three levels – self-report, carbon 
monoxide monitoring and salivary cotinine monitoring thus providing the highest 
level of confirmation available.  
 
2.4  Results  
 
2.4.0 Introduction 
This chapter reports the results of the randomised controlled trial and reflects on 
the poor recruitment rate achieved. It will go on to explain attempts made to 
pinpoint the reasons for the failure of recruitment, and ultimately determine if and 
how it would be feasible to measure the effectiveness of a smoking cessation 
intervention in remote and rural dental primary care.  
 
2.4.1 Sample 
During the recruitment period from June 2011 – December 2012, a total of 
fourteen individuals indicated that they were interested in participating in the 
randomised controlled trial after they had read the Patient Information Sheet. A 
summary of the sample progress through the trial process can be found in Figure 
2.5. 
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One potential participant was excluded when it transpired that she was 
edentulous. Of the remaining thirteen interested parties, eight failed to attend for 
the initial consent visit with KE. A second letter and telephone follow-up resulted 
in a further failure to attend.   Five individuals attended the pre-randomisation 
visit and consented to take part in the randomised controlled trial. At this stage 
they completed the questionnaire, underwent a clinical examination and provided 
samples of expired breath and saliva for the biochemical verification of their 
smoking status. 
 
Follow-up appointments with the dental therapist were arranged at which they 
would receive all necessary periodontal treatment and advice and be randomised 
to either the control or intervention group for receipt of Protocol (A) or Protocol 
(B).  
 
When the five participants were recalled at six months to repeat the data 
collection undertaken at the initial visit, only three participants attended, and it 
transpired that the remaining two individuals had not attended any of the 
appointments arranged with the dental therapist and therefore had not received 
any part of the intervention. 
 
The random nature of the allocation process and the tiny numbers involved 
resulted in all three of the participants completing the trial having been allocated 
to the intervention group and none to the control group. 
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Owing to the very small sample size, results are presented as frequencies only, 
firstly including all five participants who attended the initial visit, and then 
comparisons between results for the initial visits and six month follow-up visits 
are presented for the three participants who completed the trial. 
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Figure 2.5: Study sample analysis using CONSORT 2010 Flow Diagram (www.consort-
statement.org), accessed 09/11/13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n= 14) 
Excluded  (n= 1 ) 
   Not meeting inclusion criteria (n=1 ) 
   Declined to participate by failing to 
attend initial meeting (n=8) 
   Other reasons: attended initial 
meeting, consented and completed 
questionnaire and clinical 
examination, but failed to attend 
meeting with dental therapist (n=2) 
Analysed  (n=0) 
 Excluded from analysis (give reasons) (n=0) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n=0) 
 Received allocated intervention (n=0) 
 Did not receive allocated intervention (not 
applicable) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n=0) 
Allocated to intervention (n=3) 
 Received allocated intervention (n=3) 
 Did not receive allocated intervention (give 
reasons) (n=0) 
Analysed  (n=3) 
 Excluded from analysis (give reasons) (n=0) 
 
Allocation 
Analysis 
Follow-Up 
Randomised (n=3) 
Enrollment 
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2.4.2 Demographic characteristics 
Each of the five individuals consenting to participate in the randomised controlled 
trial was female and their ages ranged from 24 – 56 years, with a mean age of 43 
years and a median age of 44 years. One of the participants described their 
ethnicity as gypsy traveller, with the remaining four recording that they were 
white British. The reported occupations of respondents were assigned to four 
levels of occupation according to the Standard Occupational Classification 
(Office of National Statistics 2010). Two of the participants were in occupations 
requiring sub-degree level qualifications, two were in occupations requiring 
school level qualifications only, and one was unemployed and her previous 
occupations had required only school-level qualifications.  
 
The age range of the three participants who completed the trial was from 39 – 56 
years, with a mean age of 49 years and a median age of 52 years. All reported 
they were white British females and two of them held occupations requiring sub-
degree qualifications, whilst the third worked in an occupation requiring only 
school level qualifications. 
 
2.4.3 Medical status 
Three (60%) of the participants stated they were receiving treatment from their 
doctor and four (80%) reported they were currently taking prescribed medication. 
The only medical conditions reported were angina (one respondent) and blood 
disorders (two respondents). 
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In the group of respondents who completed the trial one reported receiving 
medical treatment, two reported taking prescribed medications, one reported 
having angina and two had blood disorders at the initial visit. At the six month 
follow-up visits, two of the three respondents reported receiving medical 
treatment and all three were taking prescribed medication. The reported medical 
conditions had not changed. 
 
2.4.4 Smoking-related knowledge, attitudes and behaviours 
 
Smoking-related knowledge 
As part of the self-reported questionnaire, participants completed a table listing a 
range of medical conditions and were asked to record whether they considered 
the conditions to be related to smoking or not (see Appendix 2). The average 
frequency of correct responses over all twelve physical conditions listed was 
73.3%. The frequency of correct answers can be found in Table 2.5. 
 
Table 2.5: Knowledge of smoking-related health conditions 
Smoking-related 
health conditions 
Correct response – 
initial visit all 5 
participants 
Correct response – 
initial visit, 3 
completers only 
Correct 
response – 
follow-up visit 
 No. % No. % No. % 
Arthritis 3 60 3 100 3 100 
Heart disease 5 100 3 100 3 100 
Gum disease 5 100 3 100 3 100 
Skin disease 2 40 0 0 2 67 
Broken arm 5 100 3 100 3 100 
High blood pressure 5 100 3 100 3 100 
Mouth cancer 5 100 3 100 3 100 
Lung cancer 5 100 3 100 3 100 
Toothache 1 20 1 33 1 33 
Dementia 1 20 1 33 1 33 
Bronchitis 3 60 3 100 3 100 
Liver disease 4 80 3 100 3 100 
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Smoking-related attitudes 
Table 2.6 shows the mean score for each of the twelve attitudinal items for all 
those attending the initial visits, followed by results from the initial visits for the 
three participants who completed the whole trial. They were separated out in 
order to assess any differences in attitudes between those who completed the 
trial and those who did not. 
 
Table 2.6: Smoking-related attitudes 
 Smoking-related attitude Mean scores 
  Initial (n=5) Initial (n=3) 
1 Concerned about effects on my health 4.4 4.0 
2 Concerned about effects on health of others 4.2 4.0 
3 People close want me to quit 3.6 3.7 
4 I am confident with personal problems 3.4 3.0 
5 Things have gone my way recently 3.0 3.0 
6 I want to cut down my smoking 4.0 4.0 
7 I want to quit smoking 4.4 4.7 
8 I intend to quit smoking 4.4 4.0 
9 Confident could refrain when angry 3.0 2.7 
10 Confident could refrain when under pressure 2.6 2.0 
11 Confident I could cut down 3.8 3.3 
12 Confident I could quit altogether 3.6 3.3 
 
Smoking-related behaviours 
The age on starting smoking in this sample ranged from 11 – 33 years, with a 
mean age of 17.2 years (SD=9.0) and a median of 14 years. For the three 
respondents completing the trial the age on starting smoking ranged from 12 – 
33 years, with a mean of 19.7 years (SD=1.16) and a median of 15 years.  
 
Lifetime exposure to tobacco was measured using the pack-year, calculated by 
multiplying the number of years smoked by the number of packs smoked per 
day. The mean pack-years was found to be 23.6 for all five participants and 24.3 
for the three completing the trial.   
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Nicotine dependence was measured using the Fagerstrom Nicotine Dependence 
test (sse Table 2.4, page 82) which gives a score of between 0 and 8. The full 
range of scores was found in this sample with scores of 0, 0, 5, 7 and 8 being 
recorded, giving a mean value of 4.0. The three respondents who attended for 
follow-up had a range of nicotine dependence form 0 – 7 and a mean of 4.0. All 
but one of the respondents shared their house with one other smoker, and one 
respondent shared with two other smokers. Two of the three completers lived 
with one other smoker and the other was the only smoker in the house.  
 
Two of the smokers reported that they had cut down on the quantity of tobacco 
they consumed in the previous two months, both of them in the group that 
attended for follow-up. None of the respondents had tried to quit altogether or 
stopped for at least 24 hours in the previous two months. Four of the five 
respondents reported that they wished to quit smoking in the next six months, 
one of those who completed the trial having already set a quit date. The 
remaining respondent indicated that she wished to quit but not necessarily in the 
next six months. 
 
Two of the three participants reported point abstinence for the previous seven 
days and thirty days at the six month follow-up appointment, although one had 
lapsed for a one month period towards the beginning of the six month duration of 
the trial. The remaining participant had continued to smoke throughout. The 
veracity of the self-reported smoking status was borne out by the changes in the 
salivary cotinine and carbon monoxide measurements between the initial visit 
and the 6 month follow-up visit. Participants 1 and 2 reduced their cotinine levels 
from 2.0 to 1.0, and from 4.0 to 1.0 respectively, and carbon monoxide levels fell 
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from 5.0 to 2.0, and 12.0 to 2.0 respectively. A measurement of 0 or 1 for salivary 
cotinine indicates the person is a non-smoker as does a carbon monoxide 
measurement of 7 or under. Participant 3, who admitted continuing to smoke, 
actually presented increased cotinine (from 4.0 to 6.0) and carbon monoxide 
levels (from 14.0 to 32.0) at the follow-up visit. This reflected the fact that she 
had cut down her nicotine intake prior to attending for the initial visit, but has 
since returned to her previous level of smoking. Table 2.7 shows the mean and 
median values recorded for salivary cotinine and carbon monoxide at the initial 
and six month follow-up visits. 
 
Table 2.7: Cotinine and carbon monoxide measurements at initial visit and 6 
month follow-up 
 N Cotinine (ng/mL) Carbon monoxide (ppm) 
  Mean Median SD Mean Median SD 
Initial visit 5 4.2 4.0 1.5 18.0 12.0 1.7 
At 6 months 3 2.7 1.0 2.9 12.0 2.0 1.7 
 
2.4.5 Oral health-related quality of life 
The mean OHIP-14 score was 6.2 (SD=5.8), with a range of 2 to 16. Table 2.8 
shows the total mean OHIP-14 scores and number of impacts experienced 
among all five participants who attended the initial visit, the three completers at 
the initial visit and the three completers at six months.  
 
Table 2.8: OHIP-14 scores and number of impacts experienced 
Participant 
number 
Total OHIP-14 scores Number of impacts experienced 
 Initial visit At 6 months Initial visit At 6 months 
1 5 3 2 1 
2 6 3 3 2 
3 2 1 1 1 
4 2 N/A 1 N/A 
5 16 N/A 7 N/A 
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All of the respondents, whether they went on to complete the trial or not, had 
experienced at least one of the impacts on daily living measured by OHIP-14 
at least occasionally in the previous twelve months.  
 
2.4.5  Oral health-related behaviours 
Each of the respondents had attended the dental surgery in the previous 
twelve months, two for a routine examination and three due to problems with 
their teeth. Of those completing the trial, two had attended the dentist with 
problems and one for routine care.  
 
Four of the respondents reportedly brushed their teeth twice per day, whilst 
one brushed once daily. All three of those attending for follow-up brushed 
twice daily. Two of the respondents did not use any form of interdental aid, 
but the remaining three used dental floss (3), TePe brushes (2) and 
woodsticks (1). Two of those using dental floss and TePe brushes went on to 
attend for follow-up at six months. 
  
2.4.5 Clinical examination 
 Periodontal health 
Bleeding on probing 
The mean percentage of sites displaying bleeding on probing ranged from 6% - 
50%, with a mean of 25.8% across the five participants.  The three participants 
who completed the randomised controlled trial had an initial mean percentage of 
sites showing bleeding on probing ranging from 11% - 50%, with a mean of 
31.3%. The results at six months had reduced to a range of 0% - 24% with a 
mean of 8.7%. 
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Presence of plaque 
A range of 9% - 52% of sites showing presence of plaque was found among the 
five participants at the initial visit, with a mean of 28.2%.  Presence of plaque was 
found ranging from 17% - 52% of sites on the teeth of the three participants who 
completed the trial, with a mean result of 33.3%. An improvement was found at 
the six month follow-up visit when presence of plaque had reduced to a range of 
1% - 26% of sites, with a mean of 9.7%.  
 
Pocket depth and attachment loss 
The mean pocket depths found in the five respondents ranged from 1.2mm – 
2.3mm, a mean value of 1.9mm. When only the three participants who returned 
for follow-up were considered, the mean value for pocket depth was 2.2mm, with 
a range of 2.0mm – 2.3mm. At six month follow-up pocket depths had decreased 
to a mean of 1.8mm (range 1.6mm – 2.1mm). 
 
Attachment loss over the five respondents had a mean value of 2.3mm with a 
range from 1.6mm – 2.6mm. When only those respondents completing the trial 
were included, a mean value of 2.4mm was found with a range from 2.2mm – 
2.6mm. An improvement in attachment loss was found at six month follow-up 
with a range of 1.8mm – 2.7mm and a mean value of 2.3mm. 
 
In order to assess the severity of periodontal disease at individual sites in the 
mouth, and to allow comparison with other data published among a British 
population, the percentage of sites with clinical attachment loss of over 4mm, 
over 6mm and over 9mm was calculated. At the initial visits the percentage of 
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sites with attachment loss of greater than 4mm ranged from 1% - 10%, with a 
mean of 5.8%. Only one participant showed attachment loss of over 6mm (at 1% 
of sites) and over 9mm (at 0.5% of sites). 
 
When initial values and follow-up values for clinical attachment loss of over 4 mm 
were compared in the three participants who completed the trial mean values 
were 7% and 3% respectively, with ranges from 3% - 10% at the initial visits and 
1% - 6% at the follow-up visits. 
 
2.5 Discussion and reflections on the PHaSCe trial 
The number of participants enrolled to participate in the PHaSCe trial was 
extremely disappointing. The initial recruitment strategy consisted of dental staff 
at reception and in the dental surgery informing patients about the research 
project and providing anyone interested with a leaflet giving contact details for 
the researcher. All local general medical practitioners and heads of department in 
the integrated care centre where the dental practice is based were informed and 
supported the project. The Planning and Public Involvement Officer of Argyll & 
Bute CHP ensured that patient groups were aware of the project and events 
were held in conjunction with local specialist smoking cessation services to 
capitalise on national No Smoking Day and New Year’s resolutions.  
 
On encountering difficulties in recruitment, another site was included in the study. 
This site was felt to be comparable to the original in many respects: the dental 
practice was managed by the Salaried Primary Care Dental Service of Argyll & 
Bute CHP and comprised three dental surgeries based in a community hospital 
in a small town. The same process of motivating staff to assist in recruitment was 
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undertaken as for the Lochgilphead dental practice. However, recruitment rates 
did not improve following the addition of the dental department in Dunoon to the 
trial. 
 
On reflection, the recruitment process for this study relied on potential 
participants being approached at the optimal time i.e. at the exact moment when 
they were prepared to attempt to quit smoking. Whilst the majority of smokers 
wish to quit, most are in the contemplation stage rather than in the preparation or 
action stages. It would therefore seem likely that smokers would require repeated 
prompts prior to feeling ready to avail themselves of any smoking cessation 
interventions on offer. It may be that smokers in this trial did not complete 
sufficient dental visits to reach this point, or that the dental professionals involved 
did not follow up their initial offer of support at subsequent visits.   
 
It transpired that the process of recruitment itself was rather cumbersome 
resulting in anecdotal evidence that some potential participants sought smoking 
cessation support elsewhere. The enthusiastic smoker wishing to quit 
immediately was provided with written information about the project by their 
dentist or the dental receptionist which explained that they would need to be 
seen on three separate occasions prior to determining a quit date. Two visits with 
the principal researcher were required – one to discuss the purpose of the study 
and explain what it entailed, and the second to provide informed consent after 
being given at least a week to consider whether or not to participate. This was a 
requirement of the Research Ethics Committee. After completion of the consent 
process, a third appointment was made with the dental therapist who provided 
periodontal treatment and advice prior to contacting the study administrator to 
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determine if the participant was to form part of the control or intervention group. It 
was therefore only at the fourth visit with either the dental therapist or the 
specialist stop smoking counsellor that participants were provided with their 
chosen nicotine replacement therapy and asked to set a quit date.   It is felt that 
this process placed too heavy a burden on potential participants and contributed 
greatly to the poor recruitment achieved.  
 
While the protracted nature of the recruitment process and the difficulty of 
approaching potential participants at the correct stage of readiness to quit 
undoubtedly contributed to the failure of the trial, there may have been more 
fundamental reasons e.g. dental patients did not believe that dental professionals 
had a role in smoking cessation provision. Moreover, is periodontal health a 
primary motivating factor for dental patients who are smokers to enter a smoking 
cessation programme provided in general dental practice? 
 
2.6 Conclusions and Recommendations  
In conclusion, the issue of the recruitment process to the PHaSCe trial 
contributed in part to its failure. However, this may not have been the only reason 
for the difficulties encountered. Difficulties included a lack of an appreciation of 
the requirements with regard to the evidence-base and the effectiveness of 
smoking cessation in remote-rural primary dental care.  Therefore as a first step 
there was as a need for a more rigorous and systematic examination of the 
evidence-base to highlight essential elements of a randomised controlled trial 
which could contribute to the success of a smoking cessation intervention in 
remote-rural primary dental care.  
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As the elements of this new approach were explored there emerged a need for 
modelling a smoking cessation intervention tailored to the needs of remote and 
rural populations of primary care dental patients.  For instance, is periodontal 
disease a primary motivating factor for dental patients who are smokers to quit 
smoking tobacco?  It seemed appropriate therefore to visit the Medical Research 
Council’s Framework for Developing and Evaluating Complex Interventions 
(2010) to facilitate a process to allow the modelling of a smoking cessation 
intervention in remote-rural primary dental care. On examination of the MRC 
Framework it transpired that it had been developed to add structure and rigour to 
the development and evaluation of interventions which involve many interrelated 
and complex elements which do not fit well into templates for conventional trials. 
This indicated that the MRC Framework could indeed contribute to the 
development of a successful smoking cessation intervention for this study 
population.  
 
Therefore, in view of these issues, it was decided to use the MRC Framework for 
the Development and Evaluation of Complex Interventions (Figure 2.6) to 
discover [1] the evidence-base and [2] collect data to model processes and 
outcomes from which recommendations for a feasibility study would be 
formulated with regard to a smoking cessation intervention for remote-rural 
primary dental care. 
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Figure 2.6 Key elements of the MRC Framework for Complex Interventions 
 
 
 
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC004871 
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structural equation model technique 
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3.0 Introduction 
 
The difficulty in recruiting to the PHaSCe trial led to the need for the development 
of an effective smoking cessation intervention to be configured for a remote and 
rural area of Scotland. In order to provide structure and rigour to the development 
of this complex intervention, the Medical Research Council’s (MRC) Framework 
for the Development and Evaluation of Complex Interventions was used (Figure 
2.6).  
 
The first step in the process of developing a complex intervention is to identify 
the evidence base.  This was undertaken by conducting a systematic literature 
review with a meta-analysis in order to identify the existing evidence concerning 
research into the effectiveness of smoking cessation interventions conducted in 
remote and rural areas. The MRC Framework also states that any intervention 
must be contextualised and tailored for the population for whom it is intended.  
Therefore as a second step and to enable the modelling of a smoking cessation 
intervention it is necessary to conduct a survey to gather the relevant information 
from patients accessing primary dental care in Argyll & Bute CHP.  The smoking 
and periodontal health prevalence and attitudes survey comprising a 
questionnaire and a basic periodontal examination identified the characteristics 
necessary to model a smoking cessation intervention for remote-rural primary 
dental care in Scotland.  
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3.1 Aim and objectives 
Aim 
To develop recommendations for the characteristics of a smoking cessation 
intervention for primary dental care in remote-rural Scotland. 
 
Research objectives 
3.1.1 Objective 1 
To evaluate the evidence-base regarding the effectiveness of tobacco cessation 
interventions applied by dental professionals in remote-rural primary dental care 
using a systematic literature review and meta-analysis. 
 
3.1.2 Objective 2 
To determine the prevalence and risk factors for chronic periodontitis, and its 
impact on oral health-related quality of life in a population of registered primary 
care dental patients in a rural area of Scotland. 
 
3.1.3 Objective 3 
To model a smoking cessation intervention based on smoking status, periodontal 
health status and oral health-related quality of life collected in a sample of adults 
attending a general dental practice in a remote and rural area. 
 
3.1.4 Objective 4 
To recommend the characteristics of a feasibility trial for a smoking cessation 
intervention for primary dental care in remote-rural Scotland. 
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3.2  The Systematic Literature Review 
 
3.2.0 Introduction 
This section relates to research objective 3.1.1. The narrative literature review 
considered the prevalence, pathogenesis and risk factors for chronic 
periodontitis. It has identified smoking as a major risk factor for poor periodontal 
health, and explored the effectiveness of smoking cessation interventions in 
various healthcare locations, including dental settings.  
 
Whilst evidence of the detrimental effects of cigarette smoking on general health 
began to emerge in the 1950s (Doll and Hill 1954), it was several decades later 
before the research community began to investigate how smokers could be 
effectively supported to quit. A Cochrane Review conducted in 2000 showed that 
all interventions based on behavioural and/or pharmacological support have 
higher success rates than unsupported quit attempts (Lancaster et al. 2000). 
Smoking cessation research has utilised a vast array of interventions, providers 
and settings, but comparatively little research has involved a dental component 
(Carr and Ebbert 2006).  
 
Provision of health care in a rural location presents challenges not encountered 
in more urban areas. These include geographical accessibility where long 
distances to travel may be compounded by inadequate public transport and 
higher levels of poverty. In the context of smoking cessation interventions, the 
gold standard intervention would involve weekly support meetings for a minimum 
of six weeks, which in a rural area may lead to high costs in terms of time and 
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finances (Stoops et al. 2010). Attracting healthcare providers to live and work in 
remote areas can also be difficult. Oral health provision is just as testing as other 
healthcare provision (Skillman et al. 2010). 
 
Internationally, rural populations use tobacco in different ways to urban ones, 
with a preponderance of smokeless tobacco use in rural areas. For example, in 
the United States smokeless tobacco use is three times more prevalent in rural 
communities than in urban ones (Mumford et al. 2006). Smoking rates can also 
be higher in rural populations e.g. in the rural Appalachian mountains in Kentucky 
smoking prevalence was 34.4% in 2008 as opposed to 19.8% of the United 
States population as a whole (Stoops et al. 2010). 
 
Specialist smoking cessation services are also more widely spread in rural areas 
and may lead to reduced choices regarding the type of service provided e.g. it 
may be impractical with the lower numbers seeking support to offer group 
support, which many people prefer to individual counselling (NHS Scotland and 
ASH Scotland 2004). 
 
This study aims to determine the viability of evaluating the effectiveness of 
smoking cessation interventions in improving periodontal health in patients 
attending dental primary care in a remote and rural area. A systematic literature 
review follows which will critically appraise empirical evidence from the literature 
in a structured manner to identify existing evidence relating to smoking cessation 
activities with a dental component undertaken in rural areas.  
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3.2.1 Research question 
The research question for the systematic literature review was developed in 
order to facilitate a methodical and structured search of the literature. Whilst 
endeavouring to delineate fixed parameters for the literature search, the research 
question was not so narrowly defined that potentially relevant papers would not 
be retrieved.   
 
A preliminary narrative review of the literature indicated that research into 
smoking cessation is a recent phenomenon but that it is expanding. The 
Cochrane Collaboration has completed 77 systematic reviews relating to 
smoking cessation, only one of which involves dental smoking cessation 
activities (Carr and Ebbert 2012) so it would seem that there is limited evidence 
available relating to dental care and smoking cessation.  
 
The narrative overview also revealed that most existing research into smoking 
cessation activities in a dental setting has been conducted in urban areas, and 
often in secondary and tertiary care. The extent to which literature existed which 
was relevant to a remote-rural population attending primary dental care was 
unclear and this led to the formulation of the research question: 
 “How effective are tobacco cessation interventions applied by dental health 
professionals in remote and rural primary dental care?” 
 
Therefore the aim of the systematic review was: 
To evaluate the evidence-base regarding the effectiveness of tobacco cessation 
interventions applied by dental professionals in remote-rural primary dental care 
using a systematic literature review and meta-analysis. 
 118 
3.2.2 Study Selection Criteria 
This systematic literature review involved a rigorous and methodical search of 
the research literature and unpublished materials exploring any tobacco-related 
intervention with a dental or oral health-related component undertaken in a rural 
area. The review not only aims to evaluate the effectiveness of stop smoking 
interventions undertaken in remote and rural primary dental care, but to identify 
their potential contribution to improving oral health, and to identify which 
components of the interventions are most important in achieving success. 
Therefore, the structured review, whilst defining selection criteria, sought not to 
restrict study selection to the extent that relevant material was missed.  
 
At all stages the principles espoused by the PRISMA (Preferred Reporting Items 
for Systematic reviews and Meta-Analyses) statement have been consulted in 
order to maximise the rigour of the results of the systematic literature review and 
facilitate the critical evaluation of the evidence encountered (Moher et al. 2009).  
 
3.2.3 Study Design 
In order to capture a broad overview of relevant papers, this initial search 
included epidemiological surveys, cross sectional studies, cohort studies and 
randomised controlled trials. When seeking to evaluate the effectiveness of an 
intervention it is recommended that only randomised controlled trials provide 
sufficient rigour but the research question here encapsulates the necessity for 
smoking cessation activities in dental settings as well as their effectiveness, 
hence the decision to include a variety of study designs. Handsearching of the 
references of the papers identified was undertaken, and Dr. Vivian Binnie, an 
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expert in the field of smoking cessation in the dental setting, was consulted in 
order to maximise the identification of relevant studies. 
 
3.2.4 Study participants 
The participants in the included studies in this systematic review were from 
remote-rural populations, users of tobacco in any form i.e. smokeless tobacco, 
cigarettes, roll-ups, cigars or pipes, and healthcare workers, including dental 
workers, involved in any tobacco related interventions in rural communities.  No 
geographical limitations were applied to the search as remote-rural populations 
across the world face many of the same challenges, and participants of all age 
groups and ethnicities were included.  
 
3.2.5 Study interventions 
This search has included any cross-sectional population study, cohort study or 
randomised controlled trial relating to the prevalence of tobacco use and/or oral 
disease, as well those examining the effectiveness of tobacco-related 
interventions delivered by a dental care professional i.e. dentist, dental therapist, 
dental hygienist, dental nurse or dental administrative staff.  Studies which were 
undertaken in non-dental settings such as colleges or schools, as well as those 
in dental clinics, have been included provided that any part of them involved 
dental personnel. 
 
The intensity of any tobacco cessation intervention utilised in the research 
process did not preclude inclusion i.e. brief and intensive interventions were 
equally valid for the purposes of this systematic literature search. Likewise, 
interventions may or may not have included a member of the dental team 
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providing nicotine replacement therapy or other pharmacotherapy, counselling or 
provision of self-help materials.  
 
All methods of delivery of a tobacco cessation intervention were also considered 
e.g. face-to-face delivery, telephone delivery or internet-based support. Studies 
comparing one tobacco intervention to another, as well as comparing an 
intervention to usual or no care were included in this review. 
 
3.2.6 Outcome measures 
Outcome measures sought in this systematic literature review included 
prevalence data for tobacco use and oral disease, and any measures of changes 
in these outcomes following tobacco use cessation interventions. Studies 
exploring the effectiveness of educational interventions on tobacco use 
prevalence were also included. Tobacco use cessation outcomes measured by 
self-report alone tend to overestimate success of the intervention and so data 
based on studies using biochemical verification of quitting using carbon 
monoxide or cotinine measurements are more robust (Rebagliato 2002). Despite 
this, studies were included whether or not biochemical verification was employed. 
Studies measuring either point prevalence of abstinence, usually defined as no 
tobacco use in the previous seven or thirty days, or the stronger measure of 
continuous abstinence were included. For smoking cessation outcomes only 
studies which provided follow-up data for a minimum of six months are included, 
as these are thought to more closely correspond to long-term abstinence than 
those following up for a shorter duration (Carr and Ebbert 2006).  
 121 
3.2.7 Search Strategy 
3.2.7.1 Search terms 
In the process of conducting the narrative literature review seen in Chapter 2 it 
became clear that several terms were used to denote tobacco cessation and 
tobacco cessation interventions. The same is true when identifying dental –
related terms and so an initial list of key words was developed in an attempt to 
capture all relevant data. The key words used are shown in Table 3.1. 
Table 3.1 Key words related to tobacco cessation and oral disease 
Tobacco-related terms 
 
Tobacco/nicotine/smoking control 
Tobacco/nicotine/smoking prevention 
Tobacco/nicotine/smoking abstinence 
Tobacco/nicotine/smoking cessation 
 
Dental-related terms 
 
Dentist 
Dental 
Oral 
Dental/oral health 
Oral medicine 
Periodontal/periodontitis 
 
MeSH (Medical Subject Headings) is a thesaurus of controlled vocabulary 
devised and updated by the United States National Library of Medicine. MeSH 
descriptors are used in electronic search databases such as MEDLINE and 
PubMED. When MeSH is applied to terms such as those in Table 3.2 it provides 
a comprehensive list of related terms thereby maximising the power of the 
search. The final search terms identified following this process can be seen in 
Table 3.2. 
 
Table 3.2 Search terms 
((dentist? or dental or "oral medicine" or dentistry or "oral hygiene" or Dentists or 
Dental staff or Oral health or periodont$) and (Smoking Prevention & Control or 
Smoking Cessation or "Tobacco Use Cessation") or ((Smok$ or tobacco$ or 
nicotine$ or cigar$) and (cessation$ or quit$ or abstinence$)) or antismok$)) and 
rural af. 
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3.2.7.2  Data Sources 
The following electronic databases were used in this systematic literature search 
from the date of their inception until June 2013, with no language restrictions 
applied: 
 The Cochrane Central Register of Controlled Trials (CENTRAL) 2013, 
Issue 1 
 MEDLINE (1966 – June 2013) 
 EMBASE (1988 – June 2013) 
 CINAHL (1982 – June 2013) 
 Healthstar (1975 – June 2013) 
 ERIC (1967 – June 2013) 
 PsycINFO (1984 – June 2013) 
 National Technical Information Service database (NTIS, 1964 – June 
2013) 
 Dissertation Abstracts Online (1861 – June 2013) 
 Database of Abstracts of Reviews of Effectiveness (DARE, 1995 – June 
2013)  
 Web of Science (1993 – June 2013) 
 
These databases comprise literature which has been peer-reviewed thus 
ensuring a degree of confidence in the rigour of the publications they contain.  
The exception is the ERIC database which in addition to peer-reviewed material 
contains unpublished research material and conference papers etc. In this case 
no relevant data was identified in this database. 
 
3.2.8 Search results 
When the search terms defined in Table 3.2 were entered into each of the 
databases sixty-two papers were identified.  After removing duplicate papers, 41 
studies remained.  References on all included papers were examined and 2 
further papers were identified. An expert in the area (Dr. Vivian Binnie, Clinical 
Senior University Teacher) was contacted in order to ensure the search results 
were as comprehensive as possible. No further papers were identified from this 
source. Figure 3.1 shows the process of search selection. 
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 Figure 3.1: Review process 
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to abstracts of papers 
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N=35 
Snowballing of references 
N=43 
Removal of duplicates 
N=41 
Full text of additional papers obtained 
and exclusion criteria applied 
N=35 
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3.2.9 Study Selection 
Forty one records were retrieved from the electronic databases and a further 2 
records were added following handsearching of the references on the 41 
identified papers.  Abstracts of all 43 papers were screened by the researcher 
and an experienced hospital-based librarian (JS) to ensure that they did indeed 
meet the criteria for inclusion. A systematic and consistent approach to 
determine inclusion was facilitated by use of the exclusion criteria checklist found 
in Appendix 11. 
 
Full text articles were procured for those papers which appeared to meet the 
inclusion criteria following this initial analysis, and also for those for which it was 
unclear from the abstract whether inclusion was warranted. At this stage all 
papers were reviewed by KE, the librarian (JS) and supervisors (RF and AFH) 
practised in conducting systematic literature reviews. Again, the exclusion criteria 
checklist in Appendix 11 was employed with the aim of systematising the 
process.  
 
All 43 studies identified using the search strategy above were analysed during a 
panel discussion to verify that they met the inclusion criteria, and a final decision 
made on which papers to include.  
 
Details of these 43 papers considered and the reasons for their inclusion or 
exclusion can be found in Appendix 12. A total of 35 papers remained after 
performing this detailed analysis. 
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3.2.10 Data extraction 
With a total of 35 papers included in this systematic literature review it was 
important that a methodical approach was taken to the retrieval of data. To 
facilitate this, a data extraction checklist was developed and applied in the 
process of examining each of the papers. The data extraction checklist can be 
found in Appendix 13, and is based on the STROBE checklist of items that should 
be included in reporting of observational studies (Appendix 14) and the 
CONSORT checklist for the reporting of randomised controlled trials (Appendix 
15) (Moher et al. 2010; Schultz et al. 201; von Elm et al. 2008). It is presented in 
two sections, with Section 1 being applicable to all included studies, and Section 
2 applying only to the five randomised controlled trials. 
 
3.2.11 Data synthesis 
The data derived from the observational studies included in this systematic 
literature review are summarised in a narrative presentation due to the 
heterogeneity of the study designs and outcomes which precluded a statistical 
synthesis of their findings. The descriptive synthesis of the data is presented 
according to the study design employed, the study participants and the outcomes 
sought. 
 
As the majority of studies included in this systematic literature review are 
observational, it was not possible to synthesise all the findings using statistical 
techniques. However, the five randomised controlled trials identified allowed the 
statistical findings they produced to be displayed in a meta-analysis. The meta-
analysis can be seen in Figure 3.4 on page 161 which follows a descriptive 
analysis of the data. 
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3.2.12 Characteristics of included papers 
It is clear from the papers included in this literature search that interest in the area 
of tobacco cessation is a relatively recent phenomenon as the earliest papers 
identified were from the 1990s, and almost three quarters were published from 
2000 onwards.  
 
Over half of the research included was conducted and published in the United 
States (21 papers), followed by India (6 papers), Canada (2 papers) and one 
paper each from Iran, Japan, Sudan, Sweden, Tanzania, Thailand, Ukraine and 
Vietnam.  
 
The study designs of the included papers comprised six educational 
interventions, twenty-one surveys which examined knowledge attitudes and 
practices of healthcare workers (8) and rural dwellers (13), three cohort studies 
and five randomised controlled trials.  
 
3.2.13 Results 
Nine surveys of the prevalence of tobacco use were included in the literature 
review, three of which were conducted in India among different age groups. 
Jayakrishnan et al. found that 8% of 11 – 15 year olds used tobacco daily with 
prevalence increasing with age (Jayakrishnan et al. 2011). In a group of older 
adolescents (15 – 19 year olds), Dongre et al. (2008) found that 68% of males 
and 12% of females had used tobacco in the previous 30 days, 72% of females 
using snuff to clean their teeth. Prevalence of daily tobacco use was found to be 
18% among a rural adult population in India with the most common reason for 
starting use of smokeless tobacco being to relieve toothache (Daniel et al. 2008). 
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In a rural Californian population with an average age of 16 years, Ellison et al 
(2006) found a smoking prevalence of 50% of whom 32% were daily smokers. 
Over half of the smokers had attempted to quit but failed. Walsh et al. (1999) 
found similar prevalence of smokeless tobacco use in college students in rural 
California. Forty percent of American Indian adults were found to be smokers in a 
study conducted by Hodge et al in 1995, and alarmingly, there was little 
appreciation of the health impacts smoking causes. 
 
A survey among 20-year-olds in Japan found similar, high rates of smoking in 
rural and urban populations, with 68% of males and 49% of females being 
smokers (Seki et al. 2004). In Tanzania, contrary to expectations, smoking 
prevalence was found to have fallen from 17% in 1999 to 13% in 2001 among 
university students, and the rates were identical independent of whether their 
origins were urban or rural (Astrom and Masalu 2001). Rates of tobacco use were 
found to be much lower amongst females than males among adults in rural 
Sudan, with smokeless tobacco use of 3% compared with 34% and cigarette 
smoking among women at 1% compared with 12% of men (Idris et al. 1998). 
 
A survey of knowledge regarding oral cancer conducted among patients referred 
to a dental hospital in Iran found that only 16% knew that smoking was a risk 
factor (Pakfetrat et al. 2010). In rural India village dwellers underwent an oral 
examination and 6% were found to have suspicious oral lesions. Odds ratios of 
3.06 and 4.42 were reported for bidi smokers and hookah smokers respectively 
for suspicious lesions as opposed to non-smokers (Dangi et al. 2012). 
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In a cross-sectional study, Chatrchaiwiwatana et al. (2009) interviewed and 
examined rural-dwelling males in Thailand and confirmed that smoking tobacco is 
a risk factor for periodontal disease with an odds ratio for periodontitis of 1.62 for 
smokers compared with non-smokers. Do et al established a dose-response 
relationship between smoking and periodontal ill-health in a middle-aged 
Vietnamese population, with an odds ratio for periodontitis of 7.2 for smokers 
over non-smokers (Do et al. 2003).  
 
In a 10-year prospective cohort trial conducted in Sweden, Paulander et al. 
(2004) investigated risk factors for periodontal bone loss and found smoking to be 
the most potent risk factor with a risk ratio of 3.2. Gupta et al. reported findings 
from a 10-year cohort study investigating the effects of tobacco cessation on oral 
soft tissue lesions at both 8 and 10 years (Gupta et al. 1990; Gupta et al. 1995). 
Their findings showed a significant drop in incidence of leukoplakia post quitting 
with an incidence ratio of 0.31. All other mucosal lesions had a substantial drop in 
incidence with the exception of lichen planus (Gupta et al. 1995). 
 
One of the educational intervention studies demonstrated that patient educational 
materials available in a university dental school were appropriate for readability, 
quality and content (Weiner and Weiner 2011). Jenkins and Geurink (2006) 
introduced a comprehensive school-based oral health programme in a rural area 
of Texas which included a smoking cessation component. Knowledge amongst 
both children and school staff increased as a result of this intervention. Two of the 
educational interventions were pilot projects aimed at adolescents (Semer et al. 
2005; DeMoss et al. 1997) and they explored mechanisms by means of which 
participants could be recruited to tobacco cessation programmes. Semer et al. 
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focussed on cigarette smokers and the impact of smoking on faster aging and 
poor oral health to motivate these young smokers to quit. Over half of the target 
group of smokers enrolled in the stop smoking programme. DeMoss et al. 
explored preventive strategies for smokeless tobacco use and found their 
programme to be feasible and acceptable to the target audience.  
 
The remaining educational interventions targeted dental personnel and aimed to 
increase their tobacco cessation activities. Walsh et al. (2012), compared self-
study packages with workshop-based smoking cessation training, with or without 
dentist reimbursement, and found that reimbursement had no effect on 
subsequent attitudes and practices related to smoking cessation. Workshop 
training had a greater impact on smoking cessation activities than self-study, but 
both had a positive effect. The dental involvement in the paper by Norman et al. 
1990, consisted only of being provided with patient educational literature and stop 
smoking kits for distribution to patients who smoked. In this programme aimed at 
reducing cardiovascular disease, the main outcome was increased awareness 
and this was achieved although the dental contribution did not result in many 
successful quit attempts. 
 
Among the surveys included in this systematic literature review are three which 
examine the smoking cessation activities being undertaken in dental surgeries. 
Morgan et al. concluded that the majority of dentists ask patients about their 
tobacco use and offer some advice but they are not confident with respect to 
tobacco cessation and rarely refer patients to stop smoking services (Morgan et 
al. 2011). Just under half of respondents (46%) in a questionnaire survey of 
dental professionals in Canada reported asking patients if they smoked, advising 
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them about the health benefits of quitting and assessing their motivation to quit. 
However, fewer than 10% went on to provide a smoking cessation intervention for 
patients who smoked (Brothwell and Armstrong 2004). Jennett et al. explored the 
characteristics of dental offices to determine which were most likely to accept 
change and introduce smoking cessation activities. They found that those 
surgeries which already focussed on preventive strategies, had innovative 
approaches to dental provision and who worked in small rather than large teams 
were most likely to adopt smoking cessation activities (Jennett et al. 1998). A 
survey of physicians’ smoking cessation activities in rural and urban settings in 
Ukraine revealed that those who smoked themselves, who are younger, and 
those who are based in rural areas were least likely to provide smokers with 
advice to quit (Squeir et al. 2006). Campbell et al. (1999) revealed a divergence 
in views between patients and dental practitioners’ expectations in respect of 
smoking cessation, with 59% of dental patients believing dentists should routinely 
offer smoking cessation support, whilst only 38% of dentists thought patients 
would expect this. 
 
The knowledge, attitudes and practices of dentists in relation to smoking 
cessation activities were compared with other healthcare professionals in a rural 
area of Wisconsin (Block et al. 1999). They found that dentists were much less 
confident in and supportive of providing tobacco interventions, and more likely to 
cite barriers than other healthcare professionals. Zanis et al. (2008) used a 
different approach to assess the level of smoking cessation activity being 
undertaken in healthcare settings by surveying young patients who were 
smokers. Dentists proved to be significantly less likely to broach the subject of 
quitting with smokers than physicians (52% compared with 66%). Prokhorov et al. 
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surveyed healthcare providers and educators in rural US states about smokeless 
tobacco use and found that not all dentists were aware of its oral health 
implications, and that dentists were unwilling to repeatedly ask patients about 
smokeless tobacco use or refer on to specialist services as they thought patients 
would become offended (Prokhorov et al. 2002). 
 
This systematic literature review has identified five randomised controlled trials, 
all of which were conducted in rural areas of the United States. The first 
randomised controlled study included was published in 2002 and the most recent 
in 2010. All five included studies were conducted in the United States. The 
inclusion criteria would have allowed studies conducted in a wide variety of 
settings; private and public dental practices, secondary and tertiary care dental 
facilities and any community setting where dental involvement in a tobacco 
cessation intervention had been delivered, however all five studies identified were 
undertaken in rural Californian high schools, colleges and universities. The 
participants in all of the included studies were young male users of smokeless 
tobacco who attended either high school (Walsh et al. 2010; Walsh et al. 2003; 
Gansky et al. 2002) or college (Gansky et al. 2005; Walsh et al. 1999). The age 
group for the high school students was 14 -19 years and for college students, 18 -
25 years.  
 
All of the included studies gave results for smokeless tobacco cessation as this 
was the focus of the intervention in all five papers. This reflects the high 
prevalence of smokeless tobacco use in rural areas of the United States 
(Mumford et al. 2006). No studies involving interventions targeting smoked 
tobacco were identified for inclusion.  
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Three of the included studies (Walsh et al. 2010; Gansky et al. 2005; Walsh et 
al.1999) used self-report via questionnaires only to verify tobacco use cessation. 
The other two studies (Walsh et al. 2003; Gansky et al. 2002) collected saliva 
samples from all participants at the initial visit and at one year, and conducted a 
salivary cotinine assay on 8% of the results. As participants were unaware of 
whether or not their saliva would be analysed this increased the robustness of the 
verification of tobacco use status.  
  
A minimum length of follow-up of participants was set as six months and all 
studies included exceeded this minimum standard. One study followed 
participants for two years (Gansky et al. 2002), whilst the remaining four (Walsh 
et al. 2010; Gansky et al. 2005; Walsh et al. 2003; Walsh et al. 1999) included 
results from a twelve month follow-up period. 
 
All the studies included in this review used either point prevalence of tobacco use 
abstinence or continuous abstinence from tobacco as outcome measures. While 
some researchers report point prevalence of tobacco use cessation as no 
tobacco use at all in the previous seven days, Walsh et al. (1999); Gansky et al. 
(2002); Gansky et al. (2005) and Walsh et al. (2010) used a more robust period of 
thirty days of no tobacco use to define point prevalence. Walsh et al. (2003) 
reports on continuous abstinence from tobacco use over the twelve month trial 
period of the study. Continuous abstinence is considered to be the gold standard 
measure to be used in examining the effectiveness of tobacco cessation 
interventions. 
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The control group in each of the included studies received undefined “usual care” 
or no intervention. The five included studies compared one intervention group 
with a control group. All interventions taking place in a dental setting were 
delivered by dentists or dental hygienists.   
 
All of the smokeless tobacco cessation interventions included a peer-led 
component, based on the Diffusion of Innovation Theory (Rogers 1995) or 
cognitive social learning theory (Bandura 1986). This involved screening and 
discussion of an educational video and slides of oral lesions related to smokeless 
tobacco use, and discussion of the marketing strategies of smokeless tobacco 
companies. This was followed by an oral examination, conducted in three studies 
by dentists or dental hygienists (Walsh et al. 2003; Gansky et al. 2002; Walsh et 
al. 1999) and in the others by specially trained school nurses (Walsh et al. 2010) 
or trained accredited athletic coaches (Gansky et al. 2005).  During the oral 
examination there was a demonstration of any tobacco related oral lesions in the 
student’s mouth followed by oral health-related advice to quit. Self-help materials 
and face-to-face or telephone counselling was also provided. Only one of the 
interventions described in the included studies involved the provision of nicotine 
replacement therapy – Walsh et al. (1999) offered nicotine chewing gum to 
potential quitters.  
 
On the whole, drop-out rates in these five studies were found to be similar in both 
control and intervention groups although the actual percentage drop-out rate 
varied from 10% (Gansky et al. 2002) to 28% (Walsh et al. 2010).  
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The studies conducted by Gansky et al. (2002), Walsh et al. (2003) and Gansky 
et al. (2005) recruited all high school baseball team members regardless of their 
tobacco use status, whereas Walsh et al. (2010) and Walsh et al. (1999) included 
only those students who reported using smokeless tobacco in the previous 30 
days. Smokeless tobacco users were included in all five studies regardless of 
their motivation to quit tobacco use. 
 
As randomised controlled trials offer the only study design robust enough to 
determine the effectiveness of an intervention, it was decided to examine the five 
randomised controlled trials identified in the first part of the search using the 
CONSORT checklist (Moher et al. 2010) (see Appendix 13) and undertake a 
meta-analysis. This is in line with Cochrane Collaboration guidance for assessing 
the effectiveness of an intervention (Needleman et al. 2010).  
 
The effectiveness of the interventions studied were evaluated using the odds ratio 
which was calculated via the following equation: (number of quitters in treatment 
group/number of tobacco users in treatment group)/(number of quitters in control 
group/number of tobacco users in control group). An odds ratio greater than 1 
indicated that members of the intervention group were more successful in quitting 
than those in the control group. The Mantel-Haenszel method, a fixed effect 
model, was used to give a pooled weighted average of odds ratios, with a 
confidence interval of 95% (Carr and Ebbert 2006).  
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3.2.14 Study Quality Assessment 
 
In order to maximise the value of this systematic literature review all studies have 
undergone a process of critical appraisal before inclusion. Particular attention has 
been paid to ensuring an adequate sample size, lack of bias, failures of 
randomisation or sampling and numbers of dropouts. At all stages the principles 
described in the PRISMA statement have been followed (Moher et al. 2009). 
 
Quality assessment tools have been used to ensure systematic appraisal of the 
quality of studies included and how they have been reported (see Appendices 14 
and 15). The process of quality assessment of the literature review of 
observational studies using the STROBE checklist (von Elm et al. 2008) is 
summarised in Appendix 16. The equivalent quality assessment of the 
randomised controlled trials utilising the CONSORT checklist (Moher et al. 2010) 
is summarised in Appendix 17. Detailed analysis of quality parameters of the five 
included randomised controlled trials can be found in Table 3.3.  
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Table 3.3.0: Detailed quality analysis of randomised controlled trials 
Study ID Methods Participants Interventions Outcomes Notes 
Author’s name: 
 
Walsh et al. 
 
 
 
 
 
Year: 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study design: 
Randomised controlled trial 
 
Method of randomisation: 
 
Cluster by high school 
 
Method of allocation: 
 
Stratified by size of school 
Selected from list of eligible schools 
 
Exclusions post randomisation: 
 
None reported 
 
Losses of follow-up/ withdrawals: 
 
Intervention group 48% 
Control group 34% 
 
Sample size calculations: 
 
150 students from 40 schools needed to 
show 90% power to detect significant 
difference in quit rate of 15% in 
intervention group versus 5% in control 
group 
 
Intention to treat analysis: 
Yes, those lost to follow-up assessed as 
non-quitters 
Country: 
United States 
 
Setting: 
 
Rural 
California High 
Schools 
 
Total number: 
 
41 schools 
4731 students 
 
Age: 
 
14 – 19 years 
 
Sex: 
 
Male 
 
Inclusion 
criteria: 
Consent from 
parents 
 
Exclusion 
criteria: 
None given 
Interventions: 
Peer-led education 
session 
Oral examination 
School nurse-led small 
group counselling 
sessions 
 
 
Control: 
 
No intervention 
 
 
 
 
 
Duration of study: 
 
Twelve months 
Primary outcome: 
Point prevalence of 
abstinence from 
smokeless tobacco use 
in previous 30 days 
 
 
 
 
Secondary outcomes: 
 
Initiation rate for 
smokeless tobacco use 
among baseline non-
users 
Verification of tobacco 
use status was by self-
report only. 
 
No significant difference 
was found between 
control and intervention 
groups for either ST 
cessation or initiation. 
However, cessation 
rates were significantly 
higher (62% versus 
36%, p=0.019) in the 
intervention groups 
when comparing those 
who used ST only i.e. 
did not smoke tobacco 
as well, with the control 
group. 
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Walsh et al. 2010 (Table 3.3.0) 
 
Assessment of bias 
 
Selection bias 
Was allocation of participants to groups concealed until after interventions 
were allocated? 
 
Unclear – high schools were randomly allocated, but not enough details given 
 
Performance bias  
Were the recipients of care unaware of their assigned intervention (blinded)? 
 
No, not possible as either received intervention or not. 
 
Were persons providing care unaware of their assigned intervention 
(blinded)? 
 
No, not possible as either provided intervention or not. 
 
Detection bias 
Were persons assessing care unaware of their assigned intervention 
(blinded)? 
 
Yes, data was analysed without knowledge of allocated group. 
 
Attrition bias 
Were rates of follow-up similar in the comparison groups? 
 
Intervention group 48% dropout among smokeless tobacco users, control 
group 34% dropout among smokeless tobacco users 
 
Was the analysis “intention-to-treat” (were all patients analysed as 
randomised)?  Yes 
 
Outcome Time 
(months) 
Intervention 
(observed) 
Intervention 
(total) 
Control 
(observed) 
Control 
(total) 
Retention  12 119 229 151 229 
ST use point 
prevalence 
quit 30 days 
12  64 
28% 
 59 
26% 
  p>0.05; OR=1.12, 95% CI, 0.74 – 1.69 
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Table 3.3.1: Detailed quality analysis of randomised controlled trials continued 
Study ID Methods Participants Interventions Outcomes Notes 
Author’s name: 
Walsh et al.  
 
 
 
Year: 2003 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study design: 
Randomised controlled trial 
 
Method of randomisation: 
 
Cluster by high school 
 
Method of allocation: 
 
Stratified by prevalence of smokeless 
tobacco use and size of baseball team 
 
 
 
Exclusions post randomisation: 
Less than 20% prevalence of 
smokeless tobacco use in team 
 
Losses of follow-up/ withdrawals: 
 
Intervention group 23% 
Control group 15% 
 
Sample size calculations: 
 
25/school and 28% prevalence of 
smokeless tobacco use, 334 students 
from 44 schools needed to show 10% 
cessation in intervention group versus 
1% in control group 
 
Intention to treat analysis: 
Yes 
Country: 
United States 
 
Setting: 
 
Rural 
California High 
Schools 
 
Total number: 
 
1084 
 
 
Age: 
15 – 19 years 
Sex: 
 
Male 
 
Inclusion 
criteria: 
Baseball team 
member  
Consent from 
parents 
 
Exclusion 
criteria: 
Smokeless 
tobacco use 
too low 
Interventions: 
Peer-led education 
session 
Oral examination 
Dental hygienist-led 
small group counselling 
sessions 
 
 
Control: 
 
No intervention 
 
 
 
 
 
 
Duration of study: 
 
Twelve months 
Primary outcome: 
Continuous abstinence 
from smokeless 
tobacco use 
 
 
 
 
 
Secondary outcomes: 
Verification of tobacco 
use status was by self-
report but at initial visit 
and one-year follow-up 
all participants had a 
saliva sample collected 
and 8% of these were 
analysed. This 
demonstrated that 8% 
of those claiming to be 
non-tobacco users had 
salivary cotinine levels 
showing tobacco use. 
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Walsh et al. 2003 (Table 3.3.1) 
 
Assessment of bias 
 
Selection bias 
Was allocation of participants to groups concealed until after interventions 
were allocated? 
 
Unclear – high schools were randomly allocated, but no details given 
 
Performance bias  
Were the recipients of care unaware of their assigned intervention (blinded)? 
 
No, not possible as either received intervention or not. 
 
Were persons providing care unaware of their assigned intervention 
(blinded)? 
 
No, not possible as either provided intervention or not. 
 
Detection bias 
Were persons assessing care unaware of their assigned intervention 
(blinded)? 
 
Yes, data was analysed without knowledge of allocated group. 
 
Attrition bias 
Were rates of follow-up similar in the comparison groups? 
 
Intervention group 23%, control group 15% 
 
Was the analysis “intention-to-treat” (were all patients analysed as 
randomised)?  Yes 
Outcome Time 
(months) 
Intervention 
(observed) 
Intervention 
(total) 
Control 
(observed) 
Control 
(total) 
Retention 24 109 141 141 166 
ST use 
continuous 
abstinence 
(CA) 
  
 
38 
27% CA 
 
 
23 
14% CA 
  p=0.02, OR=2.29, 95% CI, 1.36 – 3.87 
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Table 3.3.2: Detailed quality analysis of randomised controlled trials continued 
Study ID Methods Participants Interventions Outcomes Notes 
Author’s name: 
Gansky et al.  
 
 
 
Year: 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study design: 
Randomised controlled trial 
 
Method of randomisation: 
 
Cluster by high school 
 
Method of allocation: 
 
Stratified by prevalence of smokeless 
tobacco use and size of baseball team 
 
Exclusions post randomisation: 
 
Less than 20% prevalence of 
smokeless tobacco use in team 
 
Losses of follow-up/ withdrawals: 
 
Intervention group 13% 
Control group 10% 
 
Sample size calculations: 
 
25/school and 28% prevalence of 
smokeless tobacco use, 334 students 
from 44 schools needed to show 10% 
cessation in intervention group versus 
1% in control group 
 
Intention to treat analysis: 
 
Yes 
Country: 
United States 
 
Setting: 
 
Rural 
California High 
Schools 
 
Total number: 
 
1084 
 
Age: 
 
15 – 19 years 
 
Sex: 
 
Male 
 
Inclusion 
criteria: 
Baseball team 
member  
Consent from 
parents 
 
Exclusion 
criteria: 
Smokeless 
tobacco use 
too low 
Interventions: 
Peer-led education 
session 
Oral examination 
Dental hygienist-led 
small group counselling 
sessions 
 
 
Control: 
 
No intervention 
 
 
 
 
 
Duration of study: 
 
Twenty four months 
Primary outcome: 
Continuous abstinence 
from smokeless 
tobacco use 
 
 
 
 
 
Secondary outcomes: 
Verification of tobacco 
use status was by self-
report but at initial visit 
and one-year follow-up 
all participants had a 
saliva sample collected 
and 8% of these were 
analysed. This 
demonstrated that 8% 
of those claiming to be 
non-tobacco users had 
salivary cotinine levels 
showing tobacco use. 
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Gansky et al. 2002 (Table 3.3.2) 
 
Assessment of bias 
 
Selection bias 
Was allocation of participants to groups concealed until after interventions 
were allocated? 
 
Unclear – high schools were randomly allocated, but no details given 
 
Performance bias  
Were the recipients of care unaware of their assigned intervention (blinded)? 
 
No, not possible as either received intervention or not. 
 
Were persons providing care unaware of their assigned intervention 
(blinded)? 
 
No, not possible as either provided intervention or not. 
 
Detection bias 
Were persons assessing care unaware of their assigned intervention 
(blinded)? 
 
Yes, data was analysed without knowledge of allocated group. 
 
Attrition bias 
Were rates of follow-up similar in the comparison groups? 
 
Intervention group 13%, control group 10% 
 
Was the analysis “intention-to-treat” (were all patients analysed as 
randomised)?  Yes 
Outcome Time 
(months) 
Intervention 
(observed) 
Intervention 
(total) 
Control 
(observed) 
Control 
(total) 
Retention 24 123 141 149 166 
ST use 
continuous 
abstinence 
(CA) 
24  32 
23% CA 
 21 
13% CA 
  p=0.02, OR=2.05, 95% CI, 1.1 – 3.78 
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Table 3.3.3: Detailed quality analysis of randomised controlled trials continued 
Study ID Methods Participants Interventions Outcomes Notes 
Author’s name: 
Walsh et al.  
 
 
 
Year: 1999 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study design: 
Randomised controlled trial 
 
Method of randomisation: 
Cluster by high school 
 
Method of allocation: 
Stratified by prevalence of smokeless 
tobacco use and size of baseball team 
 
Exclusions post randomisation: 
None recorded 
 
 
 
Losses of follow-up/ withdrawals: 
Intervention group 10% 
Control group 5% 
 
Sample size calculations: 
 
23/college over 16 colleges to give 314 
smokeless tobacco users needed to 
show 10% cessation in intervention 
group versus 1% in control group 
 
Intention to treat analysis: 
 
Yes 
Country: 
United States 
 
Setting: 
 
Mixed Rural & 
Urban colleges 
With baseball 
and football 
teams 
 
Total number: 
 
360 
 
Age: 
 
18 – 25 years 
 
Sex: 
 
Male 
 
Inclusion 
criteria: 
Smokeless 
tobacco user 
 
Exclusion 
criteria: 
Smokeless 
tobacco use 
too low 
Interventions: 
Oral examination 
Dental hygienist-led 
small group counselling 
sessions 
Provision of nicotine 
gum 2mg 
 
 
Control: 
 
No intervention 
 
 
 
 
 
Duration of study: 
 
Twelve months 
Primary outcome: 
Smokeless tobacco 
point abstinence for 30 
days.  
 
 
Secondary outcomes: 
Self-report only 
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Walsh et al. 1999 (Table 3.3.3) 
 
Assessment of bias 
 
Selection bias 
Was allocation of participants to groups concealed until after interventions 
were allocated? 
 
Unclear – high colleges were randomly allocated, but no details given 
 
Performance bias  
Were the recipients of care unaware of their assigned intervention (blinded)? 
 
No, not possible as either received intervention or not. 
 
Were persons providing care unaware of their assigned intervention 
(blinded)? 
 
No, not possible as either provided intervention or not. 
 
Detection bias 
Were persons assessing care unaware of their assigned intervention 
(blinded)? 
 
Yes, data was analysed without knowledge of allocated group. 
 
Attrition bias 
Were rates of follow-up similar in the comparison groups? 
 
Intervention group 10%, control group 5% 
 
Was the analysis “intention-to-treat” (were all patients analysed as 
randomised)?  Yes 
Outcome Time 
(months) 
Intervention 
(observed) 
Intervention 
(total) 
Control 
(observed) 
Control 
(total) 
Retention 12 154 171 179 189 
ST use point 
abstinence for 
30 days 
12  60 
23% PA 
 30 
13% PA 
  P<0.001, OR=2.69, 95% CI, 1.62 – 4.44 
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Table 3.3.4: Detailed quality analysis of randomised controlled trials continued 
Study ID Methods Participants Interventions Outcomes Notes 
Author’s name: 
Gansky et al.  
 
 
 
Year: 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study design: 
Randomised controlled trial 
 
Method of randomisation: 
 
Cluster by college 
 
Method of allocation: 
 
Stratified by prevalence of smokeless 
tobacco use  
 
Exclusions post randomisation: 
 
None given 
 
Losses of follow-up/ withdrawals: 
 
Intervention group 21.3% 
Control group        21.2% 
 
Sample size calculations: 
 
650 smokeless tobacco users required 
for 0.15 intervention group versus 0.05 
control group giving 90% power. 
 
Intention to treat analysis: 
 
Yes 
Country: 
United States 
 
Setting: 
 
College 
baseball teams 
 
Total number: 
 
637 
 
Age: 
 
18 – 25 years 
 
Sex: 
 
Male 
 
Inclusion 
criteria: 
Baseball team 
member  
Consent from 
parents 
 
Exclusion 
criteria: 
None given 
Interventions: 
Peer-led education 
session 
Oral examination 
Dental hygienist-led 
small group counselling 
sessions 
Athletic coach group 
sessions 
 
 
Control: 
 
Usual care 
 
 
 
 
 
Duration of study: 
 
Twelve months 
Primary outcome: 
Smokeless tobacco use 
point abstinence for 30 
days 
 
 
 
 
 
Secondary outcomes: 
Self-report only 
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Gansky et al. 2005 (Table 3.3.4) 
 
Assessment of bias 
 
Selection bias 
Was allocation of participants to groups concealed until after interventions 
were allocated? 
 
Unclear – colleges were randomly allocated, but no details given 
 
Performance bias  
Were the recipients of care unaware of their assigned intervention (blinded)? 
 
No, not possible as either received intervention or not. 
 
Were persons providing care unaware of their assigned intervention 
(blinded)? 
 
No, not possible as either provided intervention or not. 
 
Detection bias 
Were persons assessing care unaware of their assigned intervention 
(blinded)? 
 
Yes, data was analysed without knowledge of allocated group. 
 
Attrition bias 
Were rates of follow-up similar in the comparison groups? 
 
Intervention group 21.3%, control group 21.2% 
 
Was the analysis “intention-to-treat” (were all patients analysed as 
randomised)?  Yes 
Outcome Time 
(months) 
Intervention 
(observed) 
Intervention 
(total) 
Control 
(observed) 
Control 
(total) 
Retention 12 225 285 277 352 
ST use point 
abstinence for 
30 days 
12  103 
36% PA 
 130 
37% PA 
  p>0.05, OR=0.98, 95% CI, 0.71 – 1.35 
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All studies provided sufficient data to allow analysis by an intention to treat 
methodology i.e. all participants lost to follow up were deemed to be continuing 
tobacco users, thereby minimising the risk of bias. Drop out rates between control 
and intervention groups were analysed to identify any possible bias. Studies 
providing data on continuous tobacco abstinence were deemed to be more robust 
than those giving point prevalence data only, as were those where tobacco status 
was verified biochemically as opposed to self-report only.  
 
Recruiting methodology was examined as some studies recruited only those 
tobacco users wishing to quit where others recruited all tobacco users. Where 
reported, the degree of nicotine dependence was also considered, as was the 
intervention provided i.e. counselling only, counselling plus nicotine replacement 
therapy etc.  
 
All studies were also analysed according to the degree of detail provided about 
randomisation strategies and whether these were adequate or not. Grade A 
represents studies in which it is clear that randomisation was blinded, Grade B 
represents those in which it is thought that blinding took place but sufficient detail 
is not given to verify this, and those studies where randomisation was not blinded 
were graded C. The method of randomisation was also noted i.e. individual or 
cluster randomisation.  
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3.2.15 Limitations of included studies 
In general, the quality of the observational studies included was high with all 
adequately describing participant eligibility criteria, study design and methodology 
(Appendix 16). Only three studies (Morgan et al. 2011; Prokhorov et al. 2002; 
Norman et al. 1990) failed to give sufficient details of the statistical methods used. 
Quality was found to be poorer with respect to reporting of sources of bias and 
possible limitations in the studies with 44.8% and 34.5% of papers respectively 
failing to fully acknowledge sources of bias and limitations. 
 
The summary of the CONSORT statement checklist in Appendix 17 
demonstrates that the randomised controlled trials included in this systematic 
literature review are of a good standard. Gansky et al. 2005 met the required 
standards regarding sequence generation, allocation concealment and 
implementation of the randomisation process but the others did not provide 
enough information to judge the quality of the process they undertook. Only one 
of the trials presented information of the trial registration details (Walsh et al. 
2010), and none of the trials provided access to the study protocol. Due to the 
behavioural nature of the interventions used in these trials, the recipients and 
deliverers of the intervention could not be blinded.  
 
The lack of biochemical verification of tobacco use status in all but one of the 
randomised controlled trials (Walsh et al. 2003) presents a potential source of 
bias as participants tend to report they have quit when this is not the case. 
 
  
148 
 
3.2.16 The meta-analysis 
The results of Walsh et al. (2010) in Figure 3.2 show that the increase in 
abstinence in the intervention group over the control group did not reach 
significance as the odds ratio includes 1. These results include participants who 
smoked cigarettes as well as used smokeless tobacco. No intervention effect at 
all was found for combined smokeless and smoked tobacco users.  However, 
when their results are analysed for smokeless tobacco users only, the results are 
highly significant in favour of the intervention (p<0.02).  
 
The results of Walsh et al. (1999), Walsh et al. (2003) and Gansky et al. (2002) 
proved significantly in favour of the intervention group over the control group as 
the odds ratio does not include 1 and so the results would not have occurred by 
chance.  Gansky et al. (2005) present results which are not significant as the 
odds ratios include 1 and so may have occurred by chance. 
 
The meta-analysis shown in Figure 3.2 demonstrates an increase in the odds 
ratio of 1.6 for tobacco abstinence in intervention groups over control groups at 
95% confidence intervals between 1.1 and 2.6 when the results of the five 
included randomised controlled trials are pooled. This indicates that the tobacco 
cessation interventions applied in the included studies had a small, but positive, 
effect in improving abstinence rates over the control groups. 
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Figure 3.2: Forest plot of trials included in the systematic review 
 
  
150 
 
3.2.17 Discussion 
 
The evidence uncovered in this systematic literature review has been gathered 
from a wide variety of study designs, study participants and outcome measures. 
However, the data is of sufficient quality to allow inferences to be drawn with 
regard to the research question for the systematic literature review: does existing 
evidence suggest that smoking cessation activities which have included a dental 
component conducted in rural areas are necessary and effective? 
 
The cross-sectional surveys of prevalence of tobacco use in rural areas identified 
in this literature review have shown that tobacco use varies with age, gender and 
geographical location. Studies in India have shown that even in children aged 11 
– 15 years, 8% are regular tobacco users (Jayakrishnan et al. 2011), and this 
increases to 68% of males aged 15 – 19 years (Dongre et al. 2008). The 
importance of encouraging dental professionals to involve themselves in tobacco 
cessation activities in rural India cannot be overemphasised when females report 
using snuff to brush their teeth, and the main reason for initiating its use is to 
relieve toothache. 
 
The gender differential is commonly found as many communities find it less 
acceptable for women to use tobacco than men. For example, Dongre et al. 
found only 12% of adolescent females using smokeless tobacco compared with 
68% of males (Dongre et al. 2008). Similarly, in Sudan, smokeless tobacco use 
was 3% in females and 34% in males (Idris et al. 1998). Even in some more 
developed parts of the world the gender gap in tobacco use exists as shown by 
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Seki et al. in Japan in 2004 where very high prevalence rates of 68% of males 
and 49% of females were found.  
 
A study of dental patients attending a dental school in Iran showed that there still 
exists a lack of knowledge of the effects of tobacco on oral health in some rural 
communities, as only 16% of this population identified smoking as a risk factor for 
oral cancer (Pakfetrat et al. 2010).  
 
The link between tobacco use and oral disease has been demonstrated in both 
cross-sectional population studies and cohort trials in this literature review. In two 
cross-sectional studies the odds ratio for periodontal disease in smokers over 
non-smokers varied from 1.62 in a rural Thai population (Chatrchaiwiwatana et al. 
2009) to 7.17 in rural Vietnam (Do et al. 2003). A cross-sectional study in rural 
India found that six percent of the population had suspicious oral lesions, with bidi 
and hookah smokers being six times more likely to present with them than non-
smokers (Dangi et al. 2012). 
 
In cohort studies in Sweden and India the role of tobacco use in oral disease was 
again confirmed, with Paulander et al. finding that smoking was the major risk 
factor for periodontal disease with an odds ratio of 3.2 (Paulander et al. 2004). 
Gupta et al. (1995) demonstrated the beneficial effects of tobacco cessation with 
the incidence of leukoplakia significantly dropping following cessation (Gupta et 
al. 1995). 
 
Educational interventions ranged from testing of the appropriateness of available 
tobacco prevention and cessation literature (Weiner and Weiner 2011) to tobacco 
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awareness raising and encouragement of tobacco cessation among 
schoolchildren (Jenkins and Geurink 2006), adolescents (Semer et al. 2005; 
DeMoss et al. 1997) and the population at large (Norman et al. 1990). These 
studies demonstrated that knowledge of the health impacts of smoking can be 
raised by educational interventions, and that recruitment to tobacco cessation 
programmes can be increased, especially when the intervention is tailored to the 
target population. 
 
Walsh et al. showed that educational interventions targeting dental professionals 
can increase their knowledge, confidence and activity levels with respect to 
tobacco cessation activities with their patients (Walsh et al. 2012). This suggests 
that investment in educating dental professionals could yield benefits to public 
health by enhancing their willingness and capacity in tobacco cessation provision. 
 
The potential for increased dental activity in tobacco cessation has been revealed 
in several studies examining current knowledge, attitudes and practices in 
tobacco cessation among dentists (Morgan et al. 2011; Squier et al. 2006; 
Brothwell and Armstrong 2004; Jennett et al. 1998). All of these studies 
demonstrated low levels of tobacco cessation provision in dental settings as well 
as lack of confidence among dental staff in providing these services. As well as 
lack of knowledge and confidence on their part, dental professionals also saw 
patient attitudes to dentists raising the issue of tobacco use as problematic as 
they are concerned patients would take offence or maybe even seek treatment 
elsewhere. The evidence in fact points to patients expecting to be asked and 
believing this to form part of the remit of the dental team (Campbell et al. 1999). 
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The literature also provides evidence that dental professionals have fallen behind 
other healthcare professionals when it comes to provision of tobacco use 
cessation (Zanis et al. 2008; Prokhorov et al. 2002; Block et al. 1999). In order to 
address this issue, it would seem prudent to introduce more training in the area of 
tobacco use cessation at both undergraduate and postgraduate levels for all 
dental care professionals. 
 
The most striking feature of this systematic literature review is the scarcity of 
robust randomised controlled trials that have been undertaken in rural areas to 
assess the effectiveness of tobacco interventions. No papers were identified 
which showed periodontal outcomes following tobacco interventions, and all five 
of the included papers used outcome indicators relating to smokeless rather than 
smoked tobacco. As smokeless tobacco use in rural Scotland is negligible, this 
undermines the transferability of the results to the population being studied here. 
However, the interventions employed to encourage cessation of smokeless and 
smoked tobacco use are very similar, and so a degree of comparison can be 
justified. For example, the smokeless tobacco users in the five included studies 
underwent an oral examination and lesions in their own mouths were pointed out 
to them. All five included studies involved a counselling element provided by 
trained healthcare workers which focussed on identifying reasons the individual 
wished to quit, setting a quit date and developing coping strategies to deal with 
withdrawal symptoms and prevent relapse. These same components are 
advocated by the Scottish Government (NHS Health Scotland and ASH Scotland 
2010) and the British Dental Association (Beaglehole and Watt 2004) among 
others.  
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The main omission found between recommendations for smoking cessation 
interventions and the smokeless tobacco interventions found in the included 
studies is the absence of provision of nicotine replacement therapy in all but one 
of them (Walsh et al. 1999). Provision of nicotine replacement therapy in 
combination with counselling has proved to give the most successful quit rates 
among smokers and it would seem likely that the same would apply to smokeless 
tobacco.  
 
Whilst there is a good deal of homogeneity in the study participants and settings 
of the included randomised controlled trials, the differences in methodology 
complicate comparisons of results. For example, the study population in three of 
the studies (Gansky et al. 2005; Walsh et al. 2003; Gansky et al. 2002) included 
all baseball team members whether or not they were tobacco users whilst Walsh 
et al. (2010) and Walsh et al. (1999) reported only on smokeless tobacco users.  
Different outcome measures are used to report results in the studies – either 
point prevalence or continuous abstinence. Four of the five randomised controlled 
trials used point prevalence, defined as no tobacco use in the previous 30 days, 
as their primary outcome measure (Gansky et al. 2005; Walsh et al. 2003; 
Gansky et al. 2002; Walsh et al. 1999). Walsh et al. (2010) used the recognised 
gold standard of tobacco abstinence outcome measures i.e. continuous 
abstinence from tobacco use throughout the twelve month study period. 
 
The lack of clarity regarding the randomisation process in most of these studies is 
disappointing and introduces an element of potential bias to the results. 
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Walsh et al. (2003) used the “bogus pipeline” methodology to enhance the validity 
of their results. This involved collecting saliva samples from all participants, and 
although only a proportion of them were analysed, participants had no way of 
knowing if their samples would be among those. The researchers found that 8% 
of those claiming to have quit tobacco use showed salivary cotinine levels 
inconsistent with non-tobacco users and so the results of the other studies 
included here are likely to overestimate the impact of the intervention delivered. 
 
Three of the randomised controlled trials included in this review demonstrated the 
effectiveness of the tobacco cessation intervention used over usual care with 
odds ratios of 2.03, 2.29 and 2.87 respectively (Gansky et al. 2002; Walsh et al. 
2003; Walsh et al. 1999). Walsh et al. (2010) and Gansky et al. (2005) showed no 
significant difference in tobacco cessation rates between the intervention and 
control groups. However, the combined results of the trials as demonstrated in 
the meta-analysis shows that evidence to date points to an overall positive effect 
on tobacco use cessation as a result of the interventions described.   
 
The conclusions drawn from this systematic literature review and meta-analysis 
that there are significant effects resulting from tobacco cessation interventions is 
supported by the Cochrane Reviews conducted by Carr and Ebbert in 2006 and 
2012. 
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3.2.18 Conclusions 
The results of this systematic literature review would suggest that tobacco use 
cessation is indeed necessary in rural populations as demonstrated by its 
prevalence which ranged from 8 – 68% in the papers included.  
 
As demonstrated in the narrative literature review, tobacco use is a major risk 
factor for both periodontal disease and oral malignancy, and the data from 
various cross-sectional and cohort trials included in this literature review have 
confirmed this in rural populations. This verifies the validity of dental professionals 
using every opportunity to support patients in quitting tobacco use. 
 
A lack of knowledge of the impact of tobacco use on oral health among rural 
populations has also been shown, but the papers included in the review verify 
that educational interventions can enhance knowledge and increase engagement 
with tobacco cessation support services.  It is therefore imperative that 
educational interventions, specifically tailored to the target population, continue to 
be provided. 
 
Dental professionals do not provide tobacco use cessation interventions as 
frequently as other healthcare professionals and do not feel adequately prepared 
to do so. This must be addressed at undergraduate and postgraduate levels in 
order that the opportunities dental professionals have to promote tobacco 
cessation are not missed. The evidence suggests that patients are far less 
sensitive about being questioned and offered support regarding their tobacco use 
than dental professionals imagine and this message should be widely 
disseminated among dental staff. 
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The research question for this systematic literature review examined the 
evidence-base regarding the effectiveness of tobacco cessation interventions 
undertaken in remote-rural areas.  To answer the research question rigorously 
conducted randomised controlled trials were included in the review.  There were 
few RCTs that assessed the effectiveness of smoking cessation programmes and 
those that did were RCTs concerning smokeless tobacco rather than smoked 
tobacco.  The RCTs included male, athletic participants and the results may not 
be considered transferable to the whole population in remote-rural areas.  
Therefore it is suggested that more research is required to demonstrate the 
effectiveness of smoking cessation interventions, and which elements ensure 
participant success. The potential benefits of smoking cessation interventions in 
remote-rural districts are required and so further research is justified. 
 
 
 
 
 
 
  
158 
 
3.3 Modelling a smoking cessation intervention for primary dental care in 
remote-rural Scotland 
 
3.3.0 Introduction 
This section explores the prevalence and knowledge of the effects of smoking, 
attitudes to smoking, and to smoking cessation in dental settings, and the oral 
health-related quality of life amongst primary dental care patients in this remote 
and rural area as well as conducting a basic periodontal clinical examination. In 
any instance where details of this study reflect those in the original randomised 
controlled trial, a link will be made to the appropriate section.  
 
The aim was to model a smoking cessation intervention for primary dental care in 
remote-rural Scotland.  The specific objectives were to: 
1. determine the prevalence and risk factors for chronic periodontitis, and its 
impact on oral health-related quality of life in a population of registered 
primary care dental patients in a rural area of Scotland. 
2. model a smoking cessation intervention based on smoking status, 
periodontal health status and oral health-related quality of life collected in 
a sample of adults attending a general dental practice in a remote and 
rural area. 
3. recommend the characteristics of a feasibility trial for a smoking cessation 
intervention for primary dental care in remote-rural Scotland 
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3.3.1  Method for the smoking and periodontal health prevalence and attitudes 
study 
 
The survey was conducted in two remote-rural salaried primary dental care 
practices located in Lochgilphead and Dunoon (Figure 1.1) in Argyll and Bute 
Community Health Partnership.  Data were collected relating to known factors 
impacting on periodontal treatment need, and detailed information of smoking-
related knowledge, attitudes and behaviours amongst those who smoked was 
also gathered. A basic periodontal examination was also undertaken. 
 
Sample population 
A convenience sample was drawn from regularly attending adult patients aged 
eighteen years and over who regularly attended the dental practices in 
Lochgilphead and Dunoon.  Regular dental attenders were defined as registered 
patients who had attended the dental practice on a yearly basis in the previous 
two years.  
 
All patients were invited to participate regardless of their smoking status and oral 
health status. The Adults with Incapacity (Scotland) Act 2000 decrees that “no 
research shall be carried out on any adult who is incapable in relation to a 
decision about participation.”  An exception is made where the research is 
investigating the cause of the adult’s incapacity, but as this does not apply to this 
study no potential participants lacking capacity to provide informed consent were 
included. No exclusion criteria other than age and an inability to provide informed 
consent were applied.  
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Sample size 
A sample size of 136 was required to provide a representative sample of the 
4,500 registered adult patients with a margin of error of 5%, confidence levels of 
95%, and 90% response rate. The Raosoft Sample Size Calculator software was 
used to produce the sample size.  
 
A convenience sample of patients attending for routine dental care on the days 
the researcher was available was included in the study. Patients attending for 
dental care were approached personally by the researcher, who explained the 
purpose of the survey, and invited them to complete a questionnaire and allow a 
basic periodontal examination.  
 
The questionnaire 
The questionnaire was the same as that described in Chapter 2 with additional 
questions relating to the role of dental health professionals in smoking cessation 
programmes (Appendix 2).   
 
The additional questions included the assessment of participants’ attitudes to 
dental professionals providing smoking cessation.  Four statements asked 
participants to what extent they agreed that: 
[1] dentists should ask about smoking status,  
[2] offer advice about stopping smoking,  
[3] provide stop smoking counselling and  
[4] provide nicotine replacement therapies.  
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A Likert-scale offering five responses ranging from “definitely agree” (scoring 5) to 
“definitely disagree” (scoring 1) was used. The statements used were those 
included by Campbell et al. (1999) and included an additional question regarding 
dentists offering nicotine replacement therapy. 
 
Participants were also asked to report if they were a current smoker, ex-smoker 
or had never smoked.  Ex-smokers were asked to record how much time had 
elapsed since they had quit smoking tobacco.  Only smokers were requested to 
respond to the remaining questions which related to their smoking attitudes and 
behaviours. This included providing information about which tobacco products 
they used, their level of nicotine dependence, lifetime exposure to tobacco, 
attitudes to their smoking habit and any recent attempts to cut down or quit 
smoking as described in Chapter 2. 
 
Finally all participants were asked whether their dentist had ever asked about 
their smoking status, offered them advice about quitting smoking or offered to 
refer them to stop smoking services (Brothwell and Armstrong 2004). 
 
Clinical Examination 
 [1] The Basic Periodontal Examination (BPE) as developed by the British Society 
of Periodontology and updated in October 2011 provides a standardised system 
of codes for scoring periodontal health as shown in Table 2.1 on page 31.  
 
As specified in the BPE guidance, World Health Organisation BPE probes with a 
0.5mm ball-end and a black band from 3.5 to 5.5mm were used to assess 
periodontal health. A probing force of 20-25 grams was applied to determine 
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periodontal pocket depths. For the purposes of recording the BPE, the mouth is 
divided into sextants and the highest score found by walking the probe round the 
sulcus of each tooth is recorded for each sextant. 
 
A calibration exercise was undertaken to test the robustness of the data collected 
by KE against that of an expert examiner (AFH). This exercise involved the 
examination of ten volunteers by both KE and the consultant AFH as gold 
standard. A period of fifteen minutes between each examination of each patient 
allowed any bleeding resulting from probing to cease.  
 
In order to maximise the value of BPE measurements as an independent variable 
in the analysis of this dataset, the scores were subdivided to signify the degree of 
complexity of the treatment need they represent. The categorisation of the 
complexity of treatment need follows the Periodontal Treatment Assessment 
advocated in the British Society of Periodontology “Referral Policy and 
Parameters of Care” as updated in 2011. All participants were categorised as 
follows: 
 Complexity 1 = BPE score of 0 – 3 in any sextant 
 Complexity 2 = BPE score of 4 in any one sextant  
 Complexity 3 = BPE score of 4 in more than one sextant, or a BPE score 
of 4 in one sextant and a concurrent medical factor affecting the 
periodontal tissues e.g. diabetes, complicating root morphologies, or non-
response to previous optimal treatment  
 
The complexity rating of a participant could be increased by one level only if they 
presented with one or more modifying factor such as significant 
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immunosuppression, furcation involvement or smoking ten or more cigarettes per 
day. 
 
These three groups, as well as representing increasing complexity of treatment 
needs, also demonstrate increasing time, material and financial resource 
requirements, and those in Complexity 3 group may require referral to secondary 
care thus substantially increasing treatment costs. 
 
Ethical considerations 
Ethical approval was obtained from the East of Scotland Research Ethics Service 
– REC reference number 10/S0501/37. NHS Highland Research & Development 
Department also approved the project – R&D reference number 684. 
 
As in the randomised controlled trial, any potential participant who did not 
demonstrate capacity to provide informed consent was excluded from the study 
(Adults with Incapacity (Scotland) Act 2000 s5).  
 
Administration of questionnaires and clinical examination 
During the period from March to October 2012, patients attending the dental 
practice in Lochgilphead and Dunoon for routine appointments were approached 
by the researcher in the dental waiting area. A brief explanation of the research 
being conducted was provided verbally and the patient asked if they would be 
willing to complete a self-administered questionnaire and undergo a basic 
periodontal examination. The self-administered questionnaire was completed in a 
private area of the waiting room away from other waiting patients. The periodontal 
examination was conducted in the dental surgery. Any patient indicating that they 
  
164 
 
wished to complete the questionnaire but required assistance, had the questions 
read to them in the dental surgery to ensure confidentiality.  
 
The basic periodontal examination was undertaken in the dental chair using 
standard high-quality lighting and WHO BPE probes, and in accordance with the 
guidance provided by the British Society of Periodontology.  
 
All questionnaires and other paperwork associated with the survey was collected 
by KE and stored in a locked filing cabinet in an office which was kept locked 
when not in use.  
 
Data Analysis 
The categorisation of variables to facilitate data analysis was conducted as 
described in Chapter 2, Section 2.3.7. The BPE data replaced the bleeding on 
probing, plaque index, pocket depth and attachment loss data and was 
categorised according to the parameters of care devised by the British Society of 
Periodontology resulting in a score of 0 – 4 for each sextant.  
 
Statistical Analysis 
The statistical analysis of all data in this survey used the SPSS V16.0. The 
questionnaire data were collated and coded, then entered onto the SPSS 
database. Statistical analysis was conducted using frequency distributions, and 
continuous data analysed using t-tests and Analysis of Variance (ANOVA), with 
statistical differences between groups being determined by post hoc Scheffe 
tests. Categorical data was analysed using chi-squared tests. Only results with a 
p-value of 0.05 or less were regarded as significant.  
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The scores for the twelve smokers’ attitudinal items in the survey questionnaire 
were subjected to a principle components factor analysis with varimax rotation 
resulting in clustering of the attitudes to form a consistent scale. Cronbach’s 
alpha was used to test the internal reliability of the scales. 
 
The strength of the relationships between age, smoking status, oral health-related 
quality of life and periodontal status were analysed using the electronic software 
package SPSS Amos, a structural equation modelling (SEM) tool. This statistical 
tool was chosen as it allows the covariance between observed variables to 
produce a small number of latent variables, in this case to predict the factors 
relevant to smokers considering quitting. 
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3.3.2 Results  
3.3.2.1 Sample 
 
Three hundred and ninety nine general dental practice patients took part in the 
study. A total of 412 patients were approached and asked to complete a 
questionnaire, of whom 13 refused. Reasons for non-participation included lack of 
time (6), not wishing to participate in a research project (4) and three people gave 
no reason. This resulted in a response rate of 96.8%. One returned questionnaire 
was found to have no data recorded except age, leaving a total of 398 valid 
questionnaires for analysis and a valid response rate of 96.6%. Seventy six 
percent of the participants were from Lochgilphead and the remainder from 
Dunoon. 
 
3.3.2.2 Demographic data 
 Age profile of sample 
The age range of participants was from 18 to 87 years. The median age was 
49.50 years and the mean age was 49.18 years (95%CI: 47.68, 50.68). The 
mean age of the sample in Dunoon was 47.26 years (95%CI: 45.72, 48.80), and 
in Lochgilphead 49.80 years (95%CI: 48.92, 50.77). There was no significant 
difference in mean age of participants in each location (t=1.44: p=0.86). 
 
The median age of the participants was 49.5 years. The sample was divided into 
two age groups – younger being forty-nine years old or younger, and older being 
fifty years or older. This meant that 50.3% of the sample was classified as 
younger and 49.7% classified as older. 
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 Gender profile of sample 
Males accounted for 39% and females for 61% of the sample. The mean age of 
52.3 years (95%CI: 51.22, 53.42) for the male participants was significantly 
higher than the mean of 47.3 years (95%CI: 46.17, 48.19) in females (t=3.33: 
p=0.02). 
 
Table 3.4: Demographic profile by age, location and gender 
  Mean age in years (95% 
CI) 
F[df] P 
Lochgilphead  Male  
(n=109) 
 
52.17 (49.36, 54.99) 
 
 
 
3.49  
[3, 394] 
 
 
 
0.06 
Female  
(n= 192) 
 
48.46 (46.34, 50.58) 
Dunoon Male  
(n=46) 
 
52.68 (48.35, 57.00) 
Female 
(n=51) 
 
42.37 (38.26, 46.48) 
 
The grouping variable “locality by gender” did not explain differences in the mean 
age of the participants. Although the women in both Lochgilphead and Dunoon 
were younger than the men, this difference did not reach statistical significance 
(Table 3.4). 
 
 Ethnicity of sample 
Three hundred and eighty-nine (92.7%) of the population were Caucasian, the 
remainder of the participants were African/Caribbean, Asian and mixed race. 
 
 Occupational profile of sample 
Respondents were asked to record their occupation which was then assigned to 
four levels of occupation according to the Standard Occupational Classification 
(Office of National Statistics, 2010). A total of 333 participants stated their 
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occupation with only 66 (16.5%) failing to do so. This tended to be amongst the 
older age group who frequently recorded that they were retired.  Table 3.5 shows 
the range of occupations across this population of respondents. 
 
Table 3.5: Occupational group by frequency 
Occupational group Code for 
occupational 
group 
Frequency % 
Skills achieved via compulsory school 
education 
1 98 29.4 
Skills requiring workplace training 2 88 26.4 
Skills requiring sub degree level qualification 3 95 28.5 
Skills requiring degree level qualification 4 52 15.6 
 
There was a significant association between age and reported occupation. No 
other significant associations were demonstrated (Table 3.6).  
 
Table 3.6: Occupational group by age group, location and gender 
 Occupational group X2 [df] P 
 1 
n (%) 
2  
n (%) 
3 
n (%) 
4 
n (%) 
  
Age group: 
Younger 
(49 years or under) 
55 
(31.2) 
55 
(31.2) 
47 
(26.7) 
19 
(10.8) 
 
9.70 [3] 
 
 
0.02 
 
 
Older 
(50 years or over) 
43 
(27.4) 
33 
(21.0) 
48 
(30.6) 
33 
(21.0) 
Location: 
Lochgilphead 73 
(29.1) 
61 
(24.3) 
72 
(28.7) 
45 
(17.9) 
 
5.28 [3] 
 
0.15 
Dunoon 25 
(30.5) 
27 
(32.9) 
23 
(28.0) 
7  
(8.5) 
Gender:        
Male 33 
(26.2) 
33 
(26.2) 
36 
(28.6) 
24 
(19.0) 
 
2.26 [3] 
 
0.52 
Female 65 
(31.4) 
55 
(26.6) 
59 
(28.5) 
28 
(13.5) 
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3.3.2.3 Reported medical status 
One hundred and forty-three (35.8%) of the participants stated they were 
receiving treatment from their doctor and 216 (54.1%) reported they were 
currently taking prescribed medication.  
 
The reported frequency of each medical condition in descending order was as 
follows: allergies (22.3%), high blood pressure (18.3), lung diseases (10%), blood 
disorders (9.8%), angina (4.5%), diabetes (4.3%), heart attack (3%), infectious 
diseases (1.3%) and epilepsy (0.8%). 
 
 Reported medical condition by age group 
Significantly larger proportions of older compared with younger participants 
reported receiving treatment, taking medication and having angina, hypertension 
and heart attacks. All eight pregnant women were in the younger age group. No 
significance was found in the proportion of people in younger and older age 
groups with respect to infectious diseases, lung diseases, epilepsy, diabetes, 
blood disorders and allergies (Table 3.7).  
 
 Reported medical condition by gender 
Significant gender differences were encountered with greater proportions of 
males reporting angina, hypertension, heart attack and diabetes, and a higher 
proportion of females reporting blood disorders, allergies and of course, 
pregnancy (Table 3.7). 
 
 Reported medical condition by participant occupation 
No significant associations were found in the proportion of participants in each of 
the four occupational groups with respect to their reported medical status except 
  
170 
 
for the proportion of those reporting they were “receiving treatment” which 
reached significance at the 5% level (Table 3.7).  
 
 Reported medical condition by locality 
The proportion of participants residing in Dunoon was significantly higher than the 
proportion of those living in Lochgilphead with respect to reporting they 
experienced heart attack and blood disorders (Table 3.7).  
 
Table 3.7: Reported medical condition by age group, gender, occupational group 
and location 
Reported medical 
condition 
Age group Gender Occupational 
group 
Location 
 X2 [df] P X2 [df] P X2 [df] P X2 [df] P 
Receiving treatment 8.39 [1] 
 
0.004 
 
0.85 [1] 0.36 8.06 [3] 0.05 2.50 [2] 0.29 
Taking medication 9.78 [1] 
 
0.002 1.12 [1] 0.29 6.15 [3] 0.11 3.20 [2] 0.20 
Angina 11.55 [1] 
 
0.001 
 
6.09 [1] 0.01 6.15 [3] 0.11 2.77 [2] 0.25 
Hypertension 7.66 [1] 
 
0.006 
 
6.46 [1] 0.01 2.38 [3] 0.50 1.10 [2] 0.58 
Heart attack 8.70 [1] 
 
0.003 
 
4.00 [1] 0.05 1.02 [3] 0.80 7.59 [2] 0.02 
Infectious diseases 0.21 [1] 
 
0.65 
 
0.01 [1] 0.96 1.47 [3] 0.69 3.49 [1] 0.06 
Lung diseases 0.94 [1] 
 
0.33 
 
0.04 [1] 0.84 4.15 [3] 0.25 3.02 [2] 0.22 
Epilepsy 0.33 [1] 
 
0.57 
 
0.04 [1] 0.84 2.41 [3] 0.49 0.13 [1] 0.72 
Diabetes 3.09 [1] 
 
0.08 
 
4.96 [1] 0.03 4.79 [3] 0.19 3.02 [2] 0.22 
Blood disorder 2.40 [1] 
 
0.12 
 
6.18 [1] 0.01 2.54 [3] 0.47 16.99[1] <0.001 
Allergies 0.004 [1] 
 
0.95 
 
6.92 [1] 0.009 2.12 [3] 0.55 0.90 [2] 0.64 
Pregnant 8.08 [1] 
 
0.004 
 
5.21 [2] 0.02 3.99 [3] 0.26 0.00 [1] 0.97 
 
A significant association was demonstrated between reported smoking status and 
reported medical condition for receiving treatment (p=0.02), blood pressure 
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problems (p=0.01), heart attack (p=0.01) and infectious diseases (p<0.01) 
(Appendix 18, Table A1). 
 
3.3.2.4 Reported smoking status 
Participants were asked to categorise themselves as current smokers, ex-
smokers and never smokers and the reported frequency of each category is 
recorded in Table 3.8. Twenty three percent stated they were current smokers. 
 
Table 3.8: Frequency of reported smoking status 
Smoking status Number Percent 
Never smoker 185 46.6 
Ex-smoker 119 30.0 
Current smoker 93 23.4 
 
Table 3.9 shows the demographic profile of the study population by smoking 
status. There was a significant association between reported smoking status with 
age, occupational group and locality. The proportion of current smokers based in 
Dunoon was twice that of Lochgilphead; the proportion of current smokers was 
double in the younger group than in the older; the proportion of people in 
occupations requiring lower educational qualifications who reported they were 
current smokers was higher than in other occupational groups.  
  
172 
 
 
Table 3.9: Reported smoking status by demographic profile 
  Reported smoking status 
  Never 
smoker 
n (%) 
Ex-smoker 
 
n (%) 
Current 
smoker 
n (%) 
X2 
[df] 
P 
Age group Younger  
(49 years or  
under) 
95 (47.7) 41 (20.6) 63 (31.7)  
23.35 
[2] 
 
<0.001 
 
 Older 
(50 years or 
over) 
90 (45.5) 78 (39.4) 30 (15.2) 
Gender Male 
 
66 (42.6) 52 (33.5) 37 (23.9)  
1.99 
[2] 
 
0.37 
 Female 
 
119 (49.2) 67 (27.7) 56 (23.1) 
Occupational 
group 
1 
 
31 (31.6) 34 (34.7) 33 (33.7)  
 
 
29.32 
[6] 
 
 
 
<0.001 
 2 
 
43 (49.4) 18 (20.7) 26 (29.9) 
 3 
 
60 (63.2) 26 (27.4) 9 (9.5) 
 4 
 
21 (40.4) 20 (38.5) 11 (21.2) 
Location Lochgilphead 
 
152 (50.7) 91 (30.3) 57 (19.0)  
14.68 
[2] 
 
0.001 
Dunoon 
 
33 (34.0) 28 (28.9) 36 (38.7) 
 
 
3.3.2.5 Knowledge of impacts of smoking on health 
Participants in this study completed a table listing a range of medical conditions 
and were asked to record whether they considered the conditions to be related to 
smoking or not (Table 3.10).  The average frequency of correct responses over 
all 12 physical conditions listed was 54.6%.  The frequency of correct answers 
ranged from 91.5% of respondents correctly asserting that smoking was related 
to lung cancer to only 10.8% correctly recording that smoking tobacco was 
implicated in dementia (Table 3.10).  
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Table 3.10: Knowledge of smoking-related health conditions 
Smoking-related health conditions Correct response 
(number) 
Correct response 
(percent) 
1. Arthritis 86 21.6 
2. Heart disease 354 88.9 
3. Gum disease 335 84.2 
4. Skin disease 116 29.1 
5. Broken arm 339 85.2 
6. High blood pressure 297 74.6 
7. Mouth cancer 363 91.2 
8. Lung cancer 364 91.5 
9. Toothache 119 29.9 
10. Dementia 43 10.8 
11. Bronchitis 322 80.9 
12. Liver disease 266 66.8 
 
 Smoking-related health knowledge by age group 
With respect to knowledge of the role of smoking in disease, age proved a factor 
in only three categories with a significantly lower proportion of the younger age 
group giving a correct answer to whether smoking was related to arthritis. 
Significantly higher proportions of younger compared to older age groups 
correctly stated that smoking was related to gum disease but not to fractures 
(broken arm) (Table 3.11). 
 
 Smoking-related health knowledge by gender  
Significantly higher proportions of female compared with male participants 
correctly stated that smoking was not related to toothache. No other significant 
differences were noted (Table 3.11).  
 
 Smoking-related health knowledge by occupational group  
A significant association was demonstrated between smoking-related health 
knowledge and occupational status for the smoking related conditions of arthritis, 
heart disease and lung cancer (Table 3.11). 
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 Smoking-related health knowledge by location  
A larger proportion of Lochgilphead participants answered correctly that arthritis 
was a smoking-related than participants in Dunoon. No other statistically 
significant differences were found in smoking-related health knowledge between 
the two localities (Table 3.11). 
 
 Smoking-related health knowledge by reported smoking status  
There was a significant association in that higher proportions of current smokers 
stated that there was no link between smoking and the diseases listed, while 
higher proportions of ex-smokers and never smokers tended to assume a 
relationship between smoking and all the conditions listed. This resulted in the 
group of smokers faring disproportionately well in questions with a negative 
response and vice versa for ex- and never smokers. Significant associations were 
therefore found in relation to skin disease and broken arm with significantly larger 
proportions of current smokers than non-smokers giving correct answers, 
whereas significantly smaller proportions of current smokers gave correct 
responses with relation to mouth cancer, lung cancer and liver disease. 
Significantly lower proportions of smokers correctly stated that arthritis could be 
smoking-related than ex-smokers or never smokers (Table 3.12). 
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Table 3.11: Smoking-related health knowledge by age group, gender, 
occupational group and location 
Smoking-
related 
health 
conditions 
Age group Gender Occupation Location 
 X2 
[df] 
P X2 
[df] 
P X2 
[df] 
P X2 [df] P 
Arthritis 13.74 
[1] 
<0.001 
 
0.02 
[1] 
0.90 14.32 
[3] 
<0.001 9.67 
[1] 
<0.001 
Heart 
disease 
0.99 
[1] 
0.32 
 
1.60 
[1] 
0.21 10.23 
[3] 
0.02 1.03 
[1] 
0.31 
Gum 
disease 
12.09 
[1] 
0.01 
 
0.02 
[1] 
0.88 1.27 
[3] 
0.74 1.15 
[1] 
0.28 
Skin 
disease 
0.14 
[1] 
0.71 
 
0.90 
[1] 
0.35 3.63 
[3] 
0.31 3.49 
[1] 
0.06 
Broken arm 9.03 
[1] 
<0.001 
 
0.00 
[1] 
0.99 3.74 
[3] 
0.29 0.21 
[1] 
0.65 
High blood 
pressure 
0.03 
[1] 
0.86 
 
0.10 
[1] 
0.75 0.14 
[3] 
0.99 0.94[1] 0.33 
Mouth 
cancer 
0.32 
[1] 
0.57 
 
0.25 
[1] 
0.62 6.04 
[3] 
0.11 0.04 
[1] 
0.85 
Lung 
cancer 
0.15 
[1] 
0.70 
 
1.91 
[1] 
0.17 18.36 
[3] 
<0.001 2.41 
[1] 
0.12 
Toothache 1.30 
[1] 
0.26 
 
4.40 
[1] 
0.04 0.86 
[3] 
0.83 0.07 
[1] 
0.80 
Dementia 3.28 
[1] 
0.07 
 
0.33 
[1] 
0.56 3.38 
[3] 
0.34 0.31 
[1] 
0.58 
Bronchitis 0.94 
[1] 
0.33 
 
1.20 
[1] 
0.16 5.74 
[3] 
0.13 0.21 
[1] 
0.65 
Liver 
disease 
2.02 
[1] 
0.16 
 
0.01 
[1] 
0.76 1.01 
[3] 
0.80 0.49 
[1] 
0.48 
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Table 3.12: Smoking-related health knowledge by reported smoking status 
Smoking-related 
health condition 
Reported smoking status X2 [df] P 
 Never 
smoker 
n (%) 
Ex-smoker 
 
n (%) 
Current 
smoker 
n (%) 
  
Arthritis 43 
(23.2%) 
31 
(26.1%) 
12 
(12.9%) 
5.83 [2] 0.05 
Heart disease 163 
(88.1%) 
110 
(92.4%) 
80 
(86.0%) 
2.41 [2] 0.30 
Gum disease 154 
(83.2%) 
99 
(83.2%) 
81 
(87.1%) 
0.80 [2] 0.67 
Skin disease 45 
(24.3%) 
32 
(26.9%) 
39 
(41.9%) 
9.73 [2] <0.001 
Broken arm 149 
(80.5%) 
102 
(85.7%) 
87 
(93.5%) 
8.32 [2] 0.02 
High blood pressure 137 
(74.1%) 
95 
(79.8%) 
64 
(68.8%) 
3.39 [2] 0.18 
Mouth cancer 170 
(91.9%) 
113 
(95.0%) 
79 
(84.9%) 
6.73 [2] 0.04 
Lung cancer 172 
(93.0%) 
113 
(95.0%) 
78 
(83.9%) 
9.24 [2] 0.01 
Toothache 48 
(25.9%) 
42 
(35.3%) 
29 
(31.2%) 
3.10 [2] 0.21 
Dementia 24 
(13.0%) 
10 
(8.4%) 
8 
(8.6%) 
2.10 [2] 0.35 
Bronchitis 145 
(78.4%) 
99 
(83.2%) 
77 
(82.2%) 
1.38 [2] 0.50 
Liver disease 137 
(74.1%) 
77 
(64.7%) 
52 
(55.9%) 
9.62 [2] <0.001 
 
3.3.2.6 Smoking–related attitudes 
 
Smokers were asked to grade their responses to a series of statements which 
assessed their attitudes to their own smoking habits using a five-point Likert –
scale ranging from “not at all” to “very much” scoring from 1 through to 5. The five 
Likert responses were condensed into three groups to facilitate analysis and 
reporting of the data as follows: “not at all concerned”, “moderately concerned” 
and “highly concerned” (Table 3.13).   
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Table 3.13: Smoking-related attitudes 
 Smoking-related attitude Category by degree of 
concern 
  Not at 
all 
n (%) 
Moderately 
n (%) 
Highly  
n (%) 
1 Concerned about effects on my health 7  
(7.6%) 
32  
(34.8%) 
53 
(57.6%) 
2 Concerned about effects on health of others 9  
(9.8%) 
33  
(35.9%) 
50 
(54.3%) 
3 People close want me to quit 16 
(17.4%) 
18  
(19.6%) 
58 
(63.0%) 
4 I am confident with personal problems 5 
(5.4%) 
23  
(25.0%) 
64 
(69.6%) 
5 Things have gone my way recently 18 
(19.6%) 
32  
(34.8%) 
42 
(45.7%) 
6 I want to cut down my smoking 7 
(7.6%) 
30  
(32.6%) 
55 
(59.8%) 
7 I want to quit smoking 11 
(12.0%) 
26  
(28.3%) 
55 
(59.8%) 
8 I intend to quit smoking 14 
(15.2%) 
24  
(26.1%) 
54 
(58.7%) 
9 Confident could refrain when angry 31 
(33.7%) 
39  
(42.4%) 
22 
(23.9%) 
10 Confident could refrain when under pressure 38 
(41.3%) 
32  
(34.8%) 
22 
(23.9%) 
11 Confident I could cut down 9 
(9.8%) 
33  
(35.9%) 
50 
(54.3%) 
12 Confident I could quit altogether 16 
(17.4%) 
34  
(37.0%) 
42 
(45.7%) 
 
Table 3.13 shows that current smokers were very concerned about the effect that 
smoking had on their own and others’ health. Sixty three percent reported that 
those close to them wanted them to quit which should assist in the success of 
any quit attempts, as should the high degree of confidence in dealing with 
personal problems reported. 
 
Almost 60% of participants reported they very much wanted to cut down or quit 
smoking, but only one quarter of respondents felt confident they could refrain 
from smoking when angry or under pressure. Over half of respondents felt 
confident they could cut down on their smoking, and 45% felt they could stop all 
together. 
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When the smoking-related attitudes were analysed by age group, gender, 
occupational group and location, participants of Dunoon had significantly lower 
mean scores for the attitude ‘Things have gone my way recently’ (Mean=2.53, 
SD=1.44) compared with participants from Lochgilphead (Mean=3.46, SD=1.28) 
(t=3.26:P=0.02).  
 
Principal component factor analysis 
All scores for the 12 attitudinal items were subjected to a principal components 
factor analysis with varimax rotation which is a method to cluster items together 
to form a consistent scale. Two scales were identified which explained 59.7% of 
the variance. Scale 1 was composed of items 1, 2, 3, 6, 7 and 8, and had an 
Eigen value of 4.66. It explained 38.8% of the variance. Scale 2 had an Eigen 
value of 2.51 and comprised items 4, 5, 9, 10, 11 and 12, and this scale 
explained a further 20.9% of the variance (Table 3.14). 
 
The items in each of the two scales described different aspects of the smoking-
related attitudes. Scale 1 was therefore conceptualised as ‘willingness to quit 
smoking’ and Scale 2 as ‘confidence to quit smoking’. 
 
On analysis of the two attitudinal scales by gender, age group, occupational 
status and location, no significant differences were found.  Smoking-related 
health knowledge did not vary significantly by attitudinal scale. Significant 
differences were found when analysing the ‘confidence to quit’ scale by lifetime 
exposure to tobacco with the mean scores for those in the high exposure group 
being significantly lower than for the low and moderate exposure groups (F=8.18: 
df=2,89: p=0.001). Similar results were found indicating a significant reduction in 
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confidence to quit with increasing levels of nicotine dependence (F=8.19: df=2,89: 
p=0.001) (Table 3.15). No significant differences in means were found between 
exposure to tobacco and nicotine dependence and the ‘willingness to quit 
smoking’ scale. 
 
Table 3.14: Smoking attitudes scales and items 
Item  Cronbach’s 
alpha 
Factor 
loading 
Mean 
(95% CI) 
 Scale 1: willingness to quit 
smoking 
0.89  21.21  
(19.80, 22.62) 
1 Concerned about effects on my 
health 
 0.85 3.44 
(3.16,3.73) 
2 Concerned about effects on health 
of others 
 0.70 3.45  
(3.16, 3.75) 
3 People close want me to quit  0.49 3.59  
(3.28, 3.89) 
6 I want to cut down my smoking  0.89 3.63  
(3.36, 3.90) 
7 I want to quit smoking  0.92 3.58  
(3.28, 3.87) 
8 I intend to quit smoking  0.89 3.51 
(3.21, 3.81) 
 Scale 2: confidence to quit 
smoking 
0.79  18.10 
(16.91, 19.28) 
4 I am confident with personal 
problems 
 0.47 3.80  
(3.55, 4.06) 
5 Things have gone my way 
recently 
 0.54 3.10  
(2.80, 3.39) 
9 Confident could refrain when 
angry 
 0.81 2.49 
(2.20, 2.78) 
10 Confident could refrain when 
under pressure 
 0.87 2.32 
(2.03, 2.60) 
11 Confident I could cut down  0.72 3.33 
(3.05, 3.60) 
12 Confident I could quit altogether  0.69 3.07 
(2.78, 3.35) 
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Table 3.15: Confidence to quit by pack years and nicotine dependence 
Confidence to quit scale  Mean Standard 
deviation 
F 
[df] 
P 
Life pack years Low 19.602 4.97  
8.18 
[2, 89] 
 
0.001  Moderate 18.802 5.73 
 High 13.901 5.35 
      
Nicotine dependence Low 19.982 5.29  
8.19 
[2, 89] 
 
0.001  Moderate 16.501,2 5.46 
 High 13.131 4.67 
*The suffixes show the significant differences in confidence to quit which existed between 
categories of life pack years and nicotine dependence 
 
With respect to quit attempts in the previous two months, there was a significant 
difference in the mean scores for the ‘willingness to quit’ scale between those 
who had not tried to cut down (t=2.06, p=0.04), tried to stop (t=4.01, p<0.001) or 
quit for at least 24 hours (t=2.39, p=0.02), and those who had (Table 3.16). A 
significant difference in mean scores for the ‘confidence to quit’ scale was found 
only for those who had and those who had not cut down (t=2.22, p=0.03) (Table 
3.16). 
 
Table 3.16: Willingness to quit scale and confidence to quit scale by quit attempts  
Willingness to quit scale 
  Mean Standard 
deviation 
t P 
Cut down No   (n=56) 20.09 7.09 
2.06 0.04 
 Yes  (n=36) 22.94 6.06 
Tried to quit No   (n=70) 19.91 6.82 
4.01 <0.001 
 Yes  (n=22) 25.32 5.03 
Stopped for >24 hours No   (n=66) 20.19 7.38 
2.39 0.02 
 Yes  (n=30) 23.30 4.93 
Confidence to quit scale 
  Mean Standard 
deviation 
t P 
Cut down No   (n=56) 17.07 5.69 
2.22 0.03 
 Yes  (n=36) 19.69 5.44 
Tried to quit No   (n=70) 17.51 5.77 
1.86 0.07 
 Yes  (n=22) 19.95 5.24 
Stopped for >24 hours No   (n=66) 17.40 5.90 
1.78 0.08 
 Yes  (n=30) 19.53 5.10 
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Participants who did not plan to stop and those who did not plan to stop within 6 
months had significantly lower mean scores for ‘confidence to quit’ compared with 
participants who had set a quit date within the next 30 days (F=5.12, p=0.003) 
scales (Table 3.17).  
 
Table 3.17: Willingness to quit scale and confidence to quit scale by readiness to 
quit 
Willingness to quit scale 
 Number of 
participants 
Mean Standard 
deviation 
F 
[df] 
P 
Don’t plan to stop 18 12.061 4.40  
 
29.33 
[3, 88] 
 
 
<0.001 
Not in next 6 months 16 20.382 6.35 
Seriously plan to stop in next 
6 months 
51 23.882,3 4.70 
Quit date set in next 30 days 7 27.143 3.02 
Confidence to quit scale 
 
Number of 
participants 
Mean 
Standard 
deviation 
F 
[df] 
P 
Don’t plan to stop 18 15.331 5.74  
 
5.12 
[3, 88] 
 
 
0.003 
Not in next 6 months 16 15.751 5.43 
Seriously plan to stop in next 
6 months 
51 19.161,2 5.45 
Quit date set in next 30 days 7 22.862 2.54 
*The suffixes show the significant differences in willingness to quit which existed between 
stages of readiness to quit 
 
The grouping variable complexity of periodontal treatment need did not explain 
differences in mean scores for ‘willingness to quit’ or ‘confidence to quit’ (Table 
3.18). 
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Table 3.18: Willingness to quit scale and confidence to quit scale by complexity of 
periodontal treatment need 
Willingness to quit scale 
 Number of 
participants 
Mean Standard 
deviation 
F 
[df] 
P 
Complexity 1 41 21.51 5.92 0.80 
[2,89] 
 
0.92 Complexity 2 40 20.90 7.47 
Complexity 3 11 21.81 7.99 
Confidence to quit scale 
 Number of 
participants 
Mean Standard 
deviation 
F 
[df] 
P 
Complexity 1 41 18.80 6.18 0.57 
[2,89] 
 
0.57 Complexity 2 40 17.76 5.41 
Complexity 3 11 17.36 5.16 
 
When examining the association between ‘willingness to quit’ with oral health-
related quality of life, significant positive correlations were found with 
experiencing pain (rp=0.39, p<0.001), experiencing discomfort when eating (rp 
=0.30, p=0.004), having to interrupt meals because of dental problems (rp =0.22, 
p=0.04) and finding it difficult to relax (rp =0.23, p=0.03).  The only significant 
association between “confidence to quit” scale and oral health-related quality of 
life was a negative correlation with feeling embarrassed by one’s teeth (rp =0.21, 
p=0.05). 
 
A significantly positive correlation was found between mean scores for 
‘willingness to quit’ with agreeing that dentists should be asking about smoking 
habits and offering support. No significant correlation was found between 
‘confidence to quit’ and agreeing that dentists should be involved in smoking 
cessation activities (Table 3.19).   
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Table 3.19: Willingness to quit scale and confidence to quit scale by agreement 
with dental involvement in smoking cessation activities 
 
Willingness to quit scale 
Extent to which agree that dentists should: rp P 
Ask if smoke 0.39 <0.001 
Offer advice  0.45 <0.001 
Provide counselling 0.33 0.001 
Provide NRT 0.44 <0.001 
Confidence to quit scale 
Extent to which agree that dentists should: rp P 
Ask if smoke 0.10 0.37 
Offer advice  0.002 0.98 
Provide counselling 0.07 0.49 
Provide NRT 0.06 0.56 
 
 
3.3.2.7 Smoking-related behaviours 
The survey population comprised 185 (46.6%) individuals who had never 
smoked, 119 (30.0%) who were ex-smokers and 93 (23.4%) who were current 
smokers.  In this population of smokers the tobacco products used were almost 
exclusively cigarettes - 61 (66.3%) - or roll-ups - 38 (41.3%), with 2 (2.2%) 
reporting that they used cannabis. One person smoked cigars. A significantly 
higher proportion of males smoked roll-ups than the proportion of females (X2 
=8.41, df =1, P=<0.001). No significant differences were found in the proportion of 
smokers using cigarettes or roll-ups by age group, occupational group or location. 
 
Age on starting smoking 
The age at which participants who reported being current smokers started 
smoking ranged from 9 to 32 years. The mean age of participants when they 
started smoking was 15.8 years (95%CI: 15.14, 16.49), with 44 (47.8%) being 15 
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years or younger, 39 (42.4%) being 16 – 19 years and 9 (9.8%) being over 20 
years of age.  No significant difference was found between proportions of 
younger and older participants [X2=23.53; df=15; p=0.74], or between male and 
female participants, with regard to the age they started smoking [X2=15.79; 
df=15; p=0.40].  
 
Quantity of tobacco smoked per day 
Current smokers were asked to report the quantity of tobacco smoked per day in 
categories of 10 or less cigarettes, 11 – 20 cigarettes, 21 – 30 cigarettes and 31 
or more cigarettes. The quantity of tobacco smoked differed significantly between 
males and females with higher proportions of males compared with females being 
in the groups that smoked most (X2 = 10.35, df =3, P=0.02). 
 
Exposure to tobacco 
One of the measures commonly used by researchers to determine the quantity of 
tobacco an individual has been exposed to over their lifetime is the pack-year. 
This is calculated by multiplying the number of years smoked (current age minus 
age on starting to smoke) by the reported quantity smoked per day.  In this 
population the mean pack-years was 26.34 (95% CI: 22.49, 30.19), with a range 
from 3 – 98. No significant differences were found for mean pack-years by 
occupational group or location but unsurprisingly, mean pack-years were 
significantly higher in the older age group (t=6.04, P<0.001). The mean pack 
years for males was also significantly higher than for females (t = 3.72, P<0.001). 
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Nicotine dependence 
The mean Fagerstrom nicotine dependence score for this population was 3.47 
(95% CI: 3.03. 3.91) and the range was from 0 to 8. When the mean Fagerstrom 
nicotine dependence test was compared by age group, gender, occupational 
group and location the only significant difference found was a higher level of 
nicotine dependence in males compared with females (t =3.24, P=0.002). 
 
Other smokers in house 
The mean number of other smokers living in the same house as the participants 
was 0.53 (95%CI: 0.39, 0.67). The majority of smokers (55.4%) did not live with 
another smoker. There was no significant relationship shown between number of 
other smokers in the house with age group, gender, occupational group or 
location (Appendix 19, Table A2).  
 
Quit attempts in previous two months 
All smokers in the questionnaire study were asked about any attempts to cut 
down or stop smoking in the previous two months. The results showed that 36 
(39.1%) had cut down in the previous two months, 22 (23.9%) had tried to quit 
and 30 (32.6%) had stopped for at least 24 hours. 
 
The proportion of younger participants who had made quit attempts in the 
previous two months was larger than the proportion of older participants to do so, 
but this reached significance only for the proportions who had quit for at least 24 
hours (X2 = 5.15, df=1, P=0.02) (Appendix 20, Tables A3 – A6). Larger 
proportions of females rather than males had made quit attempts but they did not 
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reach statistical significance. Neither occupational group nor location was 
significantly associated with quit attempts in this population.  
 
Intention to quit 
With respect to future plans, 7 (7.6%) had set a quit date in the next 30 days, 51 
(55.4%) were seriously considering stopping in the next 6 months, 16 (17.4%) did 
not plan to stop in the next 6 months and 18 (19.6%) had no plans ever to stop. A 
significantly larger proportion of older people had no intention to quit than 
younger people (X2 = 9.56, df=3, P=0.02) (Appendix 21, Table A7).   
 
3.3.2.8 Smoking cessation activities in a dental setting 
 
Attitudes to smoking cessation being offered in a dental setting 
Participants were asked to respond on a five-point Likert scale to the four 
questions shown in Table 3.20 to assess their attitudes to smoking cessation 
activities being undertaken in a dental setting. The range of scores in each 
question is from 1 – strongly disagree – to 5 – strongly agree, and the mean 
score for each can be found in Table 3.22 and Figure 3.3. The full range of 
possible responses was found in this sample with one participant strongly 
disagreeing with all questions scoring 5 and 90 participants strongly agreeing with 
each statement who scored 20. These results indicate a high level of support for 
smoking cessation activities taking place in a dental setting. 
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Table 3.20: Mean frequency attitudes to dental involvement in smoking cessation 
activities 
 Mean score 95% CI 
Do you think dentists should ask 
patients if they smoke? 
4.24 4.16 4.32 
Do you think dentists should offer 
advice about stopping smoking? 
4.02 3.92 4.11 
Do you think dentists should offer 
counselling to those wishing to quit? 
3.79 3.69 3.89 
Do you think dentists should offer 
NRT to those wishing to quit? 
3.84 3.75 3.94 
 
Figure 3.3: Agreement with smoking cessation activities in a dental setting 
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No significant differences in attitudes to smoking cessation activities in a dental 
setting were identified by age group, gender or location (Appendix 22). However, 
significantly smaller proportions of those in occupational groups requiring higher 
educational qualifications thought that dental staff should provide NRT as 
opposed to groups requiring lesser educational qualifications (Table 3.21).  
 
As all participants, whether smokers or not, responded to these items, 
comparison of means tests were performed by smoking status. This showed that 
smokers scored significantly lower mean scores when asked if dentists should 
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ask patients if they smoke, offer stop smoking advice to patients, or provide 
counselling to help smokers quit (Table 3.22).  
 
Table 3.21: Attitudes to dental involvement in smoking cessation activities by 
occupational group 
 Occupational group F [df] P 
 1 
Mean  
(95%CI) 
2 
Mean  
(95%CI) 
3 
Mean  
(95%CI) 
4 
Mean  
(95%CI) 
  
Ask if smoke 4.13 
(3.96, 
4.30) 
4.25 
(4.09, 
4.41) 
4.34 
(4.18, 
4.49) 
4.33  
(4.10, 
4.55) 
1.22 [3,329] 0.30 
Offer advice 3.89 
(3.68, 
4.10) 
3.92 
(3.71, 
4.13) 
4.07 
(3.89, 
4.26) 
4.17 
(3.88, 
4.47) 
1.28 [3,329] 0.28 
Provide counselling 3.76 
(3.56, 
3.95) 
3.70 
(3.49, 
3.92) 
3.82 
(3.63, 
4.01) 
3.96 
(3.65, 
4.28) 
0.77 [3,329] 0.51 
Provide NRT 3.861 
(3.68, 
4.03) 
3.721 
(3.49, 
3.94) 
3.761,2 
(3.56, 
3.95) 
4.252 
(3.99, 
4.51) 
3.88 [3,329] 0.01 
*The suffixes show the significant differences in attitudes which existed between occupational 
groups 
 
Table 3.22: Attitudes to dental involvement in smoking cessation activities by 
smoking status 
 Smoking status F [df] P 
 Never 
smoker 
Mean  
(95% CI) 
Ex-smoker 
 
Mean  
(95% CI) 
Current 
smoker 
Mean  
(95% CI) 
  
Ask if smoke 4.332 
(4.21,4.45) 
4.292 
(4.14,4.43) 
4.011 
(3.84,4.18) 
5.06 [2,394] 0.007 
Offer advice 4.122  
(3.99, 4.25) 
4.142 
(3.96,4.33) 
3.671 
(3.46,3.88) 
8.09 [2,394] <0.001 
Provide counselling 3.862 
(3.73,4.00) 
3.922 
(3.73,4.12) 
3.491 
(3.30,3.69) 
5.71 [2,394] 0.004 
Provide NRT 3.78 
(3.64,3.92) 
3.97 
(3.79,4.15) 
3.80 
(3.60,3.99) 
1.41 [2,394] 0.25 
*The suffixes show the significant differences in attitudes which existed between smoking 
status categories 
 
Dental staff offering smoking cessation support 
Smokers were asked to record their previous experience of dental staff asking 
them about their smoking status and offering smoking cessation support (Table 
3.23).  
 
  
189 
 
Table 3.23: Past experience of dental involvement in smoking cessation activities 
 Frequency of positive 
responses 
 Number Percentage 
Dentist asked whether you are a smoker? 64 69.6 
Dentist advice about quitting smoking? 26 28.3 
Dentist referred you to smoking cessation services? 15 16.3 
Dentist given contact details smoking cessation services? 16 17.4 
 
A significantly larger proportion of younger respondents than older respondents in 
this population reported having been asked by their dentist whether they smoke 
(X2=5.54, df=1, P=0.02).  No significant difference was found between past 
experience of smoking cessation activities in a dental setting with gender, 
occupational group or location. 
 
3.3.2.9 Oral health 
 
Oral health attitudes 
 Oral health-related quality of life 
The OHIP-14 tool was used in this study to gauge the impact of oral health on the 
overall quality of life of this population of dental patients. A mean score of 4.38 
(95%CI: 3.85, 4.91) was found, with a range of 0 – no impact – to 56 – greatly 
affected on each of the measures. The questions included in the OHIP-14 scale 
are detailed in Table 3.24. 
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Table 3.24: Oral health impact profile 
OHIP 1 Have you ever had trouble pronouncing any words because of 
problems with your teeth, mouth or dentures? 
OHIP 2 Have you felt your sense of taste has worsened because of problems 
with your teeth, mouth or dentures? 
OHIP 3 
 
Have you had painful aching in your mouth? 
OHIP 4 Have you found it uncomfortable to eat any foods because of 
problems with your teeth, mouth or dentures? 
OHIP 5 Have you been self-conscious because of your teeth, mouth or 
dentures? 
OHIP 6 Have you felt tense because of problems with your teeth, mouth or 
dentures? 
OHIP 7 Has your diet been unsatisfactory because of problems with your 
teeth, mouth or dentures? 
OHIP 8 Have you had to interrupt meals because of problems with your 
teeth, mouth or dentures? 
OHIP 9 Have you found it difficult to relax because of problems with your 
teeth, mouth or dentures? 
OHIP 10 Have you been a bit embarrassed because of your teeth, mouth or 
dentures? 
OHIP 11 Have you been a bit irritable with other people because of problems 
with your teeth, mouth or dentures? 
OHIP 12 Have you had difficulties doing your usual jobs because of problems 
with your teeth, mouth or dentures? 
OHIP 13 Have you felt that life in general was less satisfying because of 
problems with your teeth, mouth or dentures? 
OHIP 14 Have you been totally unable to function because of problems with 
your teeth, mouth or dentures? 
 
Figure 3.4 shows the frequency with which participants experienced each of the 
14 impacts on daily living, whilst Figure 3.5 details the frequency reported 
excluding ‘never’. It can be seen that physical impacts (pain and discomfort when 
eating) were most common, followed by psychological distress (feeling self-
conscious and embarrassed).  
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Figure 3.4: Percentage of participants reporting each oral health-related impact 
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Figure 3.5: Percentage of participants reporting each oral health-related impact 
by frequency excluding “never” 
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Only 31.6% of the population sampled had not experienced any of the impacts on 
daily living measured by OHIP-14 in the previous twelve months. By convention, 
for example in the Adult Dental Health Survey (ADHS) 2009 (Nuttall et al. 2011), 
results of the OHIP-14 are analysed for those reporting an impact occasionally or 
more frequently, and by following this convention the results of OHIP-14 in this 
study sample can be compared with the wider population of the United Kingdom. 
In this survey population, 52.6% were affected occasionally or more often in at 
least one of the OHIP categories as compared with 39.0% in the ADHS 2009 
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(Nuttall et al. 2011). Forty three people (10.8%) had felt totally unable to function 
due to problems in their mouth on some occasion in the previous twelve months, 
much greater than the one percent found in the ADHS. An average of 3.7 impacts 
was experienced in this population compared with 1.2 in the ADHS. However, the 
average total OHIP score was much lower in this study population – 6.8 as 
opposed to 17.4 in the ADHS – indicating that participants experienced lower 
impacts on their daily lives despite an increased frequency than that found in the 
ADHS.  
 
 Oral Health Impact Profile by age group 
Results showed that younger participants experienced significantly greater 
impacts on oral health-related quality of life than older participants with respect to 
experiencing pain in their mouths (t=1.94, P=0.05), feeling self-conscious (t=2.97, 
P=0.003)  and embarrassed (t=3.94, P<0.001) about oral problems, and having 
their ability to carry out normal tasks impaired (t=2.33, P=0.02).  
 
 Oral Health Impact Profile by gender 
Women were more likely to feel self-conscious about their teeth than men but no 
other gender differences were found (t=2.45, P=0.02).  
 
 Oral Health Impact Profile by occupational group 
Results demonstrated that participants whose occupation required lower levels of 
educational qualifications were more affected by oral health-related quality of life 
factors and this reached significance for feeling embarrassed by one’s mouth 
(F=4.02, df=3,329, P=0.008) and feeling completely unable to function due to oral 
health problems (F=0.01, df=3,329, P=0.01). 
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 Oral Health Impact Profile by location 
A highly significant difference was found between the impact of oral health-
related quality of life between the residents of Lochgilphead, 46.6% of whom had 
experienced oral health related impacts on their quality of life occasionally or 
more frequently in the past year, as opposed to 71.1% of residents of Dunoon. 
Participants from Dunoon had significantly higher mean scores in each of the 
individual OHIP-14 categories, with the exception of carrying out normal tasks 
(Appendix 23: Table A9).  
 
 Oral Health Impact Profile by smoking status 
The grouping variable smoking status significantly explained differences in mean 
impact scores for all OHIP items except OHIP 1. Current smokers had greater 
experience of OHIP 2, OHIP 3, OHIP 11 and OHIP 13 compared with those who 
had never smoked. Smokers compared with ex-smokers and never smokers had 
significantly greater mean scores for OHIP 4, OHIP 5, OHIP 7, OHIP 8, OHIP 10, 
OHIP 12 and OHIP 14. Current smokers had significantly higher mean scores 
compared with ex-smokers, who in turn had significantly greater mean scores 
than never smokers, for OHIP 6 and OHIP 9 (Table 3.25). Figure 3.6 shows the 
frequency of oral health items experienced by smoking status. 
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Figure 3.6: Percentage of participants reporting oral health-related impact by smoking status 
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Table 3.25: Oral health-related quality of life by smoking status 
 Smoking status F [df] P 
 Never 
smoker 
Mean  
(95% CI) 
Ex-smoker 
 
Mean  
(95% CI) 
Current 
smoker 
Mean  
(95% CI) 
  
OHIP-1 0.14 
(0.07,0.21) 
0.22 
(0.09,0.35) 
0.26 
(0.12,0.40) 
1.32  
[2,394] 
0.27 
OHIP-2 0.121  
(0.06, 0.18) 
0.291,2 
(0.15,0.42) 
0.422 
(0.23,0.61) 
6.65  
[2,394] 
0.001 
OHIP-3 0.701 
(0.57,0.83) 
0.891,2 
(0.70,1.09) 
1.172 
(0.92,1.43) 
6.62 
[2,394] 
0.001 
OHIP-4 0.651 
(0.52,0.78) 
0.861 
(0.67,1.04) 
1.232 
(0.96,1.49) 
9.66  
[2,394] 
<0.001 
OHIP-5 
 
0.711 
(0.55,0.86) 
0.821 
(0.60,1.03) 
1.742 
(1.43,2.05) 
24.17 
[2,394] 
<0.001 
OHIP-6 
 
0.401 
(0.28,0.52) 
0.752 
(0.54,0.96) 
1.103 
(0.82,1.37) 
13.85 
[2,394] 
<0.001 
OHIP-7 
 
0.151 
(0.08,0.22) 
0.291 
(0.17,0.42) 
0.582 
(0.38,0.78) 
12.14 
[2,394] 
<0.001 
OHIP-8 
 
0.231 
(0.15,0.30) 
0.401 
(0.26,0.53) 
0.662 
(0.45,0.86) 
10.84 
[2,394] 
<0.001 
OHIP-9 
 
0.221 
(0.14,0.29) 
0.482 
(0.32,0.64) 
0.843 
(0.60,1.08) 
17.84 
[2,394] 
<0.001 
OHIP-10 
 
0.451 
(0.33,0.57) 
0.671 
(0.48,0.86) 
1.512 
(1.20,1.81) 
29.99 
[2,394] 
<0.001 
OHIP-11 
 
0.201 
(0.12,0.28) 
0.391,2 
(0.22,0.55) 
0.572 
(0.37,0.77) 
7.39 
[2,394] 
0.001 
OHIP-12 
 
0.121 
(0.07,0.18) 
0.161 
(0.06,0.26) 
0.402 
(0.23,0.57) 
7.63 
[2,394] 
0.001 
OHIP-13 
 
0.251 
(0.17,0.34) 
0.441,2 
(0.28,0.60) 
0.692 
(0.47,0.91) 
8.65 
[2,394] 
<0.001 
OHIP-14 
 
0.051 
(0.01,0.08) 
0.181 
(0.07,0.28) 
0.442 
(0.24,0.64) 
14.13 
[2,394] 
<0.001 
*The suffixes show the significant differences in OHIP which existed between smoking status 
categories 
  
196 
 
Oral health-related behaviours: dental attendance 
In this sample, 355 respondents or 89.2% of the total had attended their dentist in 
the previous year.  Dental attendance in the previous year was not affected by 
age group, gender, occupational group, or location. A significant difference was 
found with never smokers and ex-smokers attending in the previous year more 
frequently than current smokers (X2=6.79, df=2, P=0.03). 
 
When asked for their reason for dental attendance in the previous twelve months, 
226 (56.6%) attended for a dental examination, 151 (37.8%) attended due to 
problems with their mouth and 21 (5.3%) for another reason. Age group and 
gender did not impact significantly on reason for dental attendance in the 
previous year. 
 
Those engaged in occupations requiring higher educational qualifications were 
significantly more likely to have attended their dentist for a dental examination 
rather than due to oral problems (X2=25.24, df=6, P<0.001). A significantly 
greater proportion of participants living in Dunoon (57.7%) had attended due to 
oral problems than the proportion of those in Lochgilphead (31.6%) (X2=23.12, 
df=2, P<0.001). There was a significant association between current smoking 
status with reason for dental attendance (X2=22.30, df=4, P<0.001). 
 
Oral health-related behaviours: toothbrushing 
Seventy-eight (19.5%) of participants reported brushing their teeth once daily, 
279 (69.9%) reported brushing twice daily and 41 (10.3%) reported toothbrushing 
more than twice daily.  
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No significant association was found between frequency of toothbrushing and 
age group, occupational group, location or smoking status in this population. A 
significantly higher proportion of males reported brushing their teeth only once 
per day as opposed to women (X2=18.22, df=2, P<0.001). 
 
Oral health-related behaviours: interdental cleaning 
Most respondents in this survey used either dental floss or TePe brushes for 
interdental cleaning (Figure 3.7), although a large minority (47.5%) did not use 
any method for cleaning between their teeth other than toothbrushing.   
 
No significant association was found between interdental cleaning and age 
group, occupational group, location or smoking status in this population. A 
significantly higher proportion of females reported using interdental cleaning aids 
as opposed to males (X2=16.95, df=1, P<0.001). 
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Figure 3.7: Frequency of use of interdental cleaning aids 
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3.3.2.10 Periodontal status 
 
Periodontal status – by complexity of treatment need 
The periodontal status of participants in the self-administered questionnaire study 
was measured using the Basic Periodontal Examination (BPE). A calibration 
exercise was undertaken by the principal researcher and a Consultant in 
Restorative Dentistry (AFH) to determine the reliability of the data recorded.  An 
intraclass correlation of 0.90 was found between the two examiners. There are 
varying opinions as to what level of reliability can be considered adequate but the 
intraclass correlation found in this calibration exercise exceeds the level of 0.85 
recommended by Weiner and Stewart (1984). The same methodology was used 
to assess intra-examiner calibration and this was found to be acceptable with an 
intraclass correlation of 0.92. 
 
The mean whole mouth total BPE score in this sample was 11.6. The mean for 
each individual sextant is found in Table 3.26. 
 
Table 3.26: Mean BPE per sextant 
Sextant Mean BPE score 95% CI 
Upper left 2.41 2.15 2.68 
Upper mid 1.80 1.57 2.01 
Upper right 2.45 2.17 2.72 
Lower right 2.24 1.98 2.49 
Lower mid 1.89 1.78 2.01 
Lower left 2.30 2.04 2.57 
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Table 3.27 shows the distribution of the three categories of complexity of 
periodontal treatment need across this study sample. 
 
Table 3.27: Frequency of complexity of periodontal treatment need category  
Complexity of periodontal treatment  
need category 
Number Percent 
Complexity 1 331 83.2 
Complexity 2 48 12.1 
Complexity 3 19 4.8 
 
Table 3.28 demonstrates the demographic profile and smoking status of the 
study population by category of complexity of periodontal treatment need.  
 
 Complexity of periodontal treatment need category by age group 
Proportions of younger and older participants were similar in Complexity groups 1 
and 2, but the proportion of older participants in the Complexity 3 group was 
larger than the proportion of younger participants although this failed to reach 
statistical significance at 0.05 level (Table 3.28). 
 
 Complexity of periodontal treatment need category by gender 
A significantly smaller proportion of males compared with females were found in 
the Complexity 1 and Complexity 2 groups, and correspondingly, a larger 
proportion of males than females were found in the Complexity 3 group (Table 
3.28). 
 
 Complexity of periodontal treatment need category by occupational group 
An inverse trend was apparent in the proportions of those with more complex 
periodontal treatment needs by the increasing educational qualifications required 
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by occupational group. This was particularly marked in the occupational group 
requiring the lowest level of educational qualifications and reached statistical 
significance (Table 3.28). 
 
 Complexity of periodontal treatment need category by location 
A significant result was found with respect to location and complexity of 
periodontal treatment need category with a threefold higher proportion of Dunoon 
residents being in the Complexity 3 group as compared with Lochgilphead 
participants (Table 3.28). 
 
 Complexity of periodontal treatment need category by reported smoking 
status 
The results show a highly significant association between smoking and poor 
periodontal health with only 1% of never smokers being found in the highest 
complexity of periodontal treatment need category as opposed to 12% of current 
smokers (Table 3.28). 
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Table 3.28: Complexity of periodontal treatment need category by demographic 
profile and reported smoking status 
Complexity of periodontal treatment need 
  Complexity 
1 
n (%) 
Complexity 
2 
n (%) 
Complexity 
3 
n (%) 
X2 [df] P 
Age group Younger  167 (83.5) 28 (14.0) 5 (2.5) 5.61 
[2] 
0.06 
  Older 164 (82.8) 20 (10.1) 14 (7.1) 
Gender Male 119 (76.8) 25 (16.1) 11 (7.1) 7.60 
[2] 
0.02 
 Female 212 (87.2) 23 (9.5) 8 (3.3) 
Occupation 1 74 (75.5) 13 (13.3) 11 (11.2)  
17.27 
[6] 
 
0.01  2 73 (83.0) 15 (17.0) 0 (0.0) 
 3 83 (87.4) 8 (8.4) 4 (4.2) 
 4 43 (82.7) 8 (15.4) 1 (1.9) 
Location L’gilphead 261 (86.7) 30 (10.0) 10 (3.3) 11.81 
[2] 
0.01 
Dunoon 70 (72.2) 18 (18.6) 9 (9.3) 
Smoking 
status 
Never smoker 181 (97.8) 2 (1.1) 2 (1.1)  
133.54 
[4] 
 
<0.001 
 Ex-smoker 107 (89.9) 6 (5.0) 6 (5.0) 
 Current 
smoker 
42 (45.2) 40 (43.0) 11 (11.8) 
 
 Complexity of periodontal treatment need category per sextant by smoking 
status 
Table 3.29 shows that the grouping variable smoking status significantly explains 
differences in complexity of periodontal treatment need. Current smokers had 
higher mean complexity of periodontal treatment need compared with those who 
had never smoked in the lower left sextant. In the upper mid and lower mid 
sextants, current smokers had significantly higher mean scores for complexity of 
treatment need than either ex-smokers or never smokers. In both the upper right 
and lower right sextants, mean scores for complexity of periodontal treatment 
need increased significantly between those who had never smoked and ex-
smokers, and between ex-smokers and those who had never smoked. In the 
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upper left sextant mean scores for both ex-smokers and current smokers were 
significantly higher than for never smokers. A graphical representation can be 
found in Figure 3.8. 
 
Table 3.29: Complexity of periodontal treatment need category by sextant by 
smoking status 
Sextant Smoking status Mean 
(95% CI) 
F [df] P 
Upper right Never smoker 1.641 (1.35, 1.93)  
17.89 
[2, 394] 
 
<0.001               Ex-smoker 2.722 (2.19, 3.26) 
 Smoker 3.573 (2.91, 4.23) 
Upper mid Never smoker 1.301 (1.05, 1.54)  
14.25 
[2, 394] 
 
<0.001  Ex-smoker 1.831 (1.42, 2.24) 
 Smoker 2.752 (2.20, 3.31) 
Upper left Never smoker 1.581 (1.20, 1.86)  
18.96 
[2, 394] 
 
<0.001  Ex-smoker 2.992 (2.39, 3.60) 
 Smoker 3.482 (2.85, 4.11) 
Lower left Never smoker 1.701 (1.38, 2.01)  
9.61 
[2, 394] 
 
<0.001  Ex-smoker 2.351,2 (1.85, 2.85) 
 Smoker 3.082 (2.51, 3.65) 
Lower mid Never smoker 1.681 (1.53, 1.83)  
17.93 
[2, 394] 
 
<0.001  Ex-smoker 1.751 (1.60, 1.90) 
 Smoker 2.512 (2.18, 2.83) 
Lower right Never smoker 1.591 (1.31, 1.87)  
15.91 
[2, 394] 
 
<0.001  Ex-smoker 2.552 (2.00, 3.09) 
 Smoker 3.413 (2.77, 4.05) 
*The suffixes show the significant differences in complexity of periodontal treatment need by 
sextant which existed between smoking status categories 
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Figure 3.8: Periodontal status by sextant by smoking status 
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 Complexity of periodontal treatment need category by reported medical 
condition 
A significantly greater proportion of those with the highest complexity of 
periodontal treatment needs are receiving medical treatment than those in 
Complexity groups 1 and 2. A trend towards higher prevalence of disease with 
increasing complexity of periodontal treatment need is found in medication use, 
angina, high blood pressure, heart attack and diabetes and results between 
groups reached significance for heart attack and infectious diseases (Table 3.30).  
 
Table 3.30: Complexity of periodontal treatment need category by reported 
medical condition 
Reported medical 
condition 
Complexity of periodontal treatment 
need 
 
X2 [df] P 
 Complexity 
1 
n (%) 
Complexity 
2 
n (%) 
Complexity 
3  
n (%) 
  
Receive treatment 111 (33.5) 19 (39.6) 13 (68.4) 9.82 [2] 0.01 
Taking medication 171 (51.7) 33 (68.8) 12 (63.2) 5.57 [2] 0.06 
Angina 13 (3.9) 3 (6.3) 2 (10.5) 2.19 [2] 0.34 
Hypertension 57 (17.2) 10 (20.8) 6 (31.6) 2.70 [2] 0.26 
Heart attack 7 (2.1) 3 (6.3) 2 (10.5) 6.30 [2] 0.04 
Infectious diseases 2 (6.0) 2 (4.2) 1 (5.3) 6.87 [2] 0.03 
Lung diseases 29 (8.8) 9 (18.8) 2 (10.5) 4.63 [2] 0.10 
Epilepsy 3 (0.9) 0 (0.0) 0 (0.0) 0.61 [2] 0.74 
Diabetes 13 (3.9) 2 (4.2) 2 (10.5) 1.92 [2] 0.38 
Bleeding problems 30 (9.1) 8 (16.7) 1 (5.3) 3.21 [2] 0.20 
Allergies 76 (23.0) 9 (18.8) 4 (21.1) 0.45 [2] 0.80 
Pregnant 7 (2.1) 1 (2.1) 0 (0.0) 0.41 [2] 0.82 
 
 
Periodontal status and smoking 
 Complexity of periodontal treatment need and smoking-related health 
knowledge 
Complexity of periodontal treatment need and smoking-related health knowledge 
were not found to be significantly associated in this population, with the exception 
  
206 
 
of liver disease where significantly smaller proportions of those with the most 
complex treatment needs answered correctly (X2=6.72, df=2, P=0.04). 
 
 Complexity of periodontal treatment needs and oral health-related quality 
of life 
Figure 3.9 shows the proportion of participants in the mild, moderate and severe 
complexity of periodontal treatment need groups experiencing oral health-related 
impacts on their quality of life.  
 
The grouping variable ‘complexity of periodontal treatment need’ significantly 
explained differences in mean oral health-related quality of life (OHIP) scores 
except in OHIP-12 (difficulty completing everyday tasks) and OHIP-13 (finding life 
less satisfying).  Those with the highest complexity of periodontal treatment need 
had significantly higher mean impact scores for OHIP than those in the lowest 
complexity groups for OHIP-4, OHIP-6, OHIP-7, OHIP-8 and OHIP-9.  For OHIP-
1, OHIP-2 and OHIP-11, those in the highest grouping for complexity of treatment 
need had significantly higher mean OHIP scores than those in the moderate and 
lowest complexity groups.  The grouping variable complexity of periodontal 
treatment need significantly explained differences in mean scores for OHIP items 
3, 5 and 14.  However the multiple comparison Scheffe test was conducted none 
of these separate tests reached 5% level of significance (Table 3.31).  
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Figure 3.9: Percentage of participants reporting each oral health-related impact by complexity of periodontal treatment need 
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Table 3.31: Complexity of periodontal treatment need category by mean Oral 
Health Impact Profile scores 
Mean Oral Health 
Impact Profile scores 
Complexity of periodontal treatment 
need 
F [df] P 
Complexity 1 
Mean (95% 
CI) 
Complexity 2  
Mean (95% 
CI) 
Complexity 3 
Mean (95% 
CI) 
  
OHIP-1 
Pronouncing words 
0.181* 
(0.12,0.24) 
0.171 
(0.02,0.32) 
0.532 
(0.01,1.04) 
3.00 
[2,395] 
0.05 
OHIP-2 
Sense of taste worse 
0.201 
(0.13,0.27) 
0.331 
(0.13,0.54) 
0.792 
(0.16,1.42) 
7.40 
[2,395] 
0.01 
OHIP-3 
Painful aching mouth 
0.811 
(0.70,0.91) 
1.151 
(0.79,1.51) 
1.261 
(0.62,1.90) 
3.68 
[2,395] 
0.03 
OHIP-4 
Uncomfortable to eat 
0.771 
(0.66,0.87) 
1.171,2 
(0.80,1.53) 
1.472 
(0.82,2.12) 
6.67 
[2,395] 
0.01 
OHIP-5 
Self-conscious 
0.891 
(0.76,1.03) 
1.481 
(1.09,1.87) 
1.321 
(0.60,2.04) 
5.22 
[2,395] 
0.01 
OHIP-6 
Tense 
0.571 
(0.49,0.68) 
1.001,2 
(0.64,1.36) 
1.532 
(0.80,2.25) 
9.88 
[2,395] 
<0.001 
OHIP-7 
Unsatisfactory diet 
0.221 
(0.16,0.28) 
0.561,2 
(0.30,0.82) 
0.892 
(0.27,1.51) 
12.96 
[2,395] 
<0.001 
OHIP-8 
Interrupt meals 
0.321 
(0.25,0.39) 
0.631,2 
(0.35,0.90) 
0.842 
(0.28,1.40) 
7.70 
[2,395] 
0.01 
OHIP-9 
Difficult to relax 
0.361 
(0.28,0.44) 
0.711,2 
(0.38,1.04) 
1.112 
(0.53,1.68) 
9.83 
[2,395] 
<0.001 
OHIP-10 
Felt embarrassed 
0.671 
(0.55,0.79) 
1.251 
(0.85,1.65) 
1.161 
(0.47,1.84) 
6.63 
[2,395] 
0.01 
OHIP-11 
Irritable with others 
0.301 
(0.22,0.37) 
0.381 
(0.15,0.60) 
1.052 
(0.40,1.70) 
8.76 
[2,395] 
<0.001 
OHIP-12 
Difficulty with jobs 
0.17 
(0.11,0.22) 
0.31 
(0.10,0.53) 
0.42 
(0.04,0.88) 
2.82 
[2,395] 
0.06 
OHIP-13 
Life less satisfying 
0.39 
(0.30,0.47) 
0.50 
(0.23,0.77) 
0.58 
(0.06,1.10) 
0.79 
[2,395] 
0.46 
OHIP-14 
Unable to function 
0.151 
(0.09,0.21) 
0.271 
(0.06,0.48) 
0.471 
(0.04,0.99) 
3.35 
[2,392] 
0.04 
*The suffixes show the significant differences in mean OHIP scores which existed between 
complexity of treatment need categories 
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 Complexity of periodontal treatment need by pack years 
The grouping variable complexity of periodontal treatment need significantly 
explained differences in mean pack years (Table 3.32). 
 
Table 3.32: Complexity of periodontal treatment need category by pack years  
 Complexity of periodontal treatment 
category 
F [df] P 
 Complexity 
1 
Complexity 
2 
Complexity 
3 
  
Mean life pack 
years 
17.871* 31.542 39.002 10.04 [2,89] <0.001 
95% CI (14.03, 
21.70) 
(25.77, 
37.31) 
(21.18, 
56.82) 
  
*The suffixes show the significant differences in pack years which existed between complexity 
of treatment need categories 
 
 Complexity of periodontal treatment need by nicotine dependence 
The grouping variable complexity of periodontal treatment need significantly 
explained differences in mean nicotine dependence score.  Those participants in 
Complexity 1 group had lower scores for nicotine dependence compared with 
those in Complexity 2 and 3 (Table 3.33). 
 
Table 3.33: Complexity of periodontal treatment need category by nicotine 
dependence 
 Complexity of periodontal treatment category F [df] P 
Complexity 1 Complexity 2 Complexity 3 
5.20 [2,89] 0.007 
Mean 
nicotine 
dependence  
(95% CI) 
2.711* 
(2.04, 3.37) 
4.102 
(3.51, 4.69) 
4.002 
(2.41, 5.59) 
*The suffixes show the significant differences in nicotine dependence which existed between 
complexity of treatment need categories 
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Complexity of periodontal treatment needs and smoking cessation activities in a 
dental setting 
The grouping variable ‘complexity of periodontal treatment need’ significantly 
explains differences in mean scores for agreement that dentists should offer  stop 
smoking advice and that they should provide stop smoking counselling. The 
grouping variable complexity of periodontal treatment need significantly explained 
differences in mean scores for smoking cessation activities in the dental setting.  
However when the multiple comparison Scheffe test was conducted none of 
these separate tests reached 5% level of significance (Table 3.34).  
 
Table 3.34: Complexity of periodontal treatment need category by attitudes to 
smoking cessation activities in a dental setting 
 Complexity of periodontal treatment 
need 
F [df] P 
 Complexity 
1 
n=331 
Complexity 
2  
n=48 
Complexity 
3 
n=19 
  
Should dentist ask 
if smoke? 
Mean (95% CI) 
4.27 
(4.17,4.35) 
4.02 
(3.76,4.28) 
4.37 
(3.97,4.77) 
 
2.14 [2,395] 
 
0.12 
Should dentist offer 
smoking advice? 
Mean (95% CI) 
4.071 
(3.97,4.18) 
3.771 
(3.49,4.05) 
3.681 
(3.13,4.24) 
3.13 [2,395] 0.05 
Should dentist 
provide 
counselling? 
Mean (95% CI) 
3.861 
(3.76,3.97) 
3.421 
(3.12,3.71) 
3.531 
(2.96,4.09) 
4.96 [2,395] 0.007 
Should dentist 
provide NRT? 
Mean (95% CI) 
3.84 
(3.74,3.95) 
3.83 
(3.55,4.12) 
3.84 
(3.28,4.40) 
0.02 [2,395] 0.99 
*The suffixes show the significant differences agreement with dentists offering smoking 
cessation which existed between complexity of treatment needs categories 
 
 Complexity of periodontal treatment needs by past experience of smoking 
cessation activity in a dental setting 
No significant difference was found in proportions of participants who had been 
offered smoking cessation activities in a dental setting by the complexity of their 
periodontal treatment need (Appendix 24, Table A10).   
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Complexity of periodontal treatment needs and oral health behaviours 
 Complexity of periodontal treatment needs by dental attendance 
The proportion of respondents who had attended their dentist in the previous 
twelve months did not differ significantly by complexity of periodontal treatment 
need category. However, the proportion of those attending their dentist in the 
previous twelve months due to oral problems was significantly higher in those 
with more complex periodontal treatment needs than in those with less complex 
treatment needs (Appendix 25, Table A11).   
 
 Complexity of periodontal treatment needs by oral health-related 
behaviours 
A large majority of participants in all complexity of periodontal treatment need 
categories reported brushing their teeth twice per day. No statistically significant 
association was found between complexity of treatment need and frequency of 
brushing teeth. No significant difference was found in the proportion of those 
using interdental aids with complexity of periodontal treatment need (Appendix 
26, Table A12). 
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3.3.2.11 Summary of findings of prevalence study 
 
The total of 398 participants in the prevalence study had a mean age of 49.2 
years and males represented 39% of the sample. Twenty three percent of the 
participants were current smokers, while 30% were ex-smokers and 47% had 
never smoked. A larger proportion of smokers were found in the younger age 
group and in occupations which required a low level of educational achievement. 
 
When responding to questions about which health conditions were smoking-
related, current smokers tended to underestimate the link between health 
conditions and smoking, and never smokers tended to overestimate the link. 
 
Mean scores for those participants with the greatest lifetime exposure to tobacco 
and highest nicotine dependence were significantly lower on analysis with the 
‘confidence to quit’ scale than those with lower exposure and dependence. The 
mean scores for quit activities in the previous two months were highest for those 
with a high score on the ‘willingness to quit’ scale and for both the ‘willingness to 
quit’ scale and the ‘confidence to quit’ scale with respect to readiness to quit in 
future. 
 
When analysing the ‘willingness to quit’ and ‘confidence to quit’ scales by mean 
scores for complexity of periodontal treatment need, no significant relationship 
was found. Higher mean scores were found with the ’willingness to quit’ scale for 
functional oral health-related quality of life e.g. difficulty in eating, experiencing 
pain, but significant effects were not found with the ‘confidence to quit’ scale. A 
significantly greater willingness to quit was found as mean scores for agreement 
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with dentists undertaking smoking cessation activities increased. This was not 
found with respect to confidence in quitting. 
 
The participants in this study smoked either cigarettes or roll-ups, and the mean 
age of starting smoking was 15.8 years. Both lifetime exposure to tobacco and 
nicotine dependence were found to be significantly higher in male participants as 
compared to female participants. 
 
Thirty nine percent of participants indicated that they had cut down on the 
number of cigarettes they smoked in the previous two months, and 63% stated 
that they wished to quit in the coming six months. Almost 20% of participants 
indicated that they never intended to quit smoking.  
 
Fewer than 10% of participants disagreed or strongly disagreed that dentists 
should offer smoking cessation advice and support to patients who smoke, but 
despite the high levels of support, smokers had significantly lower mean scores 
for support than ex-smokers and those who had never smoked.  
 
A significantly greater proportion of younger respondents reported being provided 
with smoking cessation advice and support from their dentist than the proportion 
of older people.  
 
Sixty eight percent of the participants reported experiencing an oral health impact 
in the previous twelve months with each individual experiencing 3.7 impacts as 
compared with 1.2 in the Adult Dental Health Survey (Nuttall et al. 2011). 
However the mean total score for OHIP was lower in this population than in the 
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ADHS indicating that they experienced more frequent impacts of oral health but 
of lower intensity.  
 
Younger participants had higher mean scores for several impacts on oral health-
related quality of life than older participants, including experiencing pain, self-
consciousness and embarrassment. A higher proportion of women rather than 
men experienced embarrassment due to oral problems. Smoking status 
explained significant differences in oral health impact scores for all OHIP items 
with the exception of ‘difficulty in pronouncing words’, with current smokers 
experiencing the greatest impact.  
 
Reported dental attendance in the previous year reached 89% in this population 
with 57% attending for routine care and 38% for emergency care. A significantly 
greater proportion of current smokers were likely to have attended for emergency 
care than ex-smokers or never smokers. 
 
Eighty percent of this population reported brushing their teeth at least twice daily, 
with a higher proportion of men than women stating they brushed only once per 
day. Almost 50% of this population did not use interdental cleaning aids, but 
dental floss and TePe brushes were those most commonly used. Significantly 
higher proportions of women rather than men used interdental cleaning aids.  
 
Using the Basic Periodontal Examination (BPE) the participants were divided into 
three groups by complexity of periodontal treatment need with 83% having low 
complexity of periodontal treatment need, 12% having moderate complexity of 
periodontal treatment need and 5% having high complexity of periodontal 
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treatment need. A higher proportion of the following groups were found to have 
high complexity of periodontal treatment need: males, those with occupations 
requiring low educational qualifications, residents of Dunoon, those with previous 
experience of myocardial infarction and infectious disease, and current smokers. 
Twelve percent of current smokers are in the highest complexity group as 
opposed to 1% of never smokers. 
 
The proportion of those in the high complexity of periodontal treatment need 
group increased with higher lifetime exposure to nicotine and nicotine 
dependence.   
 
Complexity of periodontal treatment need explained differences in oral health-
related quality of life, with increasing complexity being related to increasing 
negative impacts on oral health-related quality of life. 
 
A higher proportion of those with high complexity of periodontal treatment need 
than those with moderate or low needs reported their last dental attendance 
having been for emergency rather than routine care. However, no significant 
differences in complexity of periodontal treatment need and frequency of 
toothbrushing or use of interdental cleaning aids were found.  
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3.4 Using Structural Equation Modelling to model a smoking cessation 
intervention for primary dental care in remote-rural Scotland 
 
A path model employing structural equation modelling (SEM) procedures was 
tested to incorporate the observed questionnaire responses into a small set of 
latent variables. The advantage of such a procedure was that the interpretation 
was aided by conducting an overall analysis that incorporated, what is 
essentially, a factor analysis and multiple regression into a single statistical 
routine. The error of measurement was specified in the model and estimated in 
parallel to the substantive relationships between the latent i.e. periodontal status 
and oral health-related quality of life and raw i.e. age and smoking status 
variables. The standardised estimates that result from the analysis were 
disattenuated and therefore provided a clearer understanding of the underlying 
strength of the relationships without the confounding of measurement error. 
 
A hypothesised model was compiled that was based on familiarity with the 
previous research in this sphere. Its development specified the relationships 
between observed variables and the factor ‘oral health-related quality of life’. The 
independent variables used to construct the model included age, smoking status 
and periodontal status. Periodontal status was thought to be most closely related 
to the dependent variable i.e. oral health-related quality of life and so complexity 
of periodontal treatment need became the assigned proximal variable. Age and 
smoking status were entered as the assigned distal variables. All measures 
included in the model were normally distributed.  
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The path model was constructed using the accessible diagrammer in SPSS 
AMOS version 17. Measurement errors were entered for the BPE measurement 
observed for each sextant (e5 – e10) as these informed the periodontal status 
which is a non-independent variable. The disturbance error term of the 
periodontal status latent variable was represented by d1. Similarly the latent 
variable oral health-related quality of life required a disturbance error term d2 
derived from the indicator variables, namely: OHIPA (e3) and OHIPB (e4). The 
measurement errors in this model were all assigned a regression coefficient of ‘1’ 
to facilitate the convergence of the estimation procedures. Model parameters 
were derived using the maximum likelihood estimation as this is the most efficient 
method. The correlation between the two distal variables i.e. ‘smoking status’ and 
‘age’ was entered as this enables their effects on periodontal status and oral 
health-related quality of life to be considered independently of each other in the 
model as a whole.  
 
The model was then processed using the complete data set and with no missing 
values (n=398). All resulting coefficients were within accepted limits. A maximum 
number of six iterations were required to reach convergence. The standardised 
model showed all paths to be statistically significant (see Figure 3.10). 
 
The fit of the observed data to the specified model was analysed using a variety 
of fit indices. The values of three of the more commonly cited fit indices were as 
follows: CFI=0.969, TLI=0.959, RMSEA=0.066 and these represent a good fit of 
the data to the model. Table 3.35 shows the correlation matrix of the variables 
included in the path model. 
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Note that both smoking status and periodontal status had direct and significant 
relationships with oral health-related quality of life. In addition, smoking status 
had a further effect on oral health-related quality of life but indirectly as shown by 
the significant coefficient (0.40) between smoking and periodontal status. 
 
To test whether a simplification to the model could be made, the coefficient 
between the direct effect of smoking status upon oral health-related quality of life 
was set to zero. The model was re-estimated and found to be a significantly 
poorer fit (X2=17.91, df=1, p=0.0001) demonstrating that the attempt to consider 
a more parsimonious model without the path being specified between smoking 
status and oral health-related quality of life (i.e. set to zero) was unsuccessful. 
Therefore the substantive paths between the variables smoking, periodontal 
status and quality of life were important to include. Age was included as an 
essential covariate even though its influence was only moderate to allow 
explanation of the relationship within the model independent of age. 
 
The estimates of grouping for complexity of periodontal treatment need by 
occupational group were unreliable due to the small numbers in some groups, 
including zero. For this reason, occupational group was not included in the final 
SEM. Location was also omitted as there were not sufficient numbers of 
participants in Dunoon. To assess that the model was essentially true for both 
sexes the SEM procedure was run with the two groups (male and female) 
simultaneously with all paths constrained to be equivalent across groups. The chi 
square value was small and non-significant (X2=3.34, df=4, p=0.50) showing the 
model was acceptable for both genders. 
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Table 3.35: Correlation matrix of variables included in the SEM analysis 
  Oral health-related 
quality of life 
Periodontal 
status 
Smoking 
status 
Age 
Oral health-
related 
quality of life 
 
rp 1 0.25 0.29 -0.036 
p 
 
 <0.001 
 
<0.001 
 
0.47 
No. 
 
398 398 397 398 
Periodontal 
status 
 
rp 0.25 1 0.35 0.29 
p 
 
<0.001  <0.001 <0.001 
No. 
 
398 398 397 398 
Smoking 
status 
rp 0.29 0.35 1 -0.043 
p 
 
<0.001 <0.001  0.39 
No. 
 
397 397 397 397 
Age rp -0.036 0.29 -0.043 1 
p 
 
0.47 <0.001 0.39  
No. 
 
398 398 397 398 
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Figure 3.10: Structural equation model of smoking status, periodontal health and oral health-related quality of life. 
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3.5 Discussion 
The need to develop a smoking cessation intervention tailored to the needs of 
primary dental care patients attending and residing in remote-rural areas became 
apparent as a result of the failure of the PHaSCe trial and the findings of the 
systematic review which examined the effectiveness of smoking cessation 
interventions.  Therefore the aim of the survey was to model a smoking cessation 
intervention for primary dental care in remote-rural Scotland.  The specific 
objectives were thus: 
1. determine the prevalence and risk factors for chronic periodontitis, and its 
impact on oral health-related quality of life in a population of registered 
primary care dental patients in remote-rural Scotland. 
2. model a smoking cessation intervention based on smoking status, 
periodontal health status and oral health-related quality of life collected in 
a sample of adults attending a general dental practice in a remote-rural 
area. 
3. recommend the characteristics of a feasibility trial for a smoking cessation 
intervention for primary dental care in remote-rural Scotland 
 
3.5.1 Demography 
 
A convenience non-probability sample was gathered which reflected the 
demographic characteristics with regard to gender and age of those registered 
and attending primary dental care practices. Moreover the ethnic profile of the 
sample reflected the ethnic profile of Argyll & Bute CHP as a whole in which only 
0.5% of the population is from ethnic minority groups, mostly from Eastern 
Europe (Nicoll et al. 2012).  The socio-economic position of participants as 
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assessed by the four occupational categories showed similar proportions to those 
of the population of Argyll & Bute Community Health Partnership (CHP) and 
Scotland as a whole (Scottish Household Survey 2012).  This suggested that the 
sample population was representative of people in Argyll & Bute CHP. 
 
The medical profile of the respondents suggested that this sample population 
were healthier than those in the general Scottish population, since they reported 
less experience of cardiovascular disease, diabetes and respiratory disorders 
than those of the Scottish population as a whole (Scottish Health Survey 2012).  
Just over half of the sample reported a greater experience of prescribed 
medication suggesting they had at least one long-standing illness and receiving 
regular medical care.  This finding was similar for the Scottish population 
(Scottish Household Survey 2012).  
 
As was to be expected a strong association between socio-economic position 
and poorer health was reflected in the survey findings with a higher proportions of 
unskilled workers reporting receiving medical treatment than groups of skilled 
workers(Scottish Health Survey 2012). The Scottish Household Study explores 
long-standing illness by household income and found a differential of 36% 
between those earning under £10,000 per annum and those earning over 
£40,000 (Scottish Household Survey 2012). Oral diseases, including chronic 
periodontitis, are found to be more prevalent in lower socio-economic and 
educational groups than higher ones (Bonfim et al. 2013; Singh et al. 2013; 
Borrell and Crawford 2012; Bastos et al. 2011; Boillot et al. 2011). 
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The proportion of smokers in the study sample was directly comparable with that 
of the Scottish population as a whole – 23.4% and 24.1% respectively. Whilst the 
demographic profile of participants in Lochgilphead and Dunoon were similar, the 
proportion of smokers in Dunoon was twice that of Lochgilphead – 38% 
compared with 19%. This would suggest that the socio-economic profiles of the 
two samples vary and may reflect the fact that in Lochgilphead the Salaried 
Dental Practice is the only one available and so serves a cross-section of the 
general population, whereby in Dunoon there are also two independent dental 
practices which cater for routine patients. This results in those people who find it 
more difficult to access routine dental care e.g. those with chaotic lifestyles, 
migrating to the Salaried Dental Services where they are more easily 
accommodated than in independent practice. This is further supported by the 
finding that 50% more patients fail to attend appointments in Dunoon than in 
Lochgilphead. Despite comparisons of occupational status not demonstrating 
statistically significant differences overall, the proportion of highly skilled 
occupations among participants in Dunoon was less than half that in 
Lochgilphead perhaps indicating that more educated and affluent people are 
choosing to attend the independent dental practices. 
 
3.5.2 Smoking status 
 
The proportion of smokers in the younger age group is double that in the older 
age group in the results of this survey (31.7% compared with 15.2%) and this 
reflects findings elsewhere e.g. in the Scottish population overall in 2012, 27.8% 
of younger adults were smokers as opposed to 19.8% of older adults (Scottish 
Health Survey 2012; Scottish Household Survey 2012; Chadwick et al. 2011). 
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This suggests that as the health impacts of smoking become more apparent with 
age, so it may be suggested that with increased morbidity older people are more 
likely to quit smoking tobacco compared with younger people. Moreover, it is 
possible that health-directed smoking cessation i.e. directly related to their own 
disease experience, may be more successful than in younger people. 
 
Results from this survey mirrored those from other studies (American Cancer 
Society 2010; Department of Health 2004; Watt et al. 2000; Peto et al. 1996) in 
finding a relationship between smoking and medical conditions such as angina, 
diabetes and hypertension. Smoking status had a significant impact on reported 
rates of receiving medical treatment and myocardial infarction, with a larger 
proportion of ex-smokers and current smokers reporting these conditions. These 
results are to be expected given the negative health impacts of smoking, 
including on cardiovascular health (American Cancer Society 2007; Department 
of Health 2004; Watt et al. 2000; Peto et al. 1996). The proportion of current 
smokers reporting infectious diseases such as hepatitis was very much larger 
than proportions of never and ex-smokers and this result was highly significant. 
Nicotine is reported to be a gateway drug and the proportion of smokers found 
among those misusing injectable substances is very high (Biederman et al. 
2012).  This link to high risk behaviours may explain the significantly higher 
proportion of smokers rather than non-smokers in this study reporting infectious 
diseases.  No statistically significant effects were found related to other reported 
medical conditions.  
 
The knowledge of respondents regarding the health impacts of smoking was 
assessed by asking them to decide whether smoking was linked to the 
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development of twelve disorders presented in a list. The mean correct score 
across all disorders was 55%, and few statistically significant differences were 
found with demographic variables. Notably, however, the proportion of those in 
unskilled occupations who recorded that smoking was related to lung cancer was 
significantly lower than for other occupational groups. Smokers were also 
proportionately more likely to assert that oral and lung cancer were unrelated to 
smoking when compared with ex-smokers and never smokers and these results 
reached statistical significance. Other studies have similarly reported that 
smokers are less aware of the risk of smoking for oral and lung cancer (Terrades 
et al. 2009; van Schyack et al. 2008; West et al. 2006). In fact, there was a 
tendency across all diseases for never and ex-smokers to relate smoking with all 
disorders, whether or not they were smoking related, and for current smokers to 
fail to recognise the impact of smoking. This would seem to suggest that smokers 
are unwilling to acknowledge the harm inflicted by smoking whilst many non-
smokers are emphatic in their disapproval, and can overestimate its impact 
(O’Connor et al. 2007; Yong et al. 2005). 
 
A twelve-point attitudinal scale was used to assess smokers’ attitudes to their 
smoking habit and, after undergoing a principle component factor analysis, two 
scales were described which were conceptualised as ‘willingness to quit smoking’ 
and ‘confidence to quit smoking’. The results of analysing these two scales by 
lifetime exposure to nicotine and nicotine dependence showed that neither 
affected willingness to quit, but the greater the exposure to and dependence on 
tobacco, the lower the confidence in being able to quit. This suggests that 
smokers are aware of the extent of their dependency, and this not only negatively 
affects the strength of physiological nicotine withdrawal symptoms, but also a 
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lack of confidence in succeeding in itself makes a quit attempt less likely (Zhou et 
al. 2009; Heatherton et al. 1991). 
 
When quit attempts in the previous two months, and readiness to quit in the 
future, were analysed by the willingness to quit and confidence to quit scales, 
those who had cut down, tried to quit and stopped for at least 24 hours had 
greater mean scores than those who had not, showing a strong link between 
attitudes to quitting and recent quit behaviours (Kowalski et al. 1997).  
 
Predictably, for both the ‘willingness to quit’ and ‘confidence to quit’ scales 
significantly and progressively lower mean scores were found for those who 
planned to stop in the next thirty days, those who planned to stop in the next six 
months, those who planned to quit, but not in the next six months, and those who 
did not intend to quit. Willingness to quit was found to be low only in those who 
did not intend to quit, with moderate to high levels of willingness being 
demonstrated in all other stages of readiness to quit. Only those smokers who 
had set a quit date in the next thirty days showed significantly more confidence 
than those at other stages of readiness to quit. This contrasts with the findings of 
McEwen et al. (2006) whose respondents had high levels of confidence they 
could quit, although no significant relationship was found between confidence 
and actual quit rates. However, Manfredi et al. (2006) found a significant link 
between confidence and quit success in a group of women of low socio-economic 
status. 
 
These results suggest that the attitudinal scales could be used to indicate 
whether a reluctance to make a quit attempt is due to a lack of willingness or a 
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lack of confidence. This can then be used to inform the development of an 
individualised stop smoking intervention truly reflecting the needs of the individual 
smoker. The focus should shift towards providing interventions tailored to 
increasing the willingness and confidence of individuals in their ability to quit 
where this is found to be lacking.  
 
Smokers who participated in the survey used cigarettes (66%) or roll-ups (41%) 
with no-one reporting use of smokeless tobacco. This confirms that the results of 
the randomised controlled trials examining the effectiveness of tobacco-related 
cessation interventions found in the systematic literature review and which dealt 
with smokeless tobacco are not immediately transferable to this population 
(Walsh et al. 2010; Gansky et al. 2005; Walsh et al. 2003; Gansky et al. 2002; 
Walsh et al. 1999).  
 
Only two participants (0.5% of the sample) reported using cannabis as compared 
with 3.6% of respondents in the Scottish Crime Survey reporting use of cannabis 
in the previous month (Scottish Crime & Justice Survey 2010). This may result 
from a reluctance to admit using an illegal substance even in an anonymous 
questionnaire, but may partly be explained by the design of the questionnaire. 
Only smokers completed the second part of the questionnaire and there may be 
cannabis users who do not consider themselves to be smokers and so did not 
proceed far enough in the questionnaire to be asked the question.  
 
Mean pack-years, which represent lifetime exposure to tobacco, were 
significantly higher in the older age group as would be expected, and the 
proportion of males who were heavier smokers was significantly higher than the 
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proportion of females. The Scottish Health Survey also found that, on average, 
men were heavier smokers than women (Scottish Health Survey 2012). Males 
were also found to have significantly higher levels of nicotine dependence in this 
trial. The mean level of nicotine dependence encountered in this study sample – 
3.9 – was lower then that in a sample population drawn from patients attending a 
Scottish secondary care establishment for treatment of periodontal disease in 
which a mean nicotine dependence of 5.0 was found despite a lower overall 
exposure to tobacco – mean life pack years of 26.3 in the study sample 
compared with 21.5 in the study undertaken in secondary care (Binnie et al. 
2007). This may be explained by the higher degree of treatment need in 
periodontal patients attending for specialist care compared with those accessing 
routine treatment in primary care. Two studies undertaken among hospital 
inpatients also found higher levels of nicotine dependence than in this study – 5.0 
(Molyneux et al. 2003) and 6.0 (Gritz et al. 1991). A postal questionnaire survey 
conducted by Martinelli et al. (2008) found a mean nicotine dependence of 3.5 
which is similar to the current study score of 3.9. 
 
Sixty three percent of the study sample reported that they seriously intended to 
quit in the coming six months compared with 73% in the Scottish Health Survey 
(2012). It is unclear why this discrepancy should exist. Despite the high 
proportion of smokers in the Scottish Health Survey (2012) reporting that they 
wished to quit, only 38% reported ever having tried. This implies that even for 
those smokers who wish to quit, this only translates into a quit attempt in around 
half of cases. Reported quit behaviour in the previous six months in the study 
sample showed 24% reporting they had tried to quit smoking. Only 20% indicated 
that they had no intention of ever quitting, a significantly higher proportion of 
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whom were in the older age group. This correlates with the results of the Scottish 
Health Survey 2012 which also found the lowest desire to quit in the older age 
group. This may reflect failed quit attempts in the past or entrenched habits not 
easily amenable to change (Ryckman et al. 2009; Roddy et al. 2006; Yong et al. 
2005). Older people have been shown to be less easily persuaded of the 
negative health impacts of smoking, especially if they are long-term smokers who 
have not experienced smoking-related ill health (Wakeman et al. 1996). However, 
older smokers who experience ill-health are likely to want to quit, and to succeed 
in their quit attempt (Sachs-Ericsson et al. 2009). Paradoxically, Schofield et al. 
(2006) found some older people claiming that smoking cessation could further 
prejudice their health. 
 
In a study exploring the feasibility of introducing smoking cessation interventions 
in secondary care in Scotland, only 10% of the participants reported having no 
intention of quitting in the future, compared with 20% of the study population 
(Binnie et al. 2007). It may be postulated that as these participants had already 
committed to attending for specialist care they may more highly motivated than 
the general population of smokers attending primary care facilities. However, as a 
high proportion of the study population report never intending to quit, and a 
comparatively low proportion report wishing to quit, this cadre of dental patients 
may actually be less inclined to quit their smoking habit than the Scottish 
population at large. 
 
With respect to attitudes to dentists’ involvement in smoking cessation activities, 
there was a high level of support from all participants with 80% agreeing that 
dentists should ask patients if they smoke, 73% agreeing that they should offer 
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stop smoking advice and 63% agreeing that they should offer counselling support 
and nicotine replacement therapy. (Campbell et al. 1999) Despite the high level 
of support, smokers were significantly less agreeable to smoking cessation 
activities in the dental surgery than ex-smokers and non-smokers which may 
indicate a degree of unease about discussing the topic which has also been 
found in other studies (Roddy et al. 2006).  
 
Individuals in the younger age group of the sample reported that their dentists 
had enquired about their smoking status and offered cessation support 
significantly more frequently than older individuals. Dentists may feel less 
intimidated raising the issue of smoking with less mature patients, or may 
assume that older smokers are not interested in quitting smoking or would accrue 
less benefit from doing so which is not the case (Phillips 2012; Doolan et al. 
2008). 
 
3.5.3 Oral health-related quality of life 
 
The study questionnaire explored participants oral health-related quality of life 
and results showed that the most common impacts were pain and physical 
discomfort closely followed by psychological distress: 29.4% and 28.4% 
respectively as opposed to 30% and 19% in the ADHS 2009 (Nuttall et al. 2011). 
Sixty eight percent of the sample had experienced at least one impact of oral 
health-related quality of life in the previous twelve months, and the average total 
score was 4.4. Overall the population in the current study reported more frequent, 
but less severe, impacts on daily living as opposed to that in the ADHS (Nuttall et 
al. 2011). Strikingly, 4.8% of the study population experienced a total inability to 
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function at some point in the previous year showing that oral health can affect 
quality of life substantially. 
 
Psychological impacts on quality of life were experienced significantly more 
frequently by younger participants, by females and by those in unskilled 
occupations, findings also encountered in other studies (Locker and Quinonez 
2011; Nuttall et al. 2011; Sanders et al. 2009). Experience of pain and discomfort 
varied significantly with age, occupational group and location with younger 
people, unskilled workers and residents of Dunoon being significantly more 
affected. 
 
Smoking status had a significant impact on quality of life in this population, with 
all measures except pronouncing words adversely affecting smokers more than 
ex-smokers and never smokers. The very strong relationship found between 
smoking and poor oral health-related quality of life could be used to encourage 
both dental professionals to offer smoking cessation support and to motivate 
smokers to quit.  
 
The complexity of periodontal treatment needs of this study population was 
related to oral health-related quality of life with all but two of the OHIP-14 
categories showing significant results. Other studies have also found this link 
(Bernabe and Marcenes 2010; Jowett et al. 2009; Needleman et al. 2004). 
 
Fewer than half of the population reported that things had been going their way 
recently, and this pessimistic attitude would tend to inhibit smokers from having 
the confidence to make a quit attempt. 
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3.5.4           Oral health behaviours 
 
Dental attendance was found to be significantly less frequent among smokers 
than ex-smokers and never smokers and this replicates findings in other 
populations (Csikar et al. 2013; Millar and Locker 2007). Smokers were more 
likely to have last attended for emergency rather than for routine care, as were 
residents of Dunoon. Conversely, those with professional occupations were 
significantly less likely to report requiring emergency care (Csikar et al. 2013). 
 
Daily toothbrushing was reported by all participants in this trial with 20% brushing 
once daily, 70% twice daily and the remaining 10% brushing more than twice 
daily. These results are very similar to those found in the ADHS which found 23% 
reporting brushing once daily and 75% brushing twice a day. Males constituted a 
higher proportion of those brushing only once daily than females as has been 
found in other studies (Chadwick et al. 2011; Bertea et al. 2007). 
 
Disappointingly, almost half of the participants reported they did not use 
interdental aids to improve their oral hygiene, however 32% of the study 
population reported using dental floss as compared with 21% in the ADHS 2009 
(Chadwick et al. 2011). As in the ADHS (2009) a significantly higher proportion of 
females than males reported using interdental aids. As the study population 
comprised regular dental attenders it would be anticipated that they would have 
better oral hygiene practices than the general population. A further 19% of the 
study population reported using interdental brushes compared with 6% of the 
ADHS 2009 population (Chadwick et al. 2011). 
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3.5.5        Periodontal status 
 
The participants in this survey were divided into three groups according to the 
complexity of their periodontal treatment needs as measured by the Basic 
Periodontal Examination (British Society of Periodontology 2011). The results 
show that the periodontal need of this study population is higher than that in the 
Adult Dental Health Survey 2009 (White et al. 2011) – 83.2% compared with 92% 
in the lowest treatment need group, 12.1% compared with 7% in the moderate 
treatment need group and 4.8% compared with 1% in the highest complexity of 
treatment need group. However, the report of the ADHS (2009) suggests that 
their results underestimate the true level of periodontal treatment need in the 
population studied (White et al. 2011). 
 
A significantly higher proportion of older participants, and male participants, were 
found in the most complex periodontal treatment need group, results which 
replicate those of the ADHS 2009 (White et al. 2011). As periodontal health 
deteriorates with age, this result is to be expected. The gender difference reflects 
the higher level of nicotine exposure and lower dental attendance reported by 
males. Unskilled and semi-skilled workers were also disproportionately found in 
the group with the most severe periodontal treatment needs, as were those 
residing in Dunoon. Twelve percent of smokers were found in the severe 
complexity of periodontal need group as opposed to 1% of never smokers, 
demonstrating a highly significant finding similar to results found by Klinge and 
Norlund (2005). This reflects the findings in the ADHS that 15% of current 
smokers compared with 8% of never smokers had severe periodontal treatment 
needs (Chadwick et al. 2011). 
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A significant dose response was encountered when comparing mean pack years 
with complexity of periodontal treatment need, and those with the lowest nicotine 
dependence were significantly more likely to be in the group with lowest 
complexity of treatment need as found in previous studies (Martinelli et al. 2008; 
Binnie et al. 2007; Molyneux et al. 2003).   
 
Those with the lowest complexity of periodontal treatment need were significantly 
more in favour of dental professionals offering smoking cessation than those with 
moderate or high treatment needs who stood to benefit most from smoking 
cessation. Perhaps smokers with poor periodontal health interpreted advice and 
support from dental professionals regarding their smoking as being chastised for 
their habit and were therefore more cautious about receiving it. 
 
Unexpectedly, neither “willingness to quit” nor “confidence to quit” was 
significantly related to the level of periodontal treatment need experienced by 
participants. This implies that individuals are either unaware of their periodontal 
status, which, as these participants were regular dental attenders should not be 
the case, or they do not value good periodontal health enough to factor it into a 
decision to quit smoking. Similarly, Rosseel et al. (2010) found that the presence 
of oral conditions did not influence quit intentions among smokers. 
 
By contrast, increasing complexity of periodontal treatment need demonstrated a 
strong negative relationship with oral health-related quality of life for all reported 
impacts barring ‘ability to undertake normal tasks’ and ‘finding life less satisfying 
due to oral health problems’. This indicates that while participants did not 
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recognise poor periodontal health as serious enough to warrant an attempt to quit 
smoking, it did have a detrimental effect on their oral health-related quality of life. 
It may therefore be the case that the messages being delivered by dental care 
professionals encouraging smoking cessation in order to improve periodontal 
status have limited impact on an individual’s readiness to quit. Whilst it is 
incumbent on an oral health practitioner to inform patients of the oral health risks 
associated with smoking, it may be that delivery of messages relating to the 
improved general and oral health-related quality of life found amongst non-
smokers and ex-smokers would be more successful in motivating patients to 
make a quit attempt.  
 
Whilst there was no correlation found between overall dental attendance and 
complexity of periodontal treatment need, those who had last attended for 
emergency care had significantly higher complexity of periodontal treatment need 
than those attending for routine care. This suggests that periodontal disease 
leads to an increased likelihood of experiencing oral pain and discomfort. 
 
Oral hygiene measures such as toothbrushing and interdental cleaning disrupts 
the dental biofilm and prevents its developing to the point where periodontal 
disease occurs. For this reason the oral hygiene behaviours of the study 
population were explored. In this population reported oral hygiene measures 
were not significantly related to complexity of periodontal treatment need 
contrasting with the ADHS 2009 (White et al. 2011) which found that increased 
toothbrushing frequency resulted in lower periodontal treatment needs. Whilst 
this result is surprising, chronic periodontitis results from the interplay of a myriad 
of risk factors of which plaque is just one. As participants in this study are regular 
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dental attenders they would have been aware of the recommended frequency of 
toothbrushing and use of interdental aids and so they may have reported what 
they thought to be the correct answer, or what they did on a good day, rather 
than their usual oral hygiene routine, thus downplaying the link between plaque 
control and periodontal health. 
 
3.5.6 Modelling a smoking cessation intervention for primary dental care in 
remote-rural Scotland 
A model for smoking cessation intervention based on smoking status, periodontal 
health status and oral health-related quality of life was developed using structural 
equation modelling and the path analysis model was constructed by interpreting 
previous findings from the literature and the findings of the survey. This statistical 
modelling procedure demonstrated the direct relationship between smoking and 
oral health-related quality of life as well as an indirect effect via periodontal 
status.  The implications of the indirect link of smoking on oral health related 
quality of life via periodontal status are as follows.  First, since smoking affects 
oral health-related quality of life (greater impacts) it is possible that addressing 
oral health-related quality of life impacts via periodontal health will assist people 
to quit smoking.  The provision of appropriate periodontal care as part of a 
smoking cessation intervention in remote-rural primary dental care may improve 
people’s quality of life.  It is suggested therefore that it is by focusing on quality of 
life and employing periodontal treatment strategies that smokers could be 
encouraged to quit smoking tobacco,  the outcome being improved oral health-
related quality of life. 
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3.5.7 Limitations  
As a nonprobability convenience sample was gathered it is possible that this was 
not representative of the population however when the demographic profile of the 
sample was compared to that of Argyll and Bute it seemed to be characteristic of 
that population. The smoking status of participants in the survey was collected by 
self-report only with no biochemical verification. This may have resulted in an 
underestimation of smoking intensity, however previous research has shown a 
good correlation between self-report and biochemical validation for smoking 
status (Brugger 2013).  Therefore with regard to smoking status it is 
acknowledged that the use of a nonprobability convenience sample means that 
caution is required in generalising these findings. 
 
3.6 Conclusions  
The high degree of agreement with dentists’ involvement with smoking cessation 
activities suggests that dentistry has the potential to make a significant 
contribution to smoking cessation in remote-rural areas.   Oral health-related 
quality of life showed significant differences between categories of both 
periodontal health status and smoking status.  It would seem therefore that 
focusing on oral health-related quality of life as a primary outcome in dental-
based smoking cessation interventions rather than periodontal outcomes could 
provide a promising means of promoting both oral and general health.  
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Chapter 4: Overall Discussion & Conclusions 
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4.0 Introduction 
This thesis represents an adventurous journey through smoking cessation 
interventions in remote-rural primary dental care in Argyll and Bute Community 
Health Partnership in Scotland.  It is also represents a learning experience in 
which the importance of accessing the evidence-base to support an intervention 
together with understanding the specific elements of an intervention have been 
realised.  Therefore the initial aim of this thesis was to determine the amount of 
additional benefit for the promotion of periodontal health in a remote-rural 
population, achieved by comparing an intensive smoking cessation intervention 
provided by a dental therapist in the dental surgery, with an intensive smoking 
cessation intervention provided by an NHS smoking cessation specialist outwith a 
dental setting, but it became clear that a ‘top-down’ approach was inappropriate.   
 
4.1 Recruitment 
 
The PHaSCe trial with its the low number of participants recruited made it 
impossible to answer the research question of whether there is an additional 
benefit for the promotion of periodontal health in a remote and rural population 
achieved by an intensive smoking cessation intervention provided by a dental 
therapist in the dental surgery compared with an intensive smoking cessation 
intervention provided by an NHS Smoking Cessation Counsellor in a non-dental 
setting.   Some of the issues involved in the poor recruitment rates were 
undoubtedly the constraints applied by the Research Ethics Committee and the 
study design which combined to result in participants attending four separate 
appointments prior to commencing the smoking cessation intervention.  
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4.2 Quit rates and power calculations 
 
Evidence from research papers indicates that around 70% of smokers would like 
to quit (Scottish Health Survey 2012; van Schyack et al. 2008), however results 
of the survey conducted in this project showed that only 56% of this study 
population wished to quit in the next six months.  A further 8% had set a quit 
date. This compared with 46% contemplating giving up in the next 6 months and 
24% preparing to quit in the next 30 days in a postal questionnaire conducted by 
Martinelli et al. in 2008.  It would appear therefore that fewer of this population of 
smokers are ready to quit than in other groups of smokers and the Scottish 
population as a whole.  As quit rates among those supported by pharmacological 
and behavioural support average 15%, the actual numbers of participants 
required in both the control and intervention groups to demonstrate a difference 
with 80% power in periodontal health would have required a sample of 434. This 
would have rendered the randomised controlled trial impracticable at this stage 
and would have indicated that a multi-centre trial would be required to answer the 
research question.  
 
4.3       Recommendations 
 
Therefore, the MRC Framework for Complex Interventions (2010), facilitated a 
reconsideration of what steps needed to be put in place to permit the modelling of 
a smoking cessation intervention for remote-rural primary dental care in Scotland.  
It was necessary to revisit the evidence-based literature regarding the 
effectiveness of smoking cessation interventions in remote-rural localities.   A 
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systematic literature review demonstrated that little research into the 
effectiveness of smoking cessation interventions in remote-rural areas had been 
conducted, and that the number of randomised controlled trials investigating the 
effectiveness of smoking cessation interventions in a dental setting was 
negligible. Moreover the randomised controlled trials had focused on specific 
target populations of young men who used smokeless rather than smoked 
tobacco.  Therefore their relevance to primary care dental patients in remote-rural 
Scotland was limited (Walsh et al. 2010; Gansky et al. 2005; Walsh et al. 2003; 
Gansky et al. 2002; Walsh et al. 1999). The need for further research and the 
modelling of an intervention for patients attending remote-rural primary dental 
care was necessary.  
 
In this regard, a survey to examine prevalence of smoking, periodontal health 
together with smoking-related knowledge, attitudes (including oral health-related 
quality of life) and behaviours was undertaken.  This allowed the modelling of a 
intervention based upon a path analysis from the information gleaned in the 
systematic review and the survey.  It suggested that a smoking cessation 
intervention for remote-rural primary dental care should focus on quality of life 
and employ periodontal treatment strategies to encourage smokers to quit 
smoking tobacco.  The primary outcome being improved oral health-related 
quality of life and secondary outcome improved periodontal health status. 
 
4.4 Conclusions 
 
In conclusion, following the lack of success of the PHaSCe trial, the information 
collected from the systematic literature review and the smoking and periodontal 
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health prevalence survey permitted the modelling of a smoking cessation 
intervention for remote-rural primary dental care based on oral health-related 
quality of life and periodontal disease.  Thus a feasibility trial should incorporate 
quality of life as the primary outcome measure to assist in answering a 
reformulated research question:  
 
‘What is the additional benefit of, 
 an intensive smoking cessation intervention provided by a dental therapist 
in the dental surgery,  
Compared with, 
 an intensive smoking cessation intervention provided by an NHS smoking 
cessation specialist outwith a dental setting, 
 For, 
 the promotion of quality of life and periodontal health status  
For, 
  a population of patients attending remote-rural primary dental care? 
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Chapter 5: Recommendations 
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It is recommended that a feasibility trial of a smoking cessation intervention be 
conducted based on the evidence gathered in this research project such that the 
intervention: 
 
 Emphasises patient-centred health gains i.e. quality of life benefits rather 
than biomedical gains such as reduced pocket depths 
 Incorporates the attitudes questionnaire used in the prevalence study to 
assess the individual smoker’s willingness and confidence to quit which 
will then inform the behavioural support provided 
 Provides pharmacological support according to the smoker’s preference 
and in accordance with the evidence base available 
 Ensures dental professionals have sufficient training, knowledge and 
motivation to integrate the smoking cessation intervention into their routine 
dental care 
 
The results of the feasibility trial would subsequently be utilised to model a multi-
centre trial which would have sufficient power to determine whether there is an 
additional benefit for the promotion of periodontal health in a remote and rural 
population, achieved by comparing an intensive smoking cessation intervention 
provided by a dental therapist in the dental surgery, with an intensive smoking 
cessation intervention provided by an NHS smoking cessation specialist outwith a 
dental setting. 
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Appendices 
 
Appendix 1: Behaviour change theories 
 
Several theories of behavioural change have been described in an attempt to 
understand the factors required to elicit change away from detrimental health 
behaviours. Using a theoretically-based behaviour change model allows 
development of interventions designed to encourage individuals to adopt and 
maintain healthy choices (Family Health International, 2007). There follows a 
description of the commonly cited theories and models of health behaviour 
changes relating to addictions. 
 
Theory of Planned Behaviour 
The Theory of Planned Behaviour postulates that behaviour change occurs as a 
result of behavioural intentions and perceived behavioural control. In this model 
behavioural intentions comprise attitude to how favourable the behaviour change 
is felt to be, and the subjective norms of those people important to the individual 
i.e. the individual’s perception of what respected others actually do, as opposed 
to what they think they should do. Perceived behavioural control is a concept 
similar to self-efficacy, describing the extent to which the individual feels able to 
adopt a new behaviour (Ajzen, I. 1985). However, it has not been used to 
develop interventions, but only to explain behaviour change which has already 
taken place (Webb et al, 2010). 
 
Health Belief Model 
The Health Belief Model aims to predict the likelihood of a beneficial health 
behaviour being adopted using the following four predictors: 
 Perceived susceptibility to and severity of the disease protected against; 
 Perceived effectiveness of the preventive behaviour 
 Perceived barriers to behaviour change 
 Cues to action e.g. health warnings on cigarette packets 
This model was designed to explain lack of participation in large public health 
interventions. Literature reviews have shown that perceived barriers have the 
strongest predictive value for acceptance of behaviour change (Janz & Becker, 
1984). It has been used to explain participation in smoking cessation 
programmes amongst other public health measures but only using part of the 
model rather than the model in its entirety. 
 
Manfredi et al. (2006) developed a theoretical path model of smoking cessation 
based on the health belief model which considered the impact and 
interrelationship of various factors on future quit attempts. These included 
background factors such as race and education, mediating factors such as 
stress, health concerns and social pressure to quit, and precursors of quitting 
smoking such as situational self-efficacy, confidence and motivation and their 
relationship to recent cutting down or quitting actions and future quitting plans. 
 
Transtheoretical (Stages of Change) Model 
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Described by Prochaska and DiClemente (1982), the Transtheoretical, or Stages 
of Change Model, is based on a combination of psychotherapy models. It aims to 
assess an individual’s readiness to change to a healthier behaviour and provide 
them with strategies to do so. Many stop smoking counsellors are trained to use 
the Stages of Change component of the transtheoretical model in delivering 
counselling to their clients and this describes six stages of change:  
Precontemplation – person has no intention of changing in the foreseeable 
future; 
Contemplation – person is intending to change in the next six months; 
Preparation – person is intending to change in the immediate future, often 
described as in the next month; 
Action – person has made changes in their behaviour at some point in the 
previous six months; 
Maintenance – the person is actively avoiding return to the adverse behaviour; 
Termination – the person is free from temptation and is confident they will never 
return to the adverse behaviour. 
 
The model states that interventions should be tailored to the stage of change of 
the individual and aim to move them through the six stages. Cognitive, affective 
and evaluative processes should be employed in the early stages moving on to 
use of commitments, conditioning, contingencies and environmental controls in 
the later stages (Prochaska et al, 2008). 
 
Motivational Interviewing 
Motivational interviewing employs the use of open questions when interviewing a 
client in order that they relate their own beliefs and attitudes to their behaviour, as 
many people have mixed feelings towards giving up a behaviour they may have 
depended on for many years. Motivational interviewing helps them to resolve 
these ambivalent attitudes in a supportive environment in which the counsellor 
commits to assisting in the preparation for their quit attempt (Rubak et al, 2005). 
They are then encouraged to identify strategies for implementing change and 
coping with temptation from their own prior experience and knowledge of their 
strengths and weaknesses (van Schayck, 2008).  
 
The PRIME theory 
West (2006) developed a synthetic model of motivation in an attempt to combine 
elements of all the above theories into a comprehensive model which could 
inform interventions for addictive behaviours. The PRIME theory – Plans, 
Responses, Impulses, Motives and Evaluations – West developed indicates that 
an individual makes decisions to satisfy their needs of the moment, not for the 
long-term. A change in behaviour will result from a person wanting or needing to 
change and when they can form an image of the pleasure, satisfaction or relief 
this will afford them. Thus a smoker who feels they ought to stop smoking is 
highly unlikely to succeed whereby one who wants or needs to has a much 
higher possibility of success. This model also states that self-control is essential 
to changing behaviour and that this is a function of deliberate plans to change 
combined with a change in identity e.g. recent quitters who consider themselves 
to be non-smokers and believe they will never again smoke are much less likely 
to relapse. West believes that the behavioural support element of a smoking 
cessation intervention should focus on developing a new identity for the quitter as 
a non-smoker, thus a sudden cessation of smoking on a quit date with strong 
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rules that not even a puff can be taken after that date will reinforce this revised 
identity (West, 2009).  
 
 
 
Cut down to quit 
In contrast, a model whereby smokers decrease the number of cigarettes they 
smoke while receiving NRT as a prelude to giving up completely is known as “cut 
down to quit”. Its success rate has proved to be intermediate between no use of 
NRT and complete abstinence with NRT and behavioural support, and so it can 
be offered to those smokers who do not feel able to quit completely (Wang et al, 
2008). The evidence base for this model is not as strong as for complete 
cessation and there is no safe level of smoking, so this model should only be 
offered when conventional stop smoking support has failed.  
 
The above theoretical models share the belief that self-efficacy is required to 
enable positive behaviour change and its maintenance. To a greater or lesser 
extent, they recognise the importance of environmental and societal norms of an 
individual’s circumstances in shaping their motivation and capacity to adopt new 
behaviours.  Each model had been applied to stop smoking interventions, with 
the Stages of Change Model most commonly cited. 
 
Despite its widespread use, the Stages of Change model is controversial with 
critics who point out that the stages are not mutually exclusive, and individuals 
rarely proceed in this rational and sequential manner through the stages (West, 
2005). A randomised controlled trial conducted in 2009 did not find that the 
Stages of Change model was more successful than one that did not involve 
staging in promoting smoking cessation (Aveyard et al, 2009). 
 
Motivational interviewing is gaining support in smoking cessation services and its 
use is becoming more prevalent. The effectiveness of motivational interviewing in 
smoking cessation interventions has been demonstrated experimentally (Soria, 
2006).  
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Appendix 2: The dental health and smoking habits questionnaire, Version 1.3, 
22/05/12 
 
 
 
 
 
 
 
 
 
 
       PHaSCe 
Periodontal Health and Smoking Cessation 
 
 
 
 
Dental Health 
 and  
Smoking Habits Questionnaire 
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Dental Health and Smoking Participant Self-Completion 
Questionnaire, Version 1.3, 22/05/12 
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Participant number:  Date of Birth: / /   
 
Confidential medical history 
 
 
Yes 
 
No 
 
Don’t 
know 
 
Prefer not to 
say 
 
Are you receiving treatment from a 
doctor, hospital, clinic or specialist? 
 
    
 
Are you taking any medicines, pills, 
syrups, ointments, puffers or injectors 
prescribed for you by the doctor? 
 
If yes, please list: 
    
 
Have you had angina? 
 
    
 
Have you had blood pressure problems? 
 
    
 
Have you ever had a heart attack? 
 
    
 
Do you suffer from any infectious 
diseases, e.g. HIV, hepatitis? 
 
    
 
Do you have asthma or any other lung 
disease? 
 
    
 
Do you have epilepsy? 
 
    
 
Do you have diabetes? 
 
    
 
Do you bruise or bleed easily? 
 
    
 
Are you allergic to any medicine, foods 
or materials? 
 
    
 
Are you pregnant? 
 
    
 
Are there any other details you feel we 
should know about your medical history? 
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Gender:    Male    Female   
Ethnic origin:   White    African/Caribbean 
 
  Asian   Gypsy/traveller  Other ________ 
 
First language (if not English): ____________________________________ 
 
Occupation or previous occupation: ________________________________ 
 
In the last 12 months: Never Hardly 
ever 
Occasionally Fairly 
often 
Very 
often 
Have you ever had trouble 
pronouncing any words because of 
problems with your teeth, mouth or 
dentures? 
     
Have you felt your sense of taste has 
worsened because of problems with 
your teeth, mouth or dentures? 
     
Have you had painful aching in your 
mouth? 
     
Have you found it uncomfortable to eat 
any foods because of problems with 
your teeth, mouth or dentures? 
     
Have you been self-conscious because 
of your teeth, mouth or dentures? 
     
Have you felt tense because of 
problems with your teeth, mouth or 
dentures? 
     
Has your diet been unsatisfactory 
because of problems with your teeth, 
mouth or dentures? 
     
Have you had to interrupt meals 
because of problems with your teeth, 
mouth or dentures? 
     
Have you found it difficult to relax 
because of problems with your teeth, 
mouth or dentures? 
     
Have you been a bit embarrassed 
because of your teeth, mouth or 
dentures? 
     
Have you been a bit irritable with other 
people because of problems with your 
teeth, mouth or dentures? 
     
Have you had difficulties doing your 
usual jobs because of problems with 
your teeth, mouth or dentures? 
     
Have you felt that life in general was 
less satisfying because of problems 
with your teeth, mouth or dentures? 
     
Have you been totally unable to 
function because of problems with your 
teeth, mouth or dentures? 
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Dental history 
 
Have you been to the dentist in the last year? 
  
 
 Yes     No 
 
 
What made you go to the dentist last time you went? 
 
 Check up  Trouble with teeth  Other ______________ 
 
How often do you brush your teeth? 
 
   
 Once per day   Twice per day   Other ______________ 
 
 
How do you clean between your teeth? 
 
 
 Toothbrush only   Dental floss   Dental tape 
 
 
 TePe brushes   Woodsticks    Toothpicks 
 
 
Please complete the section below by ticking the box which most closely describes how you 
feel with 1 indicating you definitely agree and 5 indicating you definitely do not agree 
 
 Definitely 
agree 
Agree Neither 
agree nor 
disagree 
Disagree Definitely 
disagree 
How much do you agree 
that dentists should ask 
their patients if they 
smoke? 
     
How much do you agree 
that dental staff should 
offer advice about 
quitting smoking? 
     
How useful do you think 
it would be if dental staff 
could provide counselling 
to help smokers to quit? 
     
How useful do you think 
it would be if dental staff 
could provide nicotine 
replacement therapy to 
help smokers to quit? 
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Please tick the boxes below to show whether you think the following health 
problems can be caused by smoking cigarettes: 
 
 
Arthritis    Yes    No   Don’t know 
 
 
Heart disease   Yes    No   Don’t know 
 
 
Gum disease   Yes    No   Don’t know 
 
 
Skin disease   Yes    No   Don’t know 
 
 
Broken arm   Yes    No   Don’t know 
 
 
High blood pressure  Yes    No   Don’t know 
 
 
Mouth cancer   Yes    No   Don’t know 
 
 
Lung cancer   Yes    No   Don’t know 
 
 
Toothache   Yes    No   Don’t know 
 
 
Dementia   Yes    No   Don’t know 
 
 
Bronchitis   Yes    No   Don’t know 
 
 
Liver disease   Yes    No   Don’t know 
 
 
 
 
Are you a:   Smoker    Ex-smoker  Never 
smoker 
 
If an ex-smoker how long ago did you give up: _______________________________ 
 
 
The rest of the questions are for smokers only, so if you do not smoke 
please stop here and thank you for completing the questionnaire. 
Smokers please continue to the end. 
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Smoking habits 
 
 
How soon after you wake up do you smoke your first cigarette? 
 
Less than 5 minutes 6–30 minutes  31–60 minutes  over 60 minutes 
 
 
Do you wake during the night to smoke a cigarette?    Yes     No 
 
 
Do you smoke most frequently in the morning?        Yes     No 
 
 
Do you smoke if you are ill enough to spend most of the day in bed?  
 
   Yes       No 
 
 
Which of the following tobacco products do you use? 
 
  Roll-ups    Pipe   Cigars    Snuff 
 
 
  Chewing tobacco    Cannabis  Cigarettes 
 
 
Which cigarette would you find it hardest to give up? 
 
 
 First one in the morning  After a meal      Other ______________________ 
 
 
How old were you when you started smoking?  _________________________years 
 
 
How many cigarettes or roll-ups do you smoke per day?  
 
 
 10 or less   11-20  21-30   over 30   not sure 
 
 
If you smoke roll-ups, please state the quantity of tobacco you use per day: _____ 
 
 
How many other smokers live in your house? 
 
 none   1    2   3   4 or over 
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Please complete the section below by ticking the box which most closely describes 
how you feel with 1 indicating not at all and 5 indicating very much  
              
                Not at all   A little bit  Neither/nor  Somewhat   Very much 
 1 2 3 4 5 
I am concerned about the effects of 
smoking on my health 
                     
I am concerned about the effects of 
smoking on other people around me 
     
People close to me want me to quit 
smoking 
     
I am confident in dealing with my personal 
problems 
     
I feel that things have generally gone my 
way this last month 
     
I want to cut down on my smoking 
 
     
I want to quit smoking 
 
     
I intend to quit smoking 
 
     
I am confident that I could refrain from 
smoking when I am angry 
     
I am confident that I could refrain from 
smoking when I am under pressure 
     
I am confident that I could cut down on 
my smoking 
     
I am confident that I could quit smoking all 
together 
     
 
In the past 2 months have you: 
 
 
Cut down the number of cigarettes that you smoke?  Yes    No 
 
 
Tried to quit smoking?         Yes    No 
 
 
Stopped smoking for at least 24 hours?       Yes    No 
 
 
Which of the following statements best describes your plans to quit smoking? 
 
     Don’t plan to stop 
 
 
     Don’t plan to stop in next 6 months 
 
 
     Seriously considering quitting in next 6 months 
 
 
     Have set a date to quit within the next 30 days 
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Have you ever been asked by your dentist whether you smoke? 
 
 Yes     No 
 
Have you ever been offered advice by your dentist or dental staff about quitting 
smoking? 
 
 Yes     No 
 
Has anyone at your dental practice ever offered to refer you to smoking 
cessation services? 
 
 Yes     No 
 
Has anyone at your dental practice ever given you information about how to 
contact them? 
 
 Yes     No 
 
 
THANK YOU 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
297 
 
Appendix 3: Pilot study of characteristics of semi-quantitative salivary cotinine 
tests  
 
Characteristics of the tests  
 
SmokeScreen Saliva (GFC Diagnostics) employs a cotton swab to collect 
unstimulated saliva from the floor of the mouth which is then squeezed into a 
sample collector. A 1ml sample is removed using a syringe and this is deposited 
into the Smokescreen test tube. The saliva and chemicals are agitated for five 
seconds and the test tube stored upright for ten minutes when the results are 
ready.  The SmokeScreen test is a colorimetric assay whereby the pyridine ring 
structure of nicotine and its metabolites is broken down leaving it available for 
attachment by the condensing agent. No change of colour or a change to brown 
indicates a negative result and therefore no exposure to nicotine. A change of 
colour to pink indicates that nicotine is present and the depth of colour indicates 
light, medium or heavy exposure. Intermediate colour changes can be classed as 
light to medium or medium to heavy exposure. 
 
SmokeScreen Saliva was found in a comparison with laboratory gas 
chromatography to have a sensitivity of 89% and a specificity of 94% (Cope et al, 
2000). It has proven to be successful in encouraging those who are quitting 
smoking to continue with their quit attempt by demonstrating the drop in cotinine 
levels when smoking stopped (Barnfather et al, 2005). 
 
NicAlert Saliva (Nymox Pharmaceutical Corporation) uses a test strip 
impregnated with antibody-coated gold particles and a series of avidity traps 
allowing quantification. The distance that the gold migrates along the test strip 
gives an accurate measure of the amount of cotinine in the sample.  The saliva is 
collected by spitting into a plastic tube via a funnel. Once the tube is half full the 
funnel is discarded and a plastic cap incorporating a dropper is placed over the 
end. Eight drops of saliva are deposited on the padded end of the strip which is 
left for 20-30 minutes (until a blue indicator strip disappears) and the result can 
be read. There are 7 numerical bands on the test strip which correspond to 
different levels of cotinine present as follows: 
 
0 0-10 ng/mL 
1 10-30 ng/mL 
2 30-100 ng/mL 
3 100-200 ng/mL 
4 200-500 ng/mL 
5 500 – 1000 ng/mL 
6 Over 1000 ng/mL 
 
Several papers have been published comparing the results of NicAlert with 
laboratory gas chromatography/mass spectrometry, although most have used 
urine rather than saliva (Bernert et al, 2005, Gariti et al, 2002, Parker et al, 2002). 
These have shown an average sensitivity of 96% and specificity of 94%. 
 
NicAlert Saliva was found to have a sensitivity of 99% and a specificity of 96% 
compared with liquid chromatography/mass spectrometry (Montalto & Wells, 
2007).  Cooke et al, 2008 used gas chraomatography/mass spectrometry as their 
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gold standard and found NicAlert Saliva to have a sensitivity of 93% and a 
specificity of 95%. 
Method 
 
The two kits were tested using samples from eight individuals who provided two 
saliva samples and completed a questionnaire regarding their smoking history at 
the same visit. The age range of the people taking part was from 25 – 63 years, 
and three were male and five female. Three of the participants were non-
smokers, and of the five smokers the number of cigarettes smoked per day 
ranged from 10 – 30. The results from the two tests were compared and the 
acceptability of the two methods of saliva collection was rated by each 
participant.  
 
Results 
 
Cotinine levels as per tests 
 
 No. Smoking History SmokeScreen Result NicAlert Result 
1 Never smoker, 
In smoky atmosphere 
previous evening 
No colour change Level 1 
2 Long term ex-smoker No colour change Level 0 
3 Approx. 10 cigs/day Light smoker Level 3 
4 Approx. 15 cigs/day Moderate - heavy Level 4 
5 Approx. 20 cigs/day Moderate Level 4 
6 15-20 cigs/day Moderate Level 3 
7 Never smoker No colour change Level 0 
8 Approx. 10 cigs/day No change of colour Level 2 
 
 
Acceptability of tests to participants 
 
SmokeScreen Saliva 
 
Not 
acceptable 
0 Tolerable 1 Moderately 
acceptable 
2 Very 
acceptable 
5 
 
NicAlert Saliva 
 
Not 
acceptable 
0 Tolerable 0 Moderately 
acceptable 
4 Very 
acceptable 
4 
 
Conclusions 
 
The results above indicate that the NicAlert test is more sensitive than the 
SmokeScreen test as it detected exposure to second hand smoke in a non-
smoker, while the SmokeScreen failed to identify a smoker of 10 cigarettes per 
day.  
 
Differences in the level of cotinine detected were found in both tests for smokers 
claiming to smoke similar amounts. This may indicate that one of these smokers 
inhales more deeply than the other, rather than any error in detection. 
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Participants found both tests acceptable, with very little difference between the 
two. 
 
The operator found the NicAlert test easier to use. Six of the eight participants 
found it difficult to collect enough saliva with the SmokeScreen swab, and 
required several attempts. The actual process for both tests are easily 
understood and undertaken but again, the operator found the results easier to 
read on the NicAlert test strip as it gave a numerical result. A disadvantage of the 
NicAlert test is that it takes 30 minutes to obtain results as opposed to 10 minutes 
for the SmokeScreen but if tests are conducted prior to questionnaire completion 
and the oral examination this will not pose a problem. 
 
It was decided that NicAlert was to be used to measure cotinine in this research 
project
Appendix 4: Clinical examination form, Version 1.1, 24/05/10 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
              PHaSCe 
 
Periodontal Health and Smoking 
Cessation 
 
Oral Examination 
Version 1.1, 24/05/10 
 
 
 
 
 
 
 
Dental Health Services & Research Unit 
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Examination 
 
 
 
 
Extraoral examination No abnormality Abnormality – please describe 
 
Submandibular glands 
 
  
 
Temperomandibular joints 
 
  
 
Facial tissues 
 
  
 
Perioral/lips 
 
  
 
 
 
 
 
Intraoral examination 
 
 
 
Charting 
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         Soft tissue chart 
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      Periodontal Chart 
 
 
 
Buccal 
 
 
 
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
Poc                                                 
Rec                                                 
AL                                                 
 
 
Palatal 
 
 
 
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
Poc                                                 
Rec                                                 
AL                                                 
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     Periodontal Chart 
 
 
Buccal 
 
 
 
 
 
 
 
 
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
Poc                                                 
Rec                                                 
AL                                                 
 
 
 
Lingual 
 
 
 
 
 
 
 
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
Poc                                                 
Rec                                                 
AL                                                 
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     Plaque and Bleeding Scores 
 
 
 
 
PLAQUE 
                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
                
 
 
 
BLEEDING 
                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
                
 
 
 
PLAQUE AND BLEEDING 
                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
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Periodontal treatment required? 
 
 Yes     No 
 
 
Periodontal treatment appointment arranged? 
 
 Yes     No 
 
 
Appointment for any other necessary treatment arranged? 
 
 Yes     No 
 
 
Samples 
 
 
Cotinine reading   _________________________________ 
 
CO reading    _________________________________ 
 
 
 
Agree to participate in smoking cessation intervention? 
 
 Yes     No 
 
 
Initial smoking cessation visit arranged?  
 
 Yes     No   Not applicable 
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Appendix 5: Participant information sheet, Version1.1, 24/05/10 
 
 
 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
PHaSCe 
Periodontal Health and Smoking Cessation 
 
We invite you to participate in a research project. We believe it to 
be of potential importance. However, before you decide whether 
or not you wish to participate, we need to be sure that you 
understand first, why we are doing it, and secondly what it would 
involve if you agreed to participate. Read this information sheet 
carefully and be sure to ask any questions if you have any. If you 
like, you may discuss it with others. We will do our best to 
provide any further information that may ask for now or later. 
You do not have to make an immediate decision.  
Dental Health Services & Research Unit 
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My name is Karen Emslie and I am undertaking a PhD at the University of Dundee. I 
am required to undertake a project as part of my course and invite you to take part in 
the following study. However, before you decide to do so, I need to be sure that you 
understand firstly why I am doing it, and secondly what it would involve if you agreed. 
I am therefore providing you with the following information. Please read it carefully 
and be sure to ask any questions you might have and, if you want, discuss it with 
others including your friends and family. I will do my best to explain the project to you 
with any further information you may ask for now or later. 
 
What is the study about? 
Gum disease is found in people all over the world, including here in Mid Argyll, and is a 
major cause of teeth being lost. Researchers based at the University of Dundee and in 
Lochgilphead aim to find out how common the problem is in our local population and 
look at ways we can tackle it. Previous research has shown a link between smoking 
cigarettes and gum disease and the study will focus on this. Everyone taking part will 
be offered advice and treatment for any gum disease they have, and then be allocated 
to one of two groups offering different support to quit smoking. We will use the results 
to improve the service we provide to patients with gum disease.  
 
Who will take part? 
Any adult (over the age of 18) who attends the dental practice based at the Mid Argyll 
Hospital & Integrated Care Centre and is a smoker is invited to take part.  
 
What would I have to do? 
You will have your gums and mouth looked at by a trained dentist or dental therapist. 
You will also be asked to fill in a questionnaire about what you think about your dental 
health, how you care for your teeth, if your mouth bothers you or affects your mood, 
and about your smoking habits. An appointment will be arranged for you to have any 
treatment and/or advice required to improve your gum health. You will then be 
allocated to one of two groups. Each group offers participants support to stop smoking 
but in different ways, and the improvement in the gum health of people in the two 
groups will be compared at the end of the study.  
 
 
 
309 
 
Smokers in one group will be given brief advice on stopping smoking and referred to 
smoking cessation services for further advice and support. In the other group intensive 
smoking cessation support will be provided by the dental team. This would involve 4 – 
6 visits to support you in trying to stop smoking and nicotine replacement therapy will 
be offered to anyone who would like to try it. 
  
In both groups a sample of your saliva will be taken to help measure the amount of 
nicotine in your body. You will also be asked to blow into a device which measures the 
carbon monoxide in your breath as this also indicates if you have smoked recently. All 
participants will be contacted one month and three months after they enter the study 
to ask if they are still smoking. This may be done at a regular appointment or by 
telephone. After six months, participants in both groups will have the mouth 
examination, saliva and breath tests, and questionnaires repeated to see if your gum 
health has improved.  
 
NHS Highland operates a scheme whereby people referred for specialist treatment may 
receive help with their travel costs. If you would like to enquire about this please call 
01546 604989 for more information. 
 
Will everyone be asked to do the same things? 
Everyone will have their mouths looked at in same way, and receive the treatment and 
advice they need, but the support to stop smoking offered to the two groups of 
participants will be different.  
 
Will what I say be confidential? 
Yes, all the information about your dental health and smoking habits and everything 
you say will be confidential. What you say will not be passed on to family members or 
anyone else. However, during the study it will be necessary for the research team to 
check the information gathered so that the research is performed to the highest 
possible standard. With your permission, we will inform your GP of your participation in 
this study. 
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Do I have to take part? 
No. It is up to you. If you agree you will sign a consent form showing that you 
understand what is involved and that you have agreed to take part. 
 
Can I change my mind and withdraw at any time? 
Yes. You can withdraw at any time you like without giving a reason and your care from 
dental staff will not be affected. 
 
What’s in it for me? 
We cannot promise the research will help you personally but it may help to improve 
the way dental services tackle gum diseases. If you are a smoker who wants to quit, 
then it offers support in trying to do so. 
 
How do I find out more about the study? 
Ask dental staff at the Mid Argyll and they will pass your questions to the research 
team, or call Karen Emslie on 01546 604989. 
 
Will I find out more about the study? 
When the research is finished a report will be available to anyone interested. Ask 
dental staff for the report if you would like one. 
 
What if there is a problem? 
If you believe you have been harmed in any way by taking part in this study, you have 
the right to pursue a complaint and seek compensation from the University of Dundee 
who are acting as the research sponsor. Details of this are available from the research 
team. 
 
Also as a patient of the NHS you have a right to pursue a complaint through the usual 
NHS process. To do so you can submit a complaint to the: 
 
Complaints Team, NHS Highland, PO Box 57123, Inverness IV1 9AQ  
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Please note that the NHS has no legal liability for non-negligent harm. However, if you 
are harmed and this is due to someone’s negligence, you may have grounds for a legal 
action against NHS Highland but you may have to pay legal costs. 
 
Who has reviewed this study? 
The Fife & Forth Valley Research Ethics Committee, which has responsibility for 
scrutinising proposals for medical research on humans, has examined this proposal and 
has raised no objections from the point of view of medical ethics. It is a requirement 
that your records in this research be made available for scrutiny by monitors from NHS 
Highland and the University of Dundee, whose role it is to check that research is 
properly conducted and the interests of those taking part are adequately protected. 
 
Thank you for taking the time to read this information sheet and for 
considering taking part in this study. 
 
Karen Emslie, Senior Dental Officer, Researcher, Lochgilphead 
 
Ruth Freeman, Professor of Dental Public Health Research, Dental Health Services & 
Research Unit, University of Dundee 
 
Andrew Hall, Honorary Consultant in Restorative Dentistry, Dundee Dental Hospital 
and School, University of Dundee 
 
John Herrick, Clinical Dental Director, Argyll & Bute CHP, NHS Highland 
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Appendix 6: Consent form, Version 1.3, 07/09/10 
 
 
PHaSCe 
Periodontal Health and Smoking Cessation 
 
WRITTEN CONSENT FORM: Periodontal Health and Smoking Cessation 
 
Participant number:   
 
PLEASE INITIAL ALL BOXES AND SIGN YOUR NAME TO CONFIRM THAT: 
 
I have read and understand the information sheet Version 1.3, 07/09/10: 
Please initial box   
 
The researcher has explained to me what is involved in the study: 
Please initial box  
 
I have had the chance to ask questions about the study: 
Please initial box   
 
I understand that my teeth, gums and mouth will be examined: 
Please initial box   
 
I understand that I will be asked to provide a sample of saliva and breathe into a 
measuring device: 
Please initial box   
 
I understand that I can withdraw from the study at any time and for any reason and 
that this will not affect the care I receive from dental staff: 
Please initial box   
 
I understand that the research records in this study will be made available to monitors 
from NHS Highland and the University of Dundee: 
Please initial box   
 
I agree to my GP being informed of my participation in this study: 
Please initial box   
 
I agree to take part in the study: 
Please initial box   
 
Name of participant: _________________________ 
 
Signature of participant: ______________________  Date: _______ 
(please note that participants must date their own signature) 
Name of researcher: _________________________ 
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Appendix 7 
 
PROTOCOL FOR THE SUPPLY OF NICOTINE REPLACEMENT THERAPY PRODUCTS 
 
Clinical indication to which this Direction applies  
Definition of situation/condition  As an aid to treating tobacco dependence in clients participating 
in a research project among registered adult dental patients 
who attend the dental department of the Mid Argyll Community 
Hospital and Integrated Care Centre (MACHICC). Clients 
should be motivated, and be prepared to set a quit date and to 
attend regularly for review and support.  
Research protocol criteria for 
inclusion 
Aged 18 years or over 
Registered dental patients at MACHICC 
Dentate 
Capable of giving informed consent to participate 
Want to participate 
 
Research protocol criteria for 
exclusion 
Receiving stop smoking support elsewhere 
Diabetic patient 
Fulminating immune deficiency illness patient 
Terminally ill 
Taking medication known to affect periodontal health. 
Pregnant or breastfeeding 
NRT- related Clinical criteria for 
inclusion  
Tobacco users aged 18 years and over identified as sufficiently 
dependent and motivated to quit.  
Extremely motivated clients requiring combination NRT therapy 
to sustain their quit attempts.  
Extremely motivated clients requiring intermittent type NRT for 
up to 6 months to sustain a quit attempt, in keeping with 
individual product licence  
NRT – related Clinical criteria for 
exclusion  
Myocardial infarction (MI) or cerebrovascular accident (CVA) 
within the past 4 weeks  
Unstable cardiac condition for which client is attending a 
clinician or is awaiting cardiac investigations  
Severe cardiac dysrhythmia  
Moderate to severe hepatic impairment  
Moderate to severe renal impairment  
Clients on clozapine presenting with unstable mental health.  
Clients who are pregnant or breastfeeding as they are excluded 
form this research project and will be referred to a specialist 
stop smoking midwife.  
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NRT – related non – clinical criteria 
for exclusion  
Tobacco users not sufficiently motivated to quit  
Clients less than 12 years old  
Clients who have received NRT, varenicline or bupropion as 
part of a quit attempt supported by an NHS Highland organised 
stop smoking service within the previous six months, save in 
exceptional circumstances.  
Clients who have twice in the last twelve months received NRT, 
varenicline or bupropion as part of a quit attempt supported by 
an NHS Highland organised stop smoking service, save in the 
most exceptional circumstances e.g. hospitalisation for serious 
illness.  
 
In this context ‘an NHS Highland organised stop smoking 
service’ includes quit attempts through the NHS Highland Stop 
Smoking Service, the Community Pharmacy Stop Smoking 
Service, or the client’s general practice.  
Action if excluded from treatment 
for clinical reasons  
The client will be withdrawn from the research project and an 
appointment arranged for them to attend NHS Highland 
Specialist Stop Smoking Services, a specialist stop smoking 
midwife or their general medical practitioner. 
  
Characteristics of staff authorised to take responsibility for the supply or administration of 
medicines under this Protocol 
Qualifications 
 
 
 
 
 
 
 
 
 
The practitioner has undergone an NHS 
Highland approved training course in 
motivational support for stopping smoking i.e. 
Glasgow Caledonian University smoking 
cessation accredited course.  
 
The practitioner, a dental therapist, belongs to 
one of the groups authorised to apply a PGD 
as described in NHS HDL (2001)7 and is 
currently registered with the General Dental 
Council, Registration Number: 1032  
 
Additional requirements, specialist qualifications, 
training, experience and competence necessary  
The practitioner will apply her stop smoking 
skills regularly, ensure she keeps up to date 
with the best practice in the field of smoking 
cessation, and record her participation in 
relevant educational activities her continuing 
professional development portfolio. This 
portfolio will be reviewed at least annually with 
the Argyll & Bute CHP Lead Smoking 
Cessation Adviser.  
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Description of treatments available under this Protocol 
Name of 
medicine  
Pharmaceutical 
form & strength  
Legal status  
Nicotine in the form of  
 
Patches 
 
 16 hour patch: 5mg, 10mg, 15mg and 25mg  
 24 hour patch: 7mg, 14mg and 21mg  
It is recommended that high dose patches be provided for the first 6-8 weeks 
post-quit, medium dose for the following 2 weeks and low dose for a further 2 
weeks 
 
Inhalator 
 
 inhalator: 10mg/cartridge  
It is recommended that it is used whenever a craving occurs up to a 
maximum of 12 cartridges /day. Cut down after 6-12 weeks. 
 
Nasal spray 
 
            nasal spray: 500 micrograms/metered spray, 1 dose = 2 sprays  
It is recommended that for the first 8 weeks use one spray in each nostril up 
to twice every hour for 16 hours – maximum 64 sprays/day. Cut down to one 
spray in only one nostril after 8 weeks 
 
Gum 
 
 gum: 2mg and 4mg 
It is recommended that if smoke <20 cigarettes/day use 2mg gum, and if 
smoke 20 or more use 4mg gum (can also use 4mg gum if find need more 
than 15 pieces 2mg/day). Maximum dose 15 pieces of 4mg gum/day. Try to 
cut down after 12 weeks.  
 
Lozenges 
 
 lozenges: 1mg, 1.5mg, 2mg, 4mg  
It is recommended that if smoke < 20 cigarettes/day use low strength 
lozenges and higher strength if smoke 20 or more. One lozenge to be taken 
every 1-2 hours. Maximum 15 lozenges/day. Cut down after 6-12 weeks. 
 
Sublingual tablets 
 
 sublingual tablet: 2mg  
It is recommended that if smoke < 20 cigarettes/day use one tablet every 
hour, 2 tablets every hour if smoke 20 or more. Maximum 40/day. Cut down 
after 12 weeks. 
 
All NRT products within this Protocol are General Sales List items  
Dose  
Route/method of 
administration  
Frequency of 
dose  
In accordance with each client's needs and the instructions in the most recent 
British National Formulary.  
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Duration of 
treatment  
Follow up 
treatment  
 
• Routinely:  
 Up to 12 weeks supply of NRT. NRT will be supplied on a weekly basis for 
the first four weeks. For sessions 6 to 13 (quit weeks 4 – 11) clients may 
be given 1 or 2 weeks supply at the discretion of the adviser (Annex 1)  
 
• Exceptionally:  
 Some extremely motivated highly dependent clients require therapy for 
longer than 12 weeks to sustain a quit attempt. This protocol allows these 
clients to receive intermittent types of NRT for a further 3 month period in 
accordance with the individual product licence, up to an overall maximum of 
25 weeks NRT supply per quit attempt. It is essential that these clients are 
re-assessed weekly and after the initial twelve weeks are only given 1 
week’s supply at a time (Annex 1).  
 
 Some highly motivated clients who have demonstrated their commitment to 
their quit attempts will experience extreme withdrawal symptoms which 
are assessed as having a high probability of causing relapse. These 
clients will need a combination of NRT therapies (i.e. patch + an 
intermittent type NRT) in order to sustain their attempts. Such 
combination therapy will be provided in the first three months of their quit 
attempts for periods depending on each client's assessed need. A 
condition of combination therapy is that clients attend weekly for review 
and specialist support.  
 
Advice to be 
given to client 
Specific advice on use of their chosen NRT product as per latest version of the BNF 
 
General advice on: 
 
Side-effects, emphasising that these are usually transient 
Withdrawal symptoms 
Possible changes in metabolic rate e.g. weight gain, and how to manage this 
Avoid smoking while using NRT to avoid the risks of excess nicotine dose 
Give product information and self-help leaflets 
How to access further supply of NRT 
Consent The practitioner must ensure that the client reads and signs the Client Information 
Record (Appendix 5) which indicates consent to treatment. 
 
Separate consent to participation in the research project will have been obtained by 
the researcher prior to their appointment with the dental therapist. 
Identifying and 
managing 
possible adverse 
reactions 
The practitioner using this protocol must check the client’s medical history at each 
visit to ensure that they are suitable for receipt of NRT. 
 
General side-effects from NRT: 
These are mostly transient. 
More common side-effects are: 
 Gastro-intestinal disturbances (including nausea, vomiting, dyspepsia) 
 Headache 
 Dizziness 
 Influenza-like symptoms 
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 Dry mouth 
 Rash 
Less frequently:  
 Palpitation 
 
Rarely:  
 Atrial fibrillation 
 
Nasal spray: 
Sneezing  
Epistaxis 
Watering eyes 
Ear sensations 
 
Lozenges: 
Thirst 
Parasthesia of mouth 
Taste disturbance 
 
Patches: 
Skin reactions 
Vasculitis 
Blood pressure changes 
 
Patches or lozenges: 
Sleep disturbances 
Nightmares 
Chest pain 
 
Gum or lozenges: 
Mouth ulceration 
Increased salivation 
 
Gum, lozenges, sublingual lozenges, inhalator: 
Hiccups 
Throat irritation 
 
Other side-effects: 
Some of the above listed effects may also be a consequence of stopping smoking 
rather than NRT use. Others include cold-like symptoms, insomnia, vivid dreams, 
myalgia, anxiety, irritability, sleepiness, poor concentration, dysmenorrhoea, jaw 
pain. 
 
Management of specific reactions 
Skin reactions when using patches: 
This may be due to hypersensitivity to the adhesive and changing to another brand 
nay help. Otherwise client should be changed to another form of NRT. 
 
Gastrointestinal upset, jaw pain or hiccups when using gum or lozenges: 
This is due to a high proportion of the nicotine being swallowed because of poor 
technique. Reinforce advice on technique or change to an alternative NRT product. 
 
Nasal irritation, sneezing, watering eyes and throat irritation when using the nasal 
spray: 
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This usually declines after the first few days of treatment. Clients should be advised 
to use caution when driving or operating machinery if affected. 
 
If it is felt that NRT has influenced the effects of other medication, refer client 
to their GMP 
Facilities and 
supplies 
Provision has been made for the safe storage of NRT products in a locked 
cupboard within the dental surgery. 
 
The following labels will be affixed to the NRT product(s) provided to the clients: 
 
 
Details of 
treatment records 
required 
The outcome of every consultation and details of any NRT supplied must be 
entered in the Client Information Record (see Appendix 5). 
 
If the practitioner does not feel they have sufficient information to complete the 
Client Information Record then they should seek the information required from the 
client’s general medical practitioner or other source before proceeding to supply 
NRT. 
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Client’s name:…………………………..  Date: __/__/__ 
Periodontal Health & Smoking Cessation Project 
Mid Argyll CHICC 
Blarbuie Road 
Lochgilphead 
PA31 8LB 
Tel: 07917 040253 
 
KEEP OUT OF REACH OF CHILDREN 
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Annex 1 
Flow Chart 1: Routine quit and quit extending beyond 12 weeks  
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Appendix 8: Scottish Government Minimum Dataset 
 
HIGHLAND SMOKING CESSATION RECORD 
CLIENT INFORMATION RECORD 
 
CHI number  Clinic Location  
CHP      
Advisor’s Name  Advisor’s Tel No  
Title  Client Name  
Address  
 Post code  
Tel No (home)  Mobile  
    
DOB     
    
Gender Male        Female  
Pregnant at quit date? Yes     No  
Ethnic Origin  
A. Asian, Asian Scottish or  
Asian British 
B. Mixed C. Chinese D. . Black, Black 
Scottish or Black 
British 
E. White 
Indian 
Pakistani  
Bangladeshi 
Any other Asian background 
please specify: 
 
White & Black Caribbean 
White & Black African  
Any other mixed 
background please specify: 
 Caribbean 
African  
Any other Black  
background please 
specify: 
 
 
Scottish 
Other British  
Irish 
Any other white 
background please 
specify: 
 
Any other background:    
Employment Status  
In paid employment  Full time student  Unemployed  Homemaker/full time parent  
Retired  Permanently sick or disabled  Not known/missing information  
Other (please specify)   
   
Tobacco Use 
How soon after you wake up do you smoke your first cigarette? 
 Less than 5 mins  6-30 mins  31-60 mins  over 60 mins  Unknown 
How many cigarettes do you smoke per day?    
10 or less  11-20  21-30  over 30  Unknown 
How easy or difficult would you find it to go without smoking for a whole day? 
Very easy  Fairly easy  Fairly difficult  Very difficult  Unknown 
Any quit attempts in the last year? None  1  2 or 3  4 or more  Unknown  
Quit Date  Tick here if contact ended without setting quit date       
Consent 
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The Highland Smoking Cessation Service has been fully explained to me. I am aware that details from this form will be passed on to 
my GP and NHS Highland. Anonymised data will contribute to national monitoring of smoking cessation activity. I may be contacted 
within the next 12 months to answer questions about quitting smoking and the service I have received while quitting. 
I agree to be contacted in future in connection with my smoking (at 1, 3 and 12 months after quitting)    
I agree to my doctor being contacted regarding my treatment and progress with giving up smoking     
Client’s signature  Date:  
Follow Up Information  
1 Month follow up  
Was the client contacted for 1 month follow-up? Yes – Date information collected:  
No  Lost to follow-up no consent to follow-up  Died  
Has the client smoked at all (even a puff) in the last 2 weeks? 
Yes            Date of last 
cigarette: 
 No   (please conduct 3 and 12 month follow-up) Not known 
Does carbon monoxide reading confirm quit?    
Yes  ppm No    Not taken  Unknown  
Interventions used in this quit attempt: 
Group support 
One to one sessions 
Both group and one to one 
sessions  
Pharmacy scheme including support  
Buddy Scheme  
Telephone Support  
Relapse prevention 
Couple/family based support 
Not known/missing info 
Other (please specify)    
Pharmaceutical Usage 
NRT only  Bupropion  
Varenicline  
Both NRT and Bupropion          Neither        Unknown  
Date Smoking 
Status 
CO 
Reading 
Assessment 
    
Signature  
  
   Visit 1 
Signature  
  
   Visit 2 
Signature  
  
   Visit 3 
Signature  
  
   Visit 4 
Signature  
   Visit 
Signature  
Key      S = Smoker        HAP= had a Puff         NS = Non smoker        
Working with you to make Highland the healthy place to be
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Appendix 9: East of Scotland Research Ethics Committee Decision 
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Appendix 9: East of Scotland Research Ethics Committee Decision continued 
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Appendix 9: East of Scotland Research Ethics Committee Decision continued 
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Appendix 10: NHS Highland Research & Development Committee Decision 
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Appendix 10: NHS Highland Research & Development Committee Decision 
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Appendix 11: Exclusion criteria checklist 
 
 
Study no.  
 
Author(s) 
 
 
 
 
Title 
 
 
 
 
Publication 
 
 
 
 Yes No 
 
Article presenting original research? 
 
  
 
Study design is cross-sectional population, cohort or randomised 
controlled trial? 
  
 
Study includes a dental component 
 
  
 
Study related to tobacco use prevalence or cessation 
 
  
 
Study included? 
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Appendix 12: Initial Analysis of Papers for Inclusion – all databases 
 Article Authors Journal & Date Accepted Exclusion criteria 
1. Evaluation of educational material for tobacco prevention 
and cessation used in West Virginia University dental 
programs 
Wiener, R.C. & Wiener Pia, R.M. Journal of Dental 
Hygiene 2011 Summer 
85(3):204-210 
Yes Educational intervention of 
tobacco prevention materials 
2 Tobacco cessation efforts in dentistry: a rural state study Morgan, S., Gonzalez, E., Hunter, 
E. & Ha, K.H. 
General Dentistry 
2011May-Jun 
59(3):126-130 
Yes Cross-sectional survey of 
attitudes and current practice 
3. Self-reported tobacco use, knowledge on tobacco legislation 
and tobacco hazards among adolescents in rural Kerala 
State 
Jayakrishnan, R., Geetha, S., 
Binukumar, B. & Lekshmi, K. 
Indian Journal of 
Dental Research 2011 
Mar-Apr 22(2):195-199 
Yes Survey of knowledge, attitudes 
and behaviours 
4. Smokeless tobacco cessation cluster randomized trial with 
rural high school males: intervention interaction with 
baseline smoking 
 
Walsh, M.M.,  Langer, T.J. , 
Kavanagh, N.,  Mansell, C.,  
MacDougal, W.,  Kavanagh, C.  & 
Gansky, S.A.  
Nicotine & Tobacco 
Research.  2010 Jun 
12(6):543-550  
 
Yes RCT – smokeless tobacco 
cessation intervention 
5. The challenge of delivering oral health services in rural 
America 
Skillman, S.M., Doescher, M.P., 
Mouradian, W.E. & Brunson, D.K. 
Journal of Public 
Health Dentistry 2010 
Jun 70(Suppl 1):49-57 
 
No Review including smoking 
cessation. All articles cited 
assessed for inclusion 
6. An Internet-based abstinence reinforcement smoking 
cessation intervention in rural smokers 
Stoops,W., Dallery, J., Fields, N., 
Nuzzo, P., Schoenberg, N., Martin, 
C., Casey, B. & Wong, C. 
Drug & Alcohol 
Dependence.  2009  
105(1-2): 56-62 
No No dental component 
7. Periodontitis associated with tobacco smoking among rural 
Khon Kaen Thai males: analysis of two studies 
Chatrchaiwiwatana, S. & 
Ratanasirii, A. 
Journal of the Medical 
Association of Thailand 
2009 Nov 92(11):1524-
1531 
Yes Survey – prevalence of 
periodontitis and smoking 
8. The role of the dental team in preventing and diagnosing 
cancer: 4. Risk factor reduction: tobacco cessation 
Scully, C. & Warnakulasuriya, S. Dental Update 2005 
Sep 32(7):394-396, 
399-401 
No Review article. All articles cited 
assessed for inclusion 
9. Tobacco consumption among adolescents in rural Wardha: 
where and how tobacco control should focus its attention? 
Dongre, A., Deshmukh, P., Murali, 
N. & Garg, B. 
Indian Journal of 
Cancer 2008 Jul-Sep 
45(3):100-106 
Yes Survey – prevalence of 
tobacco use 
10. Is maternal smoking during early pregnancy a risk factor for 
all low birth weight infants? 
Suzuki, K., Tanaka, T., Kondo, N., 
Minai. J., Sato, M. & Yamagata, Z. 
Journal of 
Epidemiology 2008 
18(3): 89-96 
No Cohort study - no dental 
component 
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Appendix 12:  Initial Analysis of Papers for Inclusion – all databases continued 
 Article Authors Journal & Date Accepted Exclusion criteria 
11. Variability of healthcare practitioner intervention among 18- 
24-year-old tobacco users 
Zanis, D., Derr, D., Holim, R. & 
Ibrahim, J. 
Journal of Adolescent 
Health 2008 Jun 
42(6):634-636 
Yes Survey – includes dental 
smoking cessation activity 
12. Prevalence and determinants of tobacco use in a highly 
literate rural community in southern India 
Daniel, A., Nagaraj, K. & Kamath, 
R. 
The National Medical 
Journal of India 2008 
Jul-Aug 21(4):163-165 
Yes Survey – prevalence of 
tobacco use 
13. Tobacco use, cessation advice to patients and attitudes to 
tobacco control among physicians in Ukraine 
Squier, C., Hesli, V., Lowe, J., 
Ponamorenko, V. & 
Medvedovskaya, N. 
European Journal of 
Cancer Prevention 
2006 Oct 15(5):458-
463 
Yes Survey – healthcare workers 
knowledge attitudes and 
behaviours 
14. Characteristics of adolescent smoking in high school 
students in California 
Ellison, J., Mansell, C., Hoika, L., 
MacDougall, W., Gansky, S. & 
Walsh, M. 
Journal of Dental 
Hygiene 2006 Spring 
80(2):8 
Yes Survey – knowledge attitudes 
and tobacco use behaviours 
15. A rural school-based oral health program Jenkins, S. & Geurink, K. Journal of Dental 
Hygiene 2006 Jan 
80(1):26 
Yes Educational intervention 
including tobacco cessation 
16. Development and evaluation of a tobacco cessation 
motivational program for adolescents based on physical 
attractiveness and oral health 
Semer, N., Ellison, J., Mansell, C., 
Hoika, L., Macdougall, W., Gansky, 
S. & Walsh, M. 
Journal of Dental 
Hygiene 2005 Fall 
79(4):9 
Yes Educational intervention 
including tobacco cessation 
17. Tobacco, oral cancer, and treatment of dependence Warnakulasuriya, S., Sutherland,G. 
& Scully, C.  
Oral Oncology 2005 
Mar 41(3):244-260 
No Review. All articles cited 
assessed for inclusion 
18. Bidi smokers at increased risk of oral cancer Warnakulasuriya, S. Evidence-Based 
Dentistry 2005 6(1):19 
No Review. All articles cited 
assessed for inclusion 
19. Some risk factors for periodontal bone loss in 50-year-old 
individuals A 10-year cohort study 
Paulander, J., Wennstrom, J., 
Axelsson, P. & Lindhe, J. 
Journal of Clinical 
Periodontology.  2004  
31: 489-496 
 
Yes Cohort study of periodontal risk 
factors 
20.  [A trial of smoking rate survey using the coming-of-age 
ceremony for evaluating action plans to prevent tobacco use 
in the young] 
Seki, N., Sekijima, K., Tanabe, N. 
& Suzuki, H. 
Japanese Journal of 
Public Health 2004 Apr 
51(4):252-156 
Yes Survey of prevalence of 
tobacco use 
21. Smoking cessation services provided by dental 
professionals in a rural Ontario health unit 
Brothwell, D. & Armstrong, K. Journal of the 
Canadian Dental 
Association 2004 Feb 
70(2):94-98 
Yes Survey – healthcare workers 
knowledge attitudes and 
behaviours 
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Appendix 12:  Initial Analysis of Papers for Inclusion – all databases continued 
 Article Authors Journal & Date Accepted Exclusion criteria 
22. Smoking as a risk indicator for periodontal disease in the 
middle-aged Vietnamese population 
Do, G., Spencer, A., Roberts-
Thomson, K. & Ha, H. 
Community Dentistry 
& Oral Epidemiology 
2003 Dec 31(6):137-
446 
Yes Cross-sectional study 
of periodontal health and 
smoking 
23. Spit (Smokeless) Tobacco Intervention for High School 
Athletes: results after 1 year 
 
Walsh, M.,  Hilton, J.,  Ellison, J.,  
Gee, L.,  Chesney, M., Tomar, S. & 
Ernster, V. 
Addictive Behaviors  
2003 Aug 28(6):1095-
1113  
Yes RCT – smokeless tobacco 
intervention 
24. Oral screening and brief spit tobacco cessation counseling: 
a review and findings 
 
Gansky, S.,  Ellison, J.,  Kavanagh, 
C.,  Hilton, J. & Walsh, M.  
Journal of Dental 
Education 2002 Sep  
66(9):1088-1098 
Yes RCT – smokeless tobacco 
intervention 
25. Spit tobacco cessation counselling: statewide survey of 
health-care professionals and educators  
 
Prokhorov, A., Wetter, D., Padgett, 
D., De, M., Le, T. & Kitzman, H. 
Substance Use & 
Misuse 2002 Jan 
37(2):171-197 
Yes Survey – healthcare workers 
knowledge attitudes and 
behaviours 
26. Tobacco counselling practices of dentists compared to other 
health care providers in a Midwestern region 
Block, D., Block, L., Hutton, S. & 
Johnson, K. 
Journal of Dental 
Education 1999 Nov 
63(11):821-827 
Yes Survey – healthcare workers 
knowledge attitudes and 
behaviours 
27. Patient perceptions of tobacco cessation services in dental 
offices.  
 
Campbell, H., Sletten, M. & Petty T.  
 
Journal of the 
American Dental 
Association  1999 
Feb 130(2):219-226 
Yes RCT – smoking cessation in 
dental setting intervention 
28. Assessing the readiness of dentists’ offices to adopt tobacco 
cessation activities 
Jennett, P., Henry, S., Campbell, 
S., Simpson, L. & Husack, J. 
Journal of Continuing 
Education in the 
Health Professions 
1998 Spring 
18(2):119-127 
Yes Survey – healthcare workers 
knowledge attitudes and 
behaviours 
29. Tobacco education for adolescents in Mississippi. A pilot 
project 
DeMoss, L., Crews, K., Silberman, 
S., Meydrech, E. & Akin, R. 
Mississippi Dental 
Association Journal 
1997 Spring 53(1):21-
23 
Yes Pilot educational intervention 
30. Prevalence of smoking among adult American Indian clinic 
users in northern California 
Hodge, F., Cummings, S., 
Fredericks, L., Kipnis, P., Williams, 
M.& Teehee, K. 
Preventive medicine 
1995 Sep 24(5):441-
446 
Yes Survey of smoking prevalence 
31. Effect of cessation of tobacco use on the incidence of oral 
mucosal lesions in a 10-yr follow-up study of 12,212 users 
Gupta, P., Murti, P., Bhonsie, R., 
Mehta, F. & Pindborg, J. 
Oral Diseases 1995 
Mar 1(1):54-58 
Yes Cohort study - tobacco 
cessation and oral health 
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Appendix 12:  Initial Analysis of Papers for Inclusion – all databases continued 
 Article Authors Journal & Date Accepted Exclusion criteria 
32. Prevalence, patterns and correlates of spit tobacco 
in a college athlete population 
Walsh, M., Hilton, J., Ernster, V., 
Masouredis, C. & Grady, D. 
Addictive Behaviors 1994 Jul-
Aug 19(4):411-427 
Yes Survey of prevalence and 
current practice 
33. The effect of training on the use of tobacco-use 
cessation guidelines in dental settings 
Walsh, M., Belek, M., Prakash, P., Grimes, 
B., Heckman, B., Kaufman, N., Meckstroth, 
R., Kavanagh, C., Murray, J., Weintraub, J., 
Silverstein, S. & Gansky, S. 
Journal of the American 
Dental Association. 2012 
143(6):602-613  
Yes Educational intervention 
34. Challenges in global improvement of oral cancer 
outcomes: findings from rural Northern India 
Dangi, J., Kinnunen, T. & Zavras, A. Tobacco Induced Diseases. 
2012 10(5):1-5  
Yes Cross-sectional 
screening and survey 
35. Prevalence and prevention of hypertension, 
diabetes mellitus and coronary artery disease in 
India 
Singh,R., Singh, N., Vajpeyee, S., Alam, S., 
Tripathi, K., Srivastav, R., Rastogi, S., 
Goyal, R., Yeolekar, M., Sainanai, G., 
Shantaram, V., Pella, D., De Meester, F., 
Basu, T. & Ozimek, L. 
World Heart Journal. 2010 
3(1):31-43 
No No dental component 
36. Oral Cancer Knowledge among Patients referred to 
Mashad Dental School, Iran 
Pakfetrat, A., Falaki, F., Esmaily, H. & 
Shabestari, S. 
Archives of Iranian Medicine 
2010 13(6): 543-548 
Yes Survey of oral health and 
tobacco knowledge 
37.  HIV and smoking in India Ramesh Kumar, S., Swaminathan, S., 
Flanigan, T., Mayer, K. & Niaura, R. 
Indian Journal of Medical 
Research. 2009 130:15-22 
No No dental component 
38. Oral health behaviour patterns among Tanzanian 
university students: a repeat cross-sectional study 
Astrom, A. & Masalu, J. BMC Oral Health. 2001 1(2) Yes Cross-sectional study 
including tobacco use 
39. Toombak use and cigarette smoking in the Sudan: 
Estimates of prevalence in the Nile State 
Idris, A. Ibrahim, Y., Warnakulasuriya, K., 
Cooper, D., Johnson, N. & Nilsen, R. 
Preventive Medicine. 1998 
27(4):597-603  
Yes Survey of tobacco use 
prevalence 
40. A process evaluation of a two-year community 
cardiovascular risk reduction program: what was 
done and who knew about it? 
Norman, S., Greenberg, R., Marconi, K., 
Novelli, W., Felix, M., Schechter, C., Stolley, 
P. & Stunkard, A. 
Health Education Research 
1990 Mar 5(1):87-97 
Yes Educational intervention 
partially delivered by 
dentists 
41. A primary prevention study of oral cancer among 
Indian villagers. Eight-year follow-up results 
Gupta, P., Mehta, F.,  Pindborg, J., Daftary, 
D., Aghi, M.,  Bhonsie, R. & Murti, P. 
IARC Scientific Publications 
1990 103:149-156 
Yes Cohort study – risk 
factors for oral cancer 
42. Smokeless Tobacco Cessation Intervention for 
College Athletes: Results After 1 Year 
Walsh, M., Hilton, J., Masouredis, C., Gee, 
L., Chesney, M. & Ernster, V. 
American Journal of Public 
Health 1999 Feb 89(2): 228-
234 
Yes RCT – smokeless 
tobacco intervention 
43. Cluster-Randomized Controlled Trial of An Athletic 
Trainer-Directed Spit (Smokeless) Tobacco 
Intervention for Collegiate Baseball Athletes: 
Results After 1 Year 
Gansky, S., Ellison, J., Rudy, D., Begert, N., 
Letendre, M., Nelson, L., Kavanagh, C. & 
Walsh, M. 
Journal of Athletic Training 
2005 40(2): 76-87 
Yes RCT – smokeless 
tobacco intervention 
  
332 
Appendix 13: Data extraction checklist 
 
Study no. 
Section 1 
Author(s)  
Title  
Publication  
Dates of data 
extraction 
 
Country  
Study design  
Population 
characteristics 
 
Care setting  
Exclusion 
criteria 
 
Method of 
randomisation 
 
Interventions  
Outcomes  
Section 2 
Length of 
follow-up 
 
Drop-outs in 
control and 
intervention 
groups 
 
Continuous or 
point 
abstinence 
 
Verification of 
abstinence 
 
Missing data  
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Appendix 14: STROBE Checklist  
STROBE Statement—checklist of items that should be included in reports of 
observational studies 
 
 
Item 
No Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the 
title or the abstract 
(b) Provide in the abstract an informative and balanced summary of 
what was done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation 
being reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods 
of recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and 
methods of selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources 
and methods of case ascertainment and control selection. Give the 
rationale for the choice of cases and controls 
Cross-sectional study—Give the eligibility criteria, and the sources 
and methods of selection of participants 
(b) Cohort study—For matched studies, give matching criteria and 
number of exposed and unexposed 
Case-control study—For matched studies, give matching criteria 
and the number of controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if 
applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of 
methods of assessment (measurement). Describe comparability of 
assessment methods if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control 
for confounding 
(b) Describe any methods used to examine subgroups and 
interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was 
addressed 
Case-control study—If applicable, explain how matching of cases 
and controls was addressed 
Cross-sectional study—If applicable, describe analytical methods 
taking account of sampling strategy 
(e) Describe any sensitivity analyses 
Continued on next page
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Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers 
potentially eligible, examined for eligibility, confirmed eligible, included in 
the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, clinical, social) 
and information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of 
interest 
(c) Cohort study—Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over 
time 
Case-control study—Report numbers in each exposure category, or summary 
measures of exposure 
Cross-sectional study—Report numbers of outcome events or summary 
measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (eg, 95% confidence interval). Make clear which 
confounders were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk 
for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias 
or imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and other 
relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study 
and, if applicable, for the original study on which the present article is based 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for 
exposed and unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological 
background and published examples of transparent reporting. The STROBE checklist is best used in 
conjunction with this article (freely available on the Web sites of PLoS Medicine at 
http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and 
Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at 
www.strobe-statement.org. 
 
 
 
 
  
335 
Appendix 15: CONSORT checklist 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported on 
page No 
Title and abstract 
 1a Identification as a randomised trial in the title  
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts)  
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale  
2b Specific objectives or hypotheses  
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio  
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons  
Participants 4a Eligibility criteria for participants  
4b Settings and locations where the data were collected  
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were actually 
administered 
 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed  
6b Any changes to trial outcomes after the trial commenced, with reasons  
Sample size 7a How sample size was determined  
7b When applicable, explanation of any interim analyses and stopping guidelines  
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence  
8b Type of randomisation; details of any restriction (such as blocking and block size)  
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), describing 
any steps taken to conceal the sequence until interventions were assigned 
 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions  
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Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those assessing 
outcomes) and how 
 
11b If relevant, description of the similarity of interventions  
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes  
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses  
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and were 
analysed for the primary outcome 
 
13b For each group, losses and exclusions after randomisation, together with reasons  
Recruitment 14a Dates defining the periods of recruitment and follow-up  
14b Why the trial ended or was stopped  
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group  
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was by original 
assigned groups 
 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 
95% confidence interval) 
 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended  
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing pre-specified 
from exploratory 
 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms)  
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses  
Generalisability 21 Generalisability (external validity, applicability) of the trial findings  
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence  
Other information 
 
Registration 23 Registration number and name of trial registry  
Protocol 24 Where the full trial protocol can be accessed, if available  
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders  
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If 
relevant, we also recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal 
interventions  
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Appendix 16:  Summary of STROBE checklist data 
  Quality assessment 
Article & authors Year & location Participant 
eligibility criteria 
described 
Study size & 
methodology 
described 
Potential 
sources of bias 
acknowledged 
Limitations 
acknowledged 
Statistical 
methods 
described 
Weiner and Weiner [1] 2011 
West Virginia, USA 
Yes Yes No No Yes 
Morgan et al. [2] 2011 
West Virginia, USA 
Yes Yes Yes No No 
Jayakrishnan et al. [3] 2011 
Kerala, India 
Yes Yes Yes Yes Yes 
Chatrchaiwiwatana  and Ratanasirii 
[7] 
2009 
Khon Kaen, 
Thailand 
Yes Yes Yes No Yes 
Dongre et al. [9] 2008 
Wardha, India 
Yes Yes Yes No Yes 
Zanis et al. [11] 2008 
Pennsylvania, USA 
Yes Yes No Yes Yes 
Daniel et al. [12] 2008 
India 
Yes Yes No Yes Yes 
Squier et al. [13] 2006 
Ukraine 
Yes Yes No Yes Yes 
Ellison et al. [14] 2006 
California, USA 
Yes Yes Yes Yes Yes 
Jenkins and Geurink [15] 2006 
Texas, USA 
Yes Yes No Yes Yes 
Semer et al. [16] 2005 
California, USA 
Yes Yes Yes Yes Yes 
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Appendix 16:  Summary of STROBE checklist data continued 
  Quality assessment 
Article & authors Year & location Participant 
eligibility criteria 
described 
Study size & 
methodology 
described 
Potential sources 
of bias 
acknowledged 
Limitations 
acknowledged 
Statistical 
methods 
described 
Paulander et al. [19] 2004 
Varmland, Sweden 
Yes Yes Yes Yes Yes 
Seki et al. [20] 2004 
Japan 
Yes Yes No No Yes 
Brothwell and Armstrong [21] 2004 
Ontario, Canada 
Yes Yes Yes Yes Yes 
Do et al. [22] 2003 
Vietnam 
Yes Yes Yes Yes Yes 
Prokhorov et al.[25] 2002 
Texas, USA 
Yes Yes No No No 
Block et al. [26] 1999 
Midwest, USA 
Yes Yes No No Yes 
Jennett et al. [28] 1998 
Calgary, Canada 
Yes Yes No Yes Yes 
DeMoss et al. [29] 1997 
Mississippi, USA 
Yes Yes Yes Yes No 
Hodge et al. [30] 1995 
California, USA 
Yes Yes Yes Yes Yes 
Gupta et al. [31] 1995 
Kerala, India 
Yes Yes No No Yes 
Walsh et al. [32] 1994 
California, USA 
Yes Yes Yes Yes Yes 
Walsh et al. [33] 2012 
California, USA 
Yes Yes Yes Yes Yes 
Dangi et al. [34] 2012 
Northern India 
Yes Yes Yes Yes Yes 
Pakfetrat et al. [36] 2010 
Mashad, Iran 
Yes Yes No No Yes 
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Appendix 16:  Summary of STROBE checklist data continued 
  Quality assessment 
Article & authors Year & location Participant 
eligibility criteria 
described 
Study size & 
methodology 
described 
Potential sources 
of bias 
acknowledged 
Limitations 
acknowledged 
Statistical 
methods 
described 
Idris et al. [39] 1998 
Nile State, Sudan 
Yes Yes Yes Yes Yes 
Norman et al. [40] 1990 
Pennsylvania, USA 
Yes Yes No Yes No 
Gupta et al. [41] 1995 
Kerala, India 
Yes Yes No No Yes 
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Appendix 17: Summary of CONSORT checklist data 
  Walsh et al. 2010 
[4] 
Walsh et al. 2003 
[23] 
Gansky et al. 2002 
[24] 
Walsh et al. 1999 
[42] 
Gansky et al. 2005 
[43] 
Title & abstract 1a Yes No No No Yes 
 1b Yes Yes Yes Yes Yes 
Introduction 2a Yes Yes Yes Yes Yes 
 2b Yes Yes Yes Not specific Yes 
Methods       
Trial design 3a Yes Yes Yes Yes Yes 
 3b Yes Yes Yes Yes Yes 
Participants 4a Yes Yes Yes Yes Yes 
 4b Yes Yes Yes Yes Yes 
Interventions 5 Yes Yes Yes Yes Yes 
Outcomes 6a Yes Yes Yes Yes Yes 
 6b N/A N/A N/A N/A N/A 
Sample size 7a Yes Yes Yes Yes Yes 
 7b N/A N/A N/A N/A N/A 
Randomisation       
Sequence 
generation 
8a No No No No Yes 
 8b No No No No Yes 
Allocation 
concealment 
9 No No No No Yes 
Implementation 10 No No No No No 
Blinding 11a Partially Partially Partially Partially Partially 
 11b N/A N/A N/A N/A N/A 
Statistical methods 12a Yes Yes Yes Yes Yes 
 12b Yes Yes Yes Yes Yes 
Results       
Participant flow 13a Yes – no diagram Yes – no diagram Yes – no diagram Yes – no diagram Yes – no diagram 
 13b Yes Yes Yes Yes Yes 
Recruitment 14a Yes Yes Yes Yes Yes 
 14b N/A N/A N/A N/A N/A 
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Appendix 17: Summary of CONSORT checklist data continued 
  Walsh et al. 2010 
[4] 
Walsh et al. 2003 
[23] 
Gansky et al. 2002 
[24] 
Walsh et al. 1999 
[42] 
Gansky et al. 2005 
[43] 
Baseline data 15 Yes Yes Yes No Yes 
Numbers analysed 16 Yes Yes Yes Yes Yes 
Outcomes and 
estimation 
17a Yes Yes Yes Yes Yes 
 17b Yes Yes Yes Yes Yes 
Ancillary analyses 18 Yes Yes Yes Yes Yes 
Harms 19 N/A N/A N/A N/A N/A 
Discussion       
Limitations 20 Yes Yes Yes Yes Yes 
Generalisability 21 Yes Yes Yes Yes Yes 
Interpretation 22 Yes Yes Yes Yes Yes 
Other information       
Registration 23 Yes No No No No 
Protocol 24 No No No No No 
Funding 25 Yes Yes Yes Yes Yes 
 
 
 
 
 
. 
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Appendix 18 
Table A1: Reported smoking status by reported medical condition 
 Reported smoking status 
Reported medical condition Never 
smoker 
n (%) 
Ex-smoker 
 
n (%) 
Current 
smoker 
n (%) 
X2 
[df] 
P 
Receiving treatment 54 (29.2) 53 (44.5) 36 (38.7) 7.78 
[2] 
0.02 
Taking medication 93 (50.3) 72 (60.5) 51 (54.8) 3.07 
[2] 
0.22 
Angina 7 (3.8) 8 (6.7) 3 (3.2) 1.93 
[2] 
0.38 
Blood pressure problems 33 (17.8) 31 (26.1) 9 (9.7) 9.40 
[2] 
0.01 
Heart attack 1 (0.5) 8 (6.7) 3 (3.2) 9.46 
[2] 
0.01 
Infectious diseases 0 (0.0) 1 (0.8) 4 (4.3) 9.45 
[2] 
0.009 
Lung diseases 18 (9.7) 11 (9.2) 11 (11.8) 0.43 
[2] 
0.81 
Epilepsy 1 (0.5) 0 (0.0) 2 (2.2) 3.43 
[2] 
0.18 
Diabetes 5 (2.7) 9 (7.6) 3 (3.2) 4.50 
[2] 
0.11 
Blood disorder 12 (6.5) 15 (12.6) 12 (12.9) 4.36 
[2] 
0.11 
Allergies 46 (24.9) 28 (23.5) 14 (15.1) 3.64 
[2] 
0.16 
Pregnant 5 (2.7) 1 (0.8) 2 (2.2) 1.28 
[2] 
0.53 
 
Appendix 19 
Table A2: Number of other smokers in house by age group, gender, 
occupational group, location and periodontal status 
 Number of other smokers in house X2 [df] P 
 0 
n (%) 
1 
n (%) 
2 
n (%) 
3 
n (%) 
  
Younger 35 (56.5) 22 (35.5) 3 (4.8) 2 (3.2) 1.44 [3] 
 
0.70 
 Old 16 (53.3) 13 (43.3) 1 (3.3) 0 (0.0) 
Male 18 (48.6) 16 (43.2) 1 (2.7) 2 (5.4 4.31 [3] 
 
0.23 
 Female 33 (60.0) 19 (34.4) 3 (5.5) 0 (0.0) 
Occupation 1 21 (63.3) 10 (30.3) 2 (6.1) 0 (0.0)  
 
4.79 [6] 
 
 
 
0.57 
 
Occupation 2 15 (60.0) 9 (36.0) 1 (4.0) 0 (0.0) 
Occupation 3 3 (33.3) 5 (55.6) 1 (11.1) 0 (0.0) 
Occupation 4 5 (45.5) 6 (54.5) 0 (0.0) 0 (0.0) 
Lochgilphead 31 (55.4) 23 (41.1) 2 (3.6) 0 (0.0) 3.66 [3] 
 
0.30 
 Dunoon 20 (55.6) 12 (33.3) 2 (5.6) 2 (5.6) 
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Appendix 20: Quit attempts by demography 
Table A3: Quit attempts by age group 
Quit attempts Age group X2 [df] P 
 Younger 
(49 years 
or less) 
n (%) 
Older 
(50 years or 
more) 
n (%) 
  
Cut down 26 (41.9) 10 (33.3) 0.63 [1] 0.43 
Tried to quit 17 (27.4) 5 (16.7) 1.29 [1] 0.26 
Quit for at least 24 hours 25 (40.3) 5 (16.7) 5.15 [1] 0.02 
 
Table A4: Quit attempts by gender 
Quit attempts Gender X2 [df] P 
 Male 
n (%) 
Female 
n (%) 
  
Cut down 13 (35.1) 23 (41.8) 0.42 [1] 0.52 
Tried to quit 6 (16.2) 16 (29.1) 2.02 [1] 0.16 
Quit for at least 24 hours 10 (27.0) 20 (36.4) 0.88 [1] 0.35 
 
Table A5: Quit attempts by occupational group 
Quit 
attempts 
Occupational group X2 [df] P 
 1 
n (%) 
2 
n (%) 
3 
n (%) 
4 
n (%) 
  
Cut down 13 (39.4) 9 (36.0) 6 (66.7) 3 (27.3) 3.59 [3] 0.31 
Tried to quit 9 (27.3) 6 (24.0) 3 (33.3) 3 (27.3) 0.30 [3] 0.96 
Quit for at 
least 24 
hours 
 
11 (33.3) 
 
7 (28.0) 
 
4 (44.4) 
 
4 (36.4) 
 
0.87 [3] 
 
0.83 
 
Table A6: Quit attempts by location 
Quit attempts Location X2 [df] P 
 Lochgilphead 
n (%) 
Dunoon 
n (%) 
  
Cut down 21 (37.5) 15 (41.7) 0.16 [1] 0.69 
Tried to quit 15 (26.8) 7 (19.4) 0.65 [1] 0.42 
Quit for at least 24 
hours 
17 (30.4) 13 (36.1) 0.33 [1] 0.57 
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Appendix 21: Intention to quit by age group 
Table A7: Intention to quit: by age group 
Intention to quit Age group X2 [df] P 
 Younger 
(49 years 
or less) 
n (%) 
Older 
(50 years or 
more) 
n (%) 
  
No plans 7 (11.3) 11 (36.7) 9.56 [3] 
 
0.02 
 
 
Not in next 6 months 13 (21.0) 3 (10.0) 
Intend in next 6 months 38 (61.3) 13 (43.3) 
Have set quit date 4 (6.5) 3 (10.0) 
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Appendix 22 
Table A8: Attitudes to smoking cessation activities in a dental setting: by age group, gender, occupational group, location and smoking status 
 Should dentist ask if smoke? Should dentist offer smoking advice? 
 Disagree 
n (%) 
Neither/nor 
n (%) 
Agree 
n (%) 
X2 [df] P Disagree 
n (%) 
Neither/nor 
n (%) 
Agree 
n (%) 
X2 [df] P 
Younger 2 
(1.0%) 
37 
(18.5%) 
161 
(80.5%) 
1.36 [2] 0.51 
 
 
16 
(8.0%) 
43 
(21.5%) 
141 
(70.5%) 
1.14 [2] 
 
0.57 
 
Older 5 
(2.5%) 
35 
(21.0%) 
158 
(79.8%) 
13 
(6.6%) 
36 
(18.2%) 
149 
(75.3%) 
Male 4 
(2.6%) 
25 
(16.1%) 
126 
(81.3%) 
 
1.56 [2] 
 
0.46 
13 
(8.4%) 
24 
(15.5%) 
118 
(76.1%) 
 
3.23 [2] 
 
0.20 
Female 3 
(1.2%) 
47 
(19.3%) 
193 
(79.4%) 
16 
(6.6%) 
55 
(22.6%) 
172 
(70.8%) 
Occupation 1 3 
(3.1%) 
21 
(21.4%) 
74 
(75.5%) 
 
 
 
4.38 [6] 
 
 
 
0.63 
7 
(7.1%) 
28 
(28.6%) 
63 
(64.3%) 
 
 
 
6.81 [6] 
 
 
 
0.34 
Occupation 2 1 
(1.1%) 
15 
(17.0%) 
72 
(81.8%) 
7 
(8.0%) 
21 
(23.9%) 
60 
(68.2%) 
Occupation 3 0 
(0%) 
17 
(17.9%) 
78 
(82.1%) 
6 
(6.3%) 
16 
(16.8%) 
73 
76.8%) 
Occupation 4 1 
(1.9%) 
8 
(15.4%) 
43 
(82.7%) 
4 
(7.7%) 
7 
(13.5%) 
41 
(78.8%) 
Lochgilphead 6 
(2.0%) 
61 
(20.3%) 
234 
(77.7%) 
 
4.51 [2] 
 
0.11 
24 
(8.0%) 
63 
(20.9%) 
214 
(71.1%) 
 
2.06 [2] 
 
0.36 
Dunoon 1 
(1.0%) 
11 
(11.3%) 
85 
(87.6%) 
5 
(5.2%) 
16 
(16.5%) 
76 
(78.4%) 
Never smoker 1 
(0.5%) 
36 
(19.5%) 
148 
(80.0%) 
 
 
5.37 [4] 
 
 
0.25 
8 
4.3%) 
36 
(19.5%) 
141 
(76.2%) 
 
 
17.29 
[4] 
 
 
<0.001 Ex-smoker 2 
(1.7%) 
20 
(16.8%) 
97 
(81.5%) 
9 
(7.6%) 
15 
(12.6%) 
95 
(79.8%) 
Smoker 
 
4 
(4.3%) 
16 
(17.2%) 
73 
(78.5%) 
12 
(12.9%) 
27 
(29.0%) 
54 
(58.1%) 
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Table A8: Attitudes to smoking cessation activities in a dental setting: by age group, gender, occupational group, location and smoking status 
continued 
 Should dentist provide counselling? Should dentist provide NRT? 
 Disagree 
n (%) 
Neither/nor 
n (%) 
Agree 
n (%) 
X2 [df] P Disagree 
n (%) 
Neither/nor 
n (%) 
Agree 
n (%) 
X2 [df] P 
Younger 23 
(11.5%) 
51 
(25.5%) 
126 
(63.0%) 
1.04 [2] 0.59 
 
16 
(8.0%) 
58 
(29%) 
126 
(63.0%) 
0.94 [2] 
 
0.63 
 
Older 17 
(8.6%) 
55 
(27.8%) 
126 
(63.6%) 
16 
(8.1%) 
49 
(24.7%) 
133 
(67.2%) 
Male 18 
(11.6%) 
37 
(23.9%) 
100 
(64.5%) 
 
1.40 [2] 
 
0.50 
16 
(10.3%) 
37 
(23.9%) 
102 
(65.8%) 
 
2.52 [2] 
 
0.28 
Female 22 
(9.1%) 
69 
(28.4%) 
152 
(62.6%) 
16 
(6.6%) 
70 
(28.8%) 
157 
(64.6%) 
Occupation 1 9 
(9.2%) 
30 
(30.6%) 
59 
(60.2%) 
 
 
 
2.94 [6] 
 
 
 
0.82 
5 
(5.1%) 
28 
(28.6%) 
65 
(66.3%) 
 
 
 
11.13 
[6] 
 
 
 
0.08 
Occupation 2 10 
(11.4%) 
27 
(30.7%) 
51 
(58.0%) 
8 
(9.1%) 
31 
(35.2%) 
49 
(55.7%) 
Occupation 3 8 
(8.4%) 
22 
(23.2%) 
65 
(68.4%) 
10 
(10.5%) 
25 
(26.3%) 
60 
(63.2%) 
Occupation 4 6 
(11.5%) 
13 
(25.0%) 
33 
(63.5%) 
2 
(3.8%) 
8 
(15.4%) 
42 
(80.8%) 
Lochgilphead 30 
(10.0%) 
87 
(28.9%) 
184 
(61.1%) 
 
3.33 [2] 
 
0.19 
23 
(7.6%) 
83 
(27.6%) 
195 
(64.8%) 
 
0.48 [2] 
 
0.79 
Dunoon 10 
(10.3%) 
19 
(19.6%) 
68 
(70.1%) 
9 
(9.3%) 
24 
(24.7%) 
64 
(66.0%) 
Never smoker 13 
(7.0%) 
53 
(28.6%) 
119 
(64.3%) 
 
 
11.13 
[4] 
 
 
0.03 
15 
(8.1%) 
56 
(30.3%) 
114 
(61.6%) 
 
 
2.42 [4] 
 
 
0.66 Ex-smoker 13 
(10.9%) 
22 
(18.5%) 
84 
(70.6%) 
9 
(7.6%) 
27 
(22.7%) 
83 
(69.7%) 
Smoker 
 
14 
(15.1%) 
30 
(32.3%) 
49 
(52.7%) 
8 
(8.6%) 
24 
(25.8%) 
61 
(65.6%) 
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Appendix 23 
Table A9: Oral health-related quality of life by location 
 Location 
Mean difference (95% CI) 
F [df] P 
OHIP-1 0.23 (0.09 – 0.37) 3.34 [396] 0.001 
OHIP-2 0.26 (0.11 – 0.42) 3.35 [396] 0.001 
OHIP-3 0.47 (0.24 – 0.71) 3.95 [396] <0.001 
OHIP-4 0.51 (0.28 – 0.75) 4.25 [396] <0.001 
OHIP-5 0.73 (0.45 – 1.02) 5.05 [396] <0.001 
OHIP-6 0.35 (0.10 -0.60) 2.74 [396] 0.006 
OHIP-7 0.29 (0.13 – 0.45) 3.62 [396] <0.001 
OHIP-8 0.25 (0.08 – 0.42) 2.88 [396] 0.004 
OHIP-9 0.20 (0.00 – 0.39) 1.96 [396] 0.05 
OHIP-10 0.62 (0.36 – 0.88) 4.66 [396] <0.001 
OHIP-11 0.27 (0.09 – 0.45) 2.99 [396] 0.003 
OHIP-12 0.09  (0.04 – 0.22) 1.37 [396] 0.17 
OHIP-13 0.30 (0.11 – 0.49) 3.13 [396] 0.002 
OHIP-14 0.16 (0.02 – 0.30) 2.29 [396] 0.02 
*The suffixes show the significant differences in OHIP which existed between locations 
 
Appendix 24 
 
Table A10: Complexity of periodontal treatment needs by past experience of 
smoking cessation activity in a dental setting 
 Complexity of periodontal treatment 
need 
X2 [df] P 
 Complexity 1 
n (%) 
Complexity 2  
n (%) 
Complexity 3 
n (%) 
  
Have you been 
asked if you 
smoke by your 
dentist? 
27 (65.9) 29 (72.5) 8 (72.7) 0.48 [2] 0.79 
Has dentist offered 
smoking cessation 
advice? 
12 (29.3) 11 (27.5) 3 (27.3) 0.04 [2] 0.98 
Dentist offered to 
refer for smoking 
cessation? 
6 (14.6) 6 (15.0) 3 (27.3) 1.10 [2] 0.58 
Dentist given 
contact details for 
smoking 
cessation? 
9 (22.0) 5 (12.5) 2 (18.2) 1.26 [2] 0.53 
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Appendix 25 
 
Table A11: Complexity of periodontal treatment needs reason for last dental 
attendance 
Reason for 
attendance 
Complexity of periodontal treatment 
needs 
X2 [df] P 
 Complexity 
1 
n (%) 
Complexity 
2  
n (%) 
Complexity 
3 
n (%) 
  
Examination 201 
(60.7) 
18 
(37.5) 
7 
(36.8) 
 
 
15.40 [4] 
 
 
0.01 Oral problems 
 
116 
(35.0) 
26 
(54.2) 
9 
(47.4) 
Other 
 
14 
(4.2) 
4 
(8.3) 
3 
(15.8) 
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Table A12: Complexity of periodontal treatment needs by use of interdental aids 
 Complexity of periodontal 
treatment needs 
X2 [df] P 
 Complexity 
1 
n (%) 
Complexity 
2  
n (%) 
Complexity 
3 
n (%) 
  
Use of interdental 
aids 
174 
(52.6) 
24 
(50.0) 
10 
(52.6) 
0.11 [2] 0.95 
 
 
 
 
 
